Sentence,class,file
Protein Eng 1994; 7:1027-33; PMID:7809029; http://dx.doi.org/ 10.1093/protein/7.8.1027 15.,OADS,/arxiv_data1/oa_pdf/68/5e/kmab-09-01-1236165.PMC5240648.pdf
ThrombHaemost 2009; 101:1012-9; PMID:19492141; http://dx.doi.org/ 10.1160/TH08-12-0816 16.,Non-OADS,/arxiv_data1/oa_pdf/68/5e/kmab-09-01-1236165.PMC5240648.pdf
Mol Immunol 2015; 67:95-106; PMID:25637431; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/68/5e/kmab-09-01-1236165.PMC5240648.pdf
Anal Chem 2013; 85:4805-12; PMID:23581628; http://dx.doi.org/10.1021/ac400596g 19.,OADS,/arxiv_data1/oa_pdf/68/5e/kmab-09-01-1236165.PMC5240648.pdf
Protein Eng Des Sel 2012; 25:551-9; PMID:22936109; http://dx.doi.org/10.1093/protein/gzs048 20.,OADS,/arxiv_data1/oa_pdf/68/5e/kmab-09-01-1236165.PMC5240648.pdf
Int J Mol Sci 2015; 16:27497-507; PMID:26593903; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/68/5e/kmab-09-01-1236165.PMC5240648.pdf
mAbs 2014; 6:904-14; PMID:24927272; http://dx.doi.org/10.4161/mabs.28763 22.,OADS,/arxiv_data1/oa_pdf/68/5e/kmab-09-01-1236165.PMC5240648.pdf
mAbs 2014; 6:728-39; PMID:24670809; http://dx.doi.org/10.4161/ mabs.28591 23.,Non-OADS,/arxiv_data1/oa_pdf/68/5e/kmab-09-01-1236165.PMC5240648.pdf
mAbs 2015; 7:584-604;PMID:25875246; http://dx.doi.org/10.1080/19420862.2015.1029216 24.,Non-OADS,/arxiv_data1/oa_pdf/68/5e/kmab-09-01-1236165.PMC5240648.pdf
Clin J Oncol Nurs 2016;20:165-8; PMID:26991709; http://dx.doi.org/10.1188/16.CJON.165-168 26.,Non-OADS,/arxiv_data1/oa_pdf/68/5e/kmab-09-01-1236165.PMC5240648.pdf
J Immunother 2005; 28:245-51; PMID:15838381; http://dx.doi.org/10.1097/01.cji.0000161396.96582.10 27.,Non-OADS,/arxiv_data1/oa_pdf/68/5e/kmab-09-01-1236165.PMC5240648.pdf
Thromb Haemost 2008; 99:659-67; PMID:18392323; http://dx.doi.org/10.1160/TH07-08-0525 28.,Non-OADS,/arxiv_data1/oa_pdf/68/5e/kmab-09-01-1236165.PMC5240648.pdf
mAbs 2014; 6:327-39; PMID:24441081; http://dx.doi.org/10.4161/mabs.27876 30.,Non-OADS,/arxiv_data1/oa_pdf/68/5e/kmab-09-01-1236165.PMC5240648.pdf
2016 Aug-Sep;8(6):1079-87; PMID:27216574; http://dx.doi.org/10.1080/19420862.,Non-OADS,/arxiv_data1/oa_pdf/68/5e/kmab-09-01-1236165.PMC5240648.pdf
J Pharm Sci 2013; 102:3920- 4; PMID:24105735; http://dx.doi.org/10.1002/jps.23733 32.,Non-OADS,/arxiv_data1/oa_pdf/68/5e/kmab-09-01-1236165.PMC5240648.pdf
Protein Sci 2013; 22:1739-53;PMID:24115046; http://dx.doi.org/10.1002/pro.2373 33.,OADS,/arxiv_data1/oa_pdf/68/5e/kmab-09-01-1236165.PMC5240648.pdf
Mol CellProteomics 2006; 5:172-81; PMID:16204703; http://dx.doi.org/ 10.1074/mcp.M500135-MCP200 34.,OADS,/arxiv_data1/oa_pdf/68/5e/kmab-09-01-1236165.PMC5240648.pdf
J Am Soc Mass Spectrom 1998; 9:1175-88;PMID:9794085; http://dx.doi.org/10.1016/S1044-0305(98)00088-9 35.,OADS,/arxiv_data1/oa_pdf/68/5e/kmab-09-01-1236165.PMC5240648.pdf
J Am Soc Mass Spectrom 2014; 25:141-8;PMID:24249041; http://dx.doi.org/10.1007/s13361-013-0744-4 36.,OADS,/arxiv_data1/oa_pdf/68/5e/kmab-09-01-1236165.PMC5240648.pdf
Fragmentation of phosphopeptides by atmospheric pressure MALDI and ESI/Ion trap mass spectrometry.J Am Soc Mass Spectrom 2002; 13:274-83; PMID:11908807; http://dx.doi.org/10.1016/S1044-0305(01)00361-0 37.,OADS,/arxiv_data1/oa_pdf/68/5e/kmab-09-01-1236165.PMC5240648.pdf
J Proteome Res 2013; 12:1520-5; PMID:23347405; http://dx.doi.org/10.1021/pr301130k 38.,OADS,/arxiv_data1/oa_pdf/68/5e/kmab-09-01-1236165.PMC5240648.pdf
"), The Enzymes, 3rd ed, Academic Press New York London 1971:417-47; http://dx.doi.org/10.1016/S1874-6047(08)60378-9 39.",Non-OADS,/arxiv_data1/oa_pdf/68/5e/kmab-09-01-1236165.PMC5240648.pdf
Biochem J 1955; 61:232-40; PMID:13260203; http://dx.doi.org/10.1042/bj0610232 40.,Non-OADS,/arxiv_data1/oa_pdf/68/5e/kmab-09-01-1236165.PMC5240648.pdf
Biochem J 1955; 61:240-4; PMID:13260204; http://dx.doi.org/10.1042/bj0610240 41.,Non-OADS,/arxiv_data1/oa_pdf/68/5e/kmab-09-01-1236165.PMC5240648.pdf
Curr Opin Chem Biol 2001; 5:591-602; PMID:11578935; http://dx.doi.org/10.1016/S1367-5931(00)00250-7 42.,OADS,/arxiv_data1/oa_pdf/68/5e/kmab-09-01-1236165.PMC5240648.pdf
Mol Cell Proteomics 2007; 6:1942-51; PMID:17673454; http://dx.doi.org/ 10.1074/mcp.M700073-MCP200 43.,OADS,/arxiv_data1/oa_pdf/68/5e/kmab-09-01-1236165.PMC5240648.pdf
Science 2002; 298:1912- 34; PMID:12471243; http://dx.do i.org/10.1126/science.1075762 45.,OADS,/arxiv_data1/oa_pdf/68/5e/kmab-09-01-1236165.PMC5240648.pdf
Trends Biochem Sci 2002; 27:514-20; PMID:12368087; http://dx.doi.org/10.1016/S0968-0004 (02)02179-5 46.,OADS,/arxiv_data1/oa_pdf/68/5e/kmab-09-01-1236165.PMC5240648.pdf
Nat Rev Mol Cell Biol 2007; 8:530-41; PMID:17585314; http://dx.doi.org/10.1038/nrm2203 47.,OADS,/arxiv_data1/oa_pdf/68/5e/kmab-09-01-1236165.PMC5240648.pdf
Science 2003; 300:445-52; PMID:12702867;http://dx.doi.org/10.1126/science.1083653 49.,Non-OADS,/arxiv_data1/oa_pdf/68/5e/kmab-09-01-1236165.PMC5240648.pdf
Proteomics 2004; 4:1633-49;PMID:15174133; http://dx.doi.org/10.1002/pmic.200300771 50.,OADS,/arxiv_data1/oa_pdf/68/5e/kmab-09-01-1236165.PMC5240648.pdf
Mol Cell Proteo- mics 2008; 7:1598-608; PMID:18463090; http://dx.doi.org/10.1074/mcp.M700574-MCP200MABS 103,Non-OADS,/arxiv_data1/oa_pdf/68/5e/kmab-09-01-1236165.PMC5240648.pdf
"1, 43 –57 http://dx.doi.org/10.1080/19420862.2016.1236882",Non-OADS,/arxiv_data1/oa_pdf/5d/3c/kmab-09-01-1236882.PMC5240650.pdf
Curr Opin Immunol 2016; 41: 62-7; PMID:27343848; http://dx.doi.org/ 10.1016/j.coi.2016.06.001 2.,OADS,/arxiv_data1/oa_pdf/5d/3c/kmab-09-01-1236882.PMC5240650.pdf
J Comput Aided Mol Des 2014; 28: 765-78; PMID:24958623; http://dx.doi.org/10.1007/s10822-014-9758-7 3.,OADS,/arxiv_data1/oa_pdf/5d/3c/kmab-09-01-1236882.PMC5240650.pdf
Nat Biotechnol 2002; 20: 597-601; PMID:12042864; http://dx.doi.org/10.1038/nbt0602-597 4.,Non-OADS,/arxiv_data1/oa_pdf/5d/3c/kmab-09-01-1236882.PMC5240650.pdf
J Immunol 2004; 172: 6221-8; PMID:15128810;http://dx.doi.org/10.4049/jimmunol.172.10.6221 5.,Non-OADS,/arxiv_data1/oa_pdf/5d/3c/kmab-09-01-1236882.PMC5240650.pdf
PLoS Pathog 2007; 3: e9-; PMID:17238286; http://dx.doi.org/10.1371/journal.ppat.0030009 6.,Non-OADS,/arxiv_data1/oa_pdf/5d/3c/kmab-09-01-1236882.PMC5240650.pdf
"Sci Rep 2014; 4: 6881-; PMID:25375093; http://dx.doi.org/10.1038/srep06881 7.“HHS Select Agents and Toxins, ”42 C.F.R.",Non-OADS,/arxiv_data1/oa_pdf/5d/3c/kmab-09-01-1236882.PMC5240650.pdf
PLoS One 2011; 6: e17883-; PMID:21455295; http://dx.doi.org/10.1371/journal.pone.0017883 9.,Non-OADS,/arxiv_data1/oa_pdf/5d/3c/kmab-09-01-1236882.PMC5240650.pdf
Cell 2010; 141:231-42; PMID:20403321; http://dx.doi.org/10.1016/j.cell.2010.01.043 10.,OADS,/arxiv_data1/oa_pdf/5d/3c/kmab-09-01-1236882.PMC5240650.pdf
J Mol Biol 1991; 221: 193-207;PMID:1920404; http://dx.doi.org/10.1016/0022-2836(91)80214-F 11.,OADS,/arxiv_data1/oa_pdf/5d/3c/kmab-09-01-1236882.PMC5240650.pdf
Eur J Biochem 1975; 60: 281-8;PMID:1204642; http://dx.doi.org/10.1111/j.1432-1033.1975.tb21001.x 12.,Non-OADS,/arxiv_data1/oa_pdf/5d/3c/kmab-09-01-1236882.PMC5240650.pdf
JAMA 2005; 294: 2342-51; PMID:16278363; http://dx.doi.org/10.1001/jama.294.18.2342 13.,Non-OADS,/arxiv_data1/oa_pdf/5d/3c/kmab-09-01-1236882.PMC5240650.pdf
Int J Med Microbiol 2002; 291: 517-21; PMID:11890552; http://dx.doi.org/10.1078/1438-4221- 00161MABS 55,Non-OADS,/arxiv_data1/oa_pdf/5d/3c/kmab-09-01-1236882.PMC5240650.pdf
Toxicon 2013; 69: 143-51; PMID:23454625; http://dx.doi.org/10.1016/j.toxicon.2013.02.001 16.,OADS,/arxiv_data1/oa_pdf/5d/3c/kmab-09-01-1236882.PMC5240650.pdf
Toxins (Basel) 2015; 7: 49-65; PMID:25584427; http://dx.doi.org/10.3390/toxins7010049 17.,Non-OADS,/arxiv_data1/oa_pdf/5d/3c/kmab-09-01-1236882.PMC5240650.pdf
FEBS Lett 1999; 459: 80-4; PMID:10508921; http://dx.doi.org/10.1016/S0014-5793(99)01222-3 18.,OADS,/arxiv_data1/oa_pdf/5d/3c/kmab-09-01-1236882.PMC5240650.pdf
Toxins (Basel) 2015; 7: 49-65; PMID:25584427; http://dx.doi.org/10.3390/toxins7010049 19.,Non-OADS,/arxiv_data1/oa_pdf/5d/3c/kmab-09-01-1236882.PMC5240650.pdf
Vaccine 2015; 33: 7299-306; PMID:26546259; http://dx.doi.org/10.1016/j.vaccine.2015.10.094 21.,Non-OADS,/arxiv_data1/oa_pdf/5d/3c/kmab-09-01-1236882.PMC5240650.pdf
Toxins (Basel) 2013; 5: 224-48; PMID:23364220; http://dx.doi.org/10.3390/toxins5020224 22.,Non-OADS,/arxiv_data1/oa_pdf/5d/3c/kmab-09-01-1236882.PMC5240650.pdf
J Mol Biol 2014; 426: 3057-68; PMID:24907552; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/5d/3c/kmab-09-01-1236882.PMC5240650.pdf
Mol Biol Cell 2010; 21: 2543-54;PMID:20519439; http://dx.doi.org/10.1091/mbc.E09-08-0743 24.,Non-OADS,/arxiv_data1/oa_pdf/5d/3c/kmab-09-01-1236882.PMC5240650.pdf
J Biotechnol 2004; 113: 105-20; PMID:15380651; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5d/3c/kmab-09-01-1236882.PMC5240650.pdf
Biomol Eng 2005; 22: 21-30; PMID:15857780; http://dx.doi.org/10.1016/j.bioeng.2004.12.003 26.,OADS,/arxiv_data1/oa_pdf/5d/3c/kmab-09-01-1236882.PMC5240650.pdf
J Biol Chem 1997; 272: 11152-6; PMID:9111013; http://dx.doi.org/10.1074/jbc.272.17.11152 27.,OADS,/arxiv_data1/oa_pdf/5d/3c/kmab-09-01-1236882.PMC5240650.pdf
J Biol Chem 1998; 273: 35074-7; PMID:9857041; http://dx.doi.org/10.1074/jbc.273.52.35074 28.,OADS,/arxiv_data1/oa_pdf/5d/3c/kmab-09-01-1236882.PMC5240650.pdf
J Biol Chem 2000; 275: 9263-9; PMID:10734065; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5d/3c/kmab-09-01-1236882.PMC5240650.pdf
Proteins 2011; 79: 1048-60; PMID:21387408; http://dx.doi.org/10.1002/prot.22933 31.,Non-OADS,/arxiv_data1/oa_pdf/5d/3c/kmab-09-01-1236882.PMC5240650.pdf
PLoS ONE 2014; 9: e115405-; PMID:25526640; http://dx.doi.org/10.1371/journal.pone.011540532.,Non-OADS,/arxiv_data1/oa_pdf/5d/3c/kmab-09-01-1236882.PMC5240650.pdf
Anal Chem 2008; 80:9604-11; PMID:19072267; http://dx.doi.org/10.1021/ac8019398 34.,Non-OADS,/arxiv_data1/oa_pdf/5d/3c/kmab-09-01-1236882.PMC5240650.pdf
Sensors (Basel) 2009; 9: 542-55; PMID:22389616; http://dx.doi.org/10.3390/s90100542 35.,Non-OADS,/arxiv_data1/oa_pdf/5d/3c/kmab-09-01-1236882.PMC5240650.pdf
2015; 6: 27-35; http://dx.doi.org/10.1016/j.btre.2015.01.001 36.,OADS,/arxiv_data1/oa_pdf/5d/3c/kmab-09-01-1236882.PMC5240650.pdf
Toxicon 2012; 60: 874-7; PMID:22750533; http://dx.doi.org/10.1016/j.toxicon.2012.06.014 37.,OADS,/arxiv_data1/oa_pdf/5d/3c/kmab-09-01-1236882.PMC5240650.pdf
Pro- tein Eng Des Sel 2004; 17: 391-397; PMID:15187223; http://dx.doi.org/10.1093/protein/gzh043 38.,OADS,/arxiv_data1/oa_pdf/5d/3c/kmab-09-01-1236882.PMC5240650.pdf
2009; http://dx.doi.org/10.2210/pdb1J1M/pdb 39.,Non-OADS,/arxiv_data1/oa_pdf/5d/3c/kmab-09-01-1236882.PMC5240650.pdf
Proteins 2014; PMID:25136772; http://dx.doi.org/10.1002/prot.24671 40.,OADS,/arxiv_data1/oa_pdf/5d/3c/kmab-09-01-1236882.PMC5240650.pdf
Acta Crystallogr D Biol Crys- tallogr 2011; 67: 826-30; PMID:21904036; http://dx.doi.org/10.1107/ S0907444911026771 41.,OADS,/arxiv_data1/oa_pdf/5d/3c/kmab-09-01-1236882.PMC5240650.pdf
PLoS ONE2013; 8: e62417-; PMID:23638075; http://dx.doi.org/10.1371/journal.pone.0062417 42.,Non-OADS,/arxiv_data1/oa_pdf/5d/3c/kmab-09-01-1236882.PMC5240650.pdf
Toxins (Basel) 2014;6: 1512-25; PMID:24811206; http://dx.doi.org/10.3390/toxins6051512 43.,Non-OADS,/arxiv_data1/oa_pdf/5d/3c/kmab-09-01-1236882.PMC5240650.pdf
Hybridoma 1986; 5: 9-19; PMID:3957360; http://dx.doi.org/10.1089/hyb.1986.5.9 44.,OADS,/arxiv_data1/oa_pdf/5d/3c/kmab-09-01-1236882.PMC5240650.pdf
Toxins (Basel) 2014; 6: 1512-25; PMID:24811206; http://dx.doi.org/10.3390/toxins6051512 45.,Non-OADS,/arxiv_data1/oa_pdf/5d/3c/kmab-09-01-1236882.PMC5240650.pdf
MAbs 2014; 6: 1274-82; PMID:25517312; http://dx.doi.org/10.4161/mabs.29680 46.,Non-OADS,/arxiv_data1/oa_pdf/5d/3c/kmab-09-01-1236882.PMC5240650.pdf
Protein Eng Des Sel 2013; 26: 151-64;PMID:23173178; http://dx.doi.org/10.1093/protein/gzs090 47.,OADS,/arxiv_data1/oa_pdf/5d/3c/kmab-09-01-1236882.PMC5240650.pdf
Toxins (Basel) 2011; 3: 787-801; PMID:22069740; http://dx.doi.org/ 10.3390/toxins3070787 48.,Non-OADS,/arxiv_data1/oa_pdf/5d/3c/kmab-09-01-1236882.PMC5240650.pdf
Traf ﬁc 2011; 12: 939-47; PMID:21477175; http://dx.doi.org/10.1111/j.1600-0854.2011.01185.x 49.,Non-OADS,/arxiv_data1/oa_pdf/5d/3c/kmab-09-01-1236882.PMC5240650.pdf
BMC Struct Biol 2007; 7: 72-; PMID:17986339; http://dx.doi.org/10.1186/1472-6807-7-72 5 0 .,Non-OADS,/arxiv_data1/oa_pdf/5d/3c/kmab-09-01-1236882.PMC5240650.pdf
J Mol Biol 1997; 266: 1043-9; PMID:9086280; http://dx.doi.org/10.1006/jmbi.1996.086556 P. M. LEGLER ET AL.,OADS,/arxiv_data1/oa_pdf/5d/3c/kmab-09-01-1236882.PMC5240650.pdf
Biochim Biophys Acta 2013; 1834: 2147-57; PMID:23911607; http://dx.doi.org/10.1016/j.bbapap.2013.07.010 52.,OADS,/arxiv_data1/oa_pdf/5d/3c/kmab-09-01-1236882.PMC5240650.pdf
J Virol 2014; 88: 14364-79; PMID:25275138; http://dx.doi.org/10.1128/JVI.01943-14 53.,Non-OADS,/arxiv_data1/oa_pdf/5d/3c/kmab-09-01-1236882.PMC5240650.pdf
J Virol 2014; 88: 9616-23; PMID:24920796; http://dx.doi.org/10.1128/JVI.01286-14 54.,Non-OADS,/arxiv_data1/oa_pdf/5d/3c/kmab-09-01-1236882.PMC5240650.pdf
J Virol 2012; 86: 1563-76;PMID:22130533; http://dx.doi.org/10.1128/JVI.06480-11 56.,Non-OADS,/arxiv_data1/oa_pdf/5d/3c/kmab-09-01-1236882.PMC5240650.pdf
Biotechnology Reports 2015; 6: 27-35; http://dx.doi.org/10.1016/j.btre.2015.01.001 57.,OADS,/arxiv_data1/oa_pdf/5d/3c/kmab-09-01-1236882.PMC5240650.pdf
J Biol Chem 2013; 288: 36538-47; PMID:24202178; http://dx.doi.org/10.1074/jbc.M113.519207 58.,OADS,/arxiv_data1/oa_pdf/5d/3c/kmab-09-01-1236882.PMC5240650.pdf
Isolation of a highlythermal stable lama single domain antibody speci ﬁc for Staphylococ- cus aureus enterotoxin B. BMC Biotechnol 2011; 11: 86-; PMID:21933444; http://dx.doi.org/10.1186/1472-6750-11-86 59.,Non-OADS,/arxiv_data1/oa_pdf/5d/3c/kmab-09-01-1236882.PMC5240650.pdf
PLoS ONE 2013; 8: e77678-; PMID:24143255; http://dx.doi.org/10.1371/journal.pone.0077678 60.,Non-OADS,/arxiv_data1/oa_pdf/5d/3c/kmab-09-01-1236882.PMC5240650.pdf
"Pharmacol Toxicol 2001; 88: 255-60; PMID:11393586; http://dx.doi.org/10.1111/j.1600-0773.2001.880506.x 61. van HT, van BJ, van Veelen PA, Kraakman M, Heukamp LC, Koning F, Melief CJ, Ossendorp F, Offringa R. Identi ﬁcation of a novel tumor-speci ﬁc CTL epitope presented by RMA, EL-4, and MBL-2 lymphomas reveals their common origin.",Non-OADS,/arxiv_data1/oa_pdf/5d/3c/kmab-09-01-1236882.PMC5240650.pdf
J Immunol 2000; 165: 869-77; PMID:10878361; http://dx.doi.org/10.4049/jimmunol.165.2.869 62.,Non-OADS,/arxiv_data1/oa_pdf/5d/3c/kmab-09-01-1236882.PMC5240650.pdf
J Appl Crystallogr 2007; 40: 658-74; PMID:19461840; http://dx.doi.org/10.1107/S002188980702120663.,OADS,/arxiv_data1/oa_pdf/5d/3c/kmab-09-01-1236882.PMC5240650.pdf
Acta Crystallogr D Biol Crystallogr 2004; 60: 2126-32;PMID:15572765; http://dx.doi.org/10.1107/S0907444904019158 64.,OADS,/arxiv_data1/oa_pdf/5d/3c/kmab-09-01-1236882.PMC5240650.pdf
Acta Crystallogr D Biol Crystallogr 2010; 66: 486-501; PMID:20383002; http://dx.doi.org/10.1107/S0907444910007493 65.,OADS,/arxiv_data1/oa_pdf/5d/3c/kmab-09-01-1236882.PMC5240650.pdf
Acta Crystallogr D Biol Crys-tallogr 1998; 54: 905-21; PMID:9757107; http://dx.doi.org/10.1107/ S0907444998003254 66.,OADS,/arxiv_data1/oa_pdf/5d/3c/kmab-09-01-1236882.PMC5240650.pdf
Acta Crystallogr D Biol Crys-tallogr 1994; 50: 760-3; PMID:15299374; http://dx.doi.org/10.1107/ S0907444994003112 67.,OADS,/arxiv_data1/oa_pdf/5d/3c/kmab-09-01-1236882.PMC5240650.pdf
Acta Crystallogr DBiol Crystallogr 2006; 62: 439-50; PMID:16552146; http://dx.doi.org/ 10.1107/S0907444906005270 68.,OADS,/arxiv_data1/oa_pdf/5d/3c/kmab-09-01-1236882.PMC5240650.pdf
Anal Chem 2012; 84: 5198-5203; PMID:22681495; http://dx.doi.org/10.1021/ac300864j 69.,OADS,/arxiv_data1/oa_pdf/5d/3c/kmab-09-01-1236882.PMC5240650.pdf
Crystallographic re ﬁnement of ricin to 2.5 A. Pro- teins 1991; 10: 240-250; PMID:1881880; http://dx.doi.org/10.1002/ prot.340100308 70.,OADS,/arxiv_data1/oa_pdf/5d/3c/kmab-09-01-1236882.PMC5240650.pdf
Acta Crystallogr D Biol Crys- tallogr 2011; 67: 826-30; PMID:21904036; http://dx.doi.org/10.1107/ S0907444911026771 71.,OADS,/arxiv_data1/oa_pdf/5d/3c/kmab-09-01-1236882.PMC5240650.pdf
Hybridoma 1994; 13: 417-21; PMID:7860097; http://dx.doi.org/10.1089/hyb.1994.13.417 72.,OADS,/arxiv_data1/oa_pdf/5d/3c/kmab-09-01-1236882.PMC5240650.pdf
Clin Exp Immunol 2004; 136: 365-72; PMID:15086403; http://dx.doi.org/10.1111/j.1365- 2249.2004.02442.x 74.,Non-OADS,/arxiv_data1/oa_pdf/5d/3c/kmab-09-01-1236882.PMC5240650.pdf
Int Immunol 2005; 17: 365-72; PMID:15724064; http://dx.doi.org/ 10.1093/intimm/dxh216MABS 57,Non-OADS,/arxiv_data1/oa_pdf/5d/3c/kmab-09-01-1236882.PMC5240650.pdf
"1, 29 –42 http://dx.doi.org/10.1080/19420862.2016.1246096",Non-OADS,/arxiv_data1/oa_pdf/e1/fa/kmab-09-01-1246096.PMC5240653.pdf
ORCID Patricia Estep http://orcid.org/0000-0003-3055-4074 Rebecca Hurley Niles http://orcid.org/0000-0001-8568-3047 References 1.,Non-OADS,/arxiv_data1/oa_pdf/e1/fa/kmab-09-01-1246096.PMC5240653.pdf
MAbs 2016; 8:197-204; PMID:26651519; http://dx.doi.org/10.1080/19420862.2015.1125583 2.,OADS,/arxiv_data1/oa_pdf/e1/fa/kmab-09-01-1246096.PMC5240653.pdf
Sci Transl Med 2016; 8:324ra14;PMID:26843189; http://dx.doi.org/10.1126/scitranslmed.aad5640 3.,OADS,/arxiv_data1/oa_pdf/e1/fa/kmab-09-01-1246096.PMC5240653.pdf
MAbs 2016; 8:617-52; PMID:26909869; http://dx.doi.org/10.1080/19420862.2016.1153211 4.,OADS,/arxiv_data1/oa_pdf/e1/fa/kmab-09-01-1246096.PMC5240653.pdf
MAbs 2016; 8:264-77; PMID:26652308; http://dx.doi.org/ 10.1080/19420862.2015.1118596 5.,OADS,/arxiv_data1/oa_pdf/e1/fa/kmab-09-01-1246096.PMC5240653.pdf
Int Immunol 2014; 26:649-57; PMID:25135889; http://dx.doi.org/10.1093/intimm/dxu082 6.,Non-OADS,/arxiv_data1/oa_pdf/e1/fa/kmab-09-01-1246096.PMC5240653.pdf
Expert Opin Biol Ther 2007; 7:73-87; PMID:17150020; http://dx.doi.org/10.1517/14712598.7.1.73 7.,Non-OADS,/arxiv_data1/oa_pdf/e1/fa/kmab-09-01-1246096.PMC5240653.pdf
"Five birds, one stone: neu- tralization of alpha-hemolysin and 4 bi-component leukocidins of Staphylococcus aureus with a single human monoclonal antibody.MAbs 2015; 7:243-54; PMID:25523282; http://dx.doi.org/10.4161/19420862.2014.985132 9.",Non-OADS,/arxiv_data1/oa_pdf/e1/fa/kmab-09-01-1246096.PMC5240653.pdf
Protein Eng Des Sel 2013; 26:663-70; PMID:24046438; http://dx.do i.org/10.1093/protein/gzt047 10.,OADS,/arxiv_data1/oa_pdf/e1/fa/kmab-09-01-1246096.PMC5240653.pdf
J Biomol Screen 2016; 21:88-95; PMID:26442912; http://dx.doi.org/10.1177/1087057115609564 11.,OADS,/arxiv_data1/oa_pdf/e1/fa/kmab-09-01-1246096.PMC5240653.pdf
Dev Comp Immunol 2003; 27:55-77; PMID:12477501; http://dx.doi.org/10.1016/S0145-305X(02)00039-3 12.,Non-OADS,/arxiv_data1/oa_pdf/e1/fa/kmab-09-01-1246096.PMC5240653.pdf
MAbs 2015; 7:770-7; PMID:26047159; http://dx.doi.org/ 10.1080/19420862.2015.1043503 13.,OADS,/arxiv_data1/oa_pdf/e1/fa/kmab-09-01-1246096.PMC5240653.pdf
Nucleic Acids Res 2000; 28:235-42; PMID:10592235; http://dx.doi.org/10.1093/nar/ 28.1.235 14.,OADS,/arxiv_data1/oa_pdf/e1/fa/kmab-09-01-1246096.PMC5240653.pdf
J Mol Biol 2001; 313:473-8; PMID:11676532; http://dx.doi.org/10.1006/jmbi.2001.5075 16.,Non-OADS,/arxiv_data1/oa_pdf/e1/fa/kmab-09-01-1246096.PMC5240653.pdf
J Mol Biol 2010; 402:217-29; PMID:20654626; http://dx.doi.org/10.1016/j.jmb.2010.07.027 1 9 .,OADS,/arxiv_data1/oa_pdf/e1/fa/kmab-09-01-1246096.PMC5240653.pdf
Anal Biochem 2008; 383:52-60; PMID:18782554; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/e1/fa/kmab-09-01-1246096.PMC5240653.pdf
J Mol Recognit 1999; 12:279-84; PMID:10556875; http://dx.doi.org/10.1002/(SICI)1099- 1352(199909/10)12:5%3c279::AID-JMR473%3e3.0.CO;2-342 A. SIVASUBRAMANIAN ET AL.,OADS,/arxiv_data1/oa_pdf/e1/fa/kmab-09-01-1246096.PMC5240653.pdf
"1, 68 –84 http://dx.doi.org/10.1080/19420862.2016.1248012",Non-OADS,/arxiv_data1/oa_pdf/41/13/kmab-09-01-1248012.PMC5240654.pdf
ncbi.nlm.nih.gov/pubmed/24463572 ; PMID:24463572; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/41/13/kmab-09-01-1248012.PMC5240654.pdf
Available from: http://www.jbc.,Non-OADS,/arxiv_data1/oa_pdf/41/13/kmab-09-01-1248012.PMC5240654.pdf
org/content/290/12/7535.abstract ; PMID:25583986; http://dx.doi.org/ 10.1074/jbc.M114.620260 4 .,OADS,/arxiv_data1/oa_pdf/41/13/kmab-09-01-1248012.PMC5240654.pdf
Available from: http://dx.doi.org/ 10.1016/j.molimm.2015.01.003; PMID:25637431; http://dx.doi.org/ 10.1016/j.molimm.2015.01.003 7.,OADS,/arxiv_data1/oa_pdf/41/13/kmab-09-01-1248012.PMC5240654.pdf
Available from: http://www.ncbi.nlm.nih.gov/ pubmed/24994770 ; PMID:24994770; http://dx.doi.org/10.1158/1535- 7163.MCT-14-0046-T 8.,OADS,/arxiv_data1/oa_pdf/41/13/kmab-09-01-1248012.PMC5240654.pdf
Available from: http://www.pubmedcentr al.nih.gov/articleren der.fcgi?artid D3039382&tool Dpmcentrez&rendertype Dabstract ; PMID: 21123183; http://dx.doi.org/10.1074/jbc.M110.184317 9.,OADS,/arxiv_data1/oa_pdf/41/13/kmab-09-01-1248012.PMC5240654.pdf
Structure 2013; 21:1979-91; PMID:24095059; http://dx.doi.org/10.1016/j.str.2013.08.020 10.,OADS,/arxiv_data1/oa_pdf/41/13/kmab-09-01-1248012.PMC5240654.pdf
J Biol Chem 2002; 277:35035-43;PMID:12119302; http://dx.doi.org/10.1074/jbc.M205854200 11.,OADS,/arxiv_data1/oa_pdf/41/13/kmab-09-01-1248012.PMC5240654.pdf
Sci Transl Med 2011; 3:84ra44; PMID:21613623; http://dx.doi.org/10.1126/ scitranslmed.3002230 12.,Non-OADS,/arxiv_data1/oa_pdf/41/13/kmab-09-01-1248012.PMC5240654.pdf
Available from:http://dx.doi.org/10.1038/npp.2011.196; PMID:22157868; http://dx.,OADS,/arxiv_data1/oa_pdf/41/13/kmab-09-01-1248012.PMC5240654.pdf
ncbi.nlm.nih.gov/pubmed/25378646\nhttp://stm.sciencemag.org/content/6/261/261ra154.full.pdf ; PMID:25378646; http://dx.doi.org/ 10.1126/scitranslmed.3009835 14.,OADS,/arxiv_data1/oa_pdf/41/13/kmab-09-01-1248012.PMC5240654.pdf
Available from: http://www.ncbi.nlm.,Non-OADS,/arxiv_data1/oa_pdf/41/13/kmab-09-01-1248012.PMC5240654.pdf
nih.gov/pubmed/12707361 ; PMID:12707361; http://dx.doi.org/ 10.4049/jimmunol.170.9.4793 15.,Non-OADS,/arxiv_data1/oa_pdf/41/13/kmab-09-01-1248012.PMC5240654.pdf
J Clin Oncol 2011; 29:2493-8; PMID:21576633; http://dx.doi.org/10.1200/JCO.2010.32.727016.,Non-OADS,/arxiv_data1/oa_pdf/41/13/kmab-09-01-1248012.PMC5240654.pdf
MAbs 2010; 2:129-36; PMID:20190561; http://dx.doi.org/10.4161/mabs.2.2.11221 17.,Non-OADS,/arxiv_data1/oa_pdf/41/13/kmab-09-01-1248012.PMC5240654.pdf
Mol Immunol 2015; 67:95-106; PMID:25637431; http://dx.doi.org/10.1016/j.molimm.2015.01.003 18.,Non-OADS,/arxiv_data1/oa_pdf/41/13/kmab-09-01-1248012.PMC5240654.pdf
Protein Eng Des Sel 2012; 25:551-9; PMID:22936109; http://dx.doi.org/10.1093/protein/gzs048 19.,OADS,/arxiv_data1/oa_pdf/41/13/kmab-09-01-1248012.PMC5240654.pdf
MAbs 2011; 3:21-30; PMID:21081841; http://dx.doi.org/10.4161/mabs.3.1.14057 20.,Non-OADS,/arxiv_data1/oa_pdf/41/13/kmab-09-01-1248012.PMC5240654.pdf
Br J Haematol 2010; 150:574-86; PMID:20636437;http://dx.doi.org/10.1111/j.1365-2141.2010.08300.x 21.,Non-OADS,/arxiv_data1/oa_pdf/41/13/kmab-09-01-1248012.PMC5240654.pdf
J Immunol 2000; 165:7050-7; PMID:11120833; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/41/13/kmab-09-01-1248012.PMC5240654.pdf
Available from: http://www.ncbi.nlm.,Non-OADS,/arxiv_data1/oa_pdf/41/13/kmab-09-01-1248012.PMC5240654.pdf
nih.gov/pubmed/26496429 ; PMID:26496429; http://dx.doi.org/ 10.1080/19420862.2015.1111497 23.,OADS,/arxiv_data1/oa_pdf/41/13/kmab-09-01-1248012.PMC5240654.pdf
Eur J Immunol 1995; 25:1492-6; PMID:7614975; http://dx.doi.org/10.1002/eji.1830250603 24.,Non-OADS,/arxiv_data1/oa_pdf/41/13/kmab-09-01-1248012.PMC5240654.pdf
"R €othlisberger D, Honegger A, Pl €uckthun A. Domain interactions in the Fab fragment: A comparative evaluation of the single-chain Fv and Fab format engineered with variable domains of different stability.J Mol Biol 2005; 347:773-89; PMID:15769469; http://dx.doi.org/10.1016/j.jmb.2005.01.053 25.",OADS,/arxiv_data1/oa_pdf/41/13/kmab-09-01-1248012.PMC5240654.pdf
Available from: http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/41/13/kmab-09-01-1248012.PMC5240654.pdf
febslet.2014.01.051; PMID:24530501; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/41/13/kmab-09-01-1248012.PMC5240654.pdf
Mol Cancer Ther 2012; 11:1467-76; PMID:22564724; http://dx.doi.org/10.1158/1535-7163.MCT-11-1038 27.,Non-OADS,/arxiv_data1/oa_pdf/41/13/kmab-09-01-1248012.PMC5240654.pdf
Cancer Biother Radiopharm 2009; 24:155-61; PMID:19409036; http://dx.doi.org/10.1089/cbr.2009.0627 28.,Non-OADS,/arxiv_data1/oa_pdf/41/13/kmab-09-01-1248012.PMC5240654.pdf
Protein Sci 1997; 6:781-8; PMID:9098887; http://dx.doi.org/10.1002/pro.5560060404 30.,Non-OADS,/arxiv_data1/oa_pdf/41/13/kmab-09-01-1248012.PMC5240654.pdf
Methods 2004; 34:184-99; PMID:15312672; http://dx.doi.org/ 10.1016/j.ymeth.2004.04.007 3 1 .,OADS,/arxiv_data1/oa_pdf/41/13/kmab-09-01-1248012.PMC5240654.pdf
J Mol Biol 2000; 296:57-86;PMID:10656818; http://dx.doi.org/10.1006/jmbi.1999.344482 T. J. EGAN ET AL.,OADS,/arxiv_data1/oa_pdf/41/13/kmab-09-01-1248012.PMC5240654.pdf
Biol.1993; 229:969-95; PMID:8095303; http://dx.doi.org/10.1006/jmbi.1993.1099 33.,OADS,/arxiv_data1/oa_pdf/41/13/kmab-09-01-1248012.PMC5240654.pdf
Available from: http://www.sciencedirect.,Non-OADS,/arxiv_data1/oa_pdf/41/13/kmab-09-01-1248012.PMC5240654.pdf
J BiolChem 2000; 275:13668-76; PMID:10788485; http://dx.doi.org/10.1074/jbc.275.18.13668 35.,Non-OADS,/arxiv_data1/oa_pdf/41/13/kmab-09-01-1248012.PMC5240654.pdf
PLoS One 2014; 9:1-11; PMID:24978027; http://dx.doi.org/10.1371/journal.pone.0101322 36.,OADS,/arxiv_data1/oa_pdf/41/13/kmab-09-01-1248012.PMC5240654.pdf
AAPS J 2006; 8:E501-7; PMID:17025268; http://dx.doi.org/ 10.1208/aapsj080359 40.,OADS,/arxiv_data1/oa_pdf/41/13/kmab-09-01-1248012.PMC5240654.pdf
J Biol Chem 2012; 287:25266-79; PMID:22584577; http://dx.doi.org/10.1074/jbc.M111.330902 41.,OADS,/arxiv_data1/oa_pdf/41/13/kmab-09-01-1248012.PMC5240654.pdf
Eur J Immunol 1992;22:3001-11; PMID:1425924; http://dx.doi.org/10.1002/eji.1830221136 42.,Non-OADS,/arxiv_data1/oa_pdf/41/13/kmab-09-01-1248012.PMC5240654.pdf
J Immunol Methods 2006; 316:133-43; PMID:17027850; http://dx.doi.org/10.1016/j.jim.2006.08.010 43.,Non-OADS,/arxiv_data1/oa_pdf/41/13/kmab-09-01-1248012.PMC5240654.pdf
Available from:http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid D281868& toolDpmcentrez&rendertype Dabstract ; PMID:3045807; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/41/13/kmab-09-01-1248012.PMC5240654.pdf
Pro-tein Eng Des Sel 2012; 25:485-505; PMID:22763265; http://dx.doi.org/ 10.1093/protein/gzs039 46.,OADS,/arxiv_data1/oa_pdf/41/13/kmab-09-01-1248012.PMC5240654.pdf
Nat Biotechnol 2007; 25:1290-7; PMID:17934452; http://dx.doi.org/10.1038/nbt1345 47.,Non-OADS,/arxiv_data1/oa_pdf/41/13/kmab-09-01-1248012.PMC5240654.pdf
Available from: http://dx.doi.org/10.1080/19420862.2016.1162932; PMID:26984268; http://dx.doi.org/ 10.1080/19420862.2016.1162932 4 8 .,Non-OADS,/arxiv_data1/oa_pdf/41/13/kmab-09-01-1248012.PMC5240654.pdf
Protein Eng Des Sel 2009; 22:121-34; PMID:19136675; http://dx.do i.org/10.1093/protein/gzn077 49.,OADS,/arxiv_data1/oa_pdf/41/13/kmab-09-01-1248012.PMC5240654.pdf
Available from: http://dx.doi.org/ 10.1016/j.drudis.2015.02.008; PMID:25728220; http://dx.doi.org/ 10.1016/j.drudis.2015.02.008 50.,OADS,/arxiv_data1/oa_pdf/41/13/kmab-09-01-1248012.PMC5240654.pdf
Blood 2011; 117:4542-51; PMID:21300981; http://dx.doi.org/10.1182/blood-2010-09-306449 53.,Non-OADS,/arxiv_data1/oa_pdf/41/13/kmab-09-01-1248012.PMC5240654.pdf
Available from: http://www.sci encedirect.com/science/article/pii/S002228369993156X ; PMID:10512714; http://dx.doi.org/10.1006/jmbi.1999.3156 54.,OADS,/arxiv_data1/oa_pdf/41/13/kmab-09-01-1248012.PMC5240654.pdf
Cancer Res 2015; 75:159-70; PMID:25371409;http://dx.doi.org/10.1158/0008-5472.CAN-14-1670 55.,Non-OADS,/arxiv_data1/oa_pdf/41/13/kmab-09-01-1248012.PMC5240654.pdf
In ﬂu- ence of molecular size on tissue distribution of antibody fragments.MAbs 2016; 8:113-9; PMID:26496429; http://dx.doi.org/10.1080/19420862.2015.1111497 56.,OADS,/arxiv_data1/oa_pdf/41/13/kmab-09-01-1248012.PMC5240654.pdf
FEBS Lett 2014;588:936-41; PMID:24530501; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/41/13/kmab-09-01-1248012.PMC5240654.pdf
MAbs 2013; 5:1-11; PMID:23254906; http://dx.doi.org/10.4161/mabs.23043 5 8 .,Non-OADS,/arxiv_data1/oa_pdf/41/13/kmab-09-01-1248012.PMC5240654.pdf
Available from: http://www.ncbi.nlm.nih.gov/pubmed/12498801\nhttp:// linkinghub.elsevier.co m/retrieve/pii/S0022283602012378 ; PMID:12498801; http://dx.doi.org/10.1016/S0022-2836(02)01237-8 59.,OADS,/arxiv_data1/oa_pdf/41/13/kmab-09-01-1248012.PMC5240654.pdf
Nat Biotechnol 1996; 14:303-8; PMID:9630890; http://dx.doi.org/10.1038/nbt0296-192 60.,Non-OADS,/arxiv_data1/oa_pdf/41/13/kmab-09-01-1248012.PMC5240654.pdf
Available from: http://www.pubmedcentral.nih.g ov/articlerender.fcgi?artid D46060 66&tool Dpmcentrez&rendertype Dabstract ; PMID:26528439; http://dx.,OADS,/arxiv_data1/oa_pdf/41/13/kmab-09-01-1248012.PMC5240654.pdf
Nat Biotechnol 1997; 15:159-63; PMID:9035142; http://dx.doi.org/10.1038/nbt0297-159 63.,Non-OADS,/arxiv_data1/oa_pdf/41/13/kmab-09-01-1248012.PMC5240654.pdf
Availablefrom: http://www.nature.com/doi ﬁnder/10.1038/nprot.2007.321 ; PMID:17853878; http://dx.doi.org/10.1038/nprot.2007.321 64.,OADS,/arxiv_data1/oa_pdf/41/13/kmab-09-01-1248012.PMC5240654.pdf
J Mol Biol 2001; 309:657-70; PMID:11397087; http://dx.doi.org/ 10.1006/jmbi.2001.466284 T. J. EGAN ET AL.,OADS,/arxiv_data1/oa_pdf/41/13/kmab-09-01-1248012.PMC5240654.pdf
e-mail: mtaki@vetmed.hokudai.ac.jp ©2016 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/cb/c5/jvms-77-1753.PMC5240750.pdf
e-mail: paranee.yat@mahidol.edu ©2016 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/60/b0/jvms-77-1759.PMC5240751.pdf
e-mail: seyama@mbox.kannousuiken-osaka.or.jp ©2016 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/ff/e4/jvms-77-1765.PMC5240752.pdf
e-mail: kurusu@vmas.kitasato-u.ac.jp ©2016 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/ff/b1/jvms-77-1771.PMC5240753.pdf
e-mail: makoto@obihiro.ac.jp ©2016 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/fe/a4/jvms-77-1779.PMC5240754.pdf
e-mail: fvetnit@ku.ac.th ©2016 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the creative  commons Attribution Non-commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/c7/6f/jvms-77-1785.PMC5240755.pdf
e-mail: imsk0049@korea.kr ©2016 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/02/65/jvms-77-1791.PMC5240756.pdf
Available  at:http://www.efsa.europa.eu/en/topics/topic/campylobacter.htm (accessed on 5 August 2014).,Non-OADS,/arxiv_data1/oa_pdf/02/65/jvms-77-1791.PMC5240756.pdf
Available at: http://www.foodsafetykorea.go.kr/portal/ healthyfoodlife/foodPoisoningStat.do (accessed on 30 Decem-ber 2015) (In Korean).,Non-OADS,/arxiv_data1/oa_pdf/02/65/jvms-77-1791.PMC5240756.pdf
Available at: http://www.fda.gov/AnimalVet-erinary/SafetyHealth/AntimicrobialResistance/National Antimi-crobialResistanceMonitoringSystem/ucm059103.htm (accessed  on 2 February 2015).,Non-OADS,/arxiv_data1/oa_pdf/02/65/jvms-77-1791.PMC5240756.pdf
"Critically Important Antimicro- bials for Human Medicine 3rd Revision, Available at: http://apps.who.int/iris/bitstream/10665/77376/1/9789241504485_eng.pdf (accessed on 2 February 2015).",Non-OADS,/arxiv_data1/oa_pdf/02/65/jvms-77-1791.PMC5240756.pdf
e-mail: hkitagawa@kobe-u.ac.jp ©2016 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/5a/b7/jvms-77-1797.PMC5240757.pdf
e-mail: heeyoon@snu.ac.kr ©2016 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/ca/6c/jvms-77-1805.PMC5240758.pdf
e-mail: whkim@snu.ac.kr ©2016 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/2a/26/jvms-77-1811.PMC5240759.pdf
e-mail: ircpmi@obihiro.ac.jp ©2016 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/99/d7/jvms-77-1819.PMC5240760.pdf
e-mail: reekos@iwate-u.ac.jp ©2016 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/8c/bb/jvms-77-1825.PMC5240761.pdf
e-mail:	fueda@nvlu.ac.jp ©2016	The	Japanese	Society	of	 Veterinary	Science This	is	an	open-access	 article	distributed 	under	the	terms	of	the	Creative	 Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License	<http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/06/59/jvms-77-1831.PMC5240762.pdf
"PFGE analysis:	 Molecular	 subtyping	 of	L. monocyto- genes	strains	by	PFGE	was	performed	 based	on	standard- ized	laboratory	 protocol,	 PulseNet	 (https://www.cdc.gov/ listeria).",OADS,/arxiv_data1/oa_pdf/06/59/jvms-77-1831.PMC5240762.pdf
"L. monocytogenes	 MLST	 database	 (http://bigsdb.web.pasteur.fr/listeria)	 maintained 	 by the Pasteur Institute (Paris, France) is based on seven  housekeeping	 genes:	 abcZ, bglA, cat, dapE, dat, ldh and  lhkA	[26,	40].",OADS,/arxiv_data1/oa_pdf/06/59/jvms-77-1831.PMC5240762.pdf
e-mail: inoshima@gifu-u.ac.jp ©2016 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/2c/e4/jvms-77-1841.PMC5240763.pdf
e-mail: somporn62@hotmail.com ©2016 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/f8/3e/jvms-77-1847.PMC5240764.pdf
e-mail: morimoto@myu.ac.jp ©2016 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/fd/03/jvms-77-1855.PMC5240765.pdf
e-mail: koike.manabu@qst.go.jp ©2016 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/2e/b0/jvms-77-1865.PMC5240766.pdf
e-mail: zquan@yzu.edu.cn ©2016 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/de/9b/jvms-77-1873.PMC5240767.pdf
Care of animals  and animal experimentation were performed in accordance  with Animal Welfare Approved Standards for Turkeys  (http://animalwelfareapproved.org/).,Non-OADS,/arxiv_data1/oa_pdf/d0/d4/jvms-77-1877.PMC5240768.pdf
©2016 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/d0/d4/jvms-77-1877.PMC5240768.pdf
e-mail: momota@nvlu.ac.jp ©2016 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/78/9f/jvms-77-1883.PMC5240769.pdf
e-mail: scyeon@gnu.ac.kr ©2016 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/30/11/jvms-77-1887.PMC5240770.pdf
e-mail: mac@vet.ne.jp ©2016 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/f0/b6/jvms-77-1893.PMC5240771.pdf
e-mail: takataka.pc1138@gmail.com ©2016 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/fa/d8/jvms-77-1897.PMC5240772.pdf
e-mail:	mizuta@rs.noda.tus.ac.jp ©2016	The	Japanese	Society	of	 Veterinary	Science This	is	an	open-access	 article	distributed 	under	the	terms	of	the	Creative	 Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License	<http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/39/51/jvms-77-1903.PMC5240773.pdf
e-mail: paolo.franci@unipd.it ©2016 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/09/e8/jvms-77-1907.PMC5240774.pdf
©2016 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/2f/87/jvms-77-1911.PMC5240775.pdf
e-mail: miyazawak@affrc.go.jp; okadahi@affrc.go.jp ©2016 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/37/0d/jvms-77-1915.PMC5240776.pdf
"1, 114 –132 http://dx.doi.org/10.1080/15548627.2016.1252889",Non-OADS,/arxiv_data1/oa_pdf/5f/06/kaup-13-01-1252889.PMC5240830.pdf
"Nat Rev Mol Cell Biol 2010; 11:872-84; PMID:21102612; http://dx.doi.org/10.1038/nrm3013 [2] Mishra P, Chan DC.",OADS,/arxiv_data1/oa_pdf/5f/06/kaup-13-01-1252889.PMC5240830.pdf
"Nat Rev Mol Cell Biol 2014;15:634-46; PMID:25237825; http://dx.doi.org/10.1038/nrm3877 [3] Friedman JR, Nunnari J. Mitochondrial form and function.",OADS,/arxiv_data1/oa_pdf/5f/06/kaup-13-01-1252889.PMC5240830.pdf
"Nature 2014; 505:335-43; PMID:24429632; http://dx.doi.org/10.1038/nature12985 [4] Friedman JR, Lackner LL, West M, Dibenedetto JR, Nunnari J, Voeltz GK.",OADS,/arxiv_data1/oa_pdf/5f/06/kaup-13-01-1252889.PMC5240830.pdf
"Science 2011; 334:358-62; PMID:21885730; http://dx.doi.org/10.1126/science.1207385 [5] Klecker T, B €ockler S, Westermann B.",OADS,/arxiv_data1/oa_pdf/5f/06/kaup-13-01-1252889.PMC5240830.pdf
"J Mol Biol 2011; 413:743-50;PMID:21945531; http://dx.doi.org/10.1016/j.jmb.2011.09.012 [7] Kornmann B, Osman C, Walter P. The conserved GTPase Gem1 reg- ulates endoplasmic reticulum-mitochondria connections.",OADS,/arxiv_data1/oa_pdf/5f/06/kaup-13-01-1252889.PMC5240830.pdf
"Proc NatlAcad Sci USA 2011; 108:14151-6; PMID:21825164; http://dx.doi.org/ 10.1073/pnas.1111314108 [8] Hobbs AE, Srinivasan M, McCaffery JM, Jensen RE.",OADS,/arxiv_data1/oa_pdf/5f/06/kaup-13-01-1252889.PMC5240830.pdf
"J Cell Biol 2001; 152:401-10; PMID:11266455; http://dx.doi.org/ 10.1083/jcb.152.2.401 [9] Meeusen S, Nunnari J.",OADS,/arxiv_data1/oa_pdf/5f/06/kaup-13-01-1252889.PMC5240830.pdf
"J Cell Biol 2003; 163:503-10; PMID:14597773; http://dx.doi.org/10.1083/jcb.200304040 [10] Murley A, Lackner LL, Osman C, West M, Voeltz GK, Walter P, Nunnari J. ER-associated mitochondrial division links the distribu- tion of mitochondria and mitochondrial DNA in yeast.",OADS,/arxiv_data1/oa_pdf/5f/06/kaup-13-01-1252889.PMC5240830.pdf
"eLife 2013; 2: e00422; PMID:23682313; http://dx.doi.org/10.7554/eLife.00422 [11] Meisinger C, Rissler M, Chacinska A, Szklarz LKS, Milenkovic D, Kozjak V, Sch €onﬁs c hB ,L o h a u sC ,M e y e rH E ,Y a f f eM P ,e ta l .T h em i t o c h o n d r i a l morphology protein Mdm10 functi ons in assembly of the preprotein translocase of the outer membrane.",OADS,/arxiv_data1/oa_pdf/5f/06/kaup-13-01-1252889.PMC5240830.pdf
Dev Cell 2004; 7:61-71;PMID:15239954; http://dx.doi.org/10.1016/j.devcel.2004.06.003130 N. BELGAREH-TOUZ /C19EE TA L .,OADS,/arxiv_data1/oa_pdf/5f/06/kaup-13-01-1252889.PMC5240830.pdf
"Dev Cell 2013; 26:9-18; PMID:23810512; http://dx.doi.org/10.1016/j.devcel.2013.05.024 [13] Mao K, Klionsky DJ.",OADS,/arxiv_data1/oa_pdf/5f/06/kaup-13-01-1252889.PMC5240830.pdf
"Cell Cycle 2013; 12:0-1; http://dx.doi.org/10.4161/cc.26352 [14] B €ockler S, Westermann B. Mitochondrial ER contacts are crucial for mitophagy in yeast.",Non-OADS,/arxiv_data1/oa_pdf/5f/06/kaup-13-01-1252889.PMC5240830.pdf
"Dev Cell 2014; 28:450-8; PMID:24530295; http://dx.doi.org/10.1016/j.devcel.2014.01.012 [15] Kopec KO, Alva V, Lupas AN.",OADS,/arxiv_data1/oa_pdf/5f/06/kaup-13-01-1252889.PMC5240830.pdf
"Bioinformat-ics 2010; 26:1927-31; PMID:20554689; http://dx.doi.org/10.1093/bioinformatics/btq326 [16] Lang A, John Peter AT, Kornmann B. ER-mitochondria contact sites in yeast: beyond the myths of ERMES.",Non-OADS,/arxiv_data1/oa_pdf/5f/06/kaup-13-01-1252889.PMC5240830.pdf
"Curr Opin Cell Biol2015; 35:7-12; PMID:25836730; http://dx.doi.org/10.1016/j.ceb.2015.03.002 [17] AhYoung AP, Jiang J, Zhang J, Khoi Dang X, Loo JA, Zhou ZH, Egea PF.",OADS,/arxiv_data1/oa_pdf/5f/06/kaup-13-01-1252889.PMC5240830.pdf
"Mol Biosyst 2014; 10:1742- 8; PMID:24722918; http://dx.doi.org/10.1039/C4MB00001C [19] U /C20saj MM, Brlo /C20znik M, Kaferle P, /C20Zitnik M, Wolinski H, Leitner F, Kohlwein SD, Zupan B, Petrovi /C20c U. Genome-wide localization study of yeast Pex11 identi ﬁes peroxisome-mitochondria interactions through the ERMES complex.",OADS,/arxiv_data1/oa_pdf/5f/06/kaup-13-01-1252889.PMC5240830.pdf
"Genes Cells 2008; 13:1075-85; http://dx.doi.org/10.1111/j.1365-2443.2008.01228.x [21] Komander D, Rape M. The ubiquitin code.",OADS,/arxiv_data1/oa_pdf/5f/06/kaup-13-01-1252889.PMC5240830.pdf
"Annu Rev Biochem 2012; 81:203-29; PMID:22524316; http://dx.doi.org/10.1146/annurev- biochem-060310-170328 [22] Rotin D, Kumar S. Physiological functions of the HECT family of ubiquitin ligases.",OADS,/arxiv_data1/oa_pdf/5f/06/kaup-13-01-1252889.PMC5240830.pdf
"Nat Rev Mol Cell Biol 2009; 10:398-409; PMID:19436320; http://dx.doi.org/10.1038/nrm2690 [23] Smit JJ, Sixma TK.",OADS,/arxiv_data1/oa_pdf/5f/06/kaup-13-01-1252889.PMC5240830.pdf
"EMBO Rep 2014; 15:142- 54; PMID:24469331; http://dx.doi.org/10.1002/embr.201338166 [24] Zoladek T, Tobiasz A, Vaduva G, Boguta M, Martin NC, Hopper AK.",OADS,/arxiv_data1/oa_pdf/5f/06/kaup-13-01-1252889.PMC5240830.pdf
"J Cell Biol 1999; 145:1199-208; PMID:10366593; http://dx.doi.org/10.1083/jcb.145.6.1199 [26] Fritz S, Weinbach N, Westermann B. Mdm30 is an F-box protein required for maintenance of fusion-competent mitochondria inyeast.",OADS,/arxiv_data1/oa_pdf/5f/06/kaup-13-01-1252889.PMC5240830.pdf
"Mol Biol Cell 2003; 14:2303-13; PMID:12808031; http://dx.doi.org/10.1091/mbc.E02-12-0831 [27] Cohen MMJ, Leboucher GP, Livnat-Levanon N, Glickman MH, Weissman AM.",OADS,/arxiv_data1/oa_pdf/5f/06/kaup-13-01-1252889.PMC5240830.pdf
Mol Biol Cell 2008; 19:2457-64; PMID:18353967; http://dx.doi.org/10.1091/mbc.,Non-OADS,/arxiv_data1/oa_pdf/5f/06/kaup-13-01-1252889.PMC5240830.pdf
"Nat Rev Mol Cell Biol 2011; 12:9-14; PMID:21179058; http://dx.doi.org/10.1038/ nrm3028 [29] Birgisdottir AB, Lamark T, Johansen T. The LIR motif - crucial for selective autophagy.",OADS,/arxiv_data1/oa_pdf/5f/06/kaup-13-01-1252889.PMC5240830.pdf
"Dev Cell 2009; 17:87-97; PMID:19619494;http://dx.doi.org/10.1016/j.devcel.2009.06.013[31] Kanki T, Wang K, Cao Y, Baba M, Klionsky DJ.",OADS,/arxiv_data1/oa_pdf/5f/06/kaup-13-01-1252889.PMC5240830.pdf
"Dev Cell2009; 17:98-109; PMID:19619495; http://dx.doi.org/10.1016/j.devcel.2009.06.014 [32] Byrd RA, Weissman AM.",OADS,/arxiv_data1/oa_pdf/5f/06/kaup-13-01-1252889.PMC5240830.pdf
EMBO J 2013;32:2087-9; PMID:23852447; http://dx.doi.org/10.1038/emboj.2013.,OADS,/arxiv_data1/oa_pdf/5f/06/kaup-13-01-1252889.PMC5240830.pdf
"JCell Biol 2008; 183:795-803; PMID:19029340; http://dx.doi.org/ 10.1083/jcb.200809125 [34] M €uller M, K €otter P, Behrendt C, Walter E, Scheckhuber CQ, Entian KD, Reichert AS.",OADS,/arxiv_data1/oa_pdf/5f/06/kaup-13-01-1252889.PMC5240830.pdf
"Genome Biol 2006; 7:R30; PMID:16606443; http://dx.doi.org/10.1186/gb-2006-7-4-r30 [36] Gupta R, Kus B, Fladd C, Wasmuth J, Tonikian R, Sidhu S, Krogan NJ, Parkinson J, Rotin D. Ubiquitination screen using protein micro- arrays for comprehensive identi ﬁcation of Rsp5 substrates in yeast.",OADS,/arxiv_data1/oa_pdf/5f/06/kaup-13-01-1252889.PMC5240830.pdf
"Mol Syst Biol 2007; 3:116; PMID:17551511; http://dx.doi.org/10.1038/msb4100159 [37] Hoppe T, Matuschewski K, Rape M, Schlenker S, Ulrich HD, Jentsch S. Activation of a membrane-bound transcription factor by regulatedubiquitin/proteasome-dependent processing.",OADS,/arxiv_data1/oa_pdf/5f/06/kaup-13-01-1252889.PMC5240830.pdf
"Cell 2000; 102:577-86;PMID:11007476; http://dx.doi.org/10.1016/S0092-8674(00)00080-5 [38] Kami /C19nska J, Kwapisz M, Grabi /C19nska K, Or »owski J, Boguta M, Palamarczyk G, Zo »adek T. Rsp5 ubiquitin ligase affects isoprenoid pathway and cell wall organization in S. cerevisiae .",OADS,/arxiv_data1/oa_pdf/5f/06/kaup-13-01-1252889.PMC5240830.pdf
"Biochem Soc Trans 2008; 36:791-6; http://dx.doi.org/10.1042/BST0360791 [40] Neutzner A, Youle RJ.",OADS,/arxiv_data1/oa_pdf/5f/06/kaup-13-01-1252889.PMC5240830.pdf
"J Biol Chem 2005; 280:18598-603; PMID:15760898; http://dx.doi.org/10.1074/jbc.M500807200 [41] Thrower JS, Hoffman L, Rechsteiner M, Pickart CM.",OADS,/arxiv_data1/oa_pdf/5f/06/kaup-13-01-1252889.PMC5240830.pdf
"EMBO J 2000; 19:94-102; PMID:10619848; http://dx.doi.org/10.1093/emboj/19.1.94 [42] Burgess SM, Delannoy M, Jensen RE.",OADS,/arxiv_data1/oa_pdf/5f/06/kaup-13-01-1252889.PMC5240830.pdf
"J Cell Biol 1994; 126:1375-91; PMID:8089172; http://dx.doi.org/10.1083/jcb.126.6.1375 [43] Dimmer KS, Fritz S, Fuchs F, Messerschmitt M, Weinbach N, Neupert W, Westermann B.",OADS,/arxiv_data1/oa_pdf/5f/06/kaup-13-01-1252889.PMC5240830.pdf
"Mol Biol Cell 2002; 13:847-53; PMID:11907266; http://dx.doi.org/10.1091/mbc.01-12-0588 [44] Sogo LF, Yaffe MP.",OADS,/arxiv_data1/oa_pdf/5f/06/kaup-13-01-1252889.PMC5240830.pdf
J Cell Biol 1994; 126:1361-73; PMID:8089171; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5f/06/kaup-13-01-1252889.PMC5240830.pdf
"Biochim Biophys Acta 2009; 1793:1413-21; PMID:19344676; http://dx.doi.org/10.1016/j.bbamcr.2009.01.008 [47] Kissova I, Def ﬁeu M, Manon S, Camougrand N. Uth1p is involved in the autophagic degradation of mitochondria.",OADS,/arxiv_data1/oa_pdf/5f/06/kaup-13-01-1252889.PMC5240830.pdf
"J Biol Chem 2004;279:39068-74; PMID:15247238; http://dx.doi.org/10.1074/jbc.M4069 60200 [48] Tal R, Winter G, Ecker N, Klionsky DJ, Abeliovich H. Aup1p, a yeast mitochondrial protein phosphatase homolog, is required for ef ﬁcientAUTOPHAGY 131",Non-OADS,/arxiv_data1/oa_pdf/5f/06/kaup-13-01-1252889.PMC5240830.pdf
"J Biol Chem 2007; 282:5617-24; PMID:17166847; http://dx.doi.org/10.1074/jbc.M605940200 [49] Klionsky DJ, Abdalla FC, Abeliovich H, Abraham RT, Acevedo-Aro- zena A, Adeli K, Adeli K, Agholme L, Agnello M, Agostinis P, et al.",OADS,/arxiv_data1/oa_pdf/5f/06/kaup-13-01-1252889.PMC5240830.pdf
"Autophagy 2008; 4:205-13; PMID:18094608; http://dx.doi.org/10.4161/auto.5331 [51] Abeliovich H, Zarei M, Rigbolt KT, Youle RJ, Dengjel J. Involve- ment of mitochondrial dynamics in the segregation of mitochon-drial matrix proteins during stationary phase mitophagy.",OADS,/arxiv_data1/oa_pdf/5f/06/kaup-13-01-1252889.PMC5240830.pdf
"Nat Commun 2013; 4:2789; PMID:24240771; http://dx.doi.org/ 10.1038/ncomms3789 [52] Lynch-Day MA, Klionsky DJ.",OADS,/arxiv_data1/oa_pdf/5f/06/kaup-13-01-1252889.PMC5240830.pdf
"FEBS Lett 2010; 584:1359-66; PMID:20146925; http://dx.doi.org/10.1016/j.febslet.2010.02.013 [53] Lu K, Psakhye I, Jentsch S. Autophagic clearance of PolyQ proteins mediated by Ubiquitin-Atg8 adaptors of the conserved CUET pro- tein family.",OADS,/arxiv_data1/oa_pdf/5f/06/kaup-13-01-1252889.PMC5240830.pdf
Cell 2014; 158:549-63; PMID:25042851; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5f/06/kaup-13-01-1252889.PMC5240830.pdf
"Autophagy 2007; 3:145-8; PMID:17204846; http://dx.doi.org/ 10.4161/auto.3608 [55] Wu X, Li L, Jiang H. Doa1 targets ubiquitinated substrates for mito- chondria-associated degradation.",Non-OADS,/arxiv_data1/oa_pdf/5f/06/kaup-13-01-1252889.PMC5240830.pdf
"J Cell Biol 2016; 213:49-63;PMID:27044889; http://dx.doi.org/10.1083/jcb.201510098 [56] Kee Y, Lyon N, Huibregtse JM.",OADS,/arxiv_data1/oa_pdf/5f/06/kaup-13-01-1252889.PMC5240830.pdf
EMBO J2005; 24:2414-24; PMID:15933713; http://dx.doi.org/10.1038/sj.,OADS,/arxiv_data1/oa_pdf/5f/06/kaup-13-01-1252889.PMC5240830.pdf
"Exp Cell Res 2010; 316:3351-7; PMID:20846524; http://dx.doi.org/10.1016/j.yexcr.2010.09.005 [58] Baxter BK, Abeliovich H, Zhang X, Stirling AG, Burlingame AL, Goldfarb DS.",OADS,/arxiv_data1/oa_pdf/5f/06/kaup-13-01-1252889.PMC5240830.pdf
"J Biol Chem 2005; 280:39067-76; PMID:16186126; http://dx.doi.org/10.1074/jbc.M508064200 [59] Finley D, Ozkaynak E, Varshavsky A.",OADS,/arxiv_data1/oa_pdf/5f/06/kaup-13-01-1252889.PMC5240830.pdf
"Cell 1987; 48:1035-46; PMID:3030556; http://dx.doi.org/ 10.1016/0092-8674(87)90711-2 [60] Maniatis T, Fritsch ET, Sambrook J. Molecular Cloning: A Labora- tory Manual.",OADS,/arxiv_data1/oa_pdf/5f/06/kaup-13-01-1252889.PMC5240830.pdf
"Yeast 2004; 21:947-62; PMID:15334558; http://dx.doi.org/10.1002/yea.1142 [62] Longtine MS, McKenzie A, Demarini DJ, Shah NG, Wach A, Brachat A, Philippsen P, Pringle JR. Additional modules for versatile andeconomical PCR-based gene deletion and modi ﬁcation in Saccharo- myces cerevisiae .",OADS,/arxiv_data1/oa_pdf/5f/06/kaup-13-01-1252889.PMC5240830.pdf
"Yeast 2000; 16:1421-7; PMID:11054823; http://dx.doi.org/10.1002/1097-0061(200011)16:15%3c1421::AID- YEA624%3e3.0.CO;2-U [64] Mumberg D, M €uller R, Funk M. Yeast vectors for the controlled expression of heterologous proteins in different genetic backgrounds.",OADS,/arxiv_data1/oa_pdf/5f/06/kaup-13-01-1252889.PMC5240830.pdf
"Gene 1995; 156:119-22; PMID:7737504; http://dx.doi.org/10.1016/ 0378-1119(95)00037-7 [65] Rossanese OW, Reinke CA, Bevis BJ, Hammond AT, Sears IB, O’Connor J, Glick BS.",OADS,/arxiv_data1/oa_pdf/5f/06/kaup-13-01-1252889.PMC5240830.pdf
"J Cell Biol 2001; 153:47-62; PMID:11285273; http://dx.doi.org/10.1083/jcb.153.1.47 [66] Ecker DJ, Khan MI, Marsh J, Butt TR, Crooke ST. Chemical synthe- sis and expression of a cassette adapted ubiquitin gene.",OADS,/arxiv_data1/oa_pdf/5f/06/kaup-13-01-1252889.PMC5240830.pdf
"Science 2009; 325:477-81; PMID:19556461; http://dx.doi.org/10.1126/science.1175088 [70] Swanson R, Locher M, Hochstrasser M. A conserved ubiquitin ligase of the nuclear envelope/endoplasmic reticulum that functions in both ER-associated and Matalpha2 repressor degradation.",OADS,/arxiv_data1/oa_pdf/5f/06/kaup-13-01-1252889.PMC5240830.pdf
"Genes Dev 2001; 15:2660-74; PMID:11641273; http://dx.doi.org/10.1101/gad.933301 [71] Morvan J, Froissard M, Haguenauer-Tsapis R, Urban-Grimal D. The ubiquitin ligase Rsp5p is required for modi ﬁcation and sort- ing of membrane proteins into multivesicular bodies.",OADS,/arxiv_data1/oa_pdf/5f/06/kaup-13-01-1252889.PMC5240830.pdf
"Traf ﬁc 2004; 5:383-92; PMID:15086787; http://dx.doi.org/10.1111/j.1398-9219.2004.00183.x [72] Thiaville PC, El Yacoubi B, Perrochia L, Hecker A, Prigent M, Thiaville JJ, Forterre P, Namy O, Basta T, de Cr /C19ecy-Lagard V. Cross kingdom functional conservation of the core universally conserved threonylcarbamoyladenosine tRNA synthesis enzymes.",OADS,/arxiv_data1/oa_pdf/5f/06/kaup-13-01-1252889.PMC5240830.pdf
"Eukaryot Cell 2014; 13:1222-31; PMID:25038083; http://dx.doi.org/10.1128/EC.00147-14 [73] Guan J, Stromhaug PE, George MD, Habibzadegah-Tari P, Bevan A, Dunn WA, Jr, Klionsky DJ.",OADS,/arxiv_data1/oa_pdf/5f/06/kaup-13-01-1252889.PMC5240830.pdf
"Mol Biol Cell 2001; 12:3821-38; PMID:11739783; http://dx.doi.org/10.1091/mbc.12.12.3821 [74] Bugnicourt A, Mari M, Reggiori F, Haguenauer-Tsapis R, Galan JM.",OADS,/arxiv_data1/oa_pdf/5f/06/kaup-13-01-1252889.PMC5240830.pdf
Traf ﬁc 2008; 9:755-69; PMID:18298591; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5f/06/kaup-13-01-1252889.PMC5240830.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License ( http://creativecommons.org/licenses/by-nc/3.0/ ), which permits unre- stricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/15/f2/kaup-13-01-1235123.PMC5240836.pdf
"1, 169 –186 http://dx.doi.org/10.1080/15548627.2016.1235123",Non-OADS,/arxiv_data1/oa_pdf/15/f2/kaup-13-01-1235123.PMC5240836.pdf
64The data set is acces- sible at the ArrayExpress public repository for microarray dataunder the accession number E-MEXP-3291 ( http://www.webci tation.org/5zyojNu7T ).,OADS,/arxiv_data1/oa_pdf/15/f2/kaup-13-01-1235123.PMC5240836.pdf
J Hepatol 2013; 59:583-94; PMID:23567086; http://dx.doi.org/10.1016/j.jhep.2013.03.033 [3] Cusi K. The role of adipose tissue and lipotoxicity in the pathogene- sis of type 2 diabetes.,Non-OADS,/arxiv_data1/oa_pdf/15/f2/kaup-13-01-1235123.PMC5240836.pdf
"Curr Diab Rep 2010; 10:306-15;PMID:20556549; http://dx.doi.org/10.1007/s11892-010-0122-6 [4] Ibrahim SH, Kohli R, Gores GJ.",Non-OADS,/arxiv_data1/oa_pdf/15/f2/kaup-13-01-1235123.PMC5240836.pdf
J Pediatr Gastroenterol Nutr 2011; 53:131-40; PMID:21629127; http://dx.doi.org/10.1097/MPG.0b013e31820e82a1 [5] Neuschwander-Tetri BA.,Non-OADS,/arxiv_data1/oa_pdf/15/f2/kaup-13-01-1235123.PMC5240836.pdf
"Hepatology 2010; 52:774-88; PMID:20683968;http://dx.doi.org/10.1002/hep.23719 [6] Rial E, Rodriguez-Sanchez L, Ga llardo-Vara E, Zaragoza P, Moyano E, Gonzalez-Barroso MM.",OADS,/arxiv_data1/oa_pdf/15/f2/kaup-13-01-1235123.PMC5240836.pdf
"B iochim Biophys Acta 2010; 1797:800-6; PMID:20388489; http://dx.doi.org/10.1016/j.bbabio.2010.04.001 [7] Savary S, Trompier D, Andreoletti P, Le Borgne F, Demarquoy J, Lizard G. Fatty acids - induced lipotoxicity and in ﬂammation.",OADS,/arxiv_data1/oa_pdf/15/f2/kaup-13-01-1235123.PMC5240836.pdf
"Curr Drug Metab 2012; 13:1358-70; PMID:22978392; http://dx.doi.org/10.2174/138920012803762729 [8] Cazanave SC, Gores GJ.",Non-OADS,/arxiv_data1/oa_pdf/15/f2/kaup-13-01-1235123.PMC5240836.pdf
"Clin Lipidol 2010; 5:71-85;PMID:20368747; http://dx.doi.org/10.2217/clp.09.85 [9] Listenberger LL, Han X, Lewis SE, Cases S, Farese RV, Jr., Ory DS, Schaffer JE.",OADS,/arxiv_data1/oa_pdf/15/f2/kaup-13-01-1235123.PMC5240836.pdf
"Cardiovasc Res 2006; 70:566-77; PMID:16546150; http://dx.doi.org/10.1016/j.cardiores.2006.02.005 [11] McClain CJ, Barve S, Deaciuc I.",OADS,/arxiv_data1/oa_pdf/15/f2/kaup-13-01-1235123.PMC5240836.pdf
"Hepatology 2007; 45:1343-6; PMID:17538963; http://dx.doi.org/10.1002/hep.21788 [12] Chaurasia B, Summers SA.",Non-OADS,/arxiv_data1/oa_pdf/15/f2/kaup-13-01-1235123.PMC5240836.pdf
"Trends Endocrinol Metab 2015; 26:538-50;PMID:26412155; http://dx.doi.org/10.1016/j.tem.2015.07.006 [13] Flowers MT, Ntambi JM.",OADS,/arxiv_data1/oa_pdf/15/f2/kaup-13-01-1235123.PMC5240836.pdf
"Curr Opin Lipidol 2008; 19:248-56; PMID:18460915; http://dx.doi.org/10.1097/MOL.0b013e3282f9b54d [14] Stamatikos AD, Paton CM.",OADS,/arxiv_data1/oa_pdf/15/f2/kaup-13-01-1235123.PMC5240836.pdf
"Am J Physiol Endocrinol Metab 2013; 305:E767-75; PMID:23941875; http://dx.doi.org/ 10.1152/ajpendo.00268.2013 [15] Li ZZ, Berk M, McIntyre TM, Feldstein AE.",OADS,/arxiv_data1/oa_pdf/15/f2/kaup-13-01-1235123.PMC5240836.pdf
"J Biol Chem 2009; 284:5637-44; PMID:19119140; http://dx.doi.org/10.1074/jbc.M807616200 [16] Peter A, Weigert C, Staiger H, Rittig K, Cegan A, Lutz P, Machicao F, H€aring HU, Schleicher E. Induction of stearoyl-CoA desaturase pro- tects human arterial endothelial cells against lipotoxicity.",Non-OADS,/arxiv_data1/oa_pdf/15/f2/kaup-13-01-1235123.PMC5240836.pdf
"Diabetes 2009; 58:1757-65; PMID:19478146; http://dx.doi.org/10.2337/db09-0188 [18] Masuda M, Miyazaki-Anzai S, Keenan AL, Okamura K, Kendrick J, Chonchol M, Offermanns S, Ntambi JM, Kuro-O M, Miyazaki M.Saturated phosphatidic acids mediate saturated fatty acid-inducedvascular calci ﬁcation and lipotoxicity.",Non-OADS,/arxiv_data1/oa_pdf/15/f2/kaup-13-01-1235123.PMC5240836.pdf
"Mol Cell Biol 2006; 26:6786-98;PMID:16943421; http://dx.doi.org/10.1128/MCB.00077-06 [22] Feng Y, Yao Z, Klionsky DJ.",OADS,/arxiv_data1/oa_pdf/15/f2/kaup-13-01-1235123.PMC5240836.pdf
"Trends Cell Biol 2015; 25:354-63; PMID:25759175; http://dx.doi.org/10.1016/j.tcb.2015.02.002 [23] Mei S, Ni HM, Manley S, Bockus A, Kassel KM, Luyendyk JP, Copple BL, Ding WX.",OADS,/arxiv_data1/oa_pdf/15/f2/kaup-13-01-1235123.PMC5240836.pdf
"J Pharmacol Exp Ther 2011; 339:487-98; PMID:21856859; http://dx.doi.org/10.1124/ jpet.111.184341 [24] Tan SH, Shui G, Zhou J, Li JJ, Bay BH, Wenk MR, Shen HM.",OADS,/arxiv_data1/oa_pdf/15/f2/kaup-13-01-1235123.PMC5240836.pdf
"J Biol Chem 2012; 287:14364-76; PMID:22408252;http://dx.doi.org/10.1074/jbc.M111.294157 [25] Mir SU, George NM, Zahoor L, Harms R, Guinn Z, Sarvetnick NE.",OADS,/arxiv_data1/oa_pdf/15/f2/kaup-13-01-1235123.PMC5240836.pdf
J Biol Chem 2015; 290:6071-85;PMID:25548282; http://dx.doi.org/10.1074/jbc.M114.605345184 R. A. SINHA ET AL.,OADS,/arxiv_data1/oa_pdf/15/f2/kaup-13-01-1235123.PMC5240836.pdf
J Biol Chem 2012; 287:21110-20; PMID:22556413; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/15/f2/kaup-13-01-1235123.PMC5240836.pdf
J Biol Chem2013; 288:30094-104; PMID:23986436; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/15/f2/kaup-13-01-1235123.PMC5240836.pdf
"Cell Death Differ 2013; 20:3-11; PMID:22595754; http://dx.doi.org/10.1038/cdd.2012.63 [29] Singh R, Kaushik S, Wang Y, Xiang Y, Novak I, Komatsu M, Tanaka K, Cuervo AM, Czaja MJ.",OADS,/arxiv_data1/oa_pdf/15/f2/kaup-13-01-1235123.PMC5240836.pdf
"Autophagy regulates lipid metabolism.Nature 2009; 458:1131-5; PMID:19339967; http://dx.doi.org/10.1038/nature07976 [30] Sinha RA, Farah BL, Singh BK, Siddique MM, Li Y, Wu Y, Ilkayeva OR, Gooding J, Ching J, Zhou J, et al.",OADS,/arxiv_data1/oa_pdf/15/f2/kaup-13-01-1235123.PMC5240836.pdf
"Hepatology 2014; 59:1366-80; PMID:23929677; http://dx.doi.org/10.1002/hep.26667 [31] Sinha RA, You SH, Zhou J, Siddique MM, Bay BH, Zhu X, Privalsky ML, Cheng SY, Stevens RD, Summers SA, et al.",OADS,/arxiv_data1/oa_pdf/15/f2/kaup-13-01-1235123.PMC5240836.pdf
"J Clin Invest 2012; 122:2428-38; PMID:22684107; http://dx.doi.org/ 10.1172/JCI60580 [32] Rambold AS, Cohen S, Lippincott-Schwartz J. Fatty acid traf ﬁcking in starved cells: regulation by lipid droplet lipolysis, autophagy, and mitochondrial fusion dynamics.",Non-OADS,/arxiv_data1/oa_pdf/15/f2/kaup-13-01-1235123.PMC5240836.pdf
"Dev Cell 2015; 32:678-92; PMID:25752962; http://dx.doi.org/10.1016/j.devcel.2015.01.029 [33] Lapierre LR, Silvestrini MJ, Nunez L, Ames K, Wong S, Le TT, Hansen M, Mel /C19endez A. Autophagy genes are required for normal lipid levels in C. elegans.",OADS,/arxiv_data1/oa_pdf/15/f2/kaup-13-01-1235123.PMC5240836.pdf
"Autophagy 2013; 9:278-86;PMID:23321914; http://dx.doi.org/10.4161/auto.22930 [34] Ma D, Molusky MM, Song J, Hu CR, Fang F, Rui C, Mathew AV, Pennathur S, Liu F, Cheng JX, et al.",OADS,/arxiv_data1/oa_pdf/15/f2/kaup-13-01-1235123.PMC5240836.pdf
"Autophagy de ﬁciency by hepatic FIP200 deletion uncouples steatosis from liver injury in NAFLD.Mol Endocrinol 2013; 27:1643-54; PMID:23960084; http://dx.doi.org/10.1210/me.2013-1153 [35] Shibata M, Yoshimura K, Furuya N, Koike M, Ueno T, Komatsu M, Arai H, Tanaka K, Kominami E, Uchiyama Y.",Non-OADS,/arxiv_data1/oa_pdf/15/f2/kaup-13-01-1235123.PMC5240836.pdf
Biochem Bio- phys Res Commun 2009; 382:419-23; PMID:19285958; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/15/f2/kaup-13-01-1235123.PMC5240836.pdf
"J Biol Chem 2007; 282:25464-74; PMID:17595159; http://dx.doi.org/ 10.1074/jbc.M703663200 [37] Ganley IG, Lam du H, Wang J, Ding X, Chen S, Jiang X. ULK1.",OADS,/arxiv_data1/oa_pdf/15/f2/kaup-13-01-1235123.PMC5240836.pdf
"J Biol Chem 2009; 284:12297-305; PMID:19258318; http://dx.doi.org/10.1074/jbc.M900573200 [38] Hosokawa N, Hara T, Kaizuka T, Kishi C, Takamura A, Miura Y, Iemura S, Natsume T, Takehana K, Yamada N, et al.",OADS,/arxiv_data1/oa_pdf/15/f2/kaup-13-01-1235123.PMC5240836.pdf
"Mol Biol Cell 2009; 20:1981-91;PMID:19211835; http://dx.doi.org/10.1091/mbc.E08-12-1248 [39] Wong PM, Puente C, Ganley IG, Jiang X.",Non-OADS,/arxiv_data1/oa_pdf/15/f2/kaup-13-01-1235123.PMC5240836.pdf
"Autophagy 2013;9:124-37; PMID:23295650; http://dx.doi.org/10.4161/auto.23323 [40] Sinha RA, Singh BK, Zhou J, Wu Y, Farah BL, Ohba K, Lesmana R, Gooding J, Bay BH, Yen PM.",OADS,/arxiv_data1/oa_pdf/15/f2/kaup-13-01-1235123.PMC5240836.pdf
"Autophagy 2015; 11:1341-57; PMID:26103054; http://dx.doi.org/10.1080/15548627.2015.1061849 [41] Egan DF, Shackelford DB, Mihaylova MM, Gelino S, Kohnz RA, Mair W, Vasquez DS, Joshi A, Gwinn DM, Taylor R, et al.",OADS,/arxiv_data1/oa_pdf/15/f2/kaup-13-01-1235123.PMC5240836.pdf
"Science 2011; 331:456-61; PMID:21205641; http://dx.doi.org/10.1126/science.1196371 [42] Xing J, Liu H, Yang H, Chen R, Chen Y, Xu J. Upregulation of Unc- 51-like kinase 1 by nitric oxide stabilizes SIRT1, independent of auto- phagy.",OADS,/arxiv_data1/oa_pdf/15/f2/kaup-13-01-1235123.PMC5240836.pdf
PLoS One 2014; 9:e116165; PMID:25541949; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/15/f2/kaup-13-01-1235123.PMC5240836.pdf
"Cell 2013; 155:688-98; PMID:24119841; http://dx.doi.org/10.1016/j.cell.2013.09.049 [44] Joshi A, Iyengar R, Joo JH, Li-Harms XJ, Wright C, Marino R, Winborn BJ, Phillips A, Temirov J, Sciarretta S, et al.",OADS,/arxiv_data1/oa_pdf/15/f2/kaup-13-01-1235123.PMC5240836.pdf
"J Biol Chem 2011; 286:39606-14; PMID:21949238;http://dx.doi.org/10.1074/jbc.M111.262402 [46] Oosterveer MH, Grefhorst A, Groen AK, Kuipers F. The liver X receptor: control of cellular lipid homeostasis and beyond Implica-tions for drug design.",OADS,/arxiv_data1/oa_pdf/15/f2/kaup-13-01-1235123.PMC5240836.pdf
"Prog Lipid Res 2010; 49:343-52; PMID:20363253; http://dx.doi.org/10.1016/j.plipres.2010.03.002 [47] Chan EY, Longatti A, McKnight NC, Tooze SA.",OADS,/arxiv_data1/oa_pdf/15/f2/kaup-13-01-1235123.PMC5240836.pdf
"Mol Cell Biol 2009; 29:157-71; PMID:18936157; http://dx.doi.org/10.1128/MCB.01082-08 [48] Petherick KJ, Conway OJ, Mpamhanga C, Osborne SA, Kamal A, Saxty B, Ganley IG.",Non-OADS,/arxiv_data1/oa_pdf/15/f2/kaup-13-01-1235123.PMC5240836.pdf
"Autophagy 2011; 7:737-47; PMID:21460630; http://dx.doi.org/10.4161/auto.7.7.15491 [50] Lee SB, Kim S, Lee J, Park J, Lee G, Kim Y, Kim JM, Chung J. ATG1, an autophagy regulator, inhibits cell growth by negatively regulating S6 kinase.",Non-OADS,/arxiv_data1/oa_pdf/15/f2/kaup-13-01-1235123.PMC5240836.pdf
"EMBO Rep 2007; 8:360-5; PMID:17347671; http://dx.doi.org/10.1038/sj.embor.7400917 [51] Jung CH, Seo M, Otto NM, Kim DH.",OADS,/arxiv_data1/oa_pdf/15/f2/kaup-13-01-1235123.PMC5240836.pdf
"Autophagy 2011; 7:1212-21; PMID:21795849; http://dx.doi.org/10.4161/auto.7.10.16660 [52] Kim K, Pyo S, Um SH.",Non-OADS,/arxiv_data1/oa_pdf/15/f2/kaup-13-01-1235123.PMC5240836.pdf
"Hepatology 2012; 55:1727-37; PMID:221 83976; http://dx.doi.org/10.1002/hep.25537 [53] Sengupta S, Peterson TR, Laplante M, Oh S, Sabatini DM.",OADS,/arxiv_data1/oa_pdf/15/f2/kaup-13-01-1235123.PMC5240836.pdf
"Nature 2010; 468:1100-4; PMID:21179166; http://dx.doi.org/10.1038/nature09584 [54] Albers M, Blume B, Schlueter T, Wright MB, Kober I, Kremoser C, Deuschle U, Koegl M. A novel principle for partial agonism of liver X receptor ligands.",OADS,/arxiv_data1/oa_pdf/15/f2/kaup-13-01-1235123.PMC5240836.pdf
"J Biol Chem 2006; 281:4920-30; PMID:16354658; http://dx.doi.org/10.1074/jbc.M510101200 [55] Phelan CA, Weaver JM, Steger DJ, Joshi S, Maslany JT, Collins JL, Zuercher WJ, Willson TM, Walker M, Jaye M, et al.",OADS,/arxiv_data1/oa_pdf/15/f2/kaup-13-01-1235123.PMC5240836.pdf
"Mol Endocrinol 2008; 22:2241-9; PMID:18669643; http://dx.doi.org/10.1210/me.2008-0041 [56] Yamaguchi K, Yang L, McCall S, Huang J, Yu XX, Pandey SK, Bhanot S, Monia BP, Li YX, Diehl AM.",OADS,/arxiv_data1/oa_pdf/15/f2/kaup-13-01-1235123.PMC5240836.pdf
"Hepatology 2007;45:1366-74; PMID:17476695; http://dx.doi.org/10.1002/hep.21655 [57] Bailey AP, Koster G, Guillermier C, Hirst EM, MacRae JI, Lechene CP, Postle AD, Gould AP.",Non-OADS,/arxiv_data1/oa_pdf/15/f2/kaup-13-01-1235123.PMC5240836.pdf
Cell 2015; 163:340-53;PMID:26451484; http://dx.doi.org/10.1016/j.cell.2015.09.020AUTOPHAGY 185,OADS,/arxiv_data1/oa_pdf/15/f2/kaup-13-01-1235123.PMC5240836.pdf
"Nat Commun2014; 5:4834; PMID:25189398; http://dx.doi.org/10.1038/ncomms5834 [59] Inami Y, Yamashina S, Izumi K, Ueno T, Tanida I, Ikejima K, Wata- nabe S. Hepatic steatosis inhibits autophagic proteolysis viaimpairment of autophagosomal acidi ﬁcation and cathepsin expres- sion.",OADS,/arxiv_data1/oa_pdf/15/f2/kaup-13-01-1235123.PMC5240836.pdf
"Biochem Biophys Res Commun 2011; 412:618-25; PMID:21856284; http://dx.doi.org/10.1016/j.bbrc.2011.08.012 [60] Kashima J, Shintani-Ishida K, Nakajima M, Maeda H, Unuma K, Uchiyama Y, Yoshida K. Immunohistochemical study of the auto- phagy marker microtubule-associated protein 1 light chain 3 in nor- mal and steatotic human livers.",OADS,/arxiv_data1/oa_pdf/15/f2/kaup-13-01-1235123.PMC5240836.pdf
"Cell Death Dis 2014; 5:e1179; PMID:24743734; http://dx.doi.org/10.1038/cddis.2014.162 [62] Las G, Serada SB, Wikstrom JD, Twig G, Shirihai OS.",OADS,/arxiv_data1/oa_pdf/15/f2/kaup-13-01-1235123.PMC5240836.pdf
"J Biol Chem 2011; 286:42534- 44; PMID:21859708; http://dx.doi.org/10.1074/jbc.M111.242412 [63] Kovsan J, Bluher M, Tarnovscki T, Kloting N, Kirshtein B, Madar L, Shai I, Golan R, Harman-Boehm I, Sch €on MR, et al.",OADS,/arxiv_data1/oa_pdf/15/f2/kaup-13-01-1235123.PMC5240836.pdf
"J Clin Endocrinol Metab2011; 96:E268-77; PMID:21047928; http://dx.doi.org/10.1210/ jc.2010-1681 [64] Lake AD, Novak P, Hardwick RN, Flores-Keown B, Zhao F, Klimecki WT, Cherrington NJ.",OADS,/arxiv_data1/oa_pdf/15/f2/kaup-13-01-1235123.PMC5240836.pdf
Toxicol Sci 2014; 137:26-35; PMID:24097666; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/15/f2/kaup-13-01-1235123.PMC5240836.pdf
"PLoS One 2015; 10:e0119850; PMID:25786112; http://dx.doi.org/10.1371/journal.pone.0119850 [66] Martinet W, De Meyer GR, Andries L, Herman AG, Kockx MM.",OADS,/arxiv_data1/oa_pdf/15/f2/kaup-13-01-1235123.PMC5240836.pdf
"J Histochem Cytochem 2006; 54:85-96; PMID:16148314; http://dx.doi.org/10.1369/jhc.5A6743.2005 [67] Dupont N, Chauhan S, Arko-Mensah J, Castillo EF, Masedunskas A, Weigert R, Robenek H, Proikas-Cezanne T, Deretic V. Neutral lipid stores and lipase PNPLA5 contribute to autophagosome biogenesis.Curr Biol 2014; 24:609-20; PMID:24613307; http://dx.doi.org/ 10.1016/j.cub.2014.02.008 [68] Shpilka T, Welter E, Borovsky N, Amar N, Mari M, Reggiori F, Elazar Z. Lipid droplets and their component triglycerides and sterylesters regulate autophagosome biogenesis.",OADS,/arxiv_data1/oa_pdf/15/f2/kaup-13-01-1235123.PMC5240836.pdf
"EMBO J 2015; 34:2117- 31; PMID:26162625; http://dx.doi.org/10.15252/embj.201490315 [69] Ogasawara Y, Itakura E, Kono N, Mizushima N, Arai H, Nara A, Mizu- kami T, Yamamoto A. Stearoyl-CoA de saturase 1 activity is required for autophagosome formation.",OADS,/arxiv_data1/oa_pdf/15/f2/kaup-13-01-1235123.PMC5240836.pdf
"J Biol Chem 2014; 289:23938-50; PMID:25023287; http://dx.doi.org/10.1074/jbc.M114.591065 [70] Bestebroer J, V ’Kovski P, Mauthe M, Reggiori F. Hidden behind autophagy: the unconventional roles of ATG proteins.",OADS,/arxiv_data1/oa_pdf/15/f2/kaup-13-01-1235123.PMC5240836.pdf
"Traf ﬁc 2013; 14:1029-41; PMID:23837619; http://dx.doi.org/10.1111/tra.12091 [71] Madeira JB, Masuda CA, Maya-Monteiro CM, Matos GS, Montero- Lomeli M, Bozaquel-Morais BL.",OADS,/arxiv_data1/oa_pdf/15/f2/kaup-13-01-1235123.PMC5240836.pdf
"Mol Cell Biol 2015; 35:737-46; PMID:25512609; http://dx.doi.org/10.1128/MCB.01314-14 [72] Li D, Song JZ, Li H, Shan MH, Liang Y, Zhu J, Xie Z.",OADS,/arxiv_data1/oa_pdf/15/f2/kaup-13-01-1235123.PMC5240836.pdf
"FEBS Lett 2015; 589:269-76; PMID:25500271; http://dx.doi.org/ 10.1016/j.febslet.2014.11.050 [73] Shpilka T, Elazar Z. Lipid droplets regulate autophagosome biogene- sis.",OADS,/arxiv_data1/oa_pdf/15/f2/kaup-13-01-1235123.PMC5240836.pdf
"Food Chem Toxicol 2015; 80:298-309; PMID:25846498; http://dx.doi.org/10.1016/j.fct.2015.03.029 [75] Bae EJ, Xu J, Oh DY, Bandyopadhyay G, Lagakos WS, Keshwani M, Olefsky JM.",OADS,/arxiv_data1/oa_pdf/15/f2/kaup-13-01-1235123.PMC5240836.pdf
"J Biol Chem 2012; 287:18769-80; PMID:22493495; http://dx.doi.org/10.1074/jbc.M112.365544 [76] Watson PJ, Fairall L, Schwabe JW.",OADS,/arxiv_data1/oa_pdf/15/f2/kaup-13-01-1235123.PMC5240836.pdf
"Mol Cell Endocrinol 2012; 348:440-9; PMID:21925568; http://dx.doi.org/10.1016/j.mce.2011.08.033 [77] Baldan A, Bojanic DD, Edwards PA.",OADS,/arxiv_data1/oa_pdf/15/f2/kaup-13-01-1235123.PMC5240836.pdf
"Mol Cell Biol 2003; 23:5780-9; PMID:12897148; http://dx.doi.org/10.1128/MCB.23.16.5780-5789.2003 [79] Xu J, Ji J, Yan XH.",OADS,/arxiv_data1/oa_pdf/15/f2/kaup-13-01-1235123.PMC5240836.pdf
"Crit Rev Food Sci Nutr 2012; 52:373-81;PMID:22369257; http://dx.doi.org/10.1080/10408398.2010.500245 [80] Severgnini M, Sherman J, Sehgal A, Jayaprakash NK, Aubin J, Wang G, Zhang L, Peng CG, Yucius K, Butler J, et al.",Non-OADS,/arxiv_data1/oa_pdf/15/f2/kaup-13-01-1235123.PMC5240836.pdf
Cytotechnology 2012; 64:187-95; PMID:22105762; http://dx.doi.org/10.1007/s10616-011-9407-0186 R. A. SINHA ET AL.,OADS,/arxiv_data1/oa_pdf/15/f2/kaup-13-01-1235123.PMC5240836.pdf
"1, 133 –148 http://dx.doi.org/10.1080/15548627.2016.1248018",Non-OADS,/arxiv_data1/oa_pdf/38/74/kaup-13-01-1248018.PMC5240838.pdf
Annu Rev Biochem 2015; 84:435-64; PMID:25784053; http://dx.doi.org/10.1146/annurev-biochem-060614-033955 [2] Morimoto RI.,OADS,/arxiv_data1/oa_pdf/38/74/kaup-13-01-1248018.PMC5240838.pdf
Genes Dev 1998; 12:3788-96; PMID:9869631; http://dx.doi.org/10.1101/gad.12.24.3788 [3] Rubinsztein DC.,OADS,/arxiv_data1/oa_pdf/38/74/kaup-13-01-1248018.PMC5240838.pdf
"Nature 2006; 443:780-6; PMID:17051204; http://dx.doi.org/10.1038/nature05291 [4] Johansen T, Lamark T. Selective autophagy mediated by autophagic adapter proteins.",OADS,/arxiv_data1/oa_pdf/38/74/kaup-13-01-1248018.PMC5240838.pdf
"FEBS Lett 2010; 584:2635-45;PMID:20412801; http://dx.doi.org/10.1016/j.febslet.2010.04.041 [6] Wild P, McEwan DG, Dikic I.",OADS,/arxiv_data1/oa_pdf/38/74/kaup-13-01-1248018.PMC5240838.pdf
"J Cell Sci 2014; 127:3-9; PMID:24345374; http://dx.doi.org/10.1242/jcs.140426 [7] Komatsu M, Ichimura Y. Physiological signi ﬁcance of selective deg- radation of p62 by autophagy.",OADS,/arxiv_data1/oa_pdf/38/74/kaup-13-01-1248018.PMC5240838.pdf
"FEBS Lett 2010; 584:1374-8; PMID:20153326; http://dx.doi.org/10.1016/j.febslet.2010.02.017 [8] Katsuragi Y, Ichimura Y, Komatsu M. p62/SQSTM1 functions as a signaling hub and an autophagy adaptor.",OADS,/arxiv_data1/oa_pdf/38/74/kaup-13-01-1248018.PMC5240838.pdf
"FEBS J 2015; 282(24):4672- 8; PMID:26432171; http://dx.doi.org/10.1111/febs.13540 [9] Pilli M, Arko-Mensah J, Ponpuak M, Roberts E, Master S, Mandell MA, Dupont N, Ornatowski W, Jiang S, Bradfute SB, et al.",OADS,/arxiv_data1/oa_pdf/38/74/kaup-13-01-1248018.PMC5240838.pdf
"Immunity 2012; 37:223-34; PMID:22921120; http://dx.doi.org/10.1016/j.immuni.2012.04.015 [10] Lim J, Lachenmayer ML, Wu S, Liu W, Kundu M, Wang R, Komatsu M, Oh YJ, Zhao Y, Yue Z. Proteotoxic stress induces phosphorylation of p62/SQSTM1 by ULK1 to regulate selective autophagic clearance of protein aggregates.",OADS,/arxiv_data1/oa_pdf/38/74/kaup-13-01-1248018.PMC5240838.pdf
"PLoS Genet 2015; 11:e1004987;PMID:25723488; http://dx.doi.org/10.1371/journal.pgen.1004987 [11] Matsumoto G, Wada K, Okuno M, Kurosawa M, Nukina N. Serine 403 phosphorylation of p62/SQSTM1 regulates selective autophagic clearance of ubiquitinated proteins.",OADS,/arxiv_data1/oa_pdf/38/74/kaup-13-01-1248018.PMC5240838.pdf
"Mol Cell 2011; 44:279-89;PMID:22017874; http://dx.doi.org/10.1016/j.molcel.2011.07.039 [12] Ichimura Y, Waguri S, Sou YS, Kageyama S, Hasegawa J, Ishimura R, Saito T, Yang Y, Kouno T, Fukutomi T, et al.",OADS,/arxiv_data1/oa_pdf/38/74/kaup-13-01-1248018.PMC5240838.pdf
MolCell 2013; 51:618-31; PMID:24011591; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/38/74/kaup-13-01-1248018.PMC5240838.pdf
"Cell 2007; 131:1149-63; PMID:18083104; http://dx.doi.org/ 10.1016/j.cell.2007.10.035 [14] Korolchuk VI, Mansilla A, Menzies FM, Rubinsztein DC.",OADS,/arxiv_data1/oa_pdf/38/74/kaup-13-01-1248018.PMC5240838.pdf
Mol Cell 2009; 33:517-27; PMID:19250912; http://dx.doi.org/10.1016/j.molcel.2009.01.021 [15] Kopito RR.,OADS,/arxiv_data1/oa_pdf/38/74/kaup-13-01-1248018.PMC5240838.pdf
"Trends Cell Biol 2000; 10:524-30; PMID:11121744; http://dx.doi.org/ 10.1016/S0962-8924(00)01852-3 [16] Margariti A, Li H, Chen T, Martin D, Vizcay-Barrena G, Alam S, Karamariti E, Xiao Q, Zampetaki A, Zhang Z, et al.",OADS,/arxiv_data1/oa_pdf/38/74/kaup-13-01-1248018.PMC5240838.pdf
"J Biol Chem 2013; 288:859-72;PMID:23184933; http://dx.doi.org/10.1074/jbc.M112.412783 [17] Luo T, Fu J, Xu A, Su B, Ren Y, Li N, Zhu J, Zhao X, Dai R, Cao J, et al.",OADS,/arxiv_data1/oa_pdf/38/74/kaup-13-01-1248018.PMC5240838.pdf
"Autophagy 2016; 12:1355-71; PMID:25905985; http://dx.doi.org/10.1080/15548627.2015.1034405 [18] Watanabe Y, Tanaka M. p62/SQSTM1 in autophagic clearance of a non-ubiquitylated substrate.",OADS,/arxiv_data1/oa_pdf/38/74/kaup-13-01-1248018.PMC5240838.pdf
J Cell Sci 2011; 124:2692-701;PMID:21771882; http://dx.doi.org/10.1242/jcs.081232AUTOPHAGY 147,Non-OADS,/arxiv_data1/oa_pdf/38/74/kaup-13-01-1248018.PMC5240838.pdf
"PLoS One 2012; 7:e52868; PMID:23300799; http://dx.doi.org/10.1371/journal.pone.0052868 [20] Yamakawa K, Izumi Y, Takeuchi H, Yamamoto N, Kume T, Akaike A, Takahashi R, Shimohama S, Sawada H. Dopamine facilitatesa-synuclein oligomerization in human neuroblastoma SH-SY5Y cells.",OADS,/arxiv_data1/oa_pdf/38/74/kaup-13-01-1248018.PMC5240838.pdf
"Biochem Biophys Res Commun 2010; 391:129-34; PMID:19900407; http://dx.doi.org/10.1016/j.bbrc.2009.11.015 [21] Luk KC, Kehm V, Carroll J, Zhang B, O ’Brien P, Trojanowski JQ, Lee VM.",OADS,/arxiv_data1/oa_pdf/38/74/kaup-13-01-1248018.PMC5240838.pdf
"Science 2012; 338:949-53; PMID:23161999; http://dx.doi.org/10.1126/science.1227157 [22] Trinklein ND, Murray JI, Hartman SJ, Botstein D, Myers RM.",OADS,/arxiv_data1/oa_pdf/38/74/kaup-13-01-1248018.PMC5240838.pdf
"Mol Biol Cell 2004; 15:1254-61; PMID:14668476; http://dx.doi.org/10.1091/mbc.E03-10-0738 [23] Westerheide SD, Anckar J, Stevens SM, Jr, Sistonen L, Morimoto RI.",OADS,/arxiv_data1/oa_pdf/38/74/kaup-13-01-1248018.PMC5240838.pdf
"Science 2009; 323:1063-6; PMID:19229036; http://dx.doi.org/ 10.1126/science.1165946 [24] Yoon YJ, Kim JA, Shin KD, Shin DS, Han YM, Lee YJ, Lee JS, Kwon BM, Han DC.",OADS,/arxiv_data1/oa_pdf/38/74/kaup-13-01-1248018.PMC5240838.pdf
"J BiolChem 2011; 286:1737-47; PMID:21078672; http://dx.doi.org/ 10.1074/jbc.M110.179440 [25] Pankiv S, Lamark T, Bruun JA, Overvatn A, Bjorkoy G, Johansen T. Nucleocytoplasmic shuttling of p62/SQSTM1 and its role in recruit-ment of nuclear polyubiquitinated proteins to promyelocytic leuke- mia bodies.",OADS,/arxiv_data1/oa_pdf/38/74/kaup-13-01-1248018.PMC5240838.pdf
"Nat Cell Biol 2015; 17:300-10; PMID:25686249; http://dx.doi.org/10.1038/ncb3112 [27] Desai S, Liu Z, Yao J, Patel N, Chen J, Wu Y, Ahn EE, Fodstad O, Tan M. Heat shock factor 1 (HSF1) controls chemoresistance and autophagy through transcriptional regulation of autophagy-relatedprotein 7 (ATG7).",OADS,/arxiv_data1/oa_pdf/38/74/kaup-13-01-1248018.PMC5240838.pdf
"J Biol Chem 2013; 288:9165-76; PMID:23386620;http://dx.doi.org/10.1074/jbc.M112.422071 [28] Kageyama S, Sou YS, Uemura T, Kametaka S, Saito T, Ishimura R, Kouno T, Bedford L, Mayer RJ, Lee MS, et al.",OADS,/arxiv_data1/oa_pdf/38/74/kaup-13-01-1248018.PMC5240838.pdf
J Biol Chem 2014; 289:24944-55; PMID:25049227; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/38/74/kaup-13-01-1248018.PMC5240838.pdf
"Biol Pharm Bull 2008; 31:193-200;PMID:18239272; http://dx.doi.org/10.1248/bpb.31.193 [31] Shaid S, Brandts CH, Serve H, Dikic I. Ubiquitination and selective autophagy.",Non-OADS,/arxiv_data1/oa_pdf/38/74/kaup-13-01-1248018.PMC5240838.pdf
"Cell Death Differ 2013; 20:21-30; PMID:22722335;http://dx.doi.org/10.1038/cdd.2012.72 [32] Jacobs AT, Marnett LJ.",Non-OADS,/arxiv_data1/oa_pdf/38/74/kaup-13-01-1248018.PMC5240838.pdf
"J Biol Chem 2009; 284:9176-83; PMID:19179333; http://dx.doi.org/10.1074/jbc.M808656200 [33] Miyata Y, Yahara I.",OADS,/arxiv_data1/oa_pdf/38/74/kaup-13-01-1248018.PMC5240838.pdf
"Mol Biol Cell 2006; 17:1461-71;PMID:16394098; http://dx.doi.org/10.1091/mbc.E05-09-0853[35] Delgoffe GM, Kole TP, Cotter RJ, Powell JD.",OADS,/arxiv_data1/oa_pdf/38/74/kaup-13-01-1248018.PMC5240838.pdf
"Mol Immunol 2009; 46:2694-8; PMID:19586661; http://dx.doi.org/10.1016/j.molimm.2009.05.185 [36] Gidalevitz T, Prahlad V, Morimoto RI.",OADS,/arxiv_data1/oa_pdf/38/74/kaup-13-01-1248018.PMC5240838.pdf
"Cold Spring HarbPerspect Biol 2011; 3; PMID:21536706; http://dx.doi.org/10.1101/ cshperspect.a009704 [37] Pankiv S, Clausen TH, Lamark T, Brech A, Bruun JA, Outzen H, Øvervatn A, Bjørkø;y G, Johansen T. p62/SQSTM1 binds directly toAtg8/LC3 to facilitate degradation of ubiquitinated protein aggre- gates by autophagy.",OADS,/arxiv_data1/oa_pdf/38/74/kaup-13-01-1248018.PMC5240838.pdf
"J Biol Chem 2007; 282:24131-45; PMID:17580304; http://dx.doi.org/10.1074/jbc.M702824200 [38] Bjorkoy G, Lamark T, Brech A, Outzen H, Perander M, Overvatn A, Stenmark H, Johansen T. p62/SQSTM1 forms protein aggregates degraded by autophagy and has a protective effect on huntingtin- induced cell death.",OADS,/arxiv_data1/oa_pdf/38/74/kaup-13-01-1248018.PMC5240838.pdf
"J Cell Biol 2005; 171:603-14; PMID:16286508;http://dx.doi.org/10.1083/jcb.200507002 [39] Saitoh Y, Fujikake N, Okamoto Y, Popiel HA, Hatanaka Y, Ueyama M, Suzuki M, Gaumer S, Murata M, Wada K, Nagai Y, et al.",OADS,/arxiv_data1/oa_pdf/38/74/kaup-13-01-1248018.PMC5240838.pdf
"J Biol Chem 2015; 290:1442-53; PMID:25480790; http://dx.doi.org/ 10.1074/jbc.M114.590281 [40] Cha-Molstad H, Sung KS, Hwang J, Kim KA, Yu JE, Yoo YD, Jang JM, Han DH, Molstad M, Kim JG, et al.",OADS,/arxiv_data1/oa_pdf/38/74/kaup-13-01-1248018.PMC5240838.pdf
"Nat Cell Biol 2015; 17:917-29; PMID:26075355; http://dx.doi.org/10.1038/ncb3177 [41] Itakura E, Mizushima N. p62 Targeting to the autophagosome formation site requires self-oligomerization but not LC3 binding.",Non-OADS,/arxiv_data1/oa_pdf/38/74/kaup-13-01-1248018.PMC5240838.pdf
"J Cell Biol 2011; 192:17-27; PMID:21220506; http://dx.doi.org/10.1083/jcb.201009067 [42] Wurzer B, Zaffagnini G, Fracchiolla D, Turco E, Abert C, Romanov J, Martens S. Oligomerization of p62 allows for selection of ubiquiti- nated cargo and isolation membrane during selective autophagy.Elife 2015; 4:e08941; PMID:26413874; http://dx.doi.org/10.7554/eLife.08941 [43] Lazarou M, Sliter DA, Kane LA, Sarraf SA, Wang C, Burman JL, Sideris DP, Fogel AI, Youle RJ.",Non-OADS,/arxiv_data1/oa_pdf/38/74/kaup-13-01-1248018.PMC5240838.pdf
"Nature 2015; 524:309-14;PMID:26266977; http://dx.doi.org/10.1038/nature14893 [44] Kurosawa M, Matsumoto G, Sumikura H, Hatsuta H, Murayama S, Sakurai T, Shimogori T, Hattori N, Nukina N. Serine 403-phosphor-ylated p62/SQSTM1 immunoreactivity in inclusions of neurodegen- erative diseases.",OADS,/arxiv_data1/oa_pdf/38/74/kaup-13-01-1248018.PMC5240838.pdf
"Neurosci Res 2016; 103:64 –70; PMID:26302676; http://dx.doi.org/10.1016/j.neures.2015.08.002 [45] Kuusisto E, Salminen A, Alafuzoff I. Ubiquitin-binding protein p62 is present in neuronal and glial inclusions in human tauopathies and synucleinopathies.",OADS,/arxiv_data1/oa_pdf/38/74/kaup-13-01-1248018.PMC5240838.pdf
"Neuroreport 2001; 12:2085-90; PMID:11447312; http://dx.doi.org/10.1097/00001756-200107200-00009 [46] Watanabe Y, Ikegawa M, Naruse Y, Tanaka M. A novel splicing vari- ant form suppresses the activity of full-length signal transducer and activator of transcription 5A.",OADS,/arxiv_data1/oa_pdf/38/74/kaup-13-01-1248018.PMC5240838.pdf
"FEBS J 2009; 276:6312-23; PMID:19788420; http://dx.doi.org/10.1111/j.1742-4658.2009.07339.x [47] Tsujimura A, Taguchi K, Watanabe Y, Tatebe H, Tokuda T, Mizuno T, Tanaka M. Lysosomal enzyme cathepsin B enhances the aggregate forming activity of exogenous a-synuclein ﬁbrils.",OADS,/arxiv_data1/oa_pdf/38/74/kaup-13-01-1248018.PMC5240838.pdf
"PLoS One 2014; 9:e89327; PMID:24586691;http://dx.doi.org/10.1371/journal.pone.0089327 [49] Tatebe H, Watanabe Y, Kasai T, Mizuno T, Nakagawa M, Tanaka M, Tokuda T. Extracellular neurosin degrades a-synuclein in cultured cells.",OADS,/arxiv_data1/oa_pdf/38/74/kaup-13-01-1248018.PMC5240838.pdf
"Neurosci Res 2010; 67:341-6; PMID:20403393; http://dx.doi.org/10.1016/j.neures.2010.04.008 [50] N ’Diaye EN, Kajihara KK, Hsieh I, Morisaki H, Debnath J, Brown EJ.",OADS,/arxiv_data1/oa_pdf/38/74/kaup-13-01-1248018.PMC5240838.pdf
EMBO Rep 2009; 10:173-9;PMID:19148225; http://dx.doi.org/10.1038/embor.2008.238148 Y. WATANABE ET AL.,OADS,/arxiv_data1/oa_pdf/38/74/kaup-13-01-1248018.PMC5240838.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/5f/d5/dddt-11-185.PMC5241125.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2017:11 185–191Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  185Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S12125 4 Facilitated saliva secretion and reduced oral  inflammation by a novel artificial saliva system  in the treatment of salivary hypofunction Minkyung Kang1 hyounggeun Park1 Joon-ho Jun1 Miwon son1 Myung Joo Kang2 1Pharmaceutical Product research  Laboratories, Dong-A ST Research  institute, gyeonggi, 2Division of  Pharmaceutical sciences, college  of Pharmacy, Dankook University,   cheonan, chungnam, KoreaAbstract:  Saliva substitutes and/or lubricants are commonly employed to lessen dry mouth  symptoms by stimulating and/or substituting for the secretion of saliva.",Non-OADS,/arxiv_data1/oa_pdf/5f/d5/dddt-11-185.PMC5241125.pdf
"The artificial  saliva products available contain several inorganic salts found in human saliva and  antimicrobial agents to humidify and/or prevent bacterial infection in the dehydrated  mucosa.8–10 However, the therapeutic efficacy of artificial substitutes is often transient, correspondence: Myung Joo Kang Division of Pharmaceutical sciences,  college of Pharmacy, Dankook  University, 119 Dandae-ro, Dongnam-gu,  cheonan, chungnam 330-714, Korea Tel +82 41 550 1446 Fax +82 41 550 7899 email kangmj@dankook.ac.k r Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2017 Volume: 11 Running head verso: Kang et al Running head recto: Mucosal hydration and anti-inflammatory effect of artificial saliva DOI: http://dx.doi.org/10.2147/DDDT.S121254",Non-OADS,/arxiv_data1/oa_pdf/5f/d5/dddt-11-185.PMC5241125.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/5f/d5/dddt-11-185.PMC5241125.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/5f/d5/dddt-11-185.PMC5241125.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/46/1f/dddt-11-153.PMC5241126.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2017:11 153–162Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  153Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S11186 5 evaluation of a 2-aminoimidazole variant as  adjuvant treatment for dermal bacterial infections g logan Draughn1 c leigh allen1 Patricia a routh2 Maria r stone2 Kelly r Kirker3 laura Boegli3 ryan M schuchman1 Keith e linder2 ronald e Baynes2 garth James3 christian Melander4 angela Pollard5 John cavanagh1 1Department of Molecular and  structural Biochemistry, 2Department  of Population health and  Pathobiology, college of Veterinary  Medicine, north carolina state  University, raleigh, nc, Usa; 3center  for Biofilm engineering, Montana  state University, Bozeman, MT, Usa;   4Department of chemistry, north  carolina state University, raleigh,   nc, Usa; 5agile sciences inc.,   raleigh, nc, UsaAbstract:  2-Aminoimidazole (2-AI)-based compounds have been shown to efficiently disrupt  biofilm formation, disperse existing biofilms, and resensitize numerous multidrug-resistant  bacteria to antibiotics.",Non-OADS,/arxiv_data1/oa_pdf/46/1f/dddt-11-153.PMC5241126.pdf
"When wounds become colonized with biofilm-forming bacteria, the ability to heal  is compromised and they can become very difficult to treat.13 Leg ulcers, a common  chronic wound often found in immunocompromised patients,14 are predominantly  colonized by P. aeruginosa  (88%) and Staphylococcus aureus  (33%),3 two of the most  prevalent species found in chronic wound biofilms.15,16 Furthermore, resistance to the correspondence: John cavanagh Department of Molecular and structural  Biochemistry, north carolina state  University, 120 Broughton Drive,  room 128, Polk hall, campus Box 7622,  raleigh, nc 27695-7622, Usa Tel +1 919 513 4349 Fax +1 919 515 2047 email jcavana@ncsu.ed u Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2017 Volume: 11 Running head verso: Draughn et al Running head recto: H10 as dermal resensitizing agent DOI: http://dx.doi.org/10.2147/DDDT.S111865",Non-OADS,/arxiv_data1/oa_pdf/46/1f/dddt-11-153.PMC5241126.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/46/1f/dddt-11-153.PMC5241126.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/46/1f/dddt-11-153.PMC5241126.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/29/3d/dddt-11-163.PMC5241127.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2017:11 163–173Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  163Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S12674 3 resveratrol inhibits transforming growth factor- β2-induced epithelial-to-mesenchymal transition  in human retinal pigment epithelial cells by  suppressing the smad pathway ching-long chen1,2 Yi-hao chen1,2 Ming-cheng Tai2 chang-Min liang2 Da-Wen lu1,2 Jiann-T orng chen1,2 1graduate institute of Medical  science, national Defense Medical  center, Taipei, Taiwan; 2Department of  Ophthalmology, Tri-service general  hospital, national Defense Medical  center, Taipei, TaiwanAbstract:  Proliferative vitreoretinopathy (PVR) is the main cause of failure following retinal  detachment surgery.",Non-OADS,/arxiv_data1/oa_pdf/29/3d/dddt-11-163.PMC5241127.pdf
"Keywords:  resveratrol, epithelial-to-mesenchymal transition, proliferative vitreoretinopathy,  transforming growth factor- β2, retinal pigment epithelial cells Introduction Proliferative vitreoretinopathy (PVR), a fibrotic change process that occurs in 5%–10%  of all rhegmatogenous retinal detachments (RRDs), is the main cause of failure fol - lowing primary retinal detachment surgery because PVR leads to a secondary retinal  detachment.1 It is a clinical entity characterized by the growth and contraction of cellular  membranes within the vitreous cavity and on both surfaces of the retina after RRD;2  however, despite recent progress in surgical techniques, PVR is still the most common  cause of recurring retinal detachment because these membranes exert traction and lead  to the reopening of successfully treated retinal breaks, create new retinal breaks, and  distort the macula.2,3 Recently, anti-inflammatory compounds, antiproliferative agents,  and antigrowth factor inhibitors have been tested as major candidate drugs for the  pharmacological suppression of PVR, but their poor efficacy and multiple side effects  limit their use in adjunctive therapy.1 Therefore, investigating the mechanisms that correspondence: Jiann-Torng chen Department of Ophthalmology,  Tri-service general hospital,  national Defense Medical center,  325 cheng-Kung road, section 2,  Taipei 114, Taiwan, republic of china Tel +886 2 8792 7163 Fax +886 2 8792 7164 email jt66chen@gmail.co m Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2017 Volume: 11 Running head verso: Chen et al Running head recto: Resveratrol inhibits TGF- β2-induced EMT of human RPE cells DOI: http://dx.doi.org/10.2147/DDDT.S126743",Non-OADS,/arxiv_data1/oa_pdf/29/3d/dddt-11-163.PMC5241127.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/29/3d/dddt-11-163.PMC5241127.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/29/3d/dddt-11-163.PMC5241127.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/cb/31/dddt-11-175.PMC5241128.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/cb/31/dddt-11-175.PMC5241128.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/cb/31/dddt-11-175.PMC5241128.pdf
"The last column heading was presented as  “Golimumab 60 mg”, whereas this should have been pre - sented as “Golimumab 100 mg” as shown below:Journal name: Drug Design, Development and Therapy Article Designation: Corrigendum Y ear: 2017 Volume: 11 Running head verso: Toussirot et al Running head recto: Golimumab in radiographic and nonradiographic axial spondyloarthritis DOI: http://dx.doi.org/10.2147/DDDT.S128869 Table 1  Proportion of ASAS20 responders in the go-rAiSe and  go-AHeAD studies Study Placebo Golimumab  50 mgGolimumab  100 mg go-rAiSe, primary   end point at Week 141521.8 59.4 60 go-rAiSe, 2 years1738.5 60.1 71.4 go-AHeAD, primary   end point at Week 161640 71.1 nA Abbreviations:  ASAS, Assessment of SpondyloArthritis international Society;  nA, not available.",Non-OADS,/arxiv_data1/oa_pdf/cb/31/dddt-11-175.PMC5241128.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/49/d1/dddt-11-177.PMC5241129.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2017:11 177–184Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  177Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DDDT .S11903 6 immunotherapy for the treatment of colorectal  tumors: focus on approved and in-clinical-trial  monoclonal antibodies Alex Françoso1 Patricia Ucelli Simioni1–3 1Department of Biomedical Science,   Faculty of Americana, Americana,   2Department of Genetics, evolution  and Bioagents, institute of Biology,   University of Campinas, Campinas,   3Department of Biochemistry and  Microbiology, institute of Biosciences,   Universidade estadual Paulista, Rio  Claro, São Paulo, BrazilAbstract:  Colorectal cancer is considered a disease of the elderly population.",Non-OADS,/arxiv_data1/oa_pdf/49/d1/dddt-11-177.PMC5241129.pdf
"These mutations  involve genes such as KRAS , BRAF , PIK3CA , AKT1 , PTEN , NRAS , and TGFBR2 .9–15  Therefore, epigenetic and gene silencing events may increase the progression of Correspondence: Patricia Ucelli Simioni Faculdade de Americana, FAM, Rua  Joaquim Boer, 733, Jardim Luciene,  13477-360, Americana, São Paulo, Brazil Tel +55 19 9 9699 1899 email psimioni@gmail.co m Journal name: Drug Design, Development and Therapy Article Designation: Review Y ear: 2017 Volume: 11 Running head verso: Françoso and Simioni Running head recto: Monoclonal antibodies to colorectal tumors DOI: http://dx.doi.org/10.2147/DDDT.S119036",Non-OADS,/arxiv_data1/oa_pdf/49/d1/dddt-11-177.PMC5241129.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/49/d1/dddt-11-177.PMC5241129.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/49/d1/dddt-11-177.PMC5241129.pdf
"Interventions targeting individual-level eating  behavior changes (e.g., nutrition knowledge) have shown limited success with temporary  This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/15/49/nihms6441.PMC5241160.pdf
http://dx.doi.org/10.1111/ijcs.,OADS,/arxiv_data1/oa_pdf/15/49/nihms6441.PMC5241160.pdf
http://dx.doi.org/ 10.1080/00045601003595545 .,Non-OADS,/arxiv_data1/oa_pdf/15/49/nihms6441.PMC5241160.pdf
http://dx.doi.org/10.1093/fampra/cmn063 .,Non-OADS,/arxiv_data1/oa_pdf/15/49/nihms6441.PMC5241160.pdf
http://dx.doi.org/10.1016/ j.socscimed.2014.10.005 .,OADS,/arxiv_data1/oa_pdf/15/49/nihms6441.PMC5241160.pdf
http://dx.doi.org/10.1016/j.healthplacCe.,OADS,/arxiv_data1/oa_pdf/15/49/nihms6441.PMC5241160.pdf
http://dx.doi.org/10.1016/ j.jneb2012.05.013 .,OADS,/arxiv_data1/oa_pdf/15/49/nihms6441.PMC5241160.pdf
http://dx.doi.org/10.1007/s11524-011-9620-3 .,Non-OADS,/arxiv_data1/oa_pdf/15/49/nihms6441.PMC5241160.pdf
http://dx.doi.org/10.1377/hlthaff.2012.1294 .,Non-OADS,/arxiv_data1/oa_pdf/15/49/nihms6441.PMC5241160.pdf
http://dx.doi.org/10.1001/archinternmed.2009.545 .,Non-OADS,/arxiv_data1/oa_pdf/15/49/nihms6441.PMC5241160.pdf
2011; 26(2):e74– 85. http://dx.doi.org/10.4278/ajhp.100622-QUAL-210 .,Non-OADS,/arxiv_data1/oa_pdf/15/49/nihms6441.PMC5241160.pdf
http://dx.doi.org/10.1111/j.1467-789X.,Non-OADS,/arxiv_data1/oa_pdf/15/49/nihms6441.PMC5241160.pdf
http://dx.doi.org/10.1080/13576280110051055 .,Non-OADS,/arxiv_data1/oa_pdf/15/49/nihms6441.PMC5241160.pdf
http://dx.doi.org/10.1079/Bjn20061896 .,Non-OADS,/arxiv_data1/oa_pdf/15/49/nihms6441.PMC5241160.pdf
http://dx.doi.org/ 10.1177/1524839909341555 .,Non-OADS,/arxiv_data1/oa_pdf/15/49/nihms6441.PMC5241160.pdf
2012; 17(4):385– 401. http://dx.doi.org/10.1080/13557858.2011.645154 .,Non-OADS,/arxiv_data1/oa_pdf/15/49/nihms6441.PMC5241160.pdf
http://dx.doi.org/10.1093/epirev/mxp005 .,Non-OADS,/arxiv_data1/oa_pdf/15/49/nihms6441.PMC5241160.pdf
http://dx.doi.org/10.1017/S1368980015002165 .,Non-OADS,/arxiv_data1/oa_pdf/15/49/nihms6441.PMC5241160.pdf
http://dx.doi.org/10.1093/epirev/mxm009 .,Non-OADS,/arxiv_data1/oa_pdf/15/49/nihms6441.PMC5241160.pdf
http://dx.doi.org/ 10.1111/obr.12002 .,Non-OADS,/arxiv_data1/oa_pdf/15/49/nihms6441.PMC5241160.pdf
http://dx.doi.org/10.1057/jphp.2013.9 .,Non-OADS,/arxiv_data1/oa_pdf/15/49/nihms6441.PMC5241160.pdf
http://dx.doi.org/10.1111/j.1468-0009.2009.00550.x .,Non-OADS,/arxiv_data1/oa_pdf/15/49/nihms6441.PMC5241160.pdf
"2015. p.  12http://dx.doi.org/10.1186/S12966-015-0164-X Smith DM, Cummins S. Obese cities: how our environment shapes overweight.",Non-OADS,/arxiv_data1/oa_pdf/15/49/nihms6441.PMC5241160.pdf
http://dx.doi.org/10.1146/annurev.publhealth.29.020907.090926 .,Non-OADS,/arxiv_data1/oa_pdf/15/49/nihms6441.PMC5241160.pdf
http://dx.doi.org/ 10.1177/1524839909355519 .,Non-OADS,/arxiv_data1/oa_pdf/15/49/nihms6441.PMC5241160.pdf
http://dx.doi.org/10.1006/pmed.1999.0585 .,Non-OADS,/arxiv_data1/oa_pdf/15/49/nihms6441.PMC5241160.pdf
http://dx.doi.org/10.2105/AJPH.2008.140988 .,Non-OADS,/arxiv_data1/oa_pdf/15/49/nihms6441.PMC5241160.pdf
http://dx.doi.org/10.1089/jwh.1999.8.185 .,OADS,/arxiv_data1/oa_pdf/15/49/nihms6441.PMC5241160.pdf
http://www.ameriburn.org/ 2015NBRAnnualReport.pdf 2.,Non-OADS,/arxiv_data1/oa_pdf/fd/d1/nihms836103.PMC5241273.pdf
"Szczepienie dzieci chorych na autoimmunologiczne choroby –  Zalecenia European League Against Rhematism (EULAR) http://www.mp.pl/szczepienia/artykuly/wytyczne/71022,szczepie- nie-dzieci-chorych-na-autoimmunologiczne-choroby-reumaty-czne-zalecenia-european-league-against-rheumatism-eular",Non-OADS,/arxiv_data1/oa_pdf/de/59/RU-54-29021.PMC5241362.pdf
"Manchester, United Kingdomhttp://www.ipnc2016.org/IPNC2016AbstractBook.pdf abstract 154, p. 244.",Non-OADS,/arxiv_data1/oa_pdf/de/59/RU-54-29021.PMC5241362.pdf
Social Insurance Institution (2015) Statistical Portal http://www.psz.zus.pl/Default.aspx.,Non-OADS,/arxiv_data1/oa_pdf/3e/36/RU-54-29022.PMC5241363.pdf
"Status and structure of the population and its migration by administrative regions http://stat.gov.pl/obszary-tematyczne/ludnosc/ludnosc/ludnosc-stan-i-struk-tura-ludnosci-oraz-ruch-naturalny-w-przekroju-terytorial-nym-stan-w-dniu-30-vi-2015-r-,6,18.html Accessed 26 June 2016 Polish.",OADS,/arxiv_data1/oa_pdf/3e/36/RU-54-29022.PMC5241363.pdf
39. http://detect-pah.com/ access: 08.11.2016 40.,Non-OADS,/arxiv_data1/oa_pdf/72/08/RU-54-29025.PMC5241366.pdf
5. https://evs.nci.nih.gov/ftp1/CTCAE/CTCAE_4.03_2010-06- 14_QuickReference_5x7.pdf [accessed 18 Jul 2016]  6.,Non-OADS,/arxiv_data1/oa_pdf/c5/ed/JCB-8-28641.PMC5241374.pdf
Available from: https://www.nccn.org/professionals/phy-sician_gls/pdf/prostate.pdf  9.,Non-OADS,/arxiv_data1/oa_pdf/d7/d4/JCB-8-28863.PMC5241376.pdf
"http://statline.cbs.nl/StatWeb/publication/?DM=SLNL&PA=7052_95&D1=0,92&D2=1&D3=12-17&D4=l&HDR=G2,G1,G3&ST-B=T&VW=T.",OADS,/arxiv_data1/oa_pdf/1c/87/JCB-8-28974.PMC5241382.pdf
22. http://evs.nci.nih.gov/ftp1/CTCAE/CTCAE_4.03_2010-06-14   _QuickReference_5x7.pdf.,OADS,/arxiv_data1/oa_pdf/1c/87/JCB-8-28974.PMC5241382.pdf
http://www.farmacotherapeutischkompas.nl/default.asp.,Non-OADS,/arxiv_data1/oa_pdf/1c/87/JCB-8-28974.PMC5241382.pdf
"(2016, 06 30), retrieved from https://www.breastsurgeons.org/statements/PDF_Statements/APBI.pdf (2011).",Non-OADS,/arxiv_data1/oa_pdf/a3/ff/JCB-8-28987.PMC5241383.pdf
Available at: http://globocan.iarc.fr/Default.aspx.,Non-OADS,/arxiv_data1/oa_pdf/04/f5/JCB-8-29032.PMC5241384.pdf
"Available at: http://onkologia.org.pl/raporty/  Accessed: January 16, 2016.",Non-OADS,/arxiv_data1/oa_pdf/04/f5/JCB-8-29032.PMC5241384.pdf
"See http://cancer.sanger.ac.uk/cosmic/ signatures) The diversity in mutation patterns amongst cancer types can be illustrated by a comparison of signatures in small cell lung cancer, acute myeloid leukaemia and cutaneous melanoma.28In each of these cancer types one signature (but not the same one) contributed 485% of the total mutational burden.",Non-OADS,/arxiv_data1/oa_pdf/a8/c5/onc2016192a.PMC5241425.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/Mutation spectra in cancer etiology M Hollstein et al 167 © 2017 Macmillan Publishers Limited, part of Springer Nature.",Non-OADS,/arxiv_data1/oa_pdf/a8/c5/onc2016192a.PMC5241425.pdf
Methylation cutoff value was analyzed by survival signiﬁcance analysis using the tool Cutoff Finder (http://molpath.charite.,OADS,/arxiv_data1/oa_pdf/85/94/onc2016187a.PMC5241426.pdf
The results shown here are in part based upondata generated by the TCGA Research Network: http://cancergenome.nih.gov/.,OADS,/arxiv_data1/oa_pdf/85/94/onc2016187a.PMC5241426.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information accompanies this paper on the Oncogene website (http://www.nature.com/onc)ERK mediates EMT in pemetrexed resistance L-Y Chiu et al 253 © 2017 Macmillan Publishers Limited, part of Springer Nature.",Non-OADS,/arxiv_data1/oa_pdf/f6/7c/onc2016195a.PMC5241427.pdf
Primers and probes were designed by Roche Assay Design Center (http://qpcr.probe ﬁnder.com/organism.jsp).,OADS,/arxiv_data1/oa_pdf/b6/7b/onc2016191a.PMC5241429.pdf
"To view a copy of this license, visit http:// creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information accompanies this paper on the Oncogene website (http://www.nature.com/onc)RSPO1 and ovarian disorders M-C De Cian et al 218 Oncogene (2017) 208 –218 © 2017 Macmillan Publishers Limited, part of Springer Nature.",Non-OADS,/arxiv_data1/oa_pdf/b6/7b/onc2016191a.PMC5241429.pdf
"The embryonic zebrafish model is recom- mended as a well-established method for rapidly as - sessing the toxicity of homeopathic drugs.ISSN 2093-6966 [Print], ISSN 2234-6856 [Online] Journal of Pharmacopuncture 2016;19[4]:319-328 DOI: https://doi.org/10.3831/KPI.2016.19.033    This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/)which permits unrestricted noncommercial use, distribution, and reproduction in anymedium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4b/d5/2093-6966-v19-n04-319.PMC5241443.pdf
"Tel: +91-022-2743-2890    Fax: +91-022-2743-1094E-mail: mansibiotech79@gmail.com                  ⓒ 2016 Korean Pharmacopuncture Institute                      http://www.journal.ac Embryonic Zebrafish Model - A Well-Established  Method for Rapidly Assessing the Toxicity of  Homeopathic Drugs - Toxicity Evaluation of Homeopathic Drugs Using Zebrafish Embryo Model - Himanshu R Gupta1, Yogesh Patil2, Dipty Singh3, Mansee Thakur4* Original article Received: Sep 07, 2016       Reviewed: Dec 01, 2016     Accepted: Dec 01, 2016Key Words homeopathic medicine, homeopathy, traditional medicine,  therapeutic use, transmission electron microscope, zebraf - ish toxicity1 Department of Medical Genetics, MGMIUDBS, Mahatma Gandhi Mission Institute of Health Sciences, Kamothe, Navi Mumbai, India 2 MGMCET & Central Research Laboratory, Mahatma Gandhi Mission Institute for Health Sciences, Kamothe, Navi Mumbai, India 3 National Centre for Preclinical Reproductive and Genetic Toxicology (NIRRH), National Institute of Research in Reproductive Health  (ICMR), Jehangir Merwanji Street, Parel, Mumbai, India 4 Mahatma Gandhi Mission College of Engineering and Technology & Department of Medical Biotechnology, Central Research Laboratory,  MGM Medical College, MGMIHS, Kamothe, Navi Mumbai, India",Non-OADS,/arxiv_data1/oa_pdf/4b/d5/2093-6966-v19-n04-319.PMC5241443.pdf
All proce- dures for the maintenance and care of the zebrafish were http://www.journal.ac 320 Journal of Pharmacopuncture 2016;19[4]:319-328,OADS,/arxiv_data1/oa_pdf/4b/d5/2093-6966-v19-n04-319.PMC5241443.pdf
"http://www.journal.ac 321 Journal of Pharmacopuncture 2016;19[4]:319-328 in accordance with procedures described in the zebrafish  book [21, 22].",Non-OADS,/arxiv_data1/oa_pdf/4b/d5/2093-6966-v19-n04-319.PMC5241443.pdf
"http://www.journal.ac 322 UV-Vis, ultraviolet-visible spectrometry.",OADS,/arxiv_data1/oa_pdf/4b/d5/2093-6966-v19-n04-319.PMC5241443.pdf
"http://www.journal.ac 323 Journal of Pharmacopuncture 2016;19[4]:319-328 TEM, transmission electron microscopy; SAED, selected area electron diffraction; NPs, nanoparticles.",Non-OADS,/arxiv_data1/oa_pdf/4b/d5/2093-6966-v19-n04-319.PMC5241443.pdf
http://www.journal.ac324 Figure 5   (A) Survival and (B) hatching rate of zebrafish embryos exposed to different potencies of three homeopathic drugs at 96 hours  post-fertilization.Hatching Rate B Survival Rate AJournal of Pharmacopuncture 2016;19[4]:319-328,Non-OADS,/arxiv_data1/oa_pdf/4b/d5/2093-6966-v19-n04-319.PMC5241443.pdf
http://www.journal.ac325  Journal of Pharmacopuncture 2016;19[4]:319-328 Figure 6  Phenotypic observation and apoptotic pattern seen over the time course of exposures to homeopathic drugs at  different potencies from 4 hour to 96 hour post-fertilization.,Non-OADS,/arxiv_data1/oa_pdf/4b/d5/2093-6966-v19-n04-319.PMC5241443.pdf
326 http://www.journal.ac presence of NPs and conglomerates in all three homeo- pathic medicines at both dilutions.,Non-OADS,/arxiv_data1/oa_pdf/4b/d5/2093-6966-v19-n04-319.PMC5241443.pdf
"http://www.journal.ac327  Journal of Pharmacopuncture 2016;19[4]:319-328 Bellavite P , Andrioli G, Lussignoli S, Signorini A, Orto- lani R, Conforti A.",Non-OADS,/arxiv_data1/oa_pdf/4b/d5/2093-6966-v19-n04-319.PMC5241443.pdf
http://orcid.org/0000-0003-4743-1476.Conflict of interest  The authors declare that there are no conflicts of interest.,Non-OADS,/arxiv_data1/oa_pdf/4b/d5/2093-6966-v19-n04-319.PMC5241443.pdf
http://www.journal.ac328 17.,Non-OADS,/arxiv_data1/oa_pdf/4b/d5/2093-6966-v19-n04-319.PMC5241443.pdf
Available from: https://www.sciencebasedmedicine.org/contact-us/.Journal of Pharmacopuncture 2016;19[4]:319-328,Non-OADS,/arxiv_data1/oa_pdf/4b/d5/2093-6966-v19-n04-319.PMC5241443.pdf
To viewplease visit the journal online (http://dx.doi.org/10.1136/ oemed-2015-103334).,OADS,/arxiv_data1/oa_pdf/46/21/oemed-2015-103334.PMC5241501.pdf
See: http://creativecommons.org/ licenses/by-nc/4.0/ REFERENCES 1 Bureau of Labor Statistics.,Non-OADS,/arxiv_data1/oa_pdf/46/21/oemed-2015-103334.PMC5241501.pdf
2014. http://www.bls.gov/news.release/osh.nr0.htm (accessed 12 Jan 2015).,OADS,/arxiv_data1/oa_pdf/46/21/oemed-2015-103334.PMC5241501.pdf
2014. http://www.bls.gov/news.release/cfoi.nr0.htm (accessed 12 Jan 2015).,OADS,/arxiv_data1/oa_pdf/46/21/oemed-2015-103334.PMC5241501.pdf
2014. http://www.bls.gov/news.release/pdf/osh2.pdf (accessed 20 Mar 2015).,OADS,/arxiv_data1/oa_pdf/46/21/oemed-2015-103334.PMC5241501.pdf
2015. http://www.samhsa.gov/data/ (accessed 29 Apr 2015).,OADS,/arxiv_data1/oa_pdf/46/21/oemed-2015-103334.PMC5241501.pdf
2014. http://www.cdc.gov/nchs/hus/previous.,OADS,/arxiv_data1/oa_pdf/46/21/oemed-2015-103334.PMC5241501.pdf
2015. http://kff.org/health-reform/fact-sheet/ preventive-services-covered-by-private-health-plans/ (accessed 21 Jul 2015).,Non-OADS,/arxiv_data1/oa_pdf/46/21/oemed-2015-103334.PMC5241501.pdf
2015. http://www.wellsource.com/ health-risk-assessments.html (accessed 3 Apr 2015).,Non-OADS,/arxiv_data1/oa_pdf/46/21/oemed-2015-103334.PMC5241501.pdf
"From the questionnaires wecollect at inclusion and during follow-up data on current andlifelong occupational exposure to chemical, physical and bio-logical agents, postural, mechanical and organisational con-straints and stress at work (http://www.constances.fr/espace-scienti ﬁque/questionnaires.php).",OADS,/arxiv_data1/oa_pdf/0f/2a/oemed-2016-103678.PMC5241503.pdf
Thematerial needed for applying can be downloaded from theCONSTANCES website: http://www.constances.fr/index_EN.php#propose.,OADS,/arxiv_data1/oa_pdf/0f/2a/oemed-2016-103678.PMC5241503.pdf
More than 60 pro- jects covering a wide range of topics were already proposed andapproved by the Scienti ﬁc Committee; the full list is available at: http://www.constances.fr/espace-scienti ﬁque/projets-valides.,Non-OADS,/arxiv_data1/oa_pdf/0f/2a/oemed-2016-103678.PMC5241503.pdf
"First it covers only salaried workers excluding agricultural and self-employedworkers; however a collaboration was established with theCOSET project managed by the Occupational HealthDepartment of the National Institute for Health Surveillance,which is currently setting up two complementary cohorts, oneof agricultural workers and one of self-employed persons which were designed in a way that data sharing with CONSTANCESwill be possible (http://www.invs.sante.fr/Dossiers-thematiques/T ravail-et-sante/Coset-Cohortes-pour-la-surveillance-epidemiolo-gique-en-lien-avec-le-travail).",Non-OADS,/arxiv_data1/oa_pdf/0f/2a/oemed-2016-103678.PMC5241503.pdf
"Another limitation is the voluntary participation of the cohort members and the low participation rate (7.3%), the same orderof magnitude as other similar cohorts, like UK Biobank inwhich the participation rate is 5.47% (http://www.jpi-dataproject.eu/Home/Database/56?topicId=1).",Non-OADS,/arxiv_data1/oa_pdf/0f/2a/oemed-2016-103678.PMC5241503.pdf
See: http://creativecommons.org/ licenses/by-nc/4.0/ REFERENCES 1 Lynge E. From cross-sectional survey to cohort study.,Non-OADS,/arxiv_data1/oa_pdf/0f/2a/oemed-2016-103678.PMC5241503.pdf
"14 http://www.gazel.inserm.fr 15 Goldberg M, Leclerc A, Bonenfant S, et al.",Non-OADS,/arxiv_data1/oa_pdf/0f/2a/oemed-2016-103678.PMC5241503.pdf
"32 http://www.cnav.fr/33 Lenormand F. Le Système d ’information de l ’assurance maladie, le SNIIRAM et les échantillons de béné ﬁciaires.",Non-OADS,/arxiv_data1/oa_pdf/0f/2a/oemed-2016-103678.PMC5241503.pdf
"34 http://www.cepidc.vesinet.inserm.fr/ 35 Siegrist J, Wege N, Pühlhofer F, et al.",Non-OADS,/arxiv_data1/oa_pdf/0f/2a/oemed-2016-103678.PMC5241503.pdf
36 http://www.ilo.org/public/english/bureau/stat/isco/index.htm 37 http://unstats.un.org/unsd/cr/registry/regcst.asp?Cl=838 http://www.insee.fr/fr/methodes/default.asp?page=nomenclatures/pcs2003/pcs2003.,Non-OADS,/arxiv_data1/oa_pdf/0f/2a/oemed-2016-103678.PMC5241503.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source: Invited manuscript Correspondence to: Jamal A Ibdah, MD, PhD, Professor,  Director, Division of Gastroenterology and Hepatology,  Department of Internal Medicine, University of Missouri- Columbia, 1 University Blvd, Columbia, MO 65212,  United States.",Non-OADS,/arxiv_data1/oa_pdf/c7/01/WJGO-9-1.PMC5241522.pdf
World  J Gastrointest Oncol  2017; 9(1): 1-3  Available from: URL: http:// www.wjgnet.com/1948-5204/full/v9/i1/1.htm  DOI: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c7/01/WJGO-9-1.PMC5241522.pdf
1 Hepatocellular carcinoma (HCC) is most common in Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 0.425/wjgo.v9.i.World J Gastrointest Oncol   207 January 5; 9(): -3 ISSN 948-5204 (online) © 207 Baishideng Publishing Group Inc. All rights reserved.,Non-OADS,/arxiv_data1/oa_pdf/c7/01/WJGO-9-1.PMC5241522.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/c7/01/WJGO-9-1.PMC5241522.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ Manuscript source: Invited manuscript Correspondence to: Keitaro Hayashi, PhD, Associate  Professor, Department of Pharmacology and Toxicology, Dokkyo  Medical University School of Medicine, 880 Kitakobayashi,  Mibu, Shimotsuga, Tochigi 321-0293,  Japan.",Non-OADS,/arxiv_data1/oa_pdf/ce/03/WJGO-9-21.PMC5241523.pdf
World J  Gastrointest Oncol  2017; 9(1): 21-29  Available from: URL: http:// www.wjgnet.com/1948-5204/full/v9/i1/21.htm  DOI: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ce/03/WJGO-9-21.PMC5241523.pdf
Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.4251/wjgo.v9.i1.21World J Gastrointest Oncol   2017 January 15; 9(1): 21-29 ISSN 1948-5204 (online) © 2017 Baishideng Publishing Group Inc. All rights reserved.,Non-OADS,/arxiv_data1/oa_pdf/ce/03/WJGO-9-21.PMC5241523.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/ce/03/WJGO-9-21.PMC5241523.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Cosimo Sperti, MD, Department of  Surgery, Oncology and Gastroenterology, 3rd Surgical Clinic,  University of Padua, via Giustiniani 2, 35128 Padova,  Italy.",Non-OADS,/arxiv_data1/oa_pdf/48/77/WJGO-9-30.PMC5241524.pdf
"Thus, pancreatec - tomy in 80 years and old er patients, should be performed  after careful consideration of potential benefit, surgical  risk, and patient’s preferences.Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.4251/wjgo.v9.i1.30World J Gastrointest Oncol   2017 January 15; 9(1): 30-36 ISSN 1948-5204 (online) © 2017 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/48/77/WJGO-9-30.PMC5241524.pdf
World J  Gastrointest Oncol  2017; 9(1): 30-36  Available from: URL: http:// www.wjgnet.com/1948-5204/full/v9/i1/30.htm  DOI: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/48/77/WJGO-9-30.PMC5241524.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/48/77/WJGO-9-30.PMC5241524.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source: Invited manuscript Correspondence to:  Marco Falasca, PhD, Professor, Head  of Metabolic Signalling Group, School of Biomedical Sciences,  Curtin Health Innovation Research Institute, Curtin University,  Kent Street, Bentley, Perth, Western Australia 6102,  Australia.",Non-OADS,/arxiv_data1/oa_pdf/42/fb/WJGO-9-37.PMC5241525.pdf
World J Gastrointest Oncol   2017; 9(1): 37-41  Available from: URL: http://www.wjgnet.,Non-OADS,/arxiv_data1/oa_pdf/42/fb/WJGO-9-37.PMC5241525.pdf
com/1948-5204/full/v9/i1/37.htm  DOI: http://dx.doi.org/10.4251/ wjgo.v9.i1.,Non-OADS,/arxiv_data1/oa_pdf/42/fb/WJGO-9-37.PMC5241525.pdf
37Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.4251/wjgo.v9.i1.37World J Gastrointest Oncol   2017 January 15; 9(1): 37-41 ISSN 1948-5204 (online) © 2017 Baishideng Publishing Group Inc. All rights reserved.,Non-OADS,/arxiv_data1/oa_pdf/42/fb/WJGO-9-37.PMC5241525.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/42/fb/WJGO-9-37.PMC5241525.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to:  Esther Una Cidon, MD, PhD, Medical  Oncologist, Department of Medical Oncology, Royal Bournemouth  Hospital, Castle Lane East, Castle Ln E, Bournemouth BH5 2AZ,  United Kingdom.",Non-OADS,/arxiv_data1/oa_pdf/0a/d0/WJGO-9-4.PMC5241526.pdf
"Several new drugs, antiangiogenics, Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.251/wjgo.v9.i1.World J Gastrointest Oncol   2017 January 15; 9(1): -20 ISSN 198-520 (online) © 2017 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/0a/d0/WJGO-9-4.PMC5241526.pdf
World J Gastrointest Oncol  2017; 9(1): 4-20  Available  from: URL: http://www.wjgnet.com/1948-5204/full/v9/i1/4.htm   DOI: http://dx.doi.org/10.4251/wjgo.v9.i1.,Non-OADS,/arxiv_data1/oa_pdf/0a/d0/WJGO-9-4.PMC5241526.pdf
"Available from: URL: http://www.ascopost.com/News/18640 80 Y ao JC , Fazio N, Singh S, Buzzoni R, Carnaghi C, Wolin E, Tomasek  J, Raderer M, Lahner H, V oi M, Pacaud LB, Rouyrre N, Sachs C,  V alle JW, Delle Fave G, V an Cutsem E, Tesselaar M, Shimada Y , Oh  DY , Strosberg J, Kulke MH, Pavel ME.",Non-OADS,/arxiv_data1/oa_pdf/0a/d0/WJGO-9-4.PMC5241526.pdf
"Available from: URL:  http://www.onclive.com/conference-coverage/nanets-2015/lu- dotatate-shows-unprecedented-pfs-in-midgut-nets 123 Strosberg JR , Edward M. Wolin, Beth Chasen, Matthew H. Kulke,  David L Bushnell, Martyn E. Caplin, Richard P. Baum, Pamela  L. Kunz, Timothy J. Hobday, Andrew Eugene Hendifar, Kjell E.  Oberg, Maribel Lopera Sierra, Dik J. Kwekkeboom, Philippe B.  NETTER-1 phase III: Progression-free survival, radiographic  response, and preliminary overall survival results in patients with  midgut neuroendocrine tumors treated with 177-Lu-Dotatate.",Non-OADS,/arxiv_data1/oa_pdf/0a/d0/WJGO-9-4.PMC5241526.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/0a/d0/WJGO-9-4.PMC5241526.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscriptCorrespondence to: Ioannis A Voutsadakis, MD, PhD,  Division of Medical Oncology, Department of Internal Medicine,  Sault Area Hospital, Sault Ste Marie , Sault Ste.",Non-OADS,/arxiv_data1/oa_pdf/14/81/WJGO-9-42.PMC5241527.pdf
RESULTS  A significant difference was present between the two  groups in regards to pathologic response with patients  with lower platele t counts being more likely to exhibit a Retrospective StudySubmit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.4251/wjgo.v9.i1.42World J Gastrointest Oncol   2017 January 15; 9(1): 42-49 ISSN 1948-5204 (online) © 2017 Baishideng Publishing Group Inc. All rights reserved.,Non-OADS,/arxiv_data1/oa_pdf/14/81/WJGO-9-42.PMC5241527.pdf
World J Gastrointest Oncol  2017; 9(1): 42-49   Available from: URL: http://www.wjgnet.com/1948-5204/full/ v9/i1/42.htm  DOI: http://dx.doi.org/10.4251/wjgo.v9.i1.,Non-OADS,/arxiv_data1/oa_pdf/14/81/WJGO-9-42.PMC5241527.pdf
Statistical calculations were performed with  online tools available from the Technical University of  Denmark ( http://www.iscc-serv2.imm.dtu.dk /) and a  noncommercial site ( http://www.statpages.org/ ).,OADS,/arxiv_data1/oa_pdf/14/81/WJGO-9-42.PMC5241527.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/14/81/WJGO-9-42.PMC5241527.pdf
"See: http://creativecommons.org/ licenses/by ­nc/4.0/Manuscript source:  Invited manuscript Correspondence to:  Curtis K Argo, MD, MS,  Division of  Gastroenterology and Hepatology, University of Virginia, JPA  and Lee Street, MSB 2145, PO Box 800708, Charlottesville, V A  22908, United States.",Non-OADS,/arxiv_data1/oa_pdf/29/83/WJH-9-106.PMC5241528.pdf
"In general,  Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.4254/wjh.v9.i2.106World J Hepatol   2017  January 18; 9(2): 106-113 ISSN 1948-5182 (online) © 2017 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/29/83/WJH-9-106.PMC5241528.pdf
World J Hepatol  2017; 9(2):  106­113  Available from: URL:  http://www.wjgnet.co m/1948 ­5182 / full/v9/i2/106.,Non-OADS,/arxiv_data1/oa_pdf/29/83/WJH-9-106.PMC5241528.pdf
"htm  DOI: http://dx.doi.org/10.4254/wjh.v9.i2.106 INTRODUCTION The management of septic shock has evolved since  the inception of the Surviving Sepsis Campaign and  the adoption of early goal-directed therapy, with short- term mortality rates improving markedly over the past  decade[1].",Non-OADS,/arxiv_data1/oa_pdf/29/83/WJH-9-106.PMC5241528.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/29/83/WJH-9-106.PMC5241528.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to:  Dr. Jose M Ramia,  Hepato-Pancreato- Biliary Surgical Unit, Department of Surgery, Hospital Univer - sitario de Guadalajara, c/Donantes de Sangre, s/n, 19002 Guadalajara,  Spain.",Non-OADS,/arxiv_data1/oa_pdf/20/65/WJH-9-114.PMC5241529.pdf
"The average length of stay  (pre and postoperative) was 23 d. At the follow-up, no Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.4254/wjh.v9.i2.114World J Hepatol   2017  January 18; 9(2): 114-118 ISSN 1948-5182 (online) © 2017 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/20/65/WJH-9-114.PMC5241529.pdf
World J Hepatol  2017; 9(2): 114-118  Available from:  URL:  http://www.wjgnet.co m/1948-5182 /full/v9/i2/114.,Non-OADS,/arxiv_data1/oa_pdf/20/65/WJH-9-114.PMC5241529.pdf
htm   DOI: http://dx.doi.org/10.4254/wjh.v9.i2.114 INTRODUCTION Cystic echinococcosis is a zoonotic disease that is found  worldwide.,Non-OADS,/arxiv_data1/oa_pdf/20/65/WJH-9-114.PMC5241529.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/20/65/WJH-9-114.PMC5241529.pdf
"See: http://creativecommons.org/ licenses/by ­nc/4.0/ Manuscript source:  Invited manuscript Correspondence to:  Nicola Santoro, MD, PhD,  Department of  Pediatrics, Yale University School of Medicine, 330 Cedar Street,  PO Box 208064, New Haven, CT 06520,  United States.",Non-OADS,/arxiv_data1/oa_pdf/78/7c/WJH-9-69.PMC5241530.pdf
World J Hepatol  2017; 9(2): Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.4254/wjh.v9.i2.69World J Hepatol   2017  January 18; 9(2): 69-73 ISSN 1948-5182 (online) © 2017 Baishideng Publishing Group Inc. All rights reserved.,Non-OADS,/arxiv_data1/oa_pdf/78/7c/WJH-9-69.PMC5241530.pdf
Cardiac dysfunction in obese children with NAFLD 69­73  Available from: URL:  http://www.wjgnet.co m/1948 ­5182 / full/v9/i2/69.,Non-OADS,/arxiv_data1/oa_pdf/78/7c/WJH-9-69.PMC5241530.pdf
htm  DOI: http://dx.doi.org/10.4254/wjh.v9.i2.,OADS,/arxiv_data1/oa_pdf/78/7c/WJH-9-69.PMC5241530.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/78/7c/WJH-9-69.PMC5241530.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to:  Vanessa Souza-Mello, RD, PhD,  Biomedical Centre, Institute of Biology, Department of Anatomy,  State University of Rio de Janeiro, Av.",Non-OADS,/arxiv_data1/oa_pdf/2b/f5/WJH-9-74.PMC5241531.pdf
"ANG Ⅱ interaction with angiotensin  Ⅱ receptor type 1 (AT1R) mediates pro-inflammatory  and pro-fibrogenic responses, besides enhancing the  oxidative stress, which makes the liver more prone to Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.4254/wjh.v9.i2.74World J Hepatol   2017  January 18; 9(2): 74-79 ISSN 1948-5182 (online) © 2017 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/2b/f5/WJH-9-74.PMC5241531.pdf
htm  DOI: http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2b/f5/WJH-9-74.PMC5241531.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/2b/f5/WJH-9-74.PMC5241531.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to:  Dr. Dimitrios N Samonakis,  Department  of Gastroenterology and Hepatology, University Hospital of Hera - klion, Heraklion, 71110 Crete, Greece.",Non-OADS,/arxiv_data1/oa_pdf/47/c9/WJH-9-80.PMC5241532.pdf
Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.4254/wjh.v9.i2.80World J Hepatol   2017  January 18; 9(2): 80-90 ISSN 1948-5182 (online) © 2017 Baishideng Publishing Group Inc. All rights reserved.,Non-OADS,/arxiv_data1/oa_pdf/47/c9/WJH-9-80.PMC5241532.pdf
htm  DOI: http://dx.doi.,OADS,/arxiv_data1/oa_pdf/47/c9/WJH-9-80.PMC5241532.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/47/c9/WJH-9-80.PMC5241532.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscriptCorrespondence to:  Shira Zelber-Sagi, PhD,  School of Public  Health, University of Haifa, 6 Weizmann St., Haifa 3498838,  Israel.",Non-OADS,/arxiv_data1/oa_pdf/95/45/WJH-9-91.PMC5241533.pdf
"RESULTS Fibroscan was performed on a total of 91 patients,  of which 77 had a valid examination according to the  Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.4254/wjh.v9.i2.91World J Hepatol   2017  January 18; 9(2): 91-98 ISSN 1948-5182 (online) © 2017 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/95/45/WJH-9-91.PMC5241533.pdf
"World J Hepatol  2017; 9(2):  91-98  Available from: URL:  http://www.wjgnet.com/ 1948-5182 / full/v9/i2/91.htm  DOI: http://dx.doi.org/10.4254/wjh.v9.i2.91 INTRODUCTION Nonalcoholic fatty liver disease (NAFLD) is the most  common liver disease in the developed[1] and developing  countries[2,3] with estimated prevalence of 20%-40%,  and is predicted to become the leading indication for  liver transplantation in the United States[4].",Non-OADS,/arxiv_data1/oa_pdf/95/45/WJH-9-91.PMC5241533.pdf
"MATERIALS AND METHODS We conducted a cross-sectional study among morbidly  obese patients attending the bariatric clinic at the Tel-Aviv  Medical Center between the years 2013-2014 with BMI  above 40 or above 35 plus at least one co-morbidity ( i.e.,  hypertension, type 2 diabetes, cardiovascular disease,  lung disease and respiratory disorders), according to  the Israeli Health Ministry indications published on  2013 ( http://www.health.gov.il/hozer/mr33_2013.",Non-OADS,/arxiv_data1/oa_pdf/95/45/WJH-9-91.PMC5241533.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/95/45/WJH-9-91.PMC5241533.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to:  Khalid Mumtaz, MD, MSc, Assistant  Professor,  Wexner Medical Center, Gastroenterology, Hepatology  and Nutrition Division, the Ohio State University, 410 W. 10th Ave,  Columbus, OH 43210, United States.",Non-OADS,/arxiv_data1/oa_pdf/18/9b/WJH-9-99.PMC5241534.pdf
For evaluation of mean differences between baseline Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.4254/wjh.v9.i2.99World J Hepatol   2017  January 18; 9(2): 99-105 ISSN 1948-5182 (online) © 2017 Baishideng Publishing Group Inc. All rights reserved.,Non-OADS,/arxiv_data1/oa_pdf/18/9b/WJH-9-99.PMC5241534.pdf
World J Hepatol  2017; 9(2): 99-105   Available from: URL:  http://www.wjgnet.co m/1948-5182 /full/ v9/i2/99.,Non-OADS,/arxiv_data1/oa_pdf/18/9b/WJH-9-99.PMC5241534.pdf
"htm  DOI: http://dx.doi.org/10.4254/wjh.v9.i2.99 INTRODUCTION Transjugular intrahepatic portosystemic shunts (TIPS)  play an important role in the treatment of recurrent  esophageal varices, bleeding gastric varices and re­ fractory ascites.",Non-OADS,/arxiv_data1/oa_pdf/18/9b/WJH-9-99.PMC5241534.pdf
"Available from: https://optn.transplant.hrsa.gov/data/ about­data/, Accessed September 6, 2013).",OADS,/arxiv_data1/oa_pdf/18/9b/WJH-9-99.PMC5241534.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/18/9b/WJH-9-99.PMC5241534.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Carlo N De Cecco, MD, PhD, Division of  Cardiovascular Imaging, Department of Radiology and Radiological  Science, Medical University of South Carolina, 25 Courtenay Drive,  MSC 226, Charleston, SC 29425,  United States.",Non-OADS,/arxiv_data1/oa_pdf/98/4e/WJR-9-1.PMC5241535.pdf
Key words: Cardiac magnetic resonance; T1 mapping;  Magnetic resonance angiography; T2 mapping; Four  dimensional flowWorld Journal of  Radiology WJR Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 0.4329/wjr.v9.i.World J Radiol  207 January 28; 9(): -4 ISSN 949-8470 (online) © 207 Baishideng Publishing Group Inc. All rights reserved.,Non-OADS,/arxiv_data1/oa_pdf/98/4e/WJR-9-1.PMC5241535.pdf
World J Radiol  2017; 9(1): 1-4  Available from: URL:   http://www.wjgnet.com/ 1949-8470 /full/v9/i1/1.htm  DOI: http:// dx.doi.org/10.4329/wjr.v9.i1.1 Cardiovascular magnetic resonance (CMR) has become  a fundamental tool in the diagnostic and therapeutic  pathways of several cardiac and vascular diseases.,OADS,/arxiv_data1/oa_pdf/98/4e/WJR-9-1.PMC5241535.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/98/4e/WJR-9-1.PMC5241535.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source : Invited manuscriptCorrespondence to: Rossano Girometti, MD, Institute of  Radiology, Department of Medical and Biological Sciences,  University of Udine, University Hospital “S.",Non-OADS,/arxiv_data1/oa_pdf/45/7a/WJR-9-10.PMC5241536.pdf
"RESULTS In the first group, CEUS detected renal infarction or World Journal of  Radiology WJR Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.4329/wjr.v9.i1.10World J Radiol  2017 January 28; 9(1): 10-16 ISSN 1949-8470 (online) © 2017 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/45/7a/WJR-9-10.PMC5241536.pdf
"World J Radiol  2017; 9(1): 10-16  Available from:  URL:  http://www.wjgnet.com/ 1949-8470 /full/v9/i1/10.htm  DOI:  http://dx.doi.org/10.4329/wjr.v9.i1.10 INTRODUCTION Despite technical improvements, imaging of patients  with renal function impairment (RFI) is challenging.",Non-OADS,/arxiv_data1/oa_pdf/45/7a/WJR-9-10.PMC5241536.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/45/7a/WJR-9-10.PMC5241536.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript   source:   Invited   manuscript Correspondence to: Amita Shukla-Dave, PhD, Director  Quantitative Imaging,  Department of Medical Physics, Memorial  Sloan-Kettering Cancer Center, 1275 Y ork Avenue, New Y ork, NY  10065, United States.",Non-OADS,/arxiv_data1/oa_pdf/40/ec/WJR-9-17.PMC5241537.pdf
davea@mskcc.or gWorld Journal of  Radiology WJR Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.4329/wjr.v9.i1.17World J Radiol  2017 January 28; 9(1): 17-26 ISSN 1949-8470 (online) © 2017 Baishideng Publishing Group Inc. All rights reserved.,Non-OADS,/arxiv_data1/oa_pdf/40/ec/WJR-9-17.PMC5241537.pdf
Multimodality functional imaging  using DW-MRI and 18F-FDG-PET/CT during radiation therapy  for human papillomavirus negative head and neck squamous cell  carcinoma: Meixoeiro Hospital of Vigo Experienc e. World J Radiol   2017; 9(1): 17-26  Available from: URL:  http://www.wjgnet.,Non-OADS,/arxiv_data1/oa_pdf/40/ec/WJR-9-17.PMC5241537.pdf
"com/ 1949-8470 /full/v9/i1/17.htm  DOI: http://dx.doi.org/10.4329/ wjr.v9.i1.17 INTRODUCTION The Spanish Cancer Registries reported that in 2014,  241284 new cases of cancer were diagnosed in Spain[1].",Non-OADS,/arxiv_data1/oa_pdf/40/ec/WJR-9-17.PMC5241537.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/40/ec/WJR-9-17.PMC5241537.pdf
See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Dr .,Non-OADS,/arxiv_data1/oa_pdf/02/10/WJR-9-5.PMC5241538.pdf
World  J Radiol  2017; 9(1): 5-9  Available from: URL:  http://www.wjgnet.,Non-OADS,/arxiv_data1/oa_pdf/02/10/WJR-9-5.PMC5241538.pdf
com/ 1949-8470 /full/v9/i1/5.htm  DOI: http://dx.doi.org/10.4329/ wjr.v9.i1.5World Journal of  Radiology WJR Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.4329/wjr.v9.i1.,Non-OADS,/arxiv_data1/oa_pdf/02/10/WJR-9-5.PMC5241538.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/02/10/WJR-9-5.PMC5241538.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Haris S Vasiliadis, MD, PhD, Ortho - paedie Sonnenhof, Buchserstrasse 30, 3006 Bern,  Switzerland.",Non-OADS,/arxiv_data1/oa_pdf/20/87/WJO-8-1.PMC5241539.pdf
The effect Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 0.532/wjo.v8.i.World J Orthop  207 January 8; 8(): - ISSN 228-5836 (online) © 207 Baishideng Publishing Group Inc. All rights reserved.,Non-OADS,/arxiv_data1/oa_pdf/20/87/WJO-8-1.PMC5241539.pdf
World J Orthop  2017; 8(1): 1-11   Available from: URL:  http://www.wjgnet.com/ 2218-5836 /full/v8/ i1/1.htm  DOI: http://dx.doi.org/10.5312/wjo.v8.i1.1 INTRODUCTION The prevalence of primary or idiopathic osteoarthritis  (OA) of knee and hip joints has substantially increased  in general population during the last decades.,Non-OADS,/arxiv_data1/oa_pdf/20/87/WJO-8-1.PMC5241539.pdf
"Available from: URL: http://www.nutraingredients-usa.com/ Consumer-Trends/US-glucosaminegrows- slow-lags-global-sales 21 Kubo M , Ando K, Mimura T, Matsusue Y , Mori K. Chondroitin  sulfate for the treatment of hip and knee osteoarthritis: current status  and future trends.",Non-OADS,/arxiv_data1/oa_pdf/20/87/WJO-8-1.PMC5241539.pdf
"© 2017 Baishideng Publishing Group Inc. All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/20/87/WJO-8-1.PMC5241539.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source: Invited manuscript Correspondence to:  John G Kennedy, MD, MCh, MMSc,  FRCS (Orth), Department of Foot and Ankle, Hospital for  Special Surgery, 523 East 72nd Street, Suite 507, New York, NY  10021, United States.",Non-OADS,/arxiv_data1/oa_pdf/f5/aa/WJO-8-12.PMC5241540.pdf
Key words:  Osteochondral lesions of talus; Compre - hensive review; Diagnosis; Bone marrow stimulation;  Autologous autograft transfer; Biologics  Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.5312/wjo.v8.i1.12World J Orthop  2017 January 18; 8(1): 12-20 ISSN 2218-5836 (online) © 2017 Baishideng Publishing Group Inc. All rights reserved.,Non-OADS,/arxiv_data1/oa_pdf/f5/aa/WJO-8-12.PMC5241540.pdf
World J Orthop   2017; 8(1): 12-20  Available from: URL:  http://www.wjgnet.,Non-OADS,/arxiv_data1/oa_pdf/f5/aa/WJO-8-12.PMC5241540.pdf
com/ 2218-5836 /full/v8/i1/12 .htm  DOI: http://dx.doi.org/ 10.5312 /wjo.v8.i1.12 INTRODUCTION Osteocho ndral lesions of the talus (OLT) can occur in up  to 70% of acute ankle sprains and fractures[1].,Non-OADS,/arxiv_data1/oa_pdf/f5/aa/WJO-8-12.PMC5241540.pdf
"Available from:  URL: http://www.sld.cu/galerias/pdf/sitios/anestesiologia/practical_ guidelines_blood_transfusion.pdf 55 Fortier LA , Barker JU, Strauss EJ, McCarrel TM, Cole BJ.",Non-OADS,/arxiv_data1/oa_pdf/f5/aa/WJO-8-12.PMC5241540.pdf
"© 2017 Baishideng Publishing Group Inc. All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/f5/aa/WJO-8-12.PMC5241540.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source: Invited manuscript Correspondence to:  Sulaiman Alazzawi, Specialty Registrar,   Trauma and Orthopaedic Department, Royal London Hospital,  Whitechapel Road, Whitechapel, London E1 1BB,  United Kingdom.",Non-OADS,/arxiv_data1/oa_pdf/ad/24/WJO-8-21.PMC5241541.pdf
"There are 26 bones, 33 Joints and more than 100 Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.5312/wjo.v8.i1.21World J Orthop  2017 January 18; 8(1): 21-29 ISSN 2218-5836 (online) © 2017 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/ad/24/WJO-8-21.PMC5241541.pdf
"© 2017 Baishideng Publishing Group Inc. All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/ad/24/WJO-8-21.PMC5241541.pdf
See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Unsolicited manuscript Correspondence to:  Dr. med.,Non-OADS,/arxiv_data1/oa_pdf/ce/16/WJO-8-30.PMC5241542.pdf
"When considering planning ± 1  size, the accuracy in the second group was 96% (48 of  50 patients) for the cup and 94% for the stem (47 of 50 Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.5312/wjo.v8.i1.30World J Orthop  2017 January 18; 8(1): 30-35 ISSN 2218-5836 (online) © 2017 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/ce/16/WJO-8-30.PMC5241542.pdf
"World J Orthop  2017; 8(1):  30-35  Available from: URL:  http://www.wjgnet.com/ 2218-5836 / full/v8/i1/3 0.htm  DOI: http://dx.doi.org/10.5312/wjo.v8.i1.30 INTRODUCTION Preoperative planning for elective total hip arthroplasty  (THA) is of paramount importance, irrespective of the  level of difficulty.",Non-OADS,/arxiv_data1/oa_pdf/ce/16/WJO-8-30.PMC5241542.pdf
"© 2017 Baishideng Publishing Group Inc. All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/ce/16/WJO-8-30.PMC5241542.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to:  Zoe H Dailiana, MD, PhD, Associate  Professor,  Department of Orthopaedic Surgery, Faculty of  Medicine, University of Thessalia, 3 Panepistimiou St, Biopolis,  41500 Larissa, Greece.",Non-OADS,/arxiv_data1/oa_pdf/db/79/WJO-8-36.PMC5241543.pdf
Nonunion site  palpation and ROM evaluation of the adjacent joints Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.5312/wjo.v8.i1.36World J Orthop  2017 January 18; 8(1): 36-41 ISSN 2218-5836 (online) © 2017 Baishideng Publishing Group Inc. All rights reserved.,Non-OADS,/arxiv_data1/oa_pdf/db/79/WJO-8-36.PMC5241543.pdf
World J Orthop  2017; 8(1): 36-41  Available from: URL:   http://www.wjgnet.com/ 2218-5836 /full/v8/i1/36.htm  DOI: http://dx.doi.org/10.5312/wjo.v8.i1.36 INTRODUCTION Heterotopic ossification is commonly complicating  orthopaedic procedures and trauma but its highest  incidence occurs after brain injuries.,Non-OADS,/arxiv_data1/oa_pdf/db/79/WJO-8-36.PMC5241543.pdf
"© 2017 Baishideng Publishing Group Inc. All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/db/79/WJO-8-36.PMC5241543.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source: Invited manuscript Correspondence to: Barakat Sayed El-Alfy, MD,  Assistant  Professor , Orthopedic Department, Mansoura University  Hospital, Elgomhorya Street, Mansoura City 35516,  Egypt.",Non-OADS,/arxiv_data1/oa_pdf/53/b1/WJO-8-42.PMC5241544.pdf
Key words:  Ilizarov met hods; Bone defect; Soft tissue Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.5312/wjo.v8.i1.42World J Orthop  2017 January 18; 8(1): 42-48 ISSN 2218-5836 (online) © 2017 Baishideng Publishing Group Inc. All rights reserved.,Non-OADS,/arxiv_data1/oa_pdf/53/b1/WJO-8-42.PMC5241544.pdf
World J Orthop  2017; 8(1): 42-48  Available  from: URL:  http://www.wjgn et.com/ 2218-5836 /full/v8/i1/42.htm   DOI: http://dx.doi.org/10.5312/wjo.v8.i1.42 INTRODUCTION Bone loss represe nts a true challenge for orthopedic  surgeons.,Non-OADS,/arxiv_data1/oa_pdf/53/b1/WJO-8-42.PMC5241544.pdf
"© 2017 Baishideng Publishing Group Inc. All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/53/b1/WJO-8-42.PMC5241544.pdf
"See: http://creativecommons.org/ licenses/by ­nc/4.0/ Manuscript source:  Invited manuscript Correspondence to:  J Matthias Walz, MD,  Department of  Anesthesiology and Perioperative Medicine, UMass Memorial  Healthcare, 55 Lake Avenue North, Worcester, MA 01655,  United States.",Non-OADS,/arxiv_data1/oa_pdf/d4/f1/WJO-8-49.PMC5241545.pdf
"METHODS After IRB approval and written informed consent, 20  patients aged 18 to 85 years of age undergoing > 3 Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.5312/wjo.v8.i1.49World J Orthop  2017 January 18; 8(1): 49-56 ISSN 2218-5836 (online) © 2017 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/d4/f1/WJO-8-49.PMC5241545.pdf
World J Orthop   2017; 8(1): 49 ­56  Available from: URL:  http://www.wjgnet.,Non-OADS,/arxiv_data1/oa_pdf/d4/f1/WJO-8-49.PMC5241545.pdf
com/ 2218 ­5836 /full/v8/i1/49.htm  DOI: http://dx.doi.org/ 10.5312/wjo.v8.i1.49 INTRODUCTION Over 400000 elective spine fusion surgeries are  performed annually in the United States[1].,Non-OADS,/arxiv_data1/oa_pdf/d4/f1/WJO-8-49.PMC5241545.pdf
"© 2017 Baishideng Publishing Group Inc. All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/d4/f1/WJO-8-49.PMC5241545.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/   Manuscript source: Invited manuscript Correspondence to:  Wasim Sardar Khan, Knee Fellow,  Cardiff and Vale Orthopaedic Centre, Llandough University  Hospital, Cardiff and Vale NHS Trust, Longcross Street, Cardiff  CF5 2LD, United Kingdom.",Non-OADS,/arxiv_data1/oa_pdf/53/5d/WJO-8-57.PMC5241546.pdf
RESULTS The histological findings for the nine patients showing Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.5312/wjo.v8.i1.57World J Orthop  2017 January 18; 8(1): 57-61 ISSN 2218-5836 (online) © 2017 Baishideng Publishing Group Inc. All rights reserved.,Non-OADS,/arxiv_data1/oa_pdf/53/5d/WJO-8-57.PMC5241546.pdf
World J Orthop  2017; 8(1): 57-61  Available from:  URL:  http://www.wjgnet.com/ 2218-5836 /full/v8/i1/57.htm  DOI:  http://dx.doi.org/10.5312/wjo.v8.i1.57 INTRODUCTION Revision total knee arthroplasty (TKA) is a complex  procedure that generally does not achieve the same  good results as primary knee replacement.,Non-OADS,/arxiv_data1/oa_pdf/53/5d/WJO-8-57.PMC5241546.pdf
"© 2017 Baishideng Publishing Group Inc. All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/53/5d/WJO-8-57.PMC5241546.pdf
"See: http://creativecommons.org/ licenses/by ­nc/4.0/ Manuscript source:  Unsolicited manuscript Correspondence to:  Christian Wied, MD, Department of  Orthopedic Surgery, Copenhagen University Hospital Hvidovre,  Kettegaard Alle 30, 2650 Hvidovre,  Denmark.",Non-OADS,/arxiv_data1/oa_pdf/bf/96/WJO-8-62.PMC5241547.pdf
All patients underwent a standardized  TTA procedure that was performed approximately 10  cm below the knee joint and  performed with sagittal Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.5312/wjo.v8.i1.62World J Orthop  2017 January 18; 8(1): 62-67 ISSN 2218-5836 (online) © 2017 Baishideng Publishing Group Inc. All rights reserved.,Non-OADS,/arxiv_data1/oa_pdf/bf/96/WJO-8-62.PMC5241547.pdf
wjgnet.com/ 2218 ­5836 /full/v8/i1/62.htm  DOI: http://dx.doi.,OADS,/arxiv_data1/oa_pdf/bf/96/WJO-8-62.PMC5241547.pdf
"© 2017 Baishideng Publishing Group Inc. All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/bf/96/WJO-8-62.PMC5241547.pdf
"See: http://creativecommons.org/ licenses/by ­nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Dr. Allan Abbott, PhD, Med, MSc,  Physio, Grad, Cert, Clin, Ed, BExSci,  Department of Medical  and Health Sciences, Division of Physiotherapy, Faculty of Health Sciences, Linköping University, Lasarettsgatan, SE ­58183  Linköping, Sweden.",Non-OADS,/arxiv_data1/oa_pdf/c3/d7/WJO-8-68.PMC5241548.pdf
METHODS This is an observational reliability and concurrent  validity study of adolescent referrals to the Orthopaedic  department for scoliosis screening at Karolinska Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.5312/wjo.v8.i1.68World J Orthop  2017 January 18; 8(1): 68-76 ISSN 2218-5836 (online) © 2017 Baishideng Publishing Group Inc. All rights reserved.,Non-OADS,/arxiv_data1/oa_pdf/c3/d7/WJO-8-68.PMC5241548.pdf
wjgnet.com/ 2218 ­5836 /full/v8/i1/68.htm  DOI: http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c3/d7/WJO-8-68.PMC5241548.pdf
"© 2017 Baishideng Publishing Group Inc. All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/c3/d7/WJO-8-68.PMC5241548.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source: Invited manuscript Correspondence to:  Matthew A Chin, MD,  the Department of  Orthopaedic Surgery, Hahnemann University Hospital, 245 N.  15th Street, Philadelphia, PA 19102,  United States.",Non-OADS,/arxiv_data1/oa_pdf/30/13/WJO-8-77.PMC5241549.pdf
Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.5312/wjo.v8.i1.77World J Orthop  2017 January 18; 8(1): 77-81 ISSN 2218-5836 (online) © 2017 Baishideng Publishing Group Inc. All rights reserved.,Non-OADS,/arxiv_data1/oa_pdf/30/13/WJO-8-77.PMC5241549.pdf
wjgnet.com/ 2218-5836 /full/v8/i1/77.htm  DOI: http://dx.doi.,OADS,/arxiv_data1/oa_pdf/30/13/WJO-8-77.PMC5241549.pdf
"© 2017 Baishideng Publishing Group Inc. All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/30/13/WJO-8-77.PMC5241549.pdf
"See: http://creativecommons.org/ licenses/by ­nc/4.0/ Manuscript source:  Unsolicited manuscript Correspondence to:  Enrico Pola, MD, PhD, Assistant  Professor,  Spinal Unit,  Department of Orthopaedic and  Traumatology, “A.",Non-OADS,/arxiv_data1/oa_pdf/41/96/WJO-8-82.PMC5241550.pdf
Key words:  Type II odontoid fractures; Non-union;  Anabolic therapy; Teriparatide; Fracture healingSubmit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.5312/wjo.v8.i1.82World J Orthop  2017 January 18; 8(1): 82-86 ISSN 2218-5836 (online) © 2017 Baishideng Publishing Group Inc. All rights reserved.,Non-OADS,/arxiv_data1/oa_pdf/41/96/WJO-8-82.PMC5241550.pdf
World J Orthop   2017; 8(1): 82 ­86  Available from: URL:  http://www.wjgnet.,Non-OADS,/arxiv_data1/oa_pdf/41/96/WJO-8-82.PMC5241550.pdf
com/ 2218 ­5836 /full/v8/i1/82.htm  DOI: http://dx.doi.,OADS,/arxiv_data1/oa_pdf/41/96/WJO-8-82.PMC5241550.pdf
"© 2017 Baishideng Publishing Group Inc. All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/41/96/WJO-8-82.PMC5241550.pdf
e00217 http://dx.doi.org/10.1016/j.heliyon.2016.e00217 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/1a/a6/main.PMC5241574.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/1a/a6/main.PMC5241574.pdf
Article No~e00217 2 http://dx.doi.org/10.1016/j.heliyon.2016.e00217 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/1a/a6/main.PMC5241574.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/1a/a6/main.PMC5241574.pdf
Article No~e00217 3 http://dx.doi.org/10.1016/j.heliyon.2016.e00217 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/1a/a6/main.PMC5241574.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/1a/a6/main.PMC5241574.pdf
Article No~e00217 4 http://dx.doi.org/10.1016/j.heliyon.2016.e00217 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/1a/a6/main.PMC5241574.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/1a/a6/main.PMC5241574.pdf
Data analysis was performed on Article No~e00217 5 http://dx.doi.org/10.1016/j.heliyon.2016.e00217 2405-8440/© 2017 The Authors.,OADS,/arxiv_data1/oa_pdf/1a/a6/main.PMC5241574.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/1a/a6/main.PMC5241574.pdf
Data deposition Data associated with this study has been deposited at Mendeley Data under theDOI http://dx.doi.org/10.17632/j6b9jk56pm.1 [12] .,OADS,/arxiv_data1/oa_pdf/1a/a6/main.PMC5241574.pdf
Article No~e00217 6 http://dx.doi.org/10.1016/j.heliyon.2016.e00217 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/1a/a6/main.PMC5241574.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/1a/a6/main.PMC5241574.pdf
Article No~e00217 7 http://dx.doi.org/10.1016/j.heliyon.2016.e00217 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/1a/a6/main.PMC5241574.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/1a/a6/main.PMC5241574.pdf
Article No~e00217 8 http://dx.doi.org/10.1016/j.heliyon.2016.e00217 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/1a/a6/main.PMC5241574.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/1a/a6/main.PMC5241574.pdf
Article No~e00217 9 http://dx.doi.org/10.1016/j.heliyon.2016.e00217 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/1a/a6/main.PMC5241574.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/1a/a6/main.PMC5241574.pdf
Article No~e00217 10 http://dx.doi.org/10.1016/j.heliyon.2016.e00217 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/1a/a6/main.PMC5241574.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/1a/a6/main.PMC5241574.pdf
Article No~e00217 11 http://dx.doi.org/10.1016/j.heliyon.2016.e00217 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/1a/a6/main.PMC5241574.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/1a/a6/main.PMC5241574.pdf
Article No~e00217 12 http://dx.doi.org/10.1016/j.heliyon.2016.e00217 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/1a/a6/main.PMC5241574.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/1a/a6/main.PMC5241574.pdf
"One study [21], investigated MEP amplitudes during and Article No~e00217 13 http://dx.doi.org/10.1016/j.heliyon.2016.e00217 2405-8440/© 2017 The Authors.",OADS,/arxiv_data1/oa_pdf/1a/a6/main.PMC5241574.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/1a/a6/main.PMC5241574.pdf
Article No~e00217 14 http://dx.doi.org/10.1016/j.heliyon.2016.e00217 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/1a/a6/main.PMC5241574.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/1a/a6/main.PMC5241574.pdf
"Funding statement Erhard Trillingsgaard Næss-Schmidt, Asger Roer Pedersen, Jørgen Feldbæk Nielsen, and Peter William Stubbs are supported by Hammel Neurorehabilitation Article No~e00217 15 http://dx.doi.org/10.1016/j.heliyon.2016.e00217 2405-8440/© 2017 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/1a/a6/main.PMC5241574.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/1a/a6/main.PMC5241574.pdf
"Additional information Data associated with this study has been deposited at Mendeley Data under the DOI http://dx.doi.org/10.17632/j6b9jk56pm.1 References [1]S. Patterson, R. Ferguson, Increase in calf post-occlusive blood flow and strength following short-term resistance exercise training with blood flow restriction in young women, Eur.",Non-OADS,/arxiv_data1/oa_pdf/1a/a6/main.PMC5241574.pdf
Article No~e00217 16 http://dx.doi.org/10.1016/j.heliyon.2016.e00217 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/1a/a6/main.PMC5241574.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/1a/a6/main.PMC5241574.pdf
Article No~e00217 17 http://dx.doi.org/10.1016/j.heliyon.2016.e00217 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/1a/a6/main.PMC5241574.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/1a/a6/main.PMC5241574.pdf
Article No~e00217 18 http://dx.doi.org/10.1016/j.heliyon.2016.e00217 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/1a/a6/main.PMC5241574.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/1a/a6/main.PMC5241574.pdf
"In this regard, the NADPH-dependent enzyme prostaglandin reductase-1 (PGR-1) is involved in the inactivation of http://dx.doi.org/10.1016/j.redox.2017.01.002 Received 1 December 2016; Received in revised form 30 December 2016; Accepted 3 January 2017⁎Correspondence to: Área de Bioquímica y Biología Molecular, Departamento de Biología Experimental, Facultad de Ciencias Experimentales,Experimentales, Campus Universitario “Las Lagunillas ”s/n, Universidad de Jaén, E-23071 Jaén, Spain.",Non-OADS,/arxiv_data1/oa_pdf/56/20/main.PMC5241575.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/56/20/main.PMC5241575.pdf
http://dx.doi.org/10.1016/j.niox.2016.12.009 .,OADS,/arxiv_data1/oa_pdf/56/20/main.PMC5241575.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Physical activity MeasureAccelerometryPaciﬁch e a l t h Adolescents 1.,Non-OADS,/arxiv_data1/oa_pdf/67/a2/main.PMC5241576.pdf
http://dx.doi.org/10.1016/j.pmedr.2016.12.010 2211-3355/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/67/a2/main.PMC5241576.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/67/a2/main.PMC5241576.pdf
Contents lists available at ScienceDirect Preventive Medicine Reports journal homepage: http://ees.elsevier.com/pmedr,Non-OADS,/arxiv_data1/oa_pdf/67/a2/main.PMC5241576.pdf
http://www.ipenproject.org/methods_accelerometers.html .,Non-OADS,/arxiv_data1/oa_pdf/67/a2/main.PMC5241576.pdf
This  is  an  open access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/bf/80/main.PMC5241577.pdf
"For  the administration  of  general  anesthesia,  patient  was  intubated  with http://dx.doi.org/10.1016/j.ijscr.2017.01.009 2210-2612/© 2017  The  Author(s).",Non-OADS,/arxiv_data1/oa_pdf/bf/80/main.PMC5241577.pdf
"16  (2012)  1235–1239,  http://dx.doi.org/10.1007/s11605-011-1789-y [PMID.",Non-OADS,/arxiv_data1/oa_pdf/bf/80/main.PMC5241577.pdf
"A  14  (2004)  384–389,  http://dx.doi.org/10.1089/lap.2004.14.384 [PMID.",Non-OADS,/arxiv_data1/oa_pdf/bf/80/main.PMC5241577.pdf
"64 (2016) 359–362, http://dx.doi.org/10.1007/s11748-016-0639-y [PMID.",Non-OADS,/arxiv_data1/oa_pdf/bf/80/main.PMC5241577.pdf
"22  (2016)  235–237,  http://dx.doi.org/10.1093/icvts/ ivv299  [PMID.",Non-OADS,/arxiv_data1/oa_pdf/bf/80/main.PMC5241577.pdf
"34  (2010)  472–475,  http://dx.doi.org/10.1016/j.clinimag.",OADS,/arxiv_data1/oa_pdf/bf/80/main.PMC5241577.pdf
"4  (1983)  129–137,  http://dx.doi.org/10.1007/bf02076338 [PMID.",Non-OADS,/arxiv_data1/oa_pdf/bf/80/main.PMC5241577.pdf
"Case  Rep.  9  (2015)  22–37,  http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/bf/80/main.PMC5241577.pdf
"Tatar,  O.  Ergun,  H.  Altunoglu,  T.  Tatar,  Heterotaxia  associated  with polysplenia,  BMJ  Case Rep. (2014)  2014,  http://dx.doi.org/10.1136/bcr-2014- 206358 [PMID.",Non-OADS,/arxiv_data1/oa_pdf/bf/80/main.PMC5241577.pdf
"193  (2009) 1107–1117,  http://dx.doi.org/10.2214/ajr.09.2411  [PMID.",Non-OADS,/arxiv_data1/oa_pdf/bf/80/main.PMC5241577.pdf
"7  (2014)  187–192,  http://dx.doi.org/10.4103/0974-2069.",Non-OADS,/arxiv_data1/oa_pdf/bf/80/main.PMC5241577.pdf
"Pol,  Malrotation  of  the  gut  harboring  midgut  volvulus  in  an adult  with  situs  inversus  totalis:  a  clinical  delay  and  treatment  dilemma,  BMJ Case Rep.  (2015)  2015,  http://dx.doi.org/10.1136/bcr-2015-211205  [PMID.",Non-OADS,/arxiv_data1/oa_pdf/bf/80/main.PMC5241577.pdf
"Maas,  L.  Bonavina,  C.  Rosman,  J.R. Garcia,  et  al.,  Minimally  invasive  versus  open  oesophagectomy  for  patients with oesophageal cancer:  a  multicentre,  open-label,  randomised  controlled trial,  Lancet  379  (2012)  1887–1892,  http://dx.doi.org/10.1016/s0140- 6736(12)60516-9  [PMID.",Non-OADS,/arxiv_data1/oa_pdf/bf/80/main.PMC5241577.pdf
"29  (2015) 2756–2762,  http://dx.doi.org/10.1007/s00464-014-4003-y  [PMID.",Non-OADS,/arxiv_data1/oa_pdf/bf/80/main.PMC5241577.pdf
"19  (2013)  399–408,  http://dx.doi.org/10.5761/ atcs.ra.13-00262 [PMID.",Non-OADS,/arxiv_data1/oa_pdf/bf/80/main.PMC5241577.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ac/b7/main.PMC5241578.pdf
"Despite the recent publication of the National Sleep Foundation ’s Sleep duration team recommendations [1], sleep deprivation isContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/ssciSleep Science http://dx.doi.org/10.1016/j.slsci.2016.06.006 1984-0063/ &2016 Brazilian Association of Sleep.",Non-OADS,/arxiv_data1/oa_pdf/ac/b7/main.PMC5241578.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ac/b7/main.PMC5241578.pdf
http://dx.doi.org/ 10.1016/j.sleh.2014.12.010 .,OADS,/arxiv_data1/oa_pdf/ac/b7/main.PMC5241578.pdf
Available at 〈http://www.nhtsa.gov/people/injury/drow sy_driving1/Drowsy.html#NCSDR/NHTSA 〉; [accessed 30.06.15].,Non-OADS,/arxiv_data1/oa_pdf/ac/b7/main.PMC5241578.pdf
http://dx.doi.org/10.2337/db14-1475 .,Non-OADS,/arxiv_data1/oa_pdf/ac/b7/main.PMC5241578.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Contents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/dibData in Brief http://dx.doi.org/10.1016/j.dib.2016.12.030 2352-3409/ &2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/a1/b4/main.PMC5241579.pdf
"This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).DOI of original article: http://dx.doi.org/10.1016/j.solmat.2016.11.018 nCorresponding author at: China Sunergy, No.123.",Non-OADS,/arxiv_data1/oa_pdf/a1/b4/main.PMC5241579.pdf
Supporting material Transparency data associated with this paper can be found in the online version at http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a1/b4/main.PMC5241579.pdf
"[3] 〈https://www.semilab.hu/products/si/faast-cocos-mc.https://www.semilab.hu/products/pvi/pv-2000 〉,2 0 1 6 .",OADS,/arxiv_data1/oa_pdf/a1/b4/main.PMC5241579.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6b/92/main.PMC5241580.pdf
"However,  a  computed  tomography  (CT)  showed  the sigmoid  colon  herniated  through  the  abdominal  wall  defect  with- http://dx.doi.org/10.1016/j.ijscr.2017.01.006 2210-2612/© 2017  The  Author(s).",Non-OADS,/arxiv_data1/oa_pdf/6b/92/main.PMC5241580.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/92/11/main.PMC5241581.pdf
http://dx.doi.org/10.1016/j.ijscr.2016.12.013 2210-2612/© 2017  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/92/11/main.PMC5241581.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c1/92/main.PMC5241582.pdf
"In fact, patients' experience of insomnia and their perception may have an important role in thereporting of insomnia and daily function Therefore, understandingContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/ssciSleep Science http://dx.doi.org/10.1016/j.slsci.2016.07.001 1984-0063/ &2016 Brazilian Association of Sleep.",Non-OADS,/arxiv_data1/oa_pdf/c1/92/main.PMC5241582.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).✩The study was supported by the grant number of 3002556 of Kermanshah University of Medical Sciences.,Non-OADS,/arxiv_data1/oa_pdf/c1/92/main.PMC5241582.pdf
Chrom Position Ref Alt Transcript change Protein change Consequence Allele count Allele number CADD Phred 22 40749122 G T c.402 + 1G NT Splice donor 1 121298 26.6 22 40754866 A C c.483 −2ANC Splice acceptor 1 121410 25.4 22 40755311 G A c.701 + 1G NA Splice donor 1 121412 29.4 22 40757347 G T c.862 + 1G NT Splice donor 1 121402 27.8 22 40758984 G A c.1011 −1GNA Splice acceptor 1 121408 26.6 22 40757290 T TA c.807dupA p.Arg270Thrfs*14 Frameshift 1 121406 35 22 40760901 CAG C c.1212_1213delAG p.Arg404Serfs*11 Frameshift 1 121410 36 22 40760367 C T c.1189C NT p.Gln397* Stop gained 1 115304 43 22 40760914 C T c.1222C NT p.Gln408* Stop gained 1 121412 43 22 40742635 G T c.73G NT p.Glu25* Stop gained 1 92518 38 22 40760935 AAG A c.1244_1245delAG p.Lys415Thrfs*5 Frameshift 1 121410 3522 40745835 GA G c.154delA p.Thr52Hisfs*14 Frameshift 1 119038 24.222 40742697 G A c.135G NA p.Trp45* Stop gained 1 95974 37 22 40761059 AG A c.1368 + 1delG Frameshift 2 121402 35 http://dx.doi.org/10.1016/j.ymgmr.2016.12.009 2214-4269/Published by Elsevier Inc.,Non-OADS,/arxiv_data1/oa_pdf/1a/d6/main.PMC5241583.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1a/d6/main.PMC5241583.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a4/96/main.PMC5241584.pdf
"MRI included two-dimensional multi-slice turbo spin echo T1- weighted, ﬂuid attenuated inversion recovery (FLAIR), T2-weigh- ted, and gradient-echo sequences in the axial plane, as well as aContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/ssciSleep Science http://dx.doi.org/10.1016/j.slsci.2016.06.004 1984-0063/ &2016 Brazilian Association of Sleep.",OADS,/arxiv_data1/oa_pdf/a4/96/main.PMC5241584.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a4/96/main.PMC5241584.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/2d/7e/main.PMC5241585.pdf
Contents lists available at ScienceDirect International Journal for Parasitology: Drugs and Drug Resistance journal homepage: www.elsevier.com/locate/ijpddr http://dx.doi.org/10.1016/j.ijpddr.2016.12.005 2211-3207/ ©2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/2d/7e/main.PMC5241585.pdf
"https://www.pharma.us.novartis.com/product/pi/pdf/farydak.pdf .Panic, G., Flores, D., Ingram-Sieber, K., Keiser, J., 2015.",Non-OADS,/arxiv_data1/oa_pdf/2d/7e/main.PMC5241585.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6d/d8/main.PMC5241604.pdf
"At ﬁve years-old, the child begun to show dif ﬁculties in getting up from the sitting positionContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/ssciSleep Science http://dx.doi.org/10.1016/j.slsci.2016.07.004 1984-0063/ &2016 Brazilian Association of Sleep.",Non-OADS,/arxiv_data1/oa_pdf/6d/d8/main.PMC5241604.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6d/d8/main.PMC5241604.pdf
"They can be ﬁxed or adjustable advancement, and given http://dx.doi.org/10.1016/j.slsci.2016.10.003 Received 22 June 2016; Received in revised form 9 September 2016; Accepted 14 October 2016Peer review under responsibility of Brazilian Association of Sleep.",Non-OADS,/arxiv_data1/oa_pdf/a6/bd/main.PMC5241605.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/a6/bd/main.PMC5241605.pdf
"On clinical examination, the patient showed Angle Class http://dx.doi.org/10.1016/j.slsci.2016.07.005 Received 12 December 2015; Received in revised form 5 July 2016; Accepted 21 July 2016Peer review under responsibility of Brazilian Association of Sleep.",Non-OADS,/arxiv_data1/oa_pdf/2f/74/main.PMC5241606.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/2f/74/main.PMC5241606.pdf
Supplementary material Supplementary data associated with this article can be found in the online version at http://dx.doi.org/10.1016/j.slsci.2016.07.005 .,OADS,/arxiv_data1/oa_pdf/2f/74/main.PMC5241606.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/8b/86/main.PMC5241607.pdf
"One such device, the Readiband ™(Fa- tigue Science, Honolulu, USA), is gaining popularity for its use inContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/ssciSleep Science http://dx.doi.org/10.1016/j.slsci.2016.08.003 1984-0063/ &2016 Brazilian Association of Sleep.",Non-OADS,/arxiv_data1/oa_pdf/8b/86/main.PMC5241607.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/8b/86/main.PMC5241607.pdf
Available online: 〈http://sportsci.org/re source/stats/xrely.xls 〉; 2010 [accessed 10.06.15].,Non-OADS,/arxiv_data1/oa_pdf/8b/86/main.PMC5241607.pdf
http://dx.doi.org/10.1016/j.slsci.2016.11.002 Received 6 October 2016; Received in revised form 30 October 2016; Accepted 14 November 2016Peer review under responsibility of Brazilian Association of Sleep.,Non-OADS,/arxiv_data1/oa_pdf/58/b9/main.PMC5241608.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/58/b9/main.PMC5241608.pdf
"However, it is not yet clear if the treatment of patients' sleep-related problems could result in http://dx.doi.org/10.1016/j.slsci.2016.11.003 Received 28 July 2016; Received in revised form 18 October 2016; Accepted 14 November 2016Peer review under responsibility of Brazilian Association of Sleep.",Non-OADS,/arxiv_data1/oa_pdf/cd/b6/main.PMC5241609.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/cd/b6/main.PMC5241609.pdf
Supplementary material Supplementary data associated with this article can be found in the online version at http://dx.doi.org/10.1016/j.slsci.2016.11.003 .,OADS,/arxiv_data1/oa_pdf/cd/b6/main.PMC5241609.pdf
"map of sleep insuﬃciency, 2008 〈http://www.cdc.gov/sleep/data_statistics.html 〉; [accessed 14.",OADS,/arxiv_data1/oa_pdf/cd/b6/main.PMC5241609.pdf
http://dx.doi.org/10.1016/j.slsci.2016.09.004 Received 22 February 2016; Received in revised form 5 July 2016; Accepted 22 September 2016Peer review under responsibility of Brazilian Association of Sleep.,Non-OADS,/arxiv_data1/oa_pdf/8e/a6/main.PMC5241610.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/8e/a6/main.PMC5241610.pdf
"The challenge for future research is todetermine the ultimate implication of the sleep loss e ﬀects in molecular terms to clarify the mechanistic processes involved in the impairmentof cellular functional activity, and the impact of sleep deprivation on http://dx.doi.org/10.1016/j.slsci.2016.10.006 Received 16 May 2016; Received in revised form 20 October 2016; Accepted 27 October 2016Peer review under responsibility of Brazilian Association of Sleep.",Non-OADS,/arxiv_data1/oa_pdf/c4/a8/main.PMC5241611.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/c4/a8/main.PMC5241611.pdf
"J Cachex Sarcopenia Muscle 2016. http://dx.doi.org/10.1002/jcsm.12104 , [Epub ahead of print].",Non-OADS,/arxiv_data1/oa_pdf/c4/a8/main.PMC5241611.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/76/39/main.PMC5241612.pdf
Lapse in concentration while driving.Contents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/ssciSleep Science http://dx.doi.org/10.1016/j.slsci.2016.07.002 1984-0063/ &2016 Brazilian Association of Sleep.,Non-OADS,/arxiv_data1/oa_pdf/76/39/main.PMC5241612.pdf
"This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Abbreviations: EEG, Electro Encephalogram; ROC-LOC, Right of Central & Left of Central; PSD, Power spectrum Density nCorresponding author.",Non-OADS,/arxiv_data1/oa_pdf/76/39/main.PMC5241612.pdf
[5] 〈http://physionet.org/cgi-bin/atm/ATM 〉.,Non-OADS,/arxiv_data1/oa_pdf/76/39/main.PMC5241612.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9f/10/main.PMC5241614.pdf
"Moreover, longitudinal studies suggest that enduring short sleep durations and insomnia are general risk factors for the develop- ment and non-remission of neuropsychiatric disorders, particu- larly of anxiety/depressive disorders (AND) and SUD [1,6,7,12].Contents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/ssciSleep Science http://dx.doi.org/10.1016/j.slsci.2016.08.004 1984-0063/ &2016 Brazilian Association of Sleep.",Non-OADS,/arxiv_data1/oa_pdf/9f/10/main.PMC5241614.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9f/10/main.PMC5241614.pdf
"Altogether, these ﬁndings con ﬁrmed that sleep loss resulting from http://dx.doi.org/10.1016/j.slsci.2016.10.005 Received 12 April 2016; Received in revised form 26 September 2016; Accepted 24 October 2016Peer review under responsibility of Brazilian Association of Sleep.",Non-OADS,/arxiv_data1/oa_pdf/77/b1/main.PMC5241615.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/77/b1/main.PMC5241615.pdf
Prog Brain Res 2010;185:105 –29.http://dx.doi.org/10.1016/B978-0-444-53702-7.00007-5 .,OADS,/arxiv_data1/oa_pdf/77/b1/main.PMC5241615.pdf
http://dx.doi.org/10.1038/nature04286 .,Non-OADS,/arxiv_data1/oa_pdf/77/b1/main.PMC5241615.pdf
Behav Brain Res 2009;199:61 –75.http://dx.doi.org/10.1016/j.bbr.2008.11.012 .,OADS,/arxiv_data1/oa_pdf/77/b1/main.PMC5241615.pdf
Physiol Res 2014;63(Suppl1):S237 –S249 〈http://www.ncbi.nlm.nih.gov/pubmed/24564663 〉.,Non-OADS,/arxiv_data1/oa_pdf/77/b1/main.PMC5241615.pdf
Learn Mem 2010;17:332 –6.http://dx.doi.org/10.1101/lm.1828310 .,Non-OADS,/arxiv_data1/oa_pdf/77/b1/main.PMC5241615.pdf
Hippocampus 2008;18:844 –51.http://dx.doi.org/10.1002/hipo.20444 .,Non-OADS,/arxiv_data1/oa_pdf/77/b1/main.PMC5241615.pdf
BrainRes Bull 2006;71:4 –9.http://dx.doi.org/10.1016/j.brainresbull.2006.07.015 .,OADS,/arxiv_data1/oa_pdf/77/b1/main.PMC5241615.pdf
Semin Neurol 2005;25:117 –29.http://dx.doi.org/10.1055/s-0029-1237117 .,Non-OADS,/arxiv_data1/oa_pdf/77/b1/main.PMC5241615.pdf
Sleep2003;26:117 –26.http://dx.doi.org/10.1001/archsurg.2011.121 .,OADS,/arxiv_data1/oa_pdf/77/b1/main.PMC5241615.pdf
Sleep Med Rev 2013;17:91– 103. http://dx.doi.org/10.1016/ j.smrv.2012.01.004 .,Non-OADS,/arxiv_data1/oa_pdf/77/b1/main.PMC5241615.pdf
Prim Care Clin O ﬀPract 2007;34:659 –74.http://dx.doi.org/10.1016/j.pop.2007.05.009 .,Non-OADS,/arxiv_data1/oa_pdf/77/b1/main.PMC5241615.pdf
Sleep Med Rev2000;4:277– 98.http://dx.doi.org/10.1053/smrv.1999.0074 .,Non-OADS,/arxiv_data1/oa_pdf/77/b1/main.PMC5241615.pdf
Sleep Med Rev 2001;5:423– 45.http://dx.doi.org/10.1053/smrv.2001.0157 .,Non-OADS,/arxiv_data1/oa_pdf/77/b1/main.PMC5241615.pdf
http://dx.doi.org/10.5665/sleep.1642 .,Non-OADS,/arxiv_data1/oa_pdf/77/b1/main.PMC5241615.pdf
http://dx.doi.org/10.1016/0165-1781(89)90047-4 .,OADS,/arxiv_data1/oa_pdf/77/b1/main.PMC5241615.pdf
"[22] Morin CM, Belleville G, Bélanger L, Ivers H. The insomnia severity index: psychometric indicators to detect insomnia cases and evaluate treatment response.Sleep 2011;34:601 –8.http://dx.doi.org/10.1111/j.1365-2648.2010.05394.x .",Non-OADS,/arxiv_data1/oa_pdf/77/b1/main.PMC5241615.pdf
Environ Behav 2015;47:1024 –53.http://dx.doi.org/10.1177/0013916514533189.,Non-OADS,/arxiv_data1/oa_pdf/77/b1/main.PMC5241615.pdf
SleepMed Rev 2011;15:259 –67.http://dx.doi.org/10.1016/j.smrv.2010.10.001 .,OADS,/arxiv_data1/oa_pdf/77/b1/main.PMC5241615.pdf
Philos Trans R Soc Lond B Biol Sci 2014;369:20120533. http://dx.doi.org/ 10.1098/rstb.2012.0533 .,Non-OADS,/arxiv_data1/oa_pdf/77/b1/main.PMC5241615.pdf
Nat Neurosci 2007;10:385 –92.http://dx.doi.org/ 10.1038/nn1851 .,Non-OADS,/arxiv_data1/oa_pdf/77/b1/main.PMC5241615.pdf
Sleep Med 2010;11:576 –82.http://dx.doi.org/ 10.1016/j.sleep.2010.03.009 .,OADS,/arxiv_data1/oa_pdf/77/b1/main.PMC5241615.pdf
J Clin Neurol 2012;8:130– 8.http://dx.doi.org/10.3988/jcn.2012.8.2.130 .,OADS,/arxiv_data1/oa_pdf/77/b1/main.PMC5241615.pdf
J Couns Psychol 1985;32:135 –8.http://dx.doi.org/10.1037/ 0022-0167.32.1.135 .,Non-OADS,/arxiv_data1/oa_pdf/77/b1/main.PMC5241615.pdf
Psychol Bull 2010;136:375 –89.http://dx.doi.org/10.1037/ a0018883 .S.,Non-OADS,/arxiv_data1/oa_pdf/77/b1/main.PMC5241615.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/05/78/main.PMC5241616.pdf
Event-related potential (ERP) or P300 are neurophysiological measures of arousal and information processing in the brain which may be capable of compensation during sleep loss and it that may be used to investigate the CNS nature of performance duringContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/ssciSleep Science http://dx.doi.org/10.1016/j.slsci.2016.09.001 1984-0063/ &2016 Brazilian Association of Sleep.,Non-OADS,/arxiv_data1/oa_pdf/05/78/main.PMC5241616.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/05/78/main.PMC5241616.pdf
A literature search was performed between http://dx.doi.org/10.1016/j.slsci.2016.09.003 Received 30 April 2016; Received in revised form 4 September 2016; Accepted 22 September 2016Peer review under responsibility of Brazilian Association of Sleep.,OADS,/arxiv_data1/oa_pdf/80/ab/main.PMC5241617.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/80/ab/main.PMC5241617.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b8/66/main.PMC5241618.pdf
"Following the similar trend, 87% Japanese chil- dren were reported to share the bedroom with their parents [10].Contents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/ssciSleep Science http://dx.doi.org/10.1016/j.slsci.2016.07.003 1984-0063/ &2016 Brazilian Association of Sleep.",Non-OADS,/arxiv_data1/oa_pdf/b8/66/main.PMC5241618.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b8/66/main.PMC5241618.pdf
"Subjects We included 400 subjects divided in two groups: the ﬁrst group was constructed with citizens from Xalapa City in Veracruz State and from the Clinic of Sleep Disorders in Mexico City, in Mexico, they were the http://dx.doi.org/10.1016/j.slsci.2016.10.002 Received 21 November 2015; Received in revised form 27 September 2016; Accepted 14 October 2016Peer review under responsibility of Brazilian Association of Sleep.",Non-OADS,/arxiv_data1/oa_pdf/15/23/main.PMC5241619.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/15/23/main.PMC5241619.pdf
Supplementary material Supplementary data associated with this article can be found in the online version at http://dx.doi.org/10.1016/j.slsci.2016.10.002 .,OADS,/arxiv_data1/oa_pdf/15/23/main.PMC5241619.pdf
"Neurons, glial cells, and immune cells share common intercellular signals, such ashormones, neurotransmitters, cytokines and chemokines [21,22].W e know, for instance, that all lymphoid tissue receives innervation[23,24] and pro-in ﬂammatory cytokines, such as IL-1 β, TNF- α, and http://dx.doi.org/10.1016/j.slsci.2016.10.007 Received 15 March 2016; Received in revised form 15 October 2016; Accepted 24 October 2016Peer review under responsibility of Brazilian Association of Sleep.",Non-OADS,/arxiv_data1/oa_pdf/db/e6/main.PMC5241621.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/db/e6/main.PMC5241621.pdf
"References [1] National Sleep Foundation 2016, 〈https://sleepfoundation.org/shift-work/content/ what-shift-work 〉, [accessed 20.08.16].",Non-OADS,/arxiv_data1/oa_pdf/db/e6/main.PMC5241621.pdf
"Secondary objectives were to assess delays, loss of http://dx.doi.org/10.1016/j.slsci.2016.10.009 Received 21 August 2016; Received in revised form 24 October 2016; Accepted 31 October 2016Peer review under responsibility of Brazilian Association of Sleep.",Non-OADS,/arxiv_data1/oa_pdf/57/a4/main.PMC5241622.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/57/a4/main.PMC5241622.pdf
http://dx.doi.org/10.5664/jcsm.2172 .,Non-OADS,/arxiv_data1/oa_pdf/57/a4/main.PMC5241622.pdf
A number of human studies have reported no di ﬀerence in total sleep time all through the http://dx.doi.org/10.1016/j.slsci.2016.10.008 Received 9 September 2016; Received in revised form 25 October 2016; Accepted 27 October 2016Peer review under responsibility of Brazilian Association of Sleep.,Non-OADS,/arxiv_data1/oa_pdf/90/ae/main.PMC5241623.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/90/ae/main.PMC5241623.pdf
Ca ﬀeine Chem 2012:3 –21.http://dx.doi.org/10.1039/ 9781849734752-00003 .,Non-OADS,/arxiv_data1/oa_pdf/90/ae/main.PMC5241623.pdf
Behav Brain Res 2009;205:191 –9.http://dx.doi.org/10.1016/j.bbr.2009.08.012 .,OADS,/arxiv_data1/oa_pdf/90/ae/main.PMC5241623.pdf
http://dx.doi.org/10.1038/ npp.2012.94 .,Non-OADS,/arxiv_data1/oa_pdf/90/ae/main.PMC5241623.pdf
Behav Brain Res 2012;226(1):205 –10.http://dx.doi.org/ 10.1016/j.bbr.2011.09.017 .,OADS,/arxiv_data1/oa_pdf/90/ae/main.PMC5241623.pdf
We also analysed http://dx.doi.org/10.1016/j.slsci.2016.12.004 Received 27 August 2016; Received in revised form 7 November 2016; Accepted 7 December 2016Peer review under responsibility of Brazilian Association of Sleep.,OADS,/arxiv_data1/oa_pdf/8e/35/main.PMC5241624.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/8e/35/main.PMC5241624.pdf
Through these http://dx.doi.org/10.1016/j.slsci.2016.09.002 Received 12 April 2016; Received in revised form 9 August 2016; Accepted 22 September 2016Peer review under responsibility of Brazilian Association of Sleep.,Non-OADS,/arxiv_data1/oa_pdf/ff/62/main.PMC5241625.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ff/62/main.PMC5241625.pdf
showed that a small amount of amphetamine can http://dx.doi.org/10.1016/j.slsci.2016.11.004 Received 8 September 2016; Received in revised form 16 October 2016; Accepted 21 November 2016Peer review under responsibility of Brazilian Association of Sleep.,Non-OADS,/arxiv_data1/oa_pdf/89/75/main.PMC5241626.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/89/75/main.PMC5241626.pdf
"http://dx.doi.org/10.1038/npp.2011.276 , [Epub 2011 Nov 16].",Non-OADS,/arxiv_data1/oa_pdf/89/75/main.PMC5241626.pdf
doi: 〈http://doi.org/10.1155/2015/103969 〉[Epub2015 Mar 12].,Non-OADS,/arxiv_data1/oa_pdf/89/75/main.PMC5241626.pdf
doi: 〈http://doi.org/10.1007/s00204-012-0815-5 〉[Epub2012 Mar 6].,Non-OADS,/arxiv_data1/oa_pdf/89/75/main.PMC5241626.pdf
p. 379-407. doi: 〈http://doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/89/75/main.PMC5241626.pdf
Neuron 2014;83(2):404– 16. http://dx.doi.org/10.1016/j.neuron.2014.05.043 .,OADS,/arxiv_data1/oa_pdf/89/75/main.PMC5241626.pdf
"The eﬀect could be directly in ﬂuenced by changes in the steroid pro ﬁle, as a http://dx.doi.org/10.1016/j.slsci.2016.11.001 Received 1 August 2016; Received in revised form 27 October 2016; Accepted 7 November 2016Peer review under responsibility of Brazilian Association of Sleep.",Non-OADS,/arxiv_data1/oa_pdf/af/34/main.PMC5241627.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/af/34/main.PMC5241627.pdf
Available from: 〈http://www.who.int/classi ﬁcations/ icd/ICD10Volume2_en_2010.pdf 〉[accessed 24.07.16].,OADS,/arxiv_data1/oa_pdf/af/34/main.PMC5241627.pdf
Available from: 〈http://www.nhlbi.nih.gov/ ﬁles/docs/resources/sleep/ 201101011NationalSleepDisordersResearchPlanDHHSPublication11-7820.pdf 〉 [last accessed 24.07.16].,OADS,/arxiv_data1/oa_pdf/af/34/main.PMC5241627.pdf
Available from: 〈http://www.stopbang.ca/translation/translation.php 〉[accesed 24.07.16]; 2016.,Non-OADS,/arxiv_data1/oa_pdf/af/34/main.PMC5241627.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/20/d3/omw097.PMC5241711.pdf
"REFERENCES 1.http://kdigo.org/home/guidelines/ (26 September 2016, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/20/d3/omw097.PMC5241711.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/91/98/omw096.PMC5241712.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ea/09/rjw233.PMC5241713.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/9d/5a/rjw243.PMC5241714.pdf
http://www.breastcancer.org/ symptoms/understand_bc/sta tistics .,Non-OADS,/arxiv_data1/oa_pdf/8f/89/sjw169.PMC5241715.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/3c/80/rjw234.PMC5241717.pdf
http://emedicine.medscape.,Non-OADS,/arxiv_data1/oa_pdf/3c/80/rjw234.PMC5241717.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e1/b4/rjw232.PMC5241719.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License ( http://creativecommons.org/licenses/by-nc/3.0/ ), which per- mits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/49/92/kbie-07-06-1207017.PMC5241762.pdf
"6, 490 –496 http://dx.doi.org/10.1080/21655979.2016.1207017",Non-OADS,/arxiv_data1/oa_pdf/49/92/kbie-07-06-1207017.PMC5241762.pdf
"Adv Microb Physiol 1993; 35:275-306.http://www.ncbi.nlm.nih.gov/pubmed/9892551 ; PMID:8310882; http://dx.doi.org/10.1016/S0065-2911(08)60101-0 [2] Eckert C, Xu W, Xiong W, Lynch S, Ungerer J, Tao L, Gill R, Maness PC, Yu J. Ethylene-forming enzyme andbioethylene production.",OADS,/arxiv_data1/oa_pdf/49/92/kbie-07-06-1207017.PMC5241762.pdf
Biotechnol Bio Fuels 2014; 7:1-11.http://www.pubmedcentral.nih.gov/articlerender.fcgi?,Non-OADS,/arxiv_data1/oa_pdf/49/92/kbie-07-06-1207017.PMC5241762.pdf
"artidD3946592&tool Dpmcentrez&rendertype=abstract ; PMID:24387051; http://dx.doi.org/10.1186/1754-6834-7-33 [3] Ungerer J, Tao L, Davis M, Ghirardi M, Maness PC, Yu J.",OADS,/arxiv_data1/oa_pdf/49/92/kbie-07-06-1207017.PMC5241762.pdf
"Energy Environ Sci 2012; 5:8998-9006. http://xlink.rsc.org/?DOI= c2ee22555g ; http://dx.doi.org/10.1039/c2ee22555g [4] Klamt S, Mahadevan R. On the feasibility of growth-cou- pled product synthesis in microbial strains.",OADS,/arxiv_data1/oa_pdf/49/92/kbie-07-06-1207017.PMC5241762.pdf
Metab Eng2015; 30:166-78. http://www.ncbi.nlm.nih.gov/pubmed/ 26112955 ; PMID:26112955; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/49/92/kbie-07-06-1207017.PMC5241762.pdf
"A state of the art of metabolic networks of unicellularmicroalgae and cyanobacteria for biofuel production.Metab Eng 2015; 30:49-60; PMID:25916794; http://dx.doi.org/10.1016/j.ymben.2015.03.019 [6] Guerrero F, Carbonell V, Cossu M, Correddu D, Jones PR.",OADS,/arxiv_data1/oa_pdf/49/92/kbie-07-06-1207017.PMC5241762.pdf
http://www.pubmedcentral.nih.gov/article render.fcgi?artid=3503970&to ol=pmcentrez&rendertype=ab stract ; PMID:23185630; http://dx.doi.org/10.1371/journal.,OADS,/arxiv_data1/oa_pdf/49/92/kbie-07-06-1207017.PMC5241762.pdf
"wiley.com/10.1002/elsc.201300165 ; http://dx.doi.org/ 10.1002/elsc.201300165 [8] Nedbal L, Trt /C19ılek M, Cerven /C19y J, Kom /C19arek O, Pakrasi HB.",Non-OADS,/arxiv_data1/oa_pdf/49/92/kbie-07-06-1207017.PMC5241762.pdf
"Biotechnol Bioeng2008; 100:902-10; http://www.ncbi.nlm.nih.gov/pubmed/ 18383143 ; PMID:18383143; http://dx.doi.org/10.1002/ bit.21833 [9] Sinetova MA, /C20Cerven /C19y J, Zav /C20rel T, Nedbal L. On the dynamics and constraints of batch culture growth of thecyanobacterium Cyanothece sp.",OADS,/arxiv_data1/oa_pdf/49/92/kbie-07-06-1207017.PMC5241762.pdf
"J Biotech-nol 2012; 162:148-55. http://www.ncbi.nlm.nih.gov/ pubmed/22575787 ; PMID:22575787; http://dx.doi.org/ 10.1016/j.jbiotec.2012.04.009 [10] C ̌erven /C19yJ ,S ̌etl/C19ık I, Trt /C19 ılek M, Nedbal L. Photobioreactor for cultivation and real-time, in-situ measurement of O2and CO2 exchange rates, growth dynamics, and of chlo-rophyll ﬂuorescence emission of photoautotrophic microorganisms.",OADS,/arxiv_data1/oa_pdf/49/92/kbie-07-06-1207017.PMC5241762.pdf
"wiley.com/10.1002/elsc.200800123 ; http://dx.doi.org/ 10.1002/elsc.200800123 [11] Knoop H, Zilliges Y, Lockau W, Steuer R. The metabolic network of Synechocystis sp.",OADS,/arxiv_data1/oa_pdf/49/92/kbie-07-06-1207017.PMC5241762.pdf
Plant Physiol 2010; 154:410-22. http://www.pubmedcentral.nih.gov/articlerender.fcgi?,OADS,/arxiv_data1/oa_pdf/49/92/kbie-07-06-1207017.PMC5241762.pdf
"artid=2938163&tool=pmcentrez&rendertype=abstract ; PMID:20616194; http://dx.doi.org/10.1104/pp.110.157198 [12] Zav /C20rel T, Knoop H, Steuer R, Jones PR, /C20Cerven /C19y J, Trt /C19ılek M. A quantitative evaluation of ethylene production inthe recombinant cyanobacterium Synechocystis sp.",OADS,/arxiv_data1/oa_pdf/49/92/kbie-07-06-1207017.PMC5241762.pdf
202:142-51; PMID:26708481; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/49/92/kbie-07-06-1207017.PMC5241762.pdf
"ncbi.nlm.nih.gov/pubmed/23647970 ; PMID:23647970; http://dx.doi.org/10.1016/j.copbio.2013.04.004 [14] Sarsekeyeva F, Zayadan BK, Usserbaeva A, Bedbenov VS, Sinetova MA, Los DA.",OADS,/arxiv_data1/oa_pdf/49/92/kbie-07-06-1207017.PMC5241762.pdf
"Photosynth Res 2015;125:329-40; PMID:25702086; http://dx.doi.org/10.1007/s11120-015-0103-3 [15] Gudmundsson S, Nogales J. Cyanobacteria as photosyn- thetic biocatalysts: a systems biology perspective.",OADS,/arxiv_data1/oa_pdf/49/92/kbie-07-06-1207017.PMC5241762.pdf
"DOI=C4MB00335G ; PMID:25382198; http://dx.doi.org/ 10.1039/C4MB00335G [16] Angermayr SA, Gorchs Rovira A, Hellingwerf KJ.",OADS,/arxiv_data1/oa_pdf/49/92/kbie-07-06-1207017.PMC5241762.pdf
Trends Biotechnol 2015; 33(6):352-61. http://linkinghub.elsevier.com/retrieve/pii/ S0167779915000712 [17] Jones PR.,Non-OADS,/arxiv_data1/oa_pdf/49/92/kbie-07-06-1207017.PMC5241762.pdf
"Front Microbiol2013; 4:1-14; PMID:23346082; http://dx.doi.org/10.3389/fmicb.2013.00246 [19] Fernandes BD, Mota A, Teixeira JA, Vicente AA.",OADS,/arxiv_data1/oa_pdf/49/92/kbie-07-06-1207017.PMC5241762.pdf
"BiotechnolBiofuels 2016; 9:89. http://biotechnologyforbiofuels.bio medcentral.com/articles/10.1186/s13068-016-0503-4 ; PMID:27096007; http://dx.doi.org/10.1186/s13068-016-0503-4 [22] King ZA, Lloyd CJ, Feist AM, Palsson BO.",Non-OADS,/arxiv_data1/oa_pdf/49/92/kbie-07-06-1207017.PMC5241762.pdf
"Next-genera- tion genome-scale models for metabolic engineering.Curr Opin Biotechnol 2015; 35:23-9; PMID:25575024; http://dx.doi.org/10.1016/j.copbio.2014.12.016 [23] Nogales J, Gudmundsson S, Thiele I.",OADS,/arxiv_data1/oa_pdf/49/92/kbie-07-06-1207017.PMC5241762.pdf
"pubmedcentral.nih.gov/articlerender.fcgi?artid=3669157&tool=pmcentrez&rendertype=abstract ; PMID:23138691; http://dx.doi.org/10.4161/bioe.22792 [24] Erdrich P, Knoop H, Steuer R, Klamt S. Cyanobacterial biofuels: new insights and strain design strategies revealed by computational modeling.",OADS,/arxiv_data1/oa_pdf/49/92/kbie-07-06-1207017.PMC5241762.pdf
"Microb Cell Fact2014; 13:128. http://www.pubmedcentral.nih.gov/article render.fcgi?artid=4180434&tool=pmcentrez&rendertype=abstract ; PMID:25323065; http://dx.doi.org/10.1186/ s12934-014-0128-x [25] Knoop H, Steuer R. A Computational Analysis of stoi- chiometric constraints and trade-offs in cyanobacterial biofuel production.",OADS,/arxiv_data1/oa_pdf/49/92/kbie-07-06-1207017.PMC5241762.pdf
"Front Bioeng Biotechnol 2015; 3:1- 15. http://www.frontiersin.org/Synthetic_Biology/ 10.3389/fbioe.2015.00047/abstract ; PMID:25654078; http://dx.doi.org/10.3389/fbioe.2015.00047 [26] Saha R, Liu D, Hoynes-O ’C o n n o rA ,L i b e r t o nM ,Y u J, Bhattacharyya-Pakrasi M, Balassy A, Zhang F,Moon TS, Maranas CD, et al.",OADS,/arxiv_data1/oa_pdf/49/92/kbie-07-06-1207017.PMC5241762.pdf
http://mbio.asm.org/lookup/doi/10.1128/ mBio.00464-16 ; PMID:27143387; http://dx.doi.org/ 10.1128/mBio.00464-16 [27] Final Report Summary - DIRECTFUEL (Direct bio- logical conversion of solar energy to volatile hydro-carbon fuels by engineered cyanobacteria).,OADS,/arxiv_data1/oa_pdf/49/92/kbie-07-06-1207017.PMC5241762.pdf
2014. http://cordis.europa.eu/proj ect/rcn/95914_en.html496 T. ZAV /C20REL ET AL.,Non-OADS,/arxiv_data1/oa_pdf/49/92/kbie-07-06-1207017.PMC5241762.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f4/3e/rjw235.PMC5241763.pdf
Available from http://www.cdc.,Non-OADS,/arxiv_data1/oa_pdf/25/38/55.PMC5241764.pdf
Available from http://www.ipfh.org/images/ research_materials/2012_National_Foot_ Health_Assessment_June_2012.pdf.,Non-OADS,/arxiv_data1/oa_pdf/25/38/55.PMC5241764.pdf
Available  from http://www.cms.gov/Medicare/ Quality-Initiatives-Patient-Assessment- Instruments/QualityMeasures/Downloads/ Eligible-Providers-2014-Proposed-EHR-Incentive-Program-CQM.pdf.,Non-OADS,/arxiv_data1/oa_pdf/25/38/55.PMC5241764.pdf
Available  from http://asq.org/learn-about-quality/ project-planning-tools/overview/pdca-cycle.,Non-OADS,/arxiv_data1/oa_pdf/25/38/55.PMC5241764.pdf
Available from http://www.cdc.gov/diabetes/ statistics/preventive/tneweyeexrace.htm.,Non-OADS,/arxiv_data1/oa_pdf/56/c2/66.PMC5241767.pdf
Available from http://www.publix.com/ pharmacy-wellness/pharmacy/pharmacy-   services/free-medication-program.,Non-OADS,/arxiv_data1/oa_pdf/56/c2/66.PMC5241767.pdf
Available from  http://www.nightscout.info.,Non-OADS,/arxiv_data1/oa_pdf/c7/0b/60.PMC5241770.pdf
"Diabetes Australia published  a position statement on language in  diabetes (2); the American Diabetes  Association stressed the need for  patient-centered care and person-   centered language in its Standards of  Medical Care in Diabetes—2016 , stat- ing that the word “diabetic” should  no longer be used when referring  to individuals with diabetes (3); the  Obesity Society published a statement  regarding the language of obesity (4)  and offers related online resources  (http://www.uconnruddcenter.org/ weight-bias-stigma); and the disabil - ity community has also documented  its recommendations for using People  First Language (http://www.cdc.gov/ ncbddd/disabilityandhealth/pdf/   disabilityposter_photos.pdf).",Non-OADS,/arxiv_data1/oa_pdf/c0/24/51.PMC5241771.pdf
"is currently affiliated with BioSeek  Division, DiscoverX Corp., South San  Francisco, CA https://doi.org/10.2337/cd16-0020 ©2017 by the American Diabetes Association.",Non-OADS,/arxiv_data1/oa_pdf/00/ff/27.PMC5241772.pdf
Additional information  about the journal and our submission  process can be found on our website  (http://clinical.diabetesjournals.org).,Non-OADS,/arxiv_data1/oa_pdf/14/4f/3.PMC5241773.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/5f/35/rjw241.PMC5241774.pdf
"This is an Open Access article distributed under the terms of the Creative Commons  Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc- nd/ 4.0/), which permits non-commercial reproduction and distribution of the work, in any   medium, provided the original work is not altered or transformed in any way, and that the  work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/2a/3b/ciw725.PMC5241778.pdf
Available at:  http://apps.who.int/iris/bitstream/10665/208883/1/ebolasitrep_10Jun2016_eng.,OADS,/arxiv_data1/oa_pdf/2a/3b/ciw725.PMC5241778.pdf
http://www.slamviweb.org/es/ebola/FHFfinal.pdf .,Non-OADS,/arxiv_data1/oa_pdf/2a/3b/ciw725.PMC5241778.pdf
"This is an Open Access article distributed under the terms of the Creative Com - mons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/ by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in  any medium, provided the original work is not altered or transformed in any way, and that the  work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/8d/ce/ciw730.PMC5241779.pdf
"Statistical Analysis Data were analyzed using Stata software, version 12.1 for  Windows (StataCorp, College Station, Texas) and R version  2.12.1 ( http://www.r-project.org/ ), with analyses confined to the  410 children who completed 3 years of follow-up.",OADS,/arxiv_data1/oa_pdf/8d/ce/ciw730.PMC5241779.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b8/2b/rjw239.PMC5241814.pdf
Available  from: https://www.niaidnihgov/topics/strepThroat/ Documents/groupasequelaepdf.,Non-OADS,/arxiv_data1/oa_pdf/11/31/APC-10-39.PMC5241843.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7d/65/rjw221.PMC5241890.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/10/22/djw149.PMC5241904.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/5f/d5/rjw236.PMC5241908.pdf
Available from: https://www.astrazeneca.com/media- centre/press-releases/2015/ZURAMPIC-lesinurad-approved-by-US- FDA-for-patients-with-gout-22122015.html.,Non-OADS,/arxiv_data1/oa_pdf/0e/57/JPP-7-155.PMC5242027.pdf
Available from: http://www.ema.europa.eu/docs/en_GB/ document_library/EPAR-Summary_for_the_public/human/003932/ WC500203068.pdf.,Non-OADS,/arxiv_data1/oa_pdf/0e/57/JPP-7-155.PMC5242027.pdf
Available from: http://www.fda.gov/downloads/AdvisoryCommittees/ CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/ UCM467951.pdf.,Non-OADS,/arxiv_data1/oa_pdf/0e/57/JPP-7-155.PMC5242027.pdf
Available from: https://www.shire.com/newsroom/2015/ october.,Non-OADS,/arxiv_data1/oa_pdf/a8/95/JPP-7-194.PMC5242036.pdf
Available from: https://www.shire.com/newsroom/2016/january.,Non-OADS,/arxiv_data1/oa_pdf/a8/95/JPP-7-194.PMC5242036.pdf
Available from: http://www.uptodate.com/contents/ overview-of-perioperative-nutritional-support#H1.,Non-OADS,/arxiv_data1/oa_pdf/6b/cf/NJMS-7-3.PMC5242071.pdf
"Twelve sin -Qi-fang Lina   Zi-chun Chenb  Xian-guo Fuc  Jing Yangc  Luo-yuan Caoc  Long-teng Yaoa  Yong-tong Xina   Gen-bin Huanga a Department of Internal Neurology,   Ningde Municipal Hospital,   Fujian Medical University,   Ningde, Fujian, China b Clinical Pharmacy, Ningde Municipal  Hospital, Fujian Medical University,  Ningde, Fujian, China c Laboratory of Cell and Molecular Biology,  Ningde Municipal Hospital,   Fujian Medical University,   Ningde, Fujian, ChinapISSN 1738-6586 / eISSN 2005-5013   /   J Clin Neurol 2017 ;13(1):71-76   /   https://doi.org/10.3988/jcn.2017.13.1.71 Received  May 24, 2016 Revised  September 1, 2016 Accepted  September 1, 2016 Correspondence Gen-bin Huang, MD Department of Internal Neurology, Ningde Municipal Hospital, No.13, Mindong East Road, Dongqiao District, Ningde City, Fujian 352100, ChinaTel    +86-15759312366 Fax   +86-593-2292175 E-mail    genbinhuang@sina.com cc This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Com - mercial License (http://creativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial  use, distribution, and reproduction in any medium, provided the original work is properly cited.JCN  Open Access ORIGINAL ARTICLE",Non-OADS,/arxiv_data1/oa_pdf/5c/34/jcn-13-71.PMC5242144.pdf
"7,8 However, the FFS is designed to predict the Hye-Jin Choa   Sehyo Yuneb  Jin Myoung Seokc,d   Eun Bin Choc,d  Ju-Hong Minc,d   Yeon Lim Seoe  Byung-Jae Leeb   Byoung Joon Kimc,d*  Dong-Chull Choib* a Department of Neurology,   The Catholic University of Korea   College of Medicine,   Bucheon St. Mary's Hospital,   Bucheon, Korea b Departments of Medicine, cNeurology,  and ePathology, Samsung Medical  Center, Sungkyunkwan University School of Medicine, Seoul, Korea d Neuroscience Center,   Samsung Medical Center,   Seoul, Korea pISSN 1738-6586 / eISSN 2005-5013   /   J Clin Neurol 2017 ;13(1):77-83   /   https://doi.org/10.3988/jcn.2017.13.1.77 Received  June 7, 207 Revised  October 1, 2016 Accepted  October 4, 2016 Correspondence Byoung Joon Kim, MD, PhD  Department of Neurology,  Samsung Medical Center,  Sungkyunkwan University School  of Medicine, Neuroscience Center,   Samsung Medical Center,  81 Irwon-ro, Gangnam-gu,  Seoul 06351, Korea Tel    +82-2-3410-3594 Fax   +82-2-3410-0052 E-mail    bjkim@skku.edu Dong-Chull Choi, MD, PhD Department of Medicine,   Samsung Medical Center,   Sungkyunkwan University  School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul 06351, KoreaTel    +82-2-3410-3429 Fax   +82-2-3410-3849 E-mail    dcchoi@skku.edu *These authors contributed equally   to this work.",Non-OADS,/arxiv_data1/oa_pdf/d5/ce/jcn-13-77.PMC5242145.pdf
"cc This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Com - mercial License (http://creativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial  use, distribution, and reproduction in any medium, provided the original work is properly cited.JCN  Open Access ORIGINAL ARTICLE",Non-OADS,/arxiv_data1/oa_pdf/d5/ce/jcn-13-77.PMC5242145.pdf
"Continuation of the intrathecal infection was confirmed by an ele -Gregory Youngnam Chang Department of Neurology,   UC Davis Medical Center,   Sacramento, CA, USApISSN 1738-6586 / eISSN 2005-5013   /   J Clin Neurol 2017 ;13(1):103-104   /   https://doi.org/10.3988/jcn.2017.13.1.103 Received  April 29, 2016 Revised  June 6, 2016 Accepted  June 9, 2016 Correspondence Gregory Y oungnam Chang, MD, FAAN Department of Neurology,UC Davis Medical Center, 4860 Y St. Suite 3700Sacramento, CA 95817, USATel    +1-916-734-6280 Fax   +1-916-734-6525 E-mail    gycchang@ucdavis.edu cc This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Com - mercial License (http://creativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial  use, distribution, and reproduction in any medium, provided the original work is properly cited.LETTER TO THE EDITOR",Non-OADS,/arxiv_data1/oa_pdf/74/cb/jcn-13-103.PMC5242146.pdf
"Key Words     cervical spinal surgery, long-term prognosis, motor deficit, alarm criteria,  motor-evoked potential, intraoperative monitoring.Intraoperative Motor-Evoked Potential Disappearance   versus Amplitude-Decrement Alarm Criteria During  Cervical Spinal Surgery: A Long-Term Prognosis INTRODUCTION Transcranial electric stimulation of muscle motor-evoked potentials (MEPs) is an estab - lished method for effectively detecting perioperative damage to the corticospinal tract dur - ing spinal surgery.1 Numerous alarm criteria have been suggested for monitoring intraop - erative MEP changes with the aim of preventing postoperative motor deficits, including  increases in the stimulation threshold,2 changes in MEP waveform morphology,3 MEP am- plitude decrements of 50%,4,5 70%,6,7 and 80%8 compared to baseline, and the disappearance  of MEPs.9-11 Among those, the MEP disappearance has been the primary alarm criterion Dong-Gun Kima   Young-Doo Choib   Seung-Hyun Jinb   Chi Heon Kimb   Kwang-Woo Leec   Kyung Seok Parkd   Chun Kee Chungb   Sung-Min Kime a  Department of Neurology,   Myung Diagnostic Radiology Clinic,  Seoul, Korea b  Department of Neurosurgery,   Seoul National University Hospital,   Seoul National University College   of Medicine, Seoul, Korea c  Department of Neurology,   Gachon University Gil Medical Center, Inchon, Korea d  Department of Neurology,   Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seoul, Korea e  Department of Neurology,   Seoul National University Hospital,   Seoul National University College   of Medicine, Seoul, KoreapISSN 1738-6586 / eISSN 2005-5013   /   J Clin Neurol 2017 ;13(1):38-46   /   https://doi.org/10.3988/jcn.2017.13.1.38 Received  December 3, 2015 Revised  June 19, 2016 Accepted  June 20, 2016 Correspondence Sung Min Kim, MD, PhD Department of Neurology,  Seoul National University Hospital, Seoul National University  College of Medicine, 101 Daehak-ro, Jongno-gu, Seoul 03080, Korea Tel    +82-2-2072-4902 Fax   +82-2-3672-7553 E-mail    sueh916@gmail.com Chun Kee Chung, MD, PhD Department of Neurosurgery,   Seoul National University Hospital,  Seoul National University  College of Medicine, 101 Daehak-ro,  Jongno-gu, Seoul 03080, Korea Tel    +82-2-2072-2352 Fax   +82-2-744-8459 E-mail    chungc@snu.ac.kr cc This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Com - mercial License (http://creativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial  use, distribution, and reproduction in any medium, provided the original work is properly cited.JCN  Open Access ORIGINAL ARTICLE",Non-OADS,/arxiv_data1/oa_pdf/8a/fe/jcn-13-38.PMC5242147.pdf
"· Type 2 SMA (Dubowitz disease) is an intermediate form showing less-severe symptoms.Eun-Ji Ahna*  Mi-Sun Yuma*   Eun-Hee Kimb  Han-Wook Yooa,c  Beom Hee Leea,c  Gu-Hwan Kimc  Tae-Sung Koa a Department of Pediatrics,   Asan Medical Center Children’s Hospital,  University of Ulsan College of Medicine,   Seoul, Korea b Department of Pediatrics,   CHA Gangnam Medical Center,   CHA University, Seoul, Korea c Department of Medical Genetics,   Asan Medical Center Children’s Hospital, University of Ulsan College of Medicine, Seoul, KoreapISSN 1738-6586 / eISSN 2005-5013   /   J Clin Neurol 2017 ;13(1):27-31   /   https://doi.org/10.3988/jcn.2017.13.1.27 Received  April 14, 2016 Revised  June 2, 2016 Accepted  June 2, 2016 Correspondence Tae-Sung Ko, MD, PhD Department of Pediatrics,  Asan Medical Center Children’s Hospital, University of Ulsan College   of Medicine, 88 Olympic-ro, 43-gil, Songpa-gu, Seoul 05505, KoreaTel    +82-2-3010-3381 Fax   +82-2-473-3725 E-mail    tsko@amc.seoul.kr *These authors contributed equally to  this work.",Non-OADS,/arxiv_data1/oa_pdf/3d/c4/jcn-13-27.PMC5242148.pdf
"cc This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Com - mercial License (http://creativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial  use, distribution, and reproduction in any medium, provided the original work is properly cited.JCN  Open Access ORIGINAL ARTICLE",Non-OADS,/arxiv_data1/oa_pdf/3d/c4/jcn-13-27.PMC5242148.pdf
"4 Similar to CAS-related procedures for reducing cerebral microembolisms during Jun Gyo Gwona  Tae-Won Kwona  Yong-Pil Choa  Dong-Wha Kangb  Youngjin Hana  Minsu Noha  a Departments of Surgery,  b Neurology, University of Ulsan   College of Medicine,   Asan Medical Center, Seoul, KoreapISSN 1738-6586 / eISSN 2005-5013   /   J Clin Neurol 2017 ;13(1):32-37   /   https://doi.org/10.3988/jcn.2017.13.1.32 Received  March 17, 2016 Revised  June 1, 2016 Accepted  June 2, 2016 Correspondence Tae-Won Kwon, MD, PhD Department of Surgery,  University of Ulsan College of Medicine, Asan Medical Center,  88 Olympic-ro 43-gil, Songpa-gu,   Seoul 05505, KoreaTel    +82-2-3010-3492 Fax   +82-2-3010-6701 E-mail    twkwon2@amc.seoul.kr cc This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Com - mercial License (http://creativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial  use, distribution, and reproduction in any medium, provided the original work is properly cited.JCN  Open Access ORIGINAL ARTICLE",Non-OADS,/arxiv_data1/oa_pdf/bb/bb/jcn-13-32.PMC5242149.pdf
"The c.14372-2A>G variant has pre - viously been reported as a pathogenic variant, 3 while the c.102523C>T (p.Arg34175 *) vari- ant is a novel truncating variant that was not found in 298 healthy controls, the dbSNP138 Hyung Jun Parka  Jung Hwan Leeb  Se Hoon Kimc  Ji-Man Hongb  Ha Young Shinb   Seung Min Kimb  Ji Hyun Leed  Kee Duk Parka  Young-Chul Choib a Department of Neurology,   Mokdong Hospital, Ewha Womans  University School of Medicine,   Seoul, Korea b Departments of Neurology and  cPathology, Yonsei University    College of Medicine, Seoul, Korea d Department of Clinical Pharmacology  and Therapeutics, College of Medicine, Kyung Hee University, Seoul, KoreapISSN 1738-6586 / eISSN 2005-5013   /   J Clin Neurol 2017 ;13(1):116-118   /   https://doi.org/10.3988/jcn.2017.13.1.116 Received  July 22, 2016 Revised  August 14, 2016 Accepted  August 16, 2016 Correspondence Y oung-Chul Choi, MD, PhD Department of Neurology,  Gangnam Severance Hospital,  Y onsei University College of Medicine, 211 Eonju-ro, Gangnam-gu,  Seoul 06273, KoreaTel    +82-2-2019-3323 Fax   +82-2-3462-5904 E-mail    ycchoi@yuhs.ac cc This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Com - mercial License (http://creativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial  use, distribution, and reproduction in any medium, provided the original work is properly cited.JCN  Open Access LETTER TO THE EDITOR",Non-OADS,/arxiv_data1/oa_pdf/3a/ca/jcn-13-116.PMC5242150.pdf
Supplementary Materials The online-only Data Supplement is available with this article  at https://doi.org/10.3988/jcn.2017.13.1.116.Conflicts of Interest The authors have no financial conflicts of interest.,Non-OADS,/arxiv_data1/oa_pdf/3a/ca/jcn-13-116.PMC5242150.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/3a/ca/jcn-13-116.PMC5242150.pdf
"1 Further - more, even when a cyst has previously been resected, it is important to consider the risk of Pauline Joy F Santos   Shuichi Suzuki   Sumeet Vadera Department of Neurosurgery and   Neurology, University of California,   Irvine Medical Center, CA, USApISSN 1738-6586 / eISSN 2005-5013   /   J Clin Neurol 2017 ;13(1):114-115   /   https://doi.org/10.3988/jcn.2017.13.1.114 Received  June 7, 2016 Revised  August 9, 2016 Accepted  August 9, 2016 Correspondence Pauline Joy F Santos, BA Department of Neurosurgery and  Neurology, University of California, Irvine Medical Center,  101 The City Drive, Bldg 200,  Suite 210, Orange, CA 92868, USATel    +1-714-456-6966 Fax   +1-714-456-8284 E-mail       p jsantos@uci.educc This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Com - mercial License (http://creativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial  use, distribution, and reproduction in any medium, provided the original work is properly cited.LETTER TO THE EDITOR",Non-OADS,/arxiv_data1/oa_pdf/96/bc/jcn-13-114.PMC5242151.pdf
"2,3 We suggest that the clinical benefit of the  BOTOX may last for more than 3 months, which is known to be its pharmacological dura -Jung-Ick Byuna   Ji-Young Simb,c  Manho Kimb,c,d a Department of Neurology,   KyeongHee University Hospital   at Gangdong, Seoul, Korea b Department of Neurology,   Seoul National University Hospital,   Seoul, Korea c Neuroscience and dProtein Metabolism  Research Center, Seoul National  University College of Medicine,   Seoul, KoreapISSN 1738-6586 / eISSN 2005-5013 / J Clin Neurol 2017 ;13(1):98-100 / https://doi.org/10.3988/jcn.2017.13.1.98 Received  January 4, 2016 Revised  June 7, 2016 Accepted  June 9, 2016 Correspondence Manho Kim, MD, PhD Department of Neurology,  Seoul National University Hospital, Neuroscience and Protein Metabolism Research Center, College of Medicine,Seoul National University, 101 Daehak-ro, Jongno-gu, Seoul 03080, KoreaTel    +82-2-2072-1878 Fax    +82-2-2072-7424 E-mail    kimmanho@snu.ac.kr cc This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Com - mercial License (http://creativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial  use, distribution, and reproduction in any medium, provided the original work is properly cited.JCN Open Access LETTER TO THE EDITOR",Non-OADS,/arxiv_data1/oa_pdf/ed/44/jcn-13-98.PMC5242152.pdf
Available from:  http://www.asianplasticsurgeryguide.com/overview/asianeuropean - face.html.,Non-OADS,/arxiv_data1/oa_pdf/ed/44/jcn-13-98.PMC5242152.pdf
"These are mostly sequence  mutations, with also some copy-number variants.3 Although other genes have been recently  found to be related to DS, including GABRG2, SCN1B, GABRA1, STXBP1, PCDH19, and  CHD2,4,5 SCN1A is still the most clinically relevant gene in DS, with more than 1,000 SC- N1A variants having been identified.6 However, inconsistent correlations between specific Thi Thu Hang Doa*  Diem My Vub*  Thi Thuy Kieu Huynhc*  Thi Khanh Van Lec  Eun-Hwa Sohnd  Thieu Mai Thao Lee   Huu Hao Haf  Chi Bao Buib a Research Center for Genetics and  Reproductive Health, School of Medicine,  Vietnam National University HCMC,   Ho Chi Minh City, Vietnam b Center for Molecular Biomedicine,  University of Medicine and Pharmacy   HCMC, Ho Chi Minh City, Vietnam c Neurology Department,   Children Hospital 2,   Ho Chi Minh City, Vietnam d Department of Herbal Medicine   Resource, Institute of Bioscience and Biotechnology, Kangwon National   University, Samcheok, Korea e Department of Laboratory Medicine,    Faculty of Nursing and Medical   Technology, Pham Ngoc Thach   University of Medicine, Ho Chi Minh City,  Vietnam f National Institute of Forensic Medicine,  Hanoi, VietnampISSN 1738-6586 / eISSN 2005-5013   /   J Clin Neurol 2017 ;13(1):62-70   /   https://doi.org/10.3988/jcn.2017.13.1.62 cc This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Com - mercial License (http://creativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial  use, distribution, and reproduction in any medium, provided the original work is properly cited.JCN  Open Access ORIGINAL ARTICLE Received  July 7, 2016 Revised  August 18, 2016 Accepted  August 18, 2016 Correspondence Thi Thu Hang Do, PhD  Research Center for Genetics and Reproductive Health, School  of Medicine, Vietnam National  University HCMC,  Ward 6, Thu Duc District,  Ho Chi Minh City, VietnamTel    +84-8-37242160 Fax   +84-8-37242188 E-mail    hangdo009@gmail.com *These three authors contributed equally  to this work as first authors.",Non-OADS,/arxiv_data1/oa_pdf/87/c2/jcn-13-62.PMC5242153.pdf
"All of the candidate variants were examined in the 50 nor - mal control alleles and searched in global human variant da - tabases, including 1000G (http://www.1000genomes.org)  and ExAC (http://exac.broadinstitute.org/).",Non-OADS,/arxiv_data1/oa_pdf/87/c2/jcn-13-62.PMC5242153.pdf
"Missense substi - tutions were carefully analyzed with three software programs:  PolyPhen-2 (http://genetics.bwh.harvard.edu/pph2/), PROVE - AN (http://provean.jcvi.org/index.php), and VEP (http:// grch37.ensembl.org/Homo_sapiens/Tools/VEP).",OADS,/arxiv_data1/oa_pdf/87/c2/jcn-13-62.PMC5242153.pdf
The novelty  of the variants was determined by searching the Human Gene  Mutation Database (http://www.hgmd.cf.ac.uk/ac/index.,OADS,/arxiv_data1/oa_pdf/87/c2/jcn-13-62.PMC5242153.pdf
php) and the SCN1A mutation database (http://www.gzneu - rosci.com/scn1adatabase/index.php).,OADS,/arxiv_data1/oa_pdf/87/c2/jcn-13-62.PMC5242153.pdf
"In total, 131 mil - lion Chinese were aged over 65 years by the end of 2013, representing about 9.6% of the  total population (http://data.stats.gov.cn).",OADS,/arxiv_data1/oa_pdf/0f/a9/jcn-13-10.PMC5242154.pdf
"2 More and more Chinese families have accepted  the idea of transferring their elders to institutional care in nursing homes and, according to one survey conducted in 2010, 11.3% of the elderly population living in urban areas was Shanhu Xu   Xiaoqing Jin   Caixia Liu   Yu Jin  Ying Xu  Linhui Chen   Saizhu Xu Hongying Tang   Jing Yan Department of Neurology,   Zhejiang Hospital, Hangzhou, ChinapISSN 1738-6586 / eISSN 2005-5013   /   J Clin Neurol 2017 ;13(1):10-14   /   https://doi.org/10.3988/jcn.2017.13.1.10 Received  September 24, 2015 Revised  December 21, 2015 Accepted  December 23, 2015 Correspondence Jing Y an, MD Department of Neurology, Zhejiang Hospital & Zhejiang Provincial  Key Lab of Geriatrics, No.12,  LingYin Road, Xihu District,  Hangzhou, 310013, Zhejiang, China  Tel    +86-571-81595216 Fax   +86-571-87980175 E-mail    zjicu@vip.163.comcc This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Com - mercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial  use, distribution, and reproduction in any medium, provided the original work is properly cited.JCN  Open Access ORIGINAL ARTICLE",Non-OADS,/arxiv_data1/oa_pdf/0f/a9/jcn-13-10.PMC5242154.pdf
"An isolated contralateral PCA infarction secondary to herniation requires a predominant Mustafa Ansari  Gregory Youngnam Chang Department of Neurology,   UC Davis Medical Center,   Sacramento, CA, USApISSN 1738-6586 / eISSN 2005-5013   /   J Clin Neurol 2017 ;13(1):101-102   /   https://doi.org/10.3988/jcn.2017.13.1.101 Received  May 13, 2016 Revised  June 7, 2016 Accepted  June 9, 2016 Correspondence Gregory Y oungnam Chang, MD Department of Neurology, University of California at Davis Medical Center, 4860 Y St. Suite 3700, UC Davis Medical Center, Sacramento, CA 95817, USATel    +1-916-734-6280 Fax   +1-916-734-6525 E-mail    gycchang@ucdavis.edu cc This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Com - mercial License (http://creativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial  use, distribution, and reproduction in any medium, provided the original work is properly cited.LETTER TO THE EDITOR",Non-OADS,/arxiv_data1/oa_pdf/31/cd/jcn-13-101.PMC5242155.pdf
"We subsequently identified compound heterozygous c.910G>A (p.D340N) and Hyung Jun Parka   Jee Eun Leea  Gyeong Seon Choia   Heasoo Koob  Soo Jeong Hanc  Jeong Hyun Yood   Young-Chul Choie  Kee Duk Parka a Departments of Neurology, b Pathology, cRehabilitation   Medicine, and dRadiology,   Mokdong Hospital, Ewha Womans  University School of Medicine,   Seoul, Korea e Department of Neurology,   Yonsei University College of Medicine, Seoul, KoreapISSN 1738-6586 / eISSN 2005-5013   /   J Clin Neurol 2017 ;13(1):105-106   /   https://doi.org/10.3988/jcn.2017.13.1.105 Received  April 29, 2016 Revised  June 10, 2016 Accepted  June 13, 2016 Correspondence Kee Duk Park, MD, PhD Department of Neurology,  Ewha Womans University  College of Medicine, 1071  Anyangcheon-ro, Y angcheon-gu,  Seoul 07985, KoreaTel    +82-2-2650-6010 Fax   +82-2-2650-2652 E-mail    pkd1165@ewha.ac.kr cc This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Com - mercial License (http://creativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial  use, distribution, and reproduction in any medium, provided the original work is properly cited.JCN  Open Access LETTER TO THE EDITOR",Non-OADS,/arxiv_data1/oa_pdf/01/2d/jcn-13-105.PMC5242156.pdf
Supplementary Materials The online-only Data Supplement is available with this arti - cle at https://doi.org/10.3988/jcn.2017.13.1.105.,Non-OADS,/arxiv_data1/oa_pdf/01/2d/jcn-13-105.PMC5242156.pdf
"7,8Jiwon Lee  Eu Gene Park Munhyang Lee Jeehun Lee Department of Pediatrics,   Samsung Medical Center,  Sungkyunkwan University School  of Medicine, Seoul, KoreapISSN 1738-6586 / eISSN 2005-5013   /   J Clin Neurol 2017 ;13(1):47-54   /   https://doi.org/10.3988/jcn.2017.13.1.47 Received  A pril 26, 2016 Revised  J une 19, 2016 Accepted  J une 20, 2016 Correspondence Jeehun Lee, MD, PhD Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul 06351, KoreaTel    +82-2-3410-0910 Fax   +82-2-3410-0043 E-mail    jhlee0101@skku.edu cc This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Com - mercial License (http://creativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial  use, distribution, and reproduction in any medium, provided the original work is properly cited.JCN  Open Access ORIGINAL ARTICLE",Non-OADS,/arxiv_data1/oa_pdf/1e/32/jcn-13-47.PMC5242157.pdf
"The clinical manifestations in our patient suggested that the lesion in the right thalamus- midbrain junction had occurred 1 year previously, with the hearing difficulty not present -Jun-Hyung Lee   Sang-Soon Park   Jin-Young Ahn   Jae-Hyeok Heo Department of Neurology,   Seoul Medical Center, Seoul, KoreapISSN 1738-6586 / eISSN 2005-5013   /   J Clin Neurol 2017 ;13(1):107-108   /   https://doi.org/10.3988/jcn.2017.13.1.107 Received  April 19, 2016 Revised  June 12, 2016 Accepted  June 14, 2016 Correspondence Jae-Hyeok Heo, MD Department of Neurology,  Seoul Medical Center,  156 Sinnae-ro, Jungnang-gu,  Seoul 02053, KoreaTel    +82-2-2276-8669 Fax   +82-2-2276-8539 E-mail       dr jae93@gmail.comcc This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Com - mercial License (http://creativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial  use, distribution, and reproduction in any medium, provided the original work is properly cited.LETTER TO THE EDITOR",Non-OADS,/arxiv_data1/oa_pdf/9c/e1/jcn-13-107.PMC5242158.pdf
"All three patterns are caused by mutations in the Xp 21DMD gene, which encodes a 427-kDa cytoskeletal pro - tein called dystrophin.3-6Seena Vengalila   Veeramani Preethish-Kumarb  Kiran Polavarapub  Manjunath Mahadevappaa  Deepha Sekarc  Meera Purushottamc  Priya Treesa Thomasd  Saraswathi Nashia  Atchayaram Nalinia aDepartments of Neurology,   bClinical Neurosciences,   cMolecular Genetics and   d  Psychiatric Social Work,   National Institute of Mental Health and  Neurosciences, Bangalore, India pISSN 1738-6586 / eISSN 2005-5013   /   J Clin Neurol 2017 ;13(1):91-97   /   https://doi.org/10.3988/jcn.2017.13.1.91 Received  September 5, 2016 Revised  November 4, 2016 Accepted  November 7, 2016 Correspondence Atchayaram Nalini Department of Neurology,   Neuroscience Faculty Block,   National Institute of Mental Health   and Neurosciences, Hosur Road,  Bangalore 560029, India  Tel    +91-80-26995139 Fax   +91-80-26568430 E-mail    atchayaramnalini@yahoo.co.incc This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Com - mercial License (http://creativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial  use, distribution, and reproduction in any medium, provided the original work is properly cited.JCN  Open Access ORIGINAL ARTICLE",Non-OADS,/arxiv_data1/oa_pdf/eb/23/jcn-13-91.PMC5242159.pdf
"5 Cardiovascular autonomic dysfunction is relatively common in patients with PD, and can  occur independently of levodopa treatment and early in the course of the disease.6 The  manifestations of this dysfunction include orthostatic hypotension (OH), supine hyperten -Joong-Seok Kima  Dong-Woo Ryua  Ju-Hee Oha  Yang-Hyun Leea  Sung-Jin Parka   Kipyung Jeona  Jong-Yun Leea  Seong Hee Hoa  Jungmin Soa  Jin Hee Imb  Kwang-Soo Leea a Department of Neurology,   College of Medicine, The Catholic  University of Korea, Seoul, Korea b Department of Neurology, Inje University   Sanggye Paik Hospital, Seoul, KoreapISSN 1738-6586 / eISSN 2005-5013   /   J Clin Neurol 2017 ;13(1):15-20   /   https://doi.org/10.3988/jcn.2017.13.1.15 Received  March 28, 2016 Revised  May 7, 2016 Accepted  May 10, 2016 Correspondence Joong-Seok Kim, MD, PhD Department of Neurology,  Seoul St. Mary’s Hospital,  College of Medicine,  The Catholic University of Korea,  222 Banpo-daero, Seocho-gu,  Seoul 06591, KoreaTel    +82-2-2258-6078 Fax   +82-2-599-9686 E-mail    neuronet@catholic.ac.kr cc This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Com - mercial License (http://creativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial  use, distribution, and reproduction in any medium, provided the original work is properly cited.JCN  Open Access ORIGINAL ARTICLE",Non-OADS,/arxiv_data1/oa_pdf/1e/62/jcn-13-15.PMC5242160.pdf
"9,10 The PHQ-9 Mina Kima,b  Gyung-Jae Ohc,d  Young-Hoon Leec,d a Department of Nursing, Graduate School,  Chonnam National University,   Gwangju, Korea b Department of Counseling Psychology,  Graduate School of Dongshin University,  Naju, Korea c Department of Preventive Medicine &   Institute of Wonkwang Medical Science, Wonkwang University   School of Medicine, Iksan, Korea d Regional Cardiocerebrovascular Center,  Wonkwang University Hospital, Iksan, KoreapISSN 1738-6586 / eISSN 2005-5013   /   J Clin Neurol 2017 ;13(1):55-61   /   https://doi.org/10.3988/jcn.2017.13.1.55 Received  June 29, 2016 Revised  August 11, 2016 Accepted  August 11, 2016 Correspondence Y oung-Hoon Lee, MD, PhD Department of Preventive Medicine & Institute of Wonkwang Medical Science, Wonkwang University School of Medicine, 460 Iksan-daero,  Iksan 54538, KoreaTel    +82-63-859-1990 Fax   +82-63-859-1995 E-mail    lyh8275@hanmail.net cc This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Com - mercial License (http://creativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial  use, distribution, and reproduction in any medium, provided the original work is properly cited.JCN  Open Access ORIGINAL ARTICLE",Non-OADS,/arxiv_data1/oa_pdf/1c/5e/jcn-13-55.PMC5242161.pdf
Available from: http://www.index.go.kr/potal/main/ EachDtlPageDetail.do?idx_cd=1012.,OADS,/arxiv_data1/oa_pdf/1c/5e/jcn-13-55.PMC5242161.pdf
"The relation be - tween inflammation and clot formation has been described previously, and it indicates that Simone Vidalea  Arturo Consolib  Marco Arnaboldia  Domenico Consolic a Department of Neurology and Stroke  Unit, Sant’Anna Hospital, Como, Italy b Department of Interventional   Neurovascular Unit, Careggi University  Hospital, Florence, Italy c Department of Neurology,   G. Jazzolino Hospital, Vibo Valentia, ItalypISSN 1738-6586 / eISSN 2005-5013   /   J Clin Neurol 2017 ;13(1):1-9   /   https://doi.org/10.3988/jcn.2017.13.1.1 Received  September 12, 2016 Revised  October 30, 2016 Accepted  October 31, 2016 Correspondence Simone Vidale, MD Department of Neurology and  Stroke Unit, Sant’ Anna Hospital,  Via Napoleona 60, 22100 Como, ItalyTel    +39-0315859282 Fax   +39-0315854989 E-mail    simone.vidale@asst-lariana.it cc This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Com - mercial License (http://creativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial  use, distribution, and reproduction in any medium, provided the original work is properly cited.JCN  Open Access REVIEW",Non-OADS,/arxiv_data1/oa_pdf/89/6e/jcn-13-1.PMC5242162.pdf
"  Copyright © 2017 Korean Neurological Association   119Erratum to: Ataxia with Oculomotor Apraxia Type 1   without Oculomotor Apraxia: A Case Report Minwoo Leea, Nan Young Kimb, Jin Young Huhc, Young Eun Kimc, Yun Joong Kimb,c,d a Department of Neurology, Kangdong Sacred Heart Hospital, Hallym University, Seoul, Korea b Hallym Institute of Translational Genomics & Bioinformatics, Hallym University Medical Center, Anyang, Korea c Department of Neurology, Hallym University Sacred Heart Hospital, Hallym University, Anyang, Korea d ILSONG Institute of Life Science, Hallym University, Anyang, Korea J Clin Neurol 2016;12(1):126-128 / http://dx.doi.org/10.3988/jcn.2016.12.1.126   Unfortunately, the original version of this article contained an error in the nomenclature of a variant which was shown in an  electropherogram in the Figure 1.",Non-OADS,/arxiv_data1/oa_pdf/d4/b6/jcn-13-119.PMC5242163.pdf
"Likewise, p.Asp120Lysfs2 in Figure 1 and Figure legend have to be changed to p.Asn120Lysfs2.pISSN 1738-6586 / eISSN 2005-5013   /   J Clin Neurol 2017 ;13(1):119-119   /   https://doi.org/10.3988/jcn.2017.13.1.119 cc This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.JCN  Open Access ERRATUM",Non-OADS,/arxiv_data1/oa_pdf/d4/b6/jcn-13-119.PMC5242163.pdf
"8 Scoring systems to help predict death Sahar M. A. Hassaneina   Mohamed Hassan Nasr Eldinb   Hanaa A. Amerc  Adel E. Abdelhamidd  Moustafa El Houssiniee   Abir Ibrahimf a Departments of Pediatrics,  bObstetrics and Gynecology,  cClinical Pathology, Faculty of       Medicine, Ain Shams    University, Cairo, Egypt  dNeonatal Unit, the Queen Elizabeth    Hospital, King’s Lynn, UK   eCommunity Medicine, Faculty    of Medicine, Ain Shams University,   Cairo, Egypt  fMOH, Cairo, EgyptpISSN 1738-6586 / eISSN 2005-5013   /   J Clin Neurol 2017 ;13(1):84-90   /   https://doi.org/10.3988/jcn.2017.13.1.84 Received  August 5, 2016 Revised  November 4, 2016 Accepted  November 7, 2016 Correspondence Sahar M. A. Hassanein, PhD Departments of Pediatrics,   Children’s Hospital, Faculty of Medicine, Ain Shams University Abassia Square, Cairo, P .",Non-OADS,/arxiv_data1/oa_pdf/3a/b9/jcn-13-84.PMC5242164.pdf
"Box 11381, EgyptTel    +20-123183943 Fax   +20-226847024 E-mail    saharhassanein@med.asu.edu.eg cc This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Com - mercial License (http://creativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial  use, distribution, and reproduction in any medium, provided the original work is properly cited.JCN  Open Access ORIGINAL ARTICLE",Non-OADS,/arxiv_data1/oa_pdf/3a/b9/jcn-13-84.PMC5242164.pdf
"Jae Jeong Joo   Byoung June Ahn   Kyum-Yil Kwon Department of Neurology,   Soonchunhyang University Gumi Hospital,  Soonchunhyang University   School of Medicine, Gumi, KoreapISSN 1738-6586 / eISSN 2005-5013   /   J Clin Neurol 2017 ;13(1):112-113   /   https://doi.org/10.3988/jcn.2017.13.1.112 Received  May 25, 2016 Revised  July 19, 2016 Accepted  July 21, 2016 Correspondence Kyum-Yil Kwon, MD, PhD Department of Neurology,  Soonchunhyang University  Gumi Hospital, 179 1gongdan-ro,  Gumi 39371, KoreaTel    +82-54-468-9076 Fax   +82-54-468-9075 E-mail       den ovo78@schmc.ac.kr or  denovo78@naver.com cc This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Com - mercial License (http://creativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial  use, distribution, and reproduction in any medium, provided the original work is properly cited.LETTER TO THE EDITOR",Non-OADS,/arxiv_data1/oa_pdf/cf/00/jcn-13-112.PMC5242165.pdf
"This report highlights the poten -Eric J. Marrottea  Panayiotis Mitsiasa  Leonard Melvina  Asim Mahmoodb  Georgios Tsivgoulisc  Panayiotis Varelasa,b a Departments of Neurology and b Neurosurgery, Henry Ford Hospital,  Detroit, MI, USA c Second Department of Neurology, School  of Medicine, University of Athens, Athens,  GreecepISSN 1738-6586 / eISSN 2005-5013   /   J Clin Neurol 2017 ;13(1):109-111   /   https://doi.org/10.3988/jcn.2017.13.1.109 Received  April 28, 2016 Revised  June 13, 2016 Accepted  June 16, 2016 Correspondence Georgios Tsivgoulis, MD Second Department of Neurology, School of Medicine, University of Athens, Iras 39, Gerakas Attikis, Athens 15344, Greece Tel    +30 6937178635 Fax   +30 2105832471  E-mail       tsi vgoulisgiorg@yahoo.gr cc This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Com - mercial License (http://creativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial  use, distribution, and reproduction in any medium, provided the original work is properly cited.LETTER TO THE EDITOR",Non-OADS,/arxiv_data1/oa_pdf/49/3d/jcn-13-109.PMC5242166.pdf
Supplementary Materials The online-only Data Supplement is available with this arti -cle at https://doi.org/10.3988/jcn.2017.13.1.109.,Non-OADS,/arxiv_data1/oa_pdf/49/3d/jcn-13-109.PMC5242166.pdf
"6 However,  these studies also do not provide information on the duration from the onset of PD to the Su-Yun Leea  Hyun-Ju Ryua   Jeong-Wook Seob   Maeng-Seok Nohc  Sang-Myung Cheona   Jae Woo Kima a Department of Neurology,   Parkinson’s Disease Center,   College of Medicine,   Dong-A University, Busan, Korea  b Department of Preventive Medicine,  College of Medicine,   Dong-A University, Busan, Korea c Department of Statistics, Pukyong  National University, Busan, KoreapISSN 1738-6586 / eISSN 2005-5013   /   J Clin Neurol 2017 ;13(1):21-26   /   https://doi.org/10.3988/jcn.2017.13.1.21 Received  September 2, 2015 Revised  June 1, 2016 Accepted  June 2, 2016 Correspondence Jae Woo Kim, MD, PhD Department of Neurology, Parkinson’s Disease Center, College of Medicine,  Dong-A University,  32 Daesingongwon-ro, Seo-gu,  Busan 49201, KoreaTel    +82-51-240-5266 Fax   +82-51-244-8338 E-mail    jwkim@dau.ac.kr cc This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Com - mercial License (http://creativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial  use, distribution, and reproduction in any medium, provided the original work is properly cited.JCN  Open Access ORIGINAL ARTICLE",Non-OADS,/arxiv_data1/oa_pdf/9d/fb/jcn-13-21.PMC5242167.pdf
"Images of single wells were taken usingﬂuorescent microscope Zeiss AxioVert A1 (Zeiss, Jena,Germany) and AxioCam MRm, and migration into detec-tion zones was evaluated by particle analysis in ImageJ (Rasband, W.S., ImageJ, U.S. National Institutes of Health, Bethesda, MD; http://imagej.nih.gov/ij/, 1997 – 2014).",OADS,/arxiv_data1/oa_pdf/fe/23/PRP2-4-0230.PMC5242168.pdf
Available at: http://epoc.cochrane.org/sites/ 2016 | Vol.,OADS,/arxiv_data1/oa_pdf/b6/ed/PRP2-4-0242.PMC5242171.pdf
Available at: https://www.gipdatabank.nl/ (accessed 7 November 2015).,Non-OADS,/arxiv_data1/oa_pdf/b6/ed/PRP2-4-0242.PMC5242171.pdf
Available at: http://www.ema.europa.eu/ema/index.jsp?,Non-OADS,/arxiv_data1/oa_pdf/b6/ed/PRP2-4-0242.PMC5242171.pdf
Available at: http://www.ema.europa.eu/ema/index.jsp?,Non-OADS,/arxiv_data1/oa_pdf/b6/ed/PRP2-4-0242.PMC5242171.pdf
Available at: http://eur-lex.europa.eu/ LexUriServ/LexUriServ.do?uri=OJ:L:2010:348:0074:0099:EN: PDF (accessed 8 November 2015).,Non-OADS,/arxiv_data1/oa_pdf/b6/ed/PRP2-4-0242.PMC5242171.pdf
The Dutch College of General Practitioners [2013] Available at: https://www.nhg.org/standaarden/volledig/ nhg-standaard-maagklachten-derde-herziening (accessed 7 November 2015).,Non-OADS,/arxiv_data1/oa_pdf/b6/ed/PRP2-4-0242.PMC5242171.pdf
Available at: http://www.fda.gov/Drugs/DrugSafety/ PostmarketDrugSafetyInformationforPatientsandProviders/ DrugSafetyInformationforHeathcareProfessionals/ ucm079520.htm (accessed 7 November 2015).,Non-OADS,/arxiv_data1/oa_pdf/b6/ed/PRP2-4-0242.PMC5242171.pdf
Available at: http://www.fda.gov/Drugs/ DrugSafety/PostmarketDrugSafetyInformationforPatients andProviders/DrugSafetyInformationforHeathcareProfessionals/ ucm190787.htm (accessed 7 November 2015).,Non-OADS,/arxiv_data1/oa_pdf/b6/ed/PRP2-4-0242.PMC5242171.pdf
"Available at: http://www.fda.gov/Drugs/ DrugSafety/PostmarketDrugSafetyInformationforPatients andProviders/ucm190836.htm (accessed 7 November 2015).Warle-van Herwaarden MF, Kramers C, Sturkenboom MC, Van den Bemt PM, De Smet PA (2012).",Non-OADS,/arxiv_data1/oa_pdf/b6/ed/PRP2-4-0242.PMC5242171.pdf
"2004), is the highest dose clini-cally administered to more severe asthmatics (Masoli et al.2004) (Global Initiative for Asthma (GINA); 2016 PocketGuide for Asthma Management and Prevention (http://gi-nasthma.org/2016-pocket-guide-for-asthma-management-and-prevention/), and was selected to maximize identiﬁca- tion of ICS-induced gene expression.",Non-OADS,/arxiv_data1/oa_pdf/5f/d2/PRP2-4-0243.PMC5242176.pdf
One set of samples (individual #9) failed to produce sufﬁcient aRNAfor hybridization and was excluded from the analysis.Microarray data are deposited with NCBI’s Gene Expres-sion Omnibus (GEO) and are accessible through GEOSeries accession number GSE83233 (http://www.ncbi.nlm.,OADS,/arxiv_data1/oa_pdf/5f/d2/PRP2-4-0243.PMC5242176.pdf
"According to discharge  and death logbooks, 104 children were admitted with diarrhea and  died in hospital during the study period; 69% were not be screened or enrolled because they were admitted after surveillance hours, or  because death occurred soon after arrival at the hospital (see Table,  Supplemental Digital Content 1, http://links.lww.com/INF/C564)Genotyping was performed on 22% (543/2432) of positive  rotavirus stool samples (Table 3).",Non-OADS,/arxiv_data1/oa_pdf/c8/05/inf-36-168.PMC5242217.pdf
Available at: http://dhsprogram.com/pubs/pdf/fr265/fr265.pdf.,Non-OADS,/arxiv_data1/oa_pdf/c8/05/inf-36-168.PMC5242217.pdf
Available at: http://www.unicef.org/ bangladesh/SHEWAB —factsheet—-—FINAL-21 April12.pdf.,Non-OADS,/arxiv_data1/oa_pdf/c8/05/inf-36-168.PMC5242217.pdf
"www.pidj.com | 163 Age at First Confirmed RSV LRTI Hospitalization  for Infants Born and Hospitalized in the Same RSV Season The median age for infants born and hospitalized for their  first confirmed RSV LRTI in the same RSV season ranged from 7.1  (RISK) to 11.0 (REPORT) weeks (see Table, Supplemental Digital  Content 1, http://links.lww.com/INF/C555).",Non-OADS,/arxiv_data1/oa_pdf/b4/72/inf-36-160.PMC5242218.pdf
"The median duration of supplemental oxygen showed consistency across datasets at 4–5 days (see Table, Supplemental Digital Content 1, http://links.lww.com/INF/C555).",OADS,/arxiv_data1/oa_pdf/b4/72/inf-36-160.PMC5242218.pdf
Available at: http://sanac.org.za/resources/cat_view/7-publications/9-reports.,Non-OADS,/arxiv_data1/oa_pdf/05/5f/inf-36-e38.PMC5242219.pdf
Available at: http://sanac.org.za/resources/ cat_view/7-publications/9-reports.,Non-OADS,/arxiv_data1/oa_pdf/05/5f/inf-36-e38.PMC5242219.pdf
Available at: http://www.statssa.gov.za/publications/P0305/P03052011.pdf.,Non-OADS,/arxiv_data1/oa_pdf/05/5f/inf-36-e38.PMC5242219.pdf
Available at: http://sanac.org.za/resources/cat_view/7-publications/9-reports.,Non-OADS,/arxiv_data1/oa_pdf/05/5f/inf-36-e38.PMC5242219.pdf
Available at: http://apps.who.int/iris/bitstream/10665/44010/1/9789241597388_eng.pdf.,Non-OADS,/arxiv_data1/oa_pdf/05/5f/inf-36-e38.PMC5242219.pdf
( i)T h e 352 proteins from the Protein-Protein Docking Benchmark (PPDB) version 4 (http://zlab.bu.edu/benchmark4/)36were docked against their known partner (from PPDBv4) andLaine and Carbone 138PROTEINS,Non-OADS,/arxiv_data1/oa_pdf/56/3e/PROT-85-137.PMC5242317.pdf
The I Pvalues computed for all proteins from PPDBv4 using HEX areavailable at http://www.lcqb.upmc.fr/CCDGeomDock/.,OADS,/arxiv_data1/oa_pdf/56/3e/PROT-85-137.PMC5242317.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/1b/cd/omw048.PMC5242372.pdf
"Accepted for publication Nov 19, 2016. doi: 10.21147/j.issn.1000-9604.2016.06.05 View this article at: http://dx.doi.org/10.21147/j.issn.1000-9604.2016.06.05   Introduction Colon  cancer  (CC)  is  one  of  the  most  common malignancies worldwide and the leading cause of cancerdeath  in  women  and  men  worldwide  (1).",Non-OADS,/arxiv_data1/oa_pdf/1a/ea/cjcr-28-6-589.PMC5242445.pdf
"Accepted for publication Nov 23, 2016. doi: 10.21147/j.issn.1000-9604.2016.06.03 View this article at: http://dx.doi.org/10.21147/j.issn.1000-9604.2016.06.03   Introduction Gastric cancer is the fourth most common cancer and the third leading cause of cancer-related death worldwide (1).With early diagnosis, advances in surgery and standard chemotherapy, the overall survival (OS) of gastric cancer patients is increasing, particularly in Japan and Korea (2-4) However,  most  gastric  cancer  patients  in  China  are  Original Article  © Chinese Journal of Cancer Research.",Non-OADS,/arxiv_data1/oa_pdf/c6/8d/cjcr-28-6-570.PMC5242446.pdf
"Accepted for publication Dec 08, 2016. doi: 10.21147/j.issn.1000-9604.2016.06.10 View this article at: http://dx.doi.org/10.21147/j.issn.1000-9604.2016.06.10   Introduction Boron neutron capture therapy (BNCT) is a promising cancer treatment which exploits the neutron capture and fission reaction of the boron isotope, 10B.",Non-OADS,/arxiv_data1/oa_pdf/6a/d4/cjcr-28-6-634.PMC5242447.pdf
"Accepted for publication Dec 05, 2016. doi: 10.21147/j.issn.1000-9604.2016.06.01 View this article at: http://dx.doi.org/10.21147/j.issn.1000-9604.2016.06.01   Introduction Wingless-type MMTV integration site family member 1 (Wnt-1)-inducible signaling pathway (WISP) proteins are a subfamily  of  the  cysteine-rich  protein  61  (Cyr61)/ connective tissue growth factor (CTGF)/nephroblastoma overexpressed (NOV) (CCN) family.",Non-OADS,/arxiv_data1/oa_pdf/59/b7/cjcr-28-6-553.PMC5242448.pdf
"Accepted for publication Oct 16, 2016. doi: 10.21147/j.issn.1000-9604.2016.06.08 View this article at: http://dx.doi.org/10.21147/j.issn.1000-9604.2016.06.08   Introduction The mediastinum is the central portion of the thoracic cavity, limited by pleural cavities laterally, thoracic inlet superiorly, and the diaphragm inferiorly.",Non-OADS,/arxiv_data1/oa_pdf/6d/7c/cjcr-28-6-617.PMC5242449.pdf
"Accepted for publication Dec 12, 2016. doi: 10.21147/j.issn.1000-9604.2016.06.07 View this article at: http://dx.doi.org/10.21147/j.issn.1000-9604.2016.06.07   Introduction Driver gene abnormality tests are the premise of targetedtherapy for advanced non-small cell lung cancer (NSCLC).",Non-OADS,/arxiv_data1/oa_pdf/a6/b2/cjcr-28-6-606.PMC5242450.pdf
Available at: https://www.nccn.org/professionals/ physician_gls/pdf/nscl.pdf17.,Non-OADS,/arxiv_data1/oa_pdf/a6/b2/cjcr-28-6-606.PMC5242450.pdf
"Accepted for publication Nov 01, 2016. doi: 10.21147/j.issn.1000-9604.2016.06.02 View this article at: http://dx.doi.org/10.21147/j.issn.1000-9604.2016.06.02   Introduction Adjuvant systemic chemotherapy has significantly improved the prognosis of breast cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/57/27/cjcr-28-6-561.PMC5242451.pdf
"Accepted for publication Dec 09, 2016. doi: 10.21147/j.issn.1000-9604.2016.06.04 View this article at: http://dx.doi.org/10.21147/j.issn.1000-9604.2016.06.04   Introduction Circulating tumor cells (CTCs) are shed from primary or metastatic solid tumors into the circulation (1).",Non-OADS,/arxiv_data1/oa_pdf/5e/a5/cjcr-28-6-579.PMC5242452.pdf
"Accepted for publication Dec 11, 2016. doi: 10.21147/j.issn.1000-9604.2016.06.09 View this article at: http://dx.doi.org/10.21147/j.issn.1000-9604.2016.06.09    Original Article  © Chinese Journal of Cancer Research.",Non-OADS,/arxiv_data1/oa_pdf/95/39/cjcr-28-6-626.PMC5242453.pdf
"Accepted for publication Nov 23, 2016. doi: 10.21147/j.issn.1000-9604.2016.06.06 View this article at: http://dx.doi.org/10.21147/j.issn.1000-9604.2016.06.06   Introduction Colon cancer is a main cause of cancer-related death throughout the world, and the standard treatment for locally advanced resectable colon cancer, including stage III and high-risk stage II disease, is surgery followed by postoperative adjuvant chemotherapy (1-3).",Non-OADS,/arxiv_data1/oa_pdf/82/fe/cjcr-28-6-598.PMC5242454.pdf
"Climate model experiments We used output from the following: (i) the PMIP2 and PMIP3 mid-Holocene (6 ka) and preindustrial ( 0 ka) experiments, publicly avail- able online at the Earth System Grid (http://pcmdi9.llnl.gov/); (ii) the TraCE-21ka, a fully coupled, trans ient simulation conducted with the National Center for Atmospheric Research Community Climate Sys- tem Model version 3 (CCSM3) ( 43,44); and (iii) the prescribed veg- etation and dust experiments conducted with the EC-Earth model(27).",Non-OADS,/arxiv_data1/oa_pdf/00/b0/1601503.PMC5242556.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/3/1/e1601503/DC1 Supplementary Materials and Methodstable S1.,Non-OADS,/arxiv_data1/oa_pdf/00/b0/1601503.PMC5242556.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/3/1/e1600946/DC1fig.,Non-OADS,/arxiv_data1/oa_pdf/ec/e2/1600946.PMC5242557.pdf
"United Nations Development Programme, Human Development Report (United Nations Development Programme, 2014); http://hdr.undp.org/en/content/human-development-report-2014 [accessed 4 September 2015] 201.",Non-OADS,/arxiv_data1/oa_pdf/ec/e2/1600946.PMC5242557.pdf
"K. Kakaes, F. Greenword, M. Lippincott, S. Dosemagen, P. Meier, S. A. Wich, Drones and Aerial Observation: New Technologies for Property Rights, Human Rights, and GlobalDevelopment: A Primer (New America, 2015); http://drones.newamerica.org/primer/DronesAndAerialObservation.pdf 207.",Non-OADS,/arxiv_data1/oa_pdf/ec/e2/1600946.PMC5242557.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/3/1/e1601635/DC1 section S1.,Non-OADS,/arxiv_data1/oa_pdf/47/1a/1601635.PMC5242558.pdf
"Berkeley Earth, http://berkeleyearth.lbl.gov/state-list/.84.",Non-OADS,/arxiv_data1/oa_pdf/47/1a/1601635.PMC5242558.pdf
"Maine Rivers, http://mainerivers.org/watershed-profiles/.138.",Non-OADS,/arxiv_data1/oa_pdf/47/1a/1601635.PMC5242558.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/3/1/e1601992/DC1Supplementary Textfig.,Non-OADS,/arxiv_data1/oa_pdf/81/b9/1601992.PMC5242559.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3a/bf/main.PMC5242622.pdf
http://dx.doi.org/10.1016/j.jcte.2016.08.005Journal of Clinical & Translational Endocrinology 6 (2016) 23–29 Contents lists available at ScienceDirect Journal of Clinical & Translational Endocrinology journal homepage: www.elsevier.com/locate/jcte,Non-OADS,/arxiv_data1/oa_pdf/3a/bf/main.PMC5242622.pdf
"4) the mHLW has  launched Japan intractable Diseases information Center (http://www.nanbyou.or.jp), which provides up-to-date diagnostic guidelines on designated intractable diseases.",Non-OADS,/arxiv_data1/oa_pdf/36/d8/nmc-57-001.PMC5243159.pdf
"21In this study, we evaluated digital NGS as a strategy to detect low-abundance mutations and then applied themethod to detect mutations in duodenal collections of pancre-atic juice obtained from patients with and without pancreaticductal neoplasia to evaluate the diagnostic accuracy of thistest.MATERIALS AND METHODS Patients and specimens Pancreatic juice samples for this study were obtained from parti- cipants enrolled in the CAPS studies (http://clinicaltrials.gov,NCT00438906, NCT00714701 and NCT02000089).",OADS,/arxiv_data1/oa_pdf/2b/9f/gutjnl-2015-311166.PMC5243915.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ REFERENCES 1 Rahib L, Smith BD, Aizenberg R, et al.",Non-OADS,/arxiv_data1/oa_pdf/2b/9f/gutjnl-2015-311166.PMC5243915.pdf
"28 http://www.arup.utah.edu/database/smad4/SMAD4_display.php 29 Tanaka M, Fernandez-Del Castillo C, Adsay V, et al.",OADS,/arxiv_data1/oa_pdf/2b/9f/gutjnl-2015-311166.PMC5243915.pdf
"To screen known disease-associated genes, we used a TruSight One Sequencing Panel (Illumina, San Diego, CA, USA) to perform NGSwith a MiSeq sequencer (Illumina) and our pipeline for NGS dataanalysis, as described elsewhere, 14with a minor modi ﬁcation due to a software update speci ﬁc for a bioinformatics pipeline.13To identify presumably pathogenic single-nucleotide variants, weexcluded sequence variants with low-allele frequencies, i.e.,40.01, included in the 1000 Genomes Project database (http:// www.1000genomes.org/), NHLBI GO Exome Sequencing Project (ESP6500, http://evs.gs.washington.edu/EVS/), Human GeneticVariation Database (HGVD, http://www.genome.med.kyoto-u.ac.",OADS,/arxiv_data1/oa_pdf/02/8e/hgv201645.PMC5243919.pdf
"jp/SnpDB/) and integrative Japanese Genome Variation Database (iJGVD, https://ijgvd.megabank.tohoku.ac.jp/).",OADS,/arxiv_data1/oa_pdf/02/8e/hgv201645.PMC5243919.pdf
"Mutation Database professional 2016.2 (HGMD, http://www.hgmd.",OADS,/arxiv_data1/oa_pdf/02/8e/hgv201645.PMC5243919.pdf
"org/) or ClinVar (http://www.ncbi.nlm.nih.gov/clinvar/) and is the ﬁrst mutation detected in the last exon of CUL4B .B e c a u s en o n s e n s e mutations within the last exon do not activate nonsense-mediatedmessenger RNA decay, this mutation yields a stable CUL4B messenger RNA that directs the synthesis of C-terminally truncated polypeptides.16,17The C-terminal extremity is the most conserved part of the cullin family protein (Figure 2b), and the CULLIN_1 cullinfamily signature ([LIV]-[KL]-x(2)-[LIVM]-x(2)-L-[IL]-[DEQGVT]-[KRHNQ]-x-[YT]-[LIVM]-x-R-x(5,7)-[FYLV]-x-Y-x-[SAT]; PROSITE entry PS01256, http://prosite.expasy.org/), located between codons 886 and 913 in the CUL4B protein, is one of the consensus patterns within thisconserved region.",Non-OADS,/arxiv_data1/oa_pdf/02/8e/hgv201645.PMC5243919.pdf
HGV DATABASE The relevant data from this Data Report are hosted at the Human Genome Variation Database at http://dx.doi.org/10.6084/m9.,OADS,/arxiv_data1/oa_pdf/02/8e/hgv201645.PMC5243919.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ © The Author(s) 2017 Supplementary Information for this article can be found on the Human Genome Variation website (http://www.nature.com/hgv).Novel CUL4B mutation in Cabezas syndrome N Okamoto et al 3 Ofﬁcial journal of the Japan Society of Human Genetics Human Genome Variation (2017) 16045",Non-OADS,/arxiv_data1/oa_pdf/02/8e/hgv201645.PMC5243919.pdf
"The treatment can be used for muscle and joint pain, 6,7among other ailments such asFreely available online Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services1",Non-OADS,/arxiv_data1/oa_pdf/3a/b3/tre-07-435-7522-1.PMC5243944.pdf
"The results of general, head and face, eyes, neck, pulmonary,Halimi M, Leder A, Mancini JD Integration of Osteopathic Manual Treatments Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services2",Non-OADS,/arxiv_data1/oa_pdf/3a/b3/tre-07-435-7522-1.PMC5243944.pdf
"Prospective study evaluating incobotulinumtoxinA for cervical dystonia or blepharaospasm: interim resultsIntegration of Osteopathic Manual Treatments Halimi M, Leder A, Mancini JD Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services3",Non-OADS,/arxiv_data1/oa_pdf/3a/b3/tre-07-435-7522-1.PMC5243944.pdf
"New York, NY:McGraw-Hill; 2015. http://accessmedicine.mhmedical.com/Content.aspx?",Non-OADS,/arxiv_data1/oa_pdf/3a/b3/tre-07-435-7522-1.PMC5243944.pdf
"doi: 10.7556/jaoa.2016.076.Halimi M, Leder A, Mancini JD Integration of Osteopathic Manual Treatments Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services4",Non-OADS,/arxiv_data1/oa_pdf/3a/b3/tre-07-435-7522-1.PMC5243944.pdf
"699~708 (2016) © 2016 Korean Society for Food Science of Animal ResourcesDOI https://doi.org/10.5851/kosfa.2016.36.6.699 pISSN 1225-8563 eISSN 2234-246X 699Consumer Acceptability of Intramuscular Fat Damian Frank1, Seon-Tea Joo2, and Robyn Warner* Faculty of Veterinary and Agricultural Science, University of Melbourne, Parkville, 3010, Australia 1CSIRO, Agriculture & Food, 11 Julius Ave North Ryde, New South Wales, 2113, Australia 2Division of Applied Life Science (BK21+), Gyeongsang National University, Jinju 52852, Korea Abstract Fat in meat greatly improves eating quality, yet many consumers avoid visible fat, mainly because of health concerns.",Non-OADS,/arxiv_data1/oa_pdf/bf/fb/kosfa-36-699.PMC5243953.pdf
"709~718 (2016) © 2016 Korean Society for Food Science of Animal ResourcesDOI https://doi.org/10.5851/kosfa.2016.36.6.709 pISSN 1225-8563 eISSN 2234-246X 709Characteristics and Health Benefit of Highly Marbled Wagyu and Hanwoo Beef Takafumi Gotoh1 and Seon-Tea Joo* Division of Applied Life Science (BK21+), Gyeongsang National University, Jinju 52852, Korea 1Kuju Agricultural Research Center, Faculty of Agriculture, Kyushu University 8780201, Japan Abstract This review addresses the characteristics and health benefit of highly marbled Wagyu and Hanwoo beef.",Non-OADS,/arxiv_data1/oa_pdf/fb/0a/kosfa-36-709.PMC5243954.pdf
"Accessed on November 6, 2016. http://www.ekapepia.or.kr 35.",Non-OADS,/arxiv_data1/oa_pdf/fb/0a/kosfa-36-709.PMC5243954.pdf
"Accessed on November 6,2016. http://www.ekapepia.or.kr/view/eng/ system/beef.asp.",Non-OADS,/arxiv_data1/oa_pdf/fb/0a/kosfa-36-709.PMC5243954.pdf
"719~728 (2016) © 2016 Korean Society for Food Science of Animal ResourcesDOI https://doi.org/10.5851/kosfa.2016.36.6.719 pISSN 1225-8563 eISSN 2234-246X 719Identification the Key Odorants in Different Parts of Hyla Rabbit Meat via Solid  Phase Microextraction Using Gas Chromatography Mass Spectrometry Yuejie Xie, Zhifei He, Jingzhi Lv1, En Zhang2, and Hongjun Li* College of Food Science, Southwest University, Chongqing, 400715, China 1College of Animal Science and Technology, Southwest University, Chongqing, 400715, China 2Chongqing Institute for Food and Drug Control, Chongqing, 401121, China Abstract The aim of this study was to explore the volatile compounds of hind leg, foreleg, abdomen and Longissimus dorsi  in both male and female Hyla rabbit meat by solid phase microextraction tandem with gas chromatography mass spectrometry, and to seek out the ke y odorants via calculating the odor activity value and principal component analysis.",Non-OADS,/arxiv_data1/oa_pdf/89/79/kosfa-36-719.PMC5243955.pdf
"729~736 (2016) © 2016 Korean Society for Food Science of Animal ResourcesDOI https://doi.org/10.5851/kosfa.2016.36.6.729 pISSN 1225-8563 eISSN 2234-246X 729Changes of Physicochemical and Sensory Properties of Fermented Sausage from Sulfur-fed Pork Min-Gu Ju, Ji-Han Kim, Hyun-Joo Jang, Su-Jung Yeon, Go-En Hong, Woojoon Park, Han Geuk Seo, and Chi-Ho Lee* Department of Food Science and Biotechnology of Animal Resources, Konkuk University, Seoul 05029, Korea Abstract This study was performed to evaluate the quality of fermented sausages manufactured with processed sulfur-fed pigs.",Non-OADS,/arxiv_data1/oa_pdf/47/41/kosfa-36-729.PMC5243956.pdf
"737~743 (2016) © 2016 Korean Society for Food Science of Animal ResourcesDOI https://doi.org/10.5851/kosfa.2016.36.6.737 pISSN 1225-8563 eISSN 2234-246X 737Effect of Black Rice Powder Levels on Quality Properties of Emulsion-type Sausage Sin-Young Park and Hack-Youn Kim* Department of Animal Resources Science, Kongju National University, Yesan 32439, Korea Abstract The effects of black rice powder on the quality of sausage were investigated.",Non-OADS,/arxiv_data1/oa_pdf/6e/90/kosfa-36-737.PMC5243957.pdf
"744~751 (2016) © 2016 Korean Society for Food Science of Animal ResourcesDOI https://doi.org/10.5851/kosfa.2016.36.6.744 pISSN 1225-8563 eISSN 2234-246X 744Effects of Partial Beef Fat Replacement with Gelled Emulsion on Functional and Qualit y Properties of Model Sy stem Meat Emulsions Meltem Serdaroğlu*, Berker Nacak, Merve Karabıyıkoğlu, and Gökçen Keser Food Engineering Department, Engineering Faculty, Ege University, 35100 Bornova, İzmir, Turkey Abstract The objective of this study was to investigate the effects of partial beef fat replacement (0, 30, 50, 100%) with gelled emulsi on (GE) prepared with olive oil on functional and quality properties of model system meat emulsion (MSME).",Non-OADS,/arxiv_data1/oa_pdf/fd/ca/kosfa-36-744.PMC5243958.pdf
"752~759 (2016) © 2016 Korean Society for Food Science of Animal ResourcesDOI https://doi.org/10.5851/kosfa.2016.36.6.752 pISSN 1225-8563 eISSN 2234-246X 752Mathematical Model for Predicting the Growth Probability of Staphylococcus aureus in Combinations of NaCl and NaNO2 under Aerobic or Evacuated Storage Conditions Jeeyeon Lee1,2, Eunji Gwak1, Jimyeong Ha1,2, Sejeong Kim1,2, Soomin Lee1,2, Heeyoung Lee1,2, Mi-Hwa Oh3, Beom-Young Park3, Nam Su Oh4, Kyoung-Hee Choi5, and Yohan Yoon1,2* 1Department of Food and Nutrition, Sookmyung Women's University, Seoul 04310, Korea 2Risk Analysis Research Center, Sookmyung Women's University, Seoul 04310, Korea 3National Institute of Animal Science, RDA, Wanju 55365, Korea 4R&D Center, Seoul Dairy Cooperative, Ansan 15407, Korea 5Department of Oral Microbiology, College of Dentistry, Wonkwang University, Iksan 54538, Korea Abstract The objective of this study was to describe the growth patterns of Staphylococcus aureus  in combinations of NaCl and NaNO2, using a probabilistic model.",Non-OADS,/arxiv_data1/oa_pdf/48/98/kosfa-36-752.PMC5243959.pdf
Available at: http://www.fda.gov/downloads/Food/Foodbor- neIllnessContaminants/UCM297627.pdf.,Non-OADS,/arxiv_data1/oa_pdf/48/98/kosfa-36-752.PMC5243959.pdf
"760~768 (2016) © 2016 Korean Society for Food Science of Animal ResourcesDOI https://doi.org/10.5851/kosfa.2016.36.6.760 pISSN 1225-8563 eISSN 2234-246X 760Effect of Dietary Processed Sulfur on the Meat Quality in Pork under Aging Sung-Hyun Hwa†, Ji-Han Kim†, Jung-Ho Kim, Hyun-Ju Jang, Min-Gu Ju, Wonyoung Cho, and Chi-Ho Lee* Department of Food Science and Biotechnology of Animal Resources, Konkuk University, Seoul 05029, Korea Abstract The present study was performed to determine the effect of dietary supplementation with processed sulfur on the quality and sta bility of vacuum packaged pork during aging time.",Non-OADS,/arxiv_data1/oa_pdf/cd/62/kosfa-36-760.PMC5243960.pdf
"56, 1936-1945. http://dx.doi.org/10.1071/AN14680 16.",Non-OADS,/arxiv_data1/oa_pdf/cd/62/kosfa-36-760.PMC5243960.pdf
"769~778 (2016) © 2016 Korean Society for Food Science of Animal ResourcesDOI https://doi.org/10.5851/kosfa.2016.36.6.769 pISSN 1225-8563 eISSN 2234-246X 769An Efficient Method for Co-purif ication of Eggshell Matrix Proteins OC-17, OC-116, and OCX-36 Maojie Zhang, Ning Wang, Qi Xu, Putri Widyanti Harlina and Meihu Ma* National and Local Joint Engineering Research Center for Egg Processing Technology, College of Food Science and Technology, Huazhong Agricultural University, Wuhan 430070, PR China Abstract In this study, we improved the eggshell-membrane separation process by separating the shell and membrane with EDTA solution, ev al- uating effects of three different extraction solutions (acetic acid, EDTA, and phosphate solution), and co-purifying multiple e ggshell proteins with two successive ion-exchange chromatography procedures (CM Sepharose Fast Flow and DEAE Sepharose Fast Flow).The recovery and residual rates of eggshell and membrane separated by the modified method with added EDTA solution were 93.88%, 91.15% and 1.01%, 2.87%, respectively.",Non-OADS,/arxiv_data1/oa_pdf/98/d3/kosfa-36-769.PMC5243961.pdf
"779~786 (2016) © 2016 Korean Society for Food Science of Animal ResourcesDOI https://doi.org/10.5851/kosfa.2016.36.6.779 pISSN 1225-8563 eISSN 2234-246X 779Prevalence and Genetic Ch aracteristics of Meatborne Listeria monocytogenes Isolates from Livestock Farms in Korea Hyemin Oh1,2, Sejeong Kim1,2, Soomin Lee1,2, Heeyoung Lee1,2, Jimyeong Ha1,2, Jeeyeon Lee1,2, Yukyung Choi1,2, Kyoung-Hee Choi3*, and Yohan Yoon1,2* 1Department of Food and Nutrition, Sookmyung Women’ s University, Seoul 04310, Korea 2Risk Analysis Research Center, Sookmyung Women’ s University, Seoul 04310, Korea 3Department of Oral Microbiology, College of Dentistry, Wonkwang University, Iksan 54538, Korea Abstract This study aimed to evaluate the prevalence of Listeria monocytogenes  on livestock farms in Korea and determine their serotypes and genetic correlations.",Non-OADS,/arxiv_data1/oa_pdf/f2/bc/kosfa-36-779.PMC5243962.pdf
"Available from: http://www.cidrap.umn.edu/cidrap/content/fs/food-disease/causes/listerioview.html.Accesed Aug 4, 2016.",Non-OADS,/arxiv_data1/oa_pdf/f2/bc/kosfa-36-779.PMC5243962.pdf
Available at: http://www.mfds.go.kr/eng/eng/index.do?nMenuCode=120&page=1&mode=view&boardSeq=70016.Accessed 1 September 2016.,OADS,/arxiv_data1/oa_pdf/f2/bc/kosfa-36-779.PMC5243962.pdf
"787~790 (2016) © 2016 Korean Society for Food Science of Animal ResourcesDOI https://doi.org/10.5851/kosfa.2016.36.6.787 pISSN 1225-8563 eISSN 2234-246X 787Antimicrobial Activity of Kefir against Various Food Pathogens and Spoilage Bacteria Dong-Hyeon Kim, Dana Jeong, Hyunsook Kim1, Il-Byeong Kang, Jung-Whan Chon†, Kwang-Young Song, and Kun-Ho Seo* Center for One Health, College of Veterinary Medicine, Konkuk University, Seoul 05029, Korea 1Department of Food & Nutrition, College of Human Ecology, Hanyang University, Seoul 04763, Korea Abstract Kefir is a unique fermented dairy product produced by a mixture of lactic acid bacteria, acetic acid bacteria, and yeast.",Non-OADS,/arxiv_data1/oa_pdf/a4/50/kosfa-36-787.PMC5243963.pdf
"791~798 (2016) © 2016 Korean Society for Food Science of Animal ResourcesDOI https://doi.org/10.5851/kosfa.2016.36.6.791 pISSN 1225-8563 eISSN 2234-246X 791Purification and Characteriz ation of an Antioxidant Protein from Fertilized Eggs Shaohua Yang†, Zhengjiang Tang†, ShanShan Tang, Tingfang Zhang, Fei Tang, Yu Wu, Ying Wang, Lu Lu Wang, and Guoqing Liu* College of Biotechnology and Food Engineering, Hefei University of Technology, Anhui 230009, P .",Non-OADS,/arxiv_data1/oa_pdf/6a/5c/kosfa-36-791.PMC5243964.pdf
"799~806 (2016) © 2016 Korean Society for Food Science of Animal ResourcesDOI https://doi.org/10.5851/kosfa.2016.36.6.799 pISSN 1225-8563 eISSN 2234-246X 799Quality and Sensory Characterist ics of Reduced-fat Chicken Patties with Pork Back Fat Replaced by Dietary Fiber from  Wheat Sprout Yun-Sang Choi, Jung-Min Sung, Jong-Dae Park, Ko-Eun Hwang, Cheol-Won Lee, Tae-Kyung Kim, Ki-Hong Jeon, Cheon-Jei Kim1*, Young-Boong Kim* Food Processing Research Center, Korean Food Research Institute, Seongnam 13539, Korea 1Department of Food Science and Biotechnology of Animal Resources, Konkuk University, Seoul 05029, Korea Abstract The effects of reducing pork fat levels from 20% to 15% or 10% by partially substituting pork back fat with wheat sprout fiber in reduced-fat chicken patties were investigated.",Non-OADS,/arxiv_data1/oa_pdf/1c/e7/kosfa-36-799.PMC5243965.pdf
"807~818 (2016) © 2016 Korean Society for Food Science of Animal ResourcesDOI https://doi.org/10.5851/kosfa.2016.36.6.807 pISSN 1225-8563 eISSN 2234-246X 807The Effect of the Addition of En capsulated Collagen Hydrolysate on Some Quality Characteristics of Sucuk Recep Palamutoğlu* and Cemalettin Sariçoban1 Department of Nutrition and Dietetics, Afyon Health School, Afyon Kocatepe University, Turkey 1Department of Food Engineering, Agriculture Faculty, Selçuk University, Turkey Abstract The effect of addition commercial fish collagen hydrolysate and encapsulated fish collagen hydrolysate on the quality character istics of sucuk (a traditional Turkish dry-fermented sausage) was investigated.",Non-OADS,/arxiv_data1/oa_pdf/53/69/kosfa-36-807.PMC5243966.pdf
"819~828 (2016) © 2016 Korean Society for Food Science of Animal ResourcesDOI https://doi.org/10.5851/kosfa.2016.36.6.819 pISSN 1225-8563 eISSN 2234-246X 819Comparison of Characteristics of Myosin Heavy Chain-based Fiber and Meat Quality among Four Bovine Skeletal Muscles Gap-Don Kim1,2, Han-Sul Yang1,3, and Jin-Yeon Jeong1,3* 1Institute of Agriculture and Life Science, Gyeongsang National University, Jinju 52828, Korea 2Department of Animal Sciences, University of Illinois, Urbana-Champaign, IL 61801, USA  3Division of Applied Life Science (BK21 plus), Gyeongsang National University, Jinju 52828, Korea Abstract Muscle fiber characteristics account for meat quality and muscle fibers are mainly classified into three or more types accordin g to their contractile and metabolic properties.",Non-OADS,/arxiv_data1/oa_pdf/05/01/kosfa-36-819.PMC5243967.pdf
Iran  J Basic Med Sci 201 7; 20:1-8;  http://dx.doi.org/10.22038/ij bms.2017.8085         Introduction    The genus Ferula belongs to the family Apiaceae.,Non-OADS,/arxiv_data1/oa_pdf/c5/35/IJBMS-20-1.PMC5243968.pdf
Iran J Basic Med S ci 201 7; 20:17-22; http://dx.doi.org/10.22038/ijbms.2017.8087           Introduction    There is evidence in neuropsychology literature  linking growth hormone (GH) deficiency with cognitive  impairment.,Non-OADS,/arxiv_data1/oa_pdf/8b/e5/IJBMS-20-17.PMC5243969.pdf
Iran J Basic Med Sci 201 7; 20:23-28; http://dx.doi.org/10.22038/ijbms.2017.8088         Introduction   Bone nonunion and bone defec ts are the most  important problems in bone fracture healing.,Non-OADS,/arxiv_data1/oa_pdf/74/06/IJBMS-20-23.PMC5243970.pdf
"Iran J Basic Med Sci 201 7; 20:29-35; http://dx.doi.org/10.22038/ijbms.2017.8089         Introduction   Pain can  be produced by activation of the  nociceptive pathways following damage to tissues, or  by damage to nerves (1).",Non-OADS,/arxiv_data1/oa_pdf/78/25/IJBMS-20-29.PMC5243971.pdf
Iran J Basic Med Sci 201 7; 20:36-40; http://dx.doi.org/10.22038/ijbms.2017.8090                    Introduction   Ghrelin is a 28 amino acid peptide  is secreted  mainly from the stomach.,Non-OADS,/arxiv_data1/oa_pdf/b1/6b/IJBMS-20-36.PMC5243972.pdf
"CRI-D2 cell line was  supplied by na tional cell bank of Iran (NCBI), Pasteur  Institute (Tehran, Iran) and the detailed profile is  provided at http://hpacultures.org.uk .",Non-OADS,/arxiv_data1/oa_pdf/b1/6b/IJBMS-20-36.PMC5243972.pdf
The primers and  probes for real -time PCR were designed using rat  genomic sequences as templates  through NCBI  (http://www.ncbi.nlm.nih.gov/pubmed ) and Allele ID  programs.,OADS,/arxiv_data1/oa_pdf/b1/6b/IJBMS-20-36.PMC5243972.pdf
Iran J Basic Med Sci 201 7; 20:41-45; http://dx.doi.org/10.22038/ijbms.2017.8091           Introduction   Breast cancer is known as the most common  cancer and the second leading cause of death from  cancer in women around the world (1).,Non-OADS,/arxiv_data1/oa_pdf/ed/f4/IJBMS-20-41.PMC5243973.pdf
Available from:  http://www.drugbank.ca/drugs/   DB00321 .,Non-OADS,/arxiv_data1/oa_pdf/89/bc/IJBMS-20-46.PMC5243974.pdf
Available  from:  http://www.drugbank.ca/drugs/DB01113 .,Non-OADS,/arxiv_data1/oa_pdf/89/bc/IJBMS-20-46.PMC5243974.pdf
Available from: https://www.drugbank.ca/drugs/   DB0 1344 .,Non-OADS,/arxiv_data1/oa_pdf/89/bc/IJBMS-20-46.PMC5243974.pdf
"Iran J Basic Med Sci 201 7; 20:59-66;  http://dx.doi.org/10.22038/ijbms.2017.8095             Introduction   Alzheimer's disease (AD), discovered by Dr Alois  Alzheimer in 1907, is described as a degenerative  diseas e of the central nervous system (CNS)  characterized especially by premature senile mental  deterioration.",Non-OADS,/arxiv_data1/oa_pdf/20/15/IJBMS-20-59.PMC5243976.pdf
http://www.arguslab.com/arguslab.com/  ArgusLab.html.,Non-OADS,/arxiv_data1/oa_pdf/20/15/IJBMS-20-59.PMC5243976.pdf
21. http://RCSB.org .,Non-OADS,/arxiv_data1/oa_pdf/20/15/IJBMS-20-59.PMC5243976.pdf
23. http://www.molegro.com.,Non-OADS,/arxiv_data1/oa_pdf/20/15/IJBMS-20-59.PMC5243976.pdf
Iran J Basic Med Sci 201 7; 20:67-74; http://dx.doi.org/10.22038/ijbms.2017.8097         Introduction    Stroke is one the main causes of death as it  brings about brain blood support disorders.,Non-OADS,/arxiv_data1/oa_pdf/05/f5/IJBMS-20-67.PMC5243977.pdf
"Iran  J Basic Med Sci 201 7; 20:75-82;  http://dx.doi.org/10.22038/ijbms.2017.8098           Introduction   Based on the World Health Organization, 15  million people suffer from stroke in worldwide per  year (1).",Non-OADS,/arxiv_data1/oa_pdf/3a/72/IJBMS-20-75.PMC5243978.pdf
"Iran  J  Basic Med Sci 201 7; 20:83-89; http://dx.doi.org/10.22038/ijbms.2017.8099         Introduction   Cisplatin (CDDP, cis -diamine dichloro platinum) is  one of the most widely utilized anticancer drugs against  malignancies of ovaries, testicles as well as head and  neck (1, 2).",Non-OADS,/arxiv_data1/oa_pdf/93/a2/IJBMS-20-83.PMC5243979.pdf
"Iran J Basic Med Sci 201 7; 20:9-16;  http://dx.doi.org/10.22038/ijbms.2017.8086         Introduction   Pellets are spherical, free -flowing granules with a  narrow size distribution which have numerous  pharmaceutical applications.",Non-OADS,/arxiv_data1/oa_pdf/11/ed/IJBMS-20-9.PMC5243980.pdf
Iran  J Basic Med Sci 201 7; 20:90-98; http://dx.doi.org/10.22038/ijbms.2017.8101           Introduction    It has been recognized that chronic heart failure  (CHF) leads to decrements in skeletal muscle blood  flow and muscle performance.,Non-OADS,/arxiv_data1/oa_pdf/59/20/IJBMS-20-90.PMC5243981.pdf
Iran  J Basic Med Sci 201 7; 20:99-106;  http://dx.doi.org/10.2203 8/ijbms.2017.8102             Introduction   Inflammation is a biological response to tissue  injury (1).,Non-OADS,/arxiv_data1/oa_pdf/d6/48/IJBMS-20-99.PMC5243982.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER Chronic inflammatory disorders and Merkel cell carcinoma 264 www.bjcancer.com | DOI:10.1038/bjc.2016.391,Non-OADS,/arxiv_data1/oa_pdf/f8/7a/bjc2016391a.PMC5243985.pdf
"The status of TP53 mutation was positively associated with the reported status of TP53 mutation in the database (http://p53.free.fr/index.html, W: wild-type TP53, M: mutant TP53 ).",OADS,/arxiv_data1/oa_pdf/da/a4/bjc2016394a.PMC5243986.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER Overexpression of PBK/TOPK in gastric cancer 226 www.bjcancer.com | DOI:10.1038/bjc.2016.394,Non-OADS,/arxiv_data1/oa_pdf/da/a4/bjc2016394a.PMC5243986.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)COCs before first birth and ovarian cancer risk BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2016.400 269,Non-OADS,/arxiv_data1/oa_pdf/cb/2f/bjc2016400a.PMC5243988.pdf
The NF1 cohort was cross- referenced with the Finnish Cancer Registry (http://www.cancer.fi/ syoparekisteri/en/) to find all NF1 patients with a breast cancer diagnosis.,OADS,/arxiv_data1/oa_pdf/a8/36/bjc2016403a.PMC5243991.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)PDGFR- bmarker for prognosis in renal carcinoma BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2016.407 201,Non-OADS,/arxiv_data1/oa_pdf/41/9b/bjc2016407a.PMC5243993.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER Childhood neuroendocrine tumours 168 www.bjcancer.com | DOI:10.1038/bjc.2016.408,Non-OADS,/arxiv_data1/oa_pdf/2e/86/bjc2016408a.PMC5243994.pdf
"From 5412 SNPs in DNA repair genes present in the Illumina HumanOmniEx- pressExome-8 v1.2 BeadChip (http://sciencepark.mdanderson.org/ labs/wood/dna_repair_genes.html for the complete list of genes involved in different DNA repair pathways), 1457 passed the above described filters.",OADS,/arxiv_data1/oa_pdf/54/5e/bjc2016411a.PMC5243995.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER Micronuclei frequency predicts bladder cancer risk 210 www.bjcancer.com | DOI:10.1038/bjc.2016.411,Non-OADS,/arxiv_data1/oa_pdf/54/5e/bjc2016411a.PMC5243995.pdf
"To view a copy of this license, visit http:// creativecommons.org/licenses/by-nc-sa/4.0/ rThe Author(s) named above 2017 Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc) 276 www.bjcancer.com | DOI:10.1038/bjc.2016.418BRITISH JOURNAL OF CANCER Smoking and ovarian cancers",Non-OADS,/arxiv_data1/oa_pdf/13/d3/bjc2016418a.PMC5243998.pdf
"This is an Open Access article, distributed under the terms of the Creative Commons Attribution-NonCommercial- NoDerivatives licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial re-use, distribution, and reprod uc- tion in any medium, provided the original work is unaltered and is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/8d/63/S1368980016002275a.PMC5244439.pdf
The interviewer-scored and self-scored versions of t h eU K D D Qa r ea v a i l a b l ef o rd o w nload (https://sps.online surveys.ac.uk/the-uk-diabetes-and-diet-questionnaire-ukddq).,Non-OADS,/arxiv_data1/oa_pdf/8d/63/S1368980016002275a.PMC5244439.pdf
"Supplementary material To view supplementary material for this article, please visit http://dx.doi.org/10.1017/S1368980016002275 References 1.",Non-OADS,/arxiv_data1/oa_pdf/8d/63/S1368980016002275a.PMC5244439.pdf
UK Clinical Research Network (2015) Sedentary time and metabolic health in people with (or at risk of) type 2 dia-betes: UKCRN 16015. http://public.ukcrn.org.uk/search/StudyDetail.aspx?StudyID =16105 (accessed October 2015).,Non-OADS,/arxiv_data1/oa_pdf/8d/63/S1368980016002275a.PMC5244439.pdf
http://www.foodbase.org.uk/results.php?f_report_id =82 (accessed April 2010).,Non-OADS,/arxiv_data1/oa_pdf/8d/63/S1368980016002275a.PMC5244439.pdf
London: The Stationery Of ﬁce; available at http://tna.europarchive.,Non-OADS,/arxiv_data1/oa_pdf/8d/63/S1368980016002275a.PMC5244439.pdf
org/20110116113217/http://www.food.gov.uk/multimedia/ pdfs/ndnsprintedreport.pdf 24.,Non-OADS,/arxiv_data1/oa_pdf/8d/63/S1368980016002275a.PMC5244439.pdf
https://www-304.ibm.com/support/docview.wss?uid =swg21477357 (accessed March 2014).,Non-OADS,/arxiv_data1/oa_pdf/8d/63/S1368980016002275a.PMC5244439.pdf
Available from: http://www.who.int/mediacentre/ factsheets/fs348/en/.,Non-OADS,/arxiv_data1/oa_pdf/31/e2/JRMS-21-89.PMC5244639.pdf
Available from: http://www.wsj.com/articles/ hardeep‑singh‑the‑battle‑against‑misdiagnosis‑1407453373.,Non-OADS,/arxiv_data1/oa_pdf/6d/bb/JRMS-21-83.PMC5244640.pdf
Available from: http://www.theatlantic.com/magazine/ archive/2010/11/lies‑damned‑lies‑and‑medical‑science/308269/.,Non-OADS,/arxiv_data1/oa_pdf/6d/bb/JRMS-21-83.PMC5244640.pdf
Genome assembly used to produce (http://genome.ucsc.edu),OADS,/arxiv_data1/oa_pdf/4b/47/JRMS-21-95.PMC5244654.pdf
Available from: http://www.publicrelations.tums.,Non-OADS,/arxiv_data1/oa_pdf/78/ef/JRMS-21-91.PMC5244688.pdf
The US Food and Drug Administration has also  issued authorization on emergency use of Center for Disease  Control and Prevention (CDEC) Ebola NP real‑time RT‑PCR  assay (http://www.fda.gov/downloads/MedicalDevices/ Safety/Emergency Situations/UCM418810.pdf).,Non-OADS,/arxiv_data1/oa_pdf/bb/25/JRMS-21-84.PMC5244689.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ REFERENCES 1 Janakiraman V , Ecker J.",Non-OADS,/arxiv_data1/oa_pdf/50/1a/bmjqs-2016-005257.PMC5244816.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0.",Non-OADS,/arxiv_data1/oa_pdf/af/d2/CG-CGCR160113.PMC5244872.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0.",Non-OADS,/arxiv_data1/oa_pdf/5a/71/CG-CGCR160151.PMC5244873.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0.",Non-OADS,/arxiv_data1/oa_pdf/1b/31/CG-CGCR160112.PMC5244874.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0.",Non-OADS,/arxiv_data1/oa_pdf/49/9f/CG-CGCR160118.PMC5244875.pdf
https://clinicaltrials.gov/ct2/show/ NCT02077634.,Non-OADS,/arxiv_data1/oa_pdf/b3/0e/ol-13-01-0022.PMC5244876.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0.",Non-OADS,/arxiv_data1/oa_pdf/9d/21/CG-CGCR160108.PMC5244888.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0.",Non-OADS,/arxiv_data1/oa_pdf/3c/05/CG-CGCR160107.PMC5244891.pdf
This region was then  mapped on the National Center for Biotechnology Information  MapViewer platform ( http://www.ncbi.nlm.nih.gov/mapview/ )  and the precise breakpoint region was determined on the  physical map.,OADS,/arxiv_data1/oa_pdf/d1/1f/ol-13-01-0215.PMC5244987.pdf
The intensity  levels of bands from the electrophoretic  gels and photographic  films were measured using a dedicated  image analysis software  (Band Leader 3.0; http://en.bio -soft.net /chip/BandLeader.html ).,OADS,/arxiv_data1/oa_pdf/88/08/etm-13-01-0215.PMC5245065.pdf
"The integrated optical densities of the bands were quantified  using ImageJ software version 1.48u (https://imagej.nih.gov/ ij/; National Institutes of Health, Bethesda, MD, USA) .",OADS,/arxiv_data1/oa_pdf/2e/ed/ol-13-01-0081.PMC5245085.pdf
The b ioinformatics software  microRNA.org ( http: //www.microrna.org /microrna /) and  TargetScan ( http://www.targetscan.org /) were used to identify  candidate target genes of miR -433.,OADS,/arxiv_data1/oa_pdf/2e/ed/ol-13-01-0081.PMC5245085.pdf
"Supporting Information Additional Supporting Information may be found in theonline version of this article, http://dx.doi.org/10.1111/ obr.12478 Table S1.",Non-OADS,/arxiv_data1/oa_pdf/ee/0b/OBR-18-183.PMC5245104.pdf
ED visits at VA facilities were identiﬁed by stop code 130; place of service (23) was used to iden- tify non-VA ED visits (http://www.resdac.org/resconnect/articles/144).,OADS,/arxiv_data1/oa_pdf/cc/a3/JGS-63-2510.PMC5245105.pdf
U.S. UniformCode of Trusts http://uniformlaws.org/ActSummary.aspx?,Non-OADS,/arxiv_data1/oa_pdf/5b/55/BRV-92-248.PMC5245106.pdf
At least seven federal court cases involved wolves in the last 12 years (http://ecos.fws.gov/tess_public/pub/delistingReport.jsp).,Non-OADS,/arxiv_data1/oa_pdf/5b/55/BRV-92-248.PMC5245106.pdf
A series of federal court decisions between 2005 and 2014 restored federal protections for wolves (http://www.fws.gov/home/ wolfrecovery/).,Non-OADS,/arxiv_data1/oa_pdf/5b/55/BRV-92-248.PMC5245106.pdf
260 Adrian Treves and others among other national subpopulations eradicated (IUCN Red List http://www.iucnredlist.org accessed 31 August2015).,Non-OADS,/arxiv_data1/oa_pdf/5b/55/BRV-92-248.PMC5245106.pdf
"For example, theAnishinaabe (Ojibwe) value the gray wolf above otheranimals http://www.ojibwe.org/home/about_anish.html(David, 2009; Shelley et al., 2011).",Non-OADS,/arxiv_data1/oa_pdf/5b/55/BRV-92-248.PMC5245106.pdf
"Although hunters are a minority in the U.S., E.U., and likely most industrialized countries (Pergams & Zaradic,2008; see also http://www.face.eu/about-us/members/across-europe/census-of-the-number-of-hunters-in-europe-september-2010 accessed April 2015), majorities in mostregions support regulated hunting with variable bounds on its purposes, methods, locations, and sustainability (Reiter et al., 1999; Treves & Martin, 2011).",Non-OADS,/arxiv_data1/oa_pdf/5b/55/BRV-92-248.PMC5245106.pdf
"ExpressO ,A v a i l a b l e at http://works.bepress.com/michael_blumm/16.",Non-OADS,/arxiv_data1/oa_pdf/5b/55/BRV-92-248.PMC5245106.pdf
Available at http://papers.ssrn.com/sol3/Delivery.cfm/SSRN_ID2420114_code186450.pdf?abstractid=2235329&mirid=1Accessed 30.08.2015.,OADS,/arxiv_data1/oa_pdf/5b/55/BRV-92-248.PMC5245106.pdf
Available at http://www.thewildlifenews .com/2014/01/13/idaho-has-changed-the-deﬁnition-of-a-wolf-breeding-pair/Accessed 15.09.2014.,Non-OADS,/arxiv_data1/oa_pdf/5b/55/BRV-92-248.PMC5245106.pdf
Available at http://www.irishexaminer.com/lifestyle/outdoors/richard-collins/culling-wolves-a-pack-mentality-222969.html Accessed 30.08.2015.,Non-OADS,/arxiv_data1/oa_pdf/5b/55/BRV-92-248.PMC5245106.pdf
Available at http://missoulian.com/news/state-and- regional/fwp-looks-to-new-technique-to-document-wolf-population-size/article_599b1372-f7c1-11e3-9e06-0019bb2963f4.html Accessed 14.09.2014.,Non-OADS,/arxiv_data1/oa_pdf/5b/55/BRV-92-248.PMC5245106.pdf
Available at http://www.fws.gov/science/pdf/Peer-Review-Report-of-Proposed- rule-regarding-wolves.pdf Accessed 30.08.2015.,Non-OADS,/arxiv_data1/oa_pdf/5b/55/BRV-92-248.PMC5245106.pdf
Available at http://www.oed.com Accessed 29.08.2015.,Non-OADS,/arxiv_data1/oa_pdf/5b/55/BRV-92-248.PMC5245106.pdf
Available at http://thepoliticalenvironment.blogspot .se/2014/04/ofﬁcial-language-policies-sanitize-wi.html Accessed 30.06.2015.,Non-OADS,/arxiv_data1/oa_pdf/5b/55/BRV-92-248.PMC5245106.pdf
Available at http://dnr.wi.gov/news/releases/ article/?id=2978 Accessed 30.08.2015.,Non-OADS,/arxiv_data1/oa_pdf/5b/55/BRV-92-248.PMC5245106.pdf
Availableat http://faculty.nelson.wisc.edu/treves/ Accessed 30.09.2015.,Non-OADS,/arxiv_data1/oa_pdf/5b/55/BRV-92-248.PMC5245106.pdf
Available at http://faculty.nelson.wisc.edu/treves/reports/wolf_hunting_and_depredation_29Aug2013.pdf Accessed 30.08.2015.,Non-OADS,/arxiv_data1/oa_pdf/5b/55/BRV-92-248.PMC5245106.pdf
"2016 (cited January 28, 2016); Available from: https://www.niaid.",OADS,/arxiv_data1/oa_pdf/c4/bb/CTS-10-12.PMC5245108.pdf
Available from: http://www.accessdata.fda.gov/drugsatfda_docs/label/2016 /125509lbl.pdf 25.,Non-OADS,/arxiv_data1/oa_pdf/c4/bb/CTS-10-12.PMC5245108.pdf
(http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1752-8062) www.wileyonlinelibrary/cts,Non-OADS,/arxiv_data1/oa_pdf/c4/bb/CTS-10-12.PMC5245108.pdf
"Retrieved from http://www.theguardian.com/society/2016/jan/22/problem-drinkers-alcohol-industry-most-sales-ﬁgures-reveal Bot, S. M., Engels, R. C. M. E., & Knibbe, R. A.",Non-OADS,/arxiv_data1/oa_pdf/cc/2a/BJHP-22-128.PMC5245110.pdf
"Retrieved from http://oro.open.ac.uk/22913/ Hayes, A. F. (2013).",Non-OADS,/arxiv_data1/oa_pdf/cc/2a/BJHP-22-128.PMC5245110.pdf
"Retrieved from http://www.hscic.gov.uk/catalogue/PUB17712 Hofmann, W., Vohs, K. D., & Baumeister, R. F. (2012).",Non-OADS,/arxiv_data1/oa_pdf/cc/2a/BJHP-22-128.PMC5245110.pdf
"Retrieved from http://health.gov.ie/blog/press-release/govt-approves- groundbreaking-legislation-to-tackle-alcohol-misuse-varadkar Jessop, D. C., Albery, I. P., & Garrod, H. (2008).",Non-OADS,/arxiv_data1/oa_pdf/cc/2a/BJHP-22-128.PMC5245110.pdf
"Retrieved from https://www.gov.uk/government/statistics/opinions-and- lifestyle-survey-adult-drinking-habits-in-great-britain-2014 Ostaﬁn, B. D., Marlatt, G. A., & Greenwald, A. G. (2008).",Non-OADS,/arxiv_data1/oa_pdf/cc/2a/BJHP-22-128.PMC5245110.pdf
"Retrieved from http://www.reuters.com/article/us-turkey-alcohol-idUSBRE94N0IA20130524 Palfai, T. P., & Ostaﬁn, B. D. (2003).",Non-OADS,/arxiv_data1/oa_pdf/cc/2a/BJHP-22-128.PMC5245110.pdf
"Retrieved from http://www.rankingthebrands.com/The- Brand-Rankings.aspx?rankingID=281 Wind, Y. J., & Sharp, B.",Non-OADS,/arxiv_data1/oa_pdf/cc/2a/BJHP-22-128.PMC5245110.pdf
Retrieved from http://www.who.,Non-OADS,/arxiv_data1/oa_pdf/cc/2a/BJHP-22-128.PMC5245110.pdf
"Avail- able from http://hknd-group.com/portal.php?mod =view&aid =293 (accessed June 2016).Excoffier L, Laval G, Schneider S. 2005.",OADS,/arxiv_data1/oa_pdf/9f/d9/COBI-31-86.PMC5245113.pdf
Available from http://www.fishbase.org (accessed June 2016).,Non-OADS,/arxiv_data1/oa_pdf/9f/d9/COBI-31-86.PMC5245113.pdf
The quality of structures was checked using the PDB ADIT validation ser-ver ( http://deposit.pdb.org/validate/ ) and MOLPROBITY [44].,OADS,/arxiv_data1/oa_pdf/2b/e6/FEBS-283-2206.PMC5245116.pdf
"UNAIDS Corporate Publications, http://www.unaids.org/en/resources/documents/ 2015/AIDS_by_the_numbers_2015, 2013.",Non-OADS,/arxiv_data1/oa_pdf/fd/bd/HIV-18-89.PMC5245118.pdf
"We investigated per-sample percent duplicated reads, coverage of the capture region,variant calling quality and depth, variant call-rate in the capture region, heterozygosity rate, transi- tion:transversion ratio, and sex veriﬁcation usingPLINK/SEQ v0.10 (https://atgu.mgh.harvard.edu/plinkseq/index.shtml) and PLINK v1.9 (https://www.cog-genomics.org/plink2).",OADS,/arxiv_data1/oa_pdf/cd/ae/GCC-56-177.PMC5245119.pdf
Available at:https://www.aan.com/Guidelines and https://www.aan.-com/practice/quality-measures.,Non-OADS,/arxiv_data1/oa_pdf/98/be/EPI-58-68.PMC5245120.pdf
Available at:http://www.commondataelements.ninds.nih.-gov/.,OADS,/arxiv_data1/oa_pdf/98/be/EPI-58-68.PMC5245120.pdf
Available at: http://journals.lww.com/neurotodayonline/Fulltext/2016/01070/Best_Advances_of_2015__Picks_from_the_Neurology.1.aspx.,Non-OADS,/arxiv_data1/oa_pdf/98/be/EPI-58-68.PMC5245120.pdf
A list of genes across 22 autosomes was obtained from the UCSC genome annotation database for NCBI hg18 Build 36.1 (http://hgdownload.soe.ucsc.edu/goldenPath/hg18/data base/).,OADS,/arxiv_data1/oa_pdf/a9/0b/GEPI-41-108.PMC5245123.pdf
"Retrieved from http://www.ashg.org/2009meeting/ abstracts/fulltext/f10648.htm Carlson, C. S., Eberle, M. A., Rieder, M. J., Yi, Q., Kruglyak, L., & Nickerson, D. A.",Non-OADS,/arxiv_data1/oa_pdf/a9/0b/GEPI-41-108.PMC5245123.pdf
Retrieved from http://www.utstat.toronto.edu/wordpress/wp-content/uploads/ 2011/09/Multi-bin-multi-variant-tests-for-gene-based-linear-regression- analysis-of-genetic-association.pdf SUPPORTING INFORMATION Additional Supporting Information may be found online in the supporting information tab for this article.,Non-OADS,/arxiv_data1/oa_pdf/a9/0b/GEPI-41-108.PMC5245123.pdf
"ma.uni-heidelberg.de/ apps/zmf/mirwalk/) and other  programs (miRanda, Sanger miRDB, RNAhybrid and  Targetscan) were used variously for target prediction The  online tool miRWalk 2.0 (http://www.umm.uni-heidelberg.",OADS,/arxiv_data1/oa_pdf/8e/b6/etm-13-01-0079.PMC5245143.pdf
Gene  Ontology (GO) analysis was then performed to clarify the  gene function ( http://geneontology.org) .,OADS,/arxiv_data1/oa_pdf/cf/87/ol-13-01-0222.PMC5245149.pdf
"1, 218 –222 http://dx.doi.org/10.1080/15548627.2016.1248019",Non-OADS,/arxiv_data1/oa_pdf/49/42/kaup-13-01-1248019.PMC5245770.pdf
"ORCID Tomohiro Kabuta http://orcid.org/0000-0002-3058-2596 References [1] de Duve C, Pressman B, Gianetto R, Wattiaux R, Appelmans F. Tissue fractionation studies.",OADS,/arxiv_data1/oa_pdf/49/42/kaup-13-01-1248019.PMC5245770.pdf
"Biochem J 1955; 60:604-17; PMID:13249955; http://dx.doi.org/10.1042/bj0600604 [2] Appelmans F, Wattiaux R, de Duve C. Tissue fractionation studies.",OADS,/arxiv_data1/oa_pdf/49/42/kaup-13-01-1248019.PMC5245770.pdf
"Biochem J 1955; 59:438-45; PMID:14363114; http://dx.doi.org/10.1042/bj0590438[3] Klionsky DJ, Abdelmohsen K, Abe A, Abedin MJ, Abeliovich H, Acevedo Arozena A, Adachi H, Adams CM, Adams PD, Adeli K,et al.",OADS,/arxiv_data1/oa_pdf/49/42/kaup-13-01-1248019.PMC5245770.pdf
"Autophagy 2016; 12:1-222; PMID:26799652; http://dx.doi.org/10.1080/15548627.2015.1100356 [4] Nakahira K, Haspel JA, Rathinam VA, Lee SJ, Dolinay T, Lam HC, Englert JA, Rabinovitch M, Cernadas M, Kim HP, et al.",OADS,/arxiv_data1/oa_pdf/49/42/kaup-13-01-1248019.PMC5245770.pdf
"Nat Immunol 2011; 12:222-30; PMID:21151103; http://dx.doi.org/10.1038/ni.1980 [5] Paludan SR, Bowie AG.",Non-OADS,/arxiv_data1/oa_pdf/49/42/kaup-13-01-1248019.PMC5245770.pdf
"Immunity 2013; 38:870-80; PMID:23706668; http://dx.doi.org/10.1016/j.immuni.2013.05.004 [6] Fujiwara Y, Furuta A, Kikuchi H, Aizawa S, Hatanaka Y, Konya C, Uchida K, Yoshimura A, Tamai Y, Wada K, et al.",OADS,/arxiv_data1/oa_pdf/49/42/kaup-13-01-1248019.PMC5245770.pdf
"Autophagy 2013; 9:403-9;PMID:23291500; http://dx.doi.org/10.4161/auto.23002 [7] Fujiwara Y, Kikuchi H, Aizawa S, Furuta A, Hatanaka Y, Konya C, Uchida K, Wada K, Kabuta T. Direct uptake and degradation of DNA by lysosomes.",OADS,/arxiv_data1/oa_pdf/49/42/kaup-13-01-1248019.PMC5245770.pdf
"Autophagy 2013; 9:1167-71; PMID:23839276;http://dx.doi.org/10.4161/auto.24880 [8] Hase K, Fujiwara Y, Kikuchi H, Aizawa S, Hakuno F, Takahashi S, Wada K, Kabuta T. RNautophagy/DNautophagy possesses selectivityfor RNA/DNA substrates.",OADS,/arxiv_data1/oa_pdf/49/42/kaup-13-01-1248019.PMC5245770.pdf
"Nucleic Acids Res 2015; 43:6439-49;PMID:26038313; http://dx.doi.org/10.1093/nar/gkv579 [9] Aizawa S, Fujiwara Y, Contu VR, Hase K, Takahashi M, Kikuchi H, Kabuta C, Wada K, Kabuta T. Lysosomal putative RNA transporterSIDT2 mediates direct uptake of RNA by lysosomes.",OADS,/arxiv_data1/oa_pdf/49/42/kaup-13-01-1248019.PMC5245770.pdf
"Autophagy2016; 12:565-78; PMID:27046251; http://dx.doi.org/10.1080/ 15548627.2016.1145325 [10] Xu J, Yoshimura K, Mon H, Li Z, Zhu L, Iiyama K, Kusakabe T, Lee JM.",OADS,/arxiv_data1/oa_pdf/49/42/kaup-13-01-1248019.PMC5245770.pdf
"Mol Biotechnol 2014; 56:193-8; PMID:23979877; http://dx.doi.org/10.1007/s12033-013-9694-0 [11] Fujiwara Y, Hase K, Wada K, Kabuta T. An RNautophagy/ DNautophagy receptor, LAMP2C, p ossesses an arginine-rich motif that mediates RNA/DNA-binding.",OADS,/arxiv_data1/oa_pdf/49/42/kaup-13-01-1248019.PMC5245770.pdf
"Biochem Biophys ResCommun 2015; 460:281-6; PMID:25772617; http://dx.doi.org/10.1016/j.bbrc.2015.03.025 [12] Alberts B, Johnson A, Lexis J, Raff M, Roberts K, Walter P. Molecular Biology of the Cell 2008:5th edition, Garland Science2008:608 pp.",OADS,/arxiv_data1/oa_pdf/49/42/kaup-13-01-1248019.PMC5245770.pdf
"RNA 2011; 17:1057-65; PMID:21474576; http://dx.doi.org/10.1261/rna.2596511 [14] Pei J, Millay DP, Olson EN, Grishin NV.",OADS,/arxiv_data1/oa_pdf/49/42/kaup-13-01-1248019.PMC5245770.pdf
"Biol Direct 2011; 6:37; PMID:21733186; http://dx.doi.org/10.1186/1745-6150-6-37 [15] Howell DP, Krieser RJ, Eastman A, Barry MA.",OADS,/arxiv_data1/oa_pdf/49/42/kaup-13-01-1248019.PMC5245770.pdf
Mol Ther 2003; 8:957-63; PMID:14664798; http://dx.doi.org/10.1016/j.ymthe.2003.09.011222 S. AIZAWA ET AL.,OADS,/arxiv_data1/oa_pdf/49/42/kaup-13-01-1248019.PMC5245770.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/bb/3a/copd-12-285.PMC5245804.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2017:12 285–290International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  285OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S12051 0 real-life data on antibiotic prescription and  sputum culture diagnostics in acute exacerbations  of COPD in primary care erik Bathoorn1 Feikje groenhof2 ron hendrix1,3 Thys van der Molen2,4 Bhanu sinha1 huib aM Kerstjens5 alex W Friedrich1 Janwillem Wh Kocks2,4 1Department of Medical Microbiology,   University of groningen, University  Medical Center groningen,   groningen, the netherlands;   2Department of Primary Care,   University of groningen, University  Medical Center groningen,   groningen, the netherlands;   3Department of Pulmonary Diseases  and Tuberculosis, University of  groningen, University Medical  Center groningen, groningen, the  netherlands; 4Department of Medical  Microbiology, Certe – laboratory  for Infectious Diseases, groningen,   the netherlands; 5grIaC research  Institute, groningen, University of  groningen, University Medical Center  groningen, the netherlandsBackground:  Acute exacerbations of chronic obstructive pulmonary disease (AECOPD) are  generally treated with optimization of bronchodilation therapy and a course of oral corticoster - oids, mostly without antibiotics.",Non-OADS,/arxiv_data1/oa_pdf/bb/3a/copd-12-285.PMC5245804.pdf
"In 2009, the average COPD-related hospital admission rate in European  Union (EU) member states was 184 per 100,000 population aged 15 years.1 The origin  of an exacerbation in mild COPD is often nonbacterial.2 In addition, exacerbations, Correspondence: erik Bathoorn Department of Medical Microbiology,  University of groningen, University  Medical Center groningen,  hanzeplein 1, hpc eB80,  groningen 9713 gZ, the netherlands Tel +31 50 361 3480 Fax +31 50 361 9105 email d.bathoorn@umcg.n l Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Bathoorn et al Running head recto: Antimicrobial prescription policy in COPD exacerbations DOI: http://dx.doi.org/10.2147/COPD.S120510",Non-OADS,/arxiv_data1/oa_pdf/bb/3a/copd-12-285.PMC5245804.pdf
"Available from: http://www.eucast.org/fileadmin/src/media/PDFs/ EUCAST_files/Breakpoint_tables/v_6.0_Breakpoint_table.pd f.  Accessed September 28, 2016.",OADS,/arxiv_data1/oa_pdf/bb/3a/copd-12-285.PMC5245804.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/bb/3a/copd-12-285.PMC5245804.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/bb/3a/copd-12-285.PMC5245804.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/d5/9c/amep-8-063.PMC5245805.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/d5/9c/amep-8-063.PMC5245805.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Advances in Medical Education and Practice 2017:8 63–73Advances in Medical Education and Practice Dovepress submit your manuscript | www.dovepress.com Dovepress 63 REVIEW open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/AMEP .S109037 Advances in medical education and practice:  student perceptions of the flipped classroom Christopher J Ramnanan1 Lynley D Pound2 1Department of Innovation in  Medical Education, Faculty of  Medicine, University of Ottawa,   2Ottawa Hospital Research Institute,   Ottawa,  ON, CanadaAbstract:  The flipped classroom (FC) approach to teaching has been increasingly employed in  undergraduate medical education in recent years.",Non-OADS,/arxiv_data1/oa_pdf/d5/9c/amep-8-063.PMC5245805.pdf
"4Correspondence: Christopher J  RamnananDepartment of Innovation in Medical Education, Faculty of Medicine, University of Ottawa, 451 Smyth Road, Ottawa, ON K1H 8M5, CanadaTel +1 613 562 5800 ext 8702Email cramnana@uottawa.caJournal name: Advances in Medical Education and Practice Article Designation: REVIEWY ear: 2017V olume: 8Running head verso: Ramnanan and PoundRunning head recto: FC in medical educationDOI: http://dx.doi.org/10.2147/AMEP .S109037",Non-OADS,/arxiv_data1/oa_pdf/d5/9c/amep-8-063.PMC5245805.pdf
"17,18,28,29,31  One recent study of a FC application in emergency medicine qualitatively compared feedback between a group of students who received a live lecture on trauma management and a group that instead used open access online resources (https://flippedemclassroom.wordpress.com/2014/04/14/approach-to-trauma-by-stella-yiu/) for their pre-session preparation (Yiu, O’Brien, Day, Frank, unpublished data).",Non-OADS,/arxiv_data1/oa_pdf/d5/9c/amep-8-063.PMC5245805.pdf
Available from: https://cft.vanderbilt.edu/guides-sub-pages/flipping-the-classroom/.,Non-OADS,/arxiv_data1/oa_pdf/d5/9c/amep-8-063.PMC5245805.pdf
"Advances in Medical Education and Practice Publish your work in this journal Submit your manuscript here: http://www.dovepress.com/advances-in-medical-education-and-practice-journalAdvances in Medical Education and Practice is an international, peer-  reviewed, open access journal that aims to present and publish research on Medical Education covering medical, dental, nursing and allied   health care professional education.",Non-OADS,/arxiv_data1/oa_pdf/d5/9c/amep-8-063.PMC5245805.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Advances in Medical Education and Practice 2017:8submit your manuscript | www.dovepress.com Dovepress Dovepress Dovepress 73 FC in medical education 37.,Non-OADS,/arxiv_data1/oa_pdf/d5/9c/amep-8-063.PMC5245805.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/c6/0b/tcrm-13-069.PMC5245806.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Therapeutics and Clinical Risk Management 2017:13 69–79Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  69PeRsPeCTivesopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/TCRM.S12180 4 Advances in the management of cardiovascular  risk for patients with type 2 diabetes: perspectives  from the Academy for Cardiovascular Risk,  Outcomes and safety studies in Type 2 Diabetes Guntram schernthaner1 sarah Jarvis2 Chaim Lotan3 Martin Prázný4 Christoph Wanner5 Thomas C Wascher6 1Department of Medicine,   Rudolfstiftung Hospital, vienna,   Austria; 2Richford Gate Medical  Practice, London, UK; 3Cardiovascular  Division, Heart institute, Hadassah- Hebrew University Medical Center,   Jerusalem, israel; 4First Faculty of  Medicine, Charles University, Prague,   Czech Republic; 5Department of  Medicine, University Hospital,   Würzburg, Germany; 6First Medical  Department, Hanusch-Krankenhaus,   vienna, AustriaAbstract:  Diabetes is a global health emergency projected to affect 642 million people by  2040.",Non-OADS,/arxiv_data1/oa_pdf/c6/0b/tcrm-13-069.PMC5245806.pdf
"Keywords:  type 2 diabetes, cardiovascular risk, SGLT2 inhibitor, CVOTs, empagliflozin Introduction Diabetes accounts for 12% of worldwide health expenditure; one in 11 adults, or  412 million people, has diabetes (projected to increase to 642 million by 2040),1  and of these patients, 90% have type 2 diabetes (T2D).1 Diabetes affects multiple  organs, including the eyes, kidneys, nerves, and heart, which results in a range of  comorbidities, as well as increased risks of cancer, serious psychiatric illness, cogni - tive decline, chronic liver disease, and accelerated arthritis.2 T2D is also associated with cardiovascular (CV) risk factors, such as dyslipidemia,  hypertension, hyperglycemia, obesity, and increased oxidative stress.3 CV disease  (CVD) is the leading cause of mortality in patients with diabetes, accounting  for ~50% of deaths and reducing the life expectancy of a 60-year-old patient with  T2D by an average of 12 years compared with the general population.1,4 Although  microvascular complications have been reduced by improved glycemic control with  glucose-lowering drugs,5–8 the effect of these drugs on macrovascular outcomes is  less certain.9,10 Consequently, in 2008, the US Food and Drug Administration (FDA) Correspondence: Guntram schernthaner Department of Medicine, Rudolfstiftung  Hospital, Juchgasse 25, 1030  vienna, Austria email guntram@schernthaner.e u Journal name: Therapeutics and Clinical Risk Management Article Designation: Perspectives Y ear: 2017 Volume: 13 Running head verso: Schernthaner et al Running head recto: Management of cardiovascular risk for patients with type 2 diabetes DOI: http://dx.doi.org/10.2147/TCRM.S121804",Non-OADS,/arxiv_data1/oa_pdf/c6/0b/tcrm-13-069.PMC5245806.pdf
"Available from:   http://www.Diabetesatlas.org/Resources/2015-Atlas.htm l. Accessed  October 17, 2016.",Non-OADS,/arxiv_data1/oa_pdf/c6/0b/tcrm-13-069.PMC5245806.pdf
Avail - able from:  http://www.World-Heart-Federation.org/Cardiovascular- Health/Cardiovascular-Disease-Risk-Factors/Diabetes /.,Non-OADS,/arxiv_data1/oa_pdf/c6/0b/tcrm-13-069.PMC5245806.pdf
Available from: http://www.ema.,Non-OADS,/arxiv_data1/oa_pdf/c6/0b/tcrm-13-069.PMC5245806.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/c6/0b/tcrm-13-069.PMC5245806.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/c6/0b/tcrm-13-069.PMC5245806.pdf
"Available from: http://www.fda.gov/Safety/ MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ ucm494252.ht m. Accessed May 5, 2016.",Non-OADS,/arxiv_data1/oa_pdf/c6/0b/tcrm-13-069.PMC5245806.pdf
"Available from: http://www.ema.europa.eu/docs/ en_GB/document_library/Referrals_document/SGLT2_inhibitors__20/ European_Commission_final_decision /WC500206515.pd f. Accessed  June 14, 2016.",Non-OADS,/arxiv_data1/oa_pdf/c6/0b/tcrm-13-069.PMC5245806.pdf
"Available from: http://www.Fda.Gov/Safety/ MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ ucm506554.ht m. Accessed June 15, 2016.",OADS,/arxiv_data1/oa_pdf/c6/0b/tcrm-13-069.PMC5245806.pdf
Available from: https://clinicaltrials.gov/ct2/show/NCT01730534?,Non-OADS,/arxiv_data1/oa_pdf/c6/0b/tcrm-13-069.PMC5245806.pdf
"Available from: http://www.cdc.gov/diabetes/ pubs/pdf/ndfs_2011.pd f. Accessed October 17, 2016.",Non-OADS,/arxiv_data1/oa_pdf/c6/0b/tcrm-13-069.PMC5245806.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/fa/4f/amep-8-057.PMC5245808.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/fa/4f/amep-8-057.PMC5245808.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Advances in Medical Education and Practice 2017:8 57–61Advances in Medical Education and Practice Dovepress submit your manuscript | www.dovepress.com Dovepress 57 PErsPEctivEs open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/AMEP .S123215 Flipping the classroom to teach Millennial  residents medical leadership: a proof of concept Alicia t Lucardie1 Lizanne Berkenbosch2 Jochem van den Berg3 Jamiu O Busari3,4 1Faculty of Health, Medicine and  Life sciences, Maastricht University,   2Department of Pediatrics,   Maastricht University Medical  centre, Maastricht, 3Department of  Pediatrics, Zuyderland Medical center,   Heerlen, 4Department of Educational  Development and research, Faculty  of Health, Medicine and Life sciences,   Maastricht University, Maastricht,  the NetherlandsIntroduction: The ongoing changes in health care delivery have resulted in the reform of  educational content and methods of training in postgraduate medical leadership education.",Non-OADS,/arxiv_data1/oa_pdf/fa/4f/amep-8-057.PMC5245808.pdf
"However, despite the implementation of several reforms in the medical curricula, a correspondence: Jamiu O Busari Department of Pediatrics, Zuyderland Medical center, Henri Dunantstraat 5, 6401 cX Heerlen, the Netherlandstel +31 45 576 7222Fax +31 45 574 1383Email Jamiu.busari@maastrichtuniversity.nlJournal name: Advances in Medical Education and Practice Article Designation: PerspectivesY ear: 2017V olume: 8Running head verso: Lucardie et alRunning head recto: Flipped classroom in postgraduate medical educationDOI: http://dx.doi.org/10.2147/AMEP .S123215",Non-OADS,/arxiv_data1/oa_pdf/fa/4f/amep-8-057.PMC5245808.pdf
"Advances in Medical Education and Practice Publish your work in this journal Submit your manuscript here: http://www.dovepress.com/advances-in-medical-education-and-practice-journalAdvances in Medical Education and Practice is an international, peer-  reviewed, open access journal that aims to present and publish research on Medical Education covering medical, dental, nursing and allied   health care professional education.",Non-OADS,/arxiv_data1/oa_pdf/fa/4f/amep-8-057.PMC5245808.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Advances in Medical Education and Practice 2017:8submit your manuscript | www.dovepress.com Dovepress Dovepress Dovepress 61 Flipped classroom in postgraduate medical education  11.,Non-OADS,/arxiv_data1/oa_pdf/fa/4f/amep-8-057.PMC5245808.pdf
Available from: https://icenetblog.royalcollege.ca/2015/12/04/meded-and-leadership-a-synopsis-of-a-new-dutch-framework/.,Non-OADS,/arxiv_data1/oa_pdf/fa/4f/amep-8-057.PMC5245808.pdf
Available from: https://www.aims.org.au/documents/item/352.,Non-OADS,/arxiv_data1/oa_pdf/fa/4f/amep-8-057.PMC5245808.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/5f/27/dddt-11-211.PMC5245809.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2017:11 211–223Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  211Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DDDT .S10423 3 Spotlight on mavrilimumab for the treatment of  rheumatoid arthritis: evidence to date Chiara Crotti1 Maria Gabriella Raimondo1 Andrea Becciolini2 Martina Biggioggero1 ennio Giulio Favalli2 1Department of Clinical Sciences  and Health Community, University  of Milan, Division of Rheumatology,   Gaetano Pini institute, 2Department  of Rheumatology, Gaetano Pini  institute, Milan, italyAbstract:  The introduction of biological therapies into clinical practice has dramatically  modified the natural history of chronic inflammatory diseases, such as rheumatoid arthritis (RA).",Non-OADS,/arxiv_data1/oa_pdf/5f/27/dddt-11-211.PMC5245809.pdf
"Moreover, the increasing knowledge about RA pathways Correspondence: ennio Giulio Favalli Department of Rheumatology, Gaetano  Pini institute, Milan, via Gaetano Pini, 9,  Milan 20122, italy Tel +39 02 5829 6421 Fax +39 02 5829 6315 email ennio.favalli@gmail.co m Journal name: Drug Design, Development and Therapy Article Designation: Review Y ear: 2017 Volume: 11 Running head verso: Crotti et al Running head recto: Mavrilimumab in the treatment of RA DOI: http://dx.doi.org/10.2147/DDDT.S104233",Non-OADS,/arxiv_data1/oa_pdf/5f/27/dddt-11-211.PMC5245809.pdf
Available from: https://clinicaltrials.gov/ct2/ results?term =NCT0099544 9.,Non-OADS,/arxiv_data1/oa_pdf/5f/27/dddt-11-211.PMC5245809.pdf
Available from: https://clinicaltrials.gov/ct2/show/ NCT0235459 9.,Non-OADS,/arxiv_data1/oa_pdf/5f/27/dddt-11-211.PMC5245809.pdf
Available from: https://clinicaltrials.gov/ct2/show/ NCT0237909 1.,Non-OADS,/arxiv_data1/oa_pdf/5f/27/dddt-11-211.PMC5245809.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/5f/27/dddt-11-211.PMC5245809.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/5f/27/dddt-11-211.PMC5245809.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/95/56/bctt-9-021.PMC5245810.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/95/56/bctt-9-021.PMC5245810.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Breast Cancer - Targets and Therapy 2017:9 21–27Breast Cancer - Targets and Therapy Dovepress submit your manuscript | www.dovepress.com Dovepress 21 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/BCTT .S125431 Association between telomere length and CYP19  TTTA repetition polymorphism in healthy and  breast cancer-diagnosed women Blanca Murillo-Ortiz1  Sandra Martínez-Garza1  David Suárez García1  Rosa del Carmen Castillo  Valenzuela2  Juan Francisco García Regalado 2  Gerardo Cano Velázquez1 1Institute Mexican of Social Security,   Department Oncology, Unit of  Research in Clinical Epidemiology,   2Department of Medical Sciences,   University of Guanajuato, León Guanajuato, MexicoIntroduction: Several studies have reported an increase in breast cancer (BC) risk when  patients are carriers of the CYP19 TTA polymorphism with ≥10 repeats; moreover, it has been  reported that telomere length is associated with a higher susceptibility of developing cancer.",Non-OADS,/arxiv_data1/oa_pdf/95/56/bctt-9-021.PMC5245810.pdf
"Furthermore, it was demonstrated that the higher concentrations of estradiol in situ in BC are due to catalyzing production Correspondence: Blanca Murillo-Ortiz Instituto Mexicano del Seguro Social, Servicio de Oncología, Unidad Médica de Alta Especialidad, No 1 del Bajío, Unidad de Investigación en Epidemiología Clínica, B López Mateos Esq Insurgentes S/N, Colonia Los Paraísos, CP 37320, León, Guanajuato, México   Tel/fax +52 477 718 3039   Email bomo907@hotmail.comJournal name: Breast Cancer - Targets and Therapy Article Designation: ORIGINAL RESEARCHY ear: 2017V olume: 9Running head verso: Murillo-Ortiz et alRunning head recto: CYP19 TTTA repetition polymorphism and telomere lengthDOI: http://dx.doi.org/10.2147/BCTT.S125431",Non-OADS,/arxiv_data1/oa_pdf/95/56/bctt-9-021.PMC5245810.pdf
"Breast Cancer - Targets and Therapy 2017:9submit your manuscript | www.dovepress.com Dovepress Dovepress Breast Cancer - Targets and Therapy Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/breast-cancer---targets-and-therapy-journal Breast Cancer - Targets and Therapy is an international, peer-   reviewed open access journal focusing on breast cancer research,  identification of therapeutic targets and the optimal use of preven-tative and integrated treatment interventions to achieve improved  outcomes, enhanced survival and quality of life for the cancer patient.",Non-OADS,/arxiv_data1/oa_pdf/95/56/bctt-9-021.PMC5245810.pdf
"Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 27 CYP19 TTTA repetition polymorphism and telomere length a direct effect on telomere length, which is an important risk  factor for the development of BC.",Non-OADS,/arxiv_data1/oa_pdf/95/56/bctt-9-021.PMC5245810.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/3f/fd/cia-12-137.PMC5245868.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Interventions in Aging 2017:12 137–143Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  137OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S11359 7 Cranberry juice concentrate does not significantly  decrease the incidence of acquired bacteriuria  in female hip fracture patients receiving urine  catheter: a double-blind randomized trial Anna-Karin gunnarsson1 lena gunningberg2 sune larsson1 Kenneth B Jonsson1 1Institution of surgical sciences,   Uppsala University, Uppsala, sweden;   2Institution of Public health and  Caring sciences, Uppsala University,   Uppsala, swedenBackground:  Urinary tract infection (UTI) is a common complication among patients with hip  fractures.",Non-OADS,/arxiv_data1/oa_pdf/3f/fd/cia-12-137.PMC5245868.pdf
"Pressure ulcers, renal failure, delirium, and urinary tract infections  (UTIs) are common.1–4 The reported incidence of UTIs among hospital patients with  hip fracture is high.4–6 UTI increases the risk of developing acute delirium, the length of  hospital stay is prolonged, patients have a greater risk for subsequent falls, and quality  of life deteriorates.5,7–10 Treating a symptomatic UTI with antibiotics is expensive,11  confers side effects,12 and can result in development of antimicrobial resistance.8 The  overall cost to society is significant.13,14 For these reasons, there is a need for preven - tive measures to avoid UTIs in hospitalized patients.Correspondence: Anna-Karin  gunnarsson Institution of surgical sciences,  Uppsala University hospital,  se-751 85 Uppsala, sweden Tel +46 18 611 4481 Fax +46 18 50 9427 email anna-karin.gunnarsson@ akademiska.s e Journal name: Clinical Interventions in Aging Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Gunnarsson et al Running head recto: Cranberry juice concentrate to female hip fracture patients: a RTC DOI: http://dx.doi.org/10.2147/CIA.S113597",Non-OADS,/arxiv_data1/oa_pdf/3f/fd/cia-12-137.PMC5245868.pdf
Available from: http://www.cranberryinstitute.,Non-OADS,/arxiv_data1/oa_pdf/3f/fd/cia-12-137.PMC5245868.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/3f/fd/cia-12-137.PMC5245868.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/3f/fd/cia-12-137.PMC5245868.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/e0/fe/ott-10-363.PMC5245910.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2017:10 363–370OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  363Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/ 10.2147/OTT .S12455 6 Validation of a novel prognostic scoring system  using inflammatory response biomarkers in patients  undergoing curative thoracoscopic esophagectomy  for esophageal squamous cell carcinoma Noriyuki Hirahara Yusuke Fujii T etsu Yamamoto Ryoji Hyakudomi Takanori Hirayama Takahito Taniura Kazunari Ishitobi Y oshitsugu Tajima Department of Digestive and general  surgery, shimane University Faculty  of Medicine, shimane, JapanBackground:  Systemic inflammatory markers, including the lymphocyte-to-monocyte  ratio, neutrophil-to-lymphocyte ratio, and platelet-to-lymphocyte ratio have been shown  to predict postoperative recurrence and survival in various types of cancer.",Non-OADS,/arxiv_data1/oa_pdf/e0/fe/ott-10-363.PMC5245910.pdf
"Colaprico et al1  showed interesting networks of pathways that could regulate target genes in breast Correspondence: Noriyuki Hirahara Department of Digestive and general  surgery, shimane University Faculty of  Medicine, 89-1 enya-cho, izumo, shimane  693-8501, Japan Tel +81 853 20 2232 Fax +81 853 20 2229 email norinorihirahara@yahoo.co.j p Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2017 Volume: 10 Running head verso: Hirahara et al Running head recto: Validation of a novel prognostic scoring system for esophageal cancer DOI: http://dx.doi.org/10.2147/OTT.S124556",OADS,/arxiv_data1/oa_pdf/e0/fe/ott-10-363.PMC5245910.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/e0/fe/ott-10-363.PMC5245910.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/e0/fe/ott-10-363.PMC5245910.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/94/f5/jpr-10-175.PMC5245911.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/94/f5/jpr-10-175.PMC5245911.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Pain Research  2017:10 175–181Journal of Pain Research Dovepress submit your manuscript | www.dovepress.com Dovepress  175 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JPR.S118105Association between lymphocyte expression of  the apoptotic receptor Fas and pain in critically ill  patients Elizabeth DE  Papathanassoglou1,* Meropi DA Mpouzika2,* Margarita Giannakopoulou3 Evangelos Bozas3 Nicos Middleton2 George Tsiaousis2 Andreas Karabinis4,5 1Faculty of Nursing, University of  Alberta, Edmonton, AB, Canada;   2Department of Nursing, Cyprus  University of T echnology, Limassol,   Cyprus; 3Department of Nursing,   School of Health Sciences, National and Kapodistrian University of Athens,   4Surgical Care Unit, The Onassis  Cardiac Surgery Center, Kallithea,   5School of Medicine, National and  Kapodistrian University of Athens,  Athens, Greece *These authors contributed equally to  this workObjective: Lymphocyte apoptosis in critical illness is associated with immunosuppression.",Non-OADS,/arxiv_data1/oa_pdf/94/f5/jpr-10-175.PMC5245911.pdf
"3 Apart from pain attributed to conditions related to admission diagnoses, care  procedures are also associated with significant increases in pain.4Correspondence: Elizabeth DE  PapathanassoglouFaculty of Nursing, University of Alberta, Edmonton Clinic Health Academy, 11405-87th Avenue, Edmonton, AB T6G 1C9, CanadaTel +1 780 492 5674Email papathan@ualberta.caJournal name: Journal of Pain Research  Article Designation: ORIGINAL RESEARCHY ear: 2017V olume: 10Running head verso: Papathanassoglou et alRunning head recto: Fas and pain in critical illnessDOI: http://dx.doi.org/10.2147/JPR.S118105",Non-OADS,/arxiv_data1/oa_pdf/94/f5/jpr-10-175.PMC5245911.pdf
"Journal of Pain Research  2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Pain Research  Publish your work in this journal Submit your manuscript here:  https://www.dovepress.com/journal-of-pain-research-journal The Journal of Pain Research is an international, peer reviewed, open  access, online journal that welcomes laboratory and clinical findings   in the fields of pain research and the prevention and management of pain.",Non-OADS,/arxiv_data1/oa_pdf/94/f5/jpr-10-175.PMC5245911.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 181 Fas and pain in critical illness  6.,Non-OADS,/arxiv_data1/oa_pdf/94/f5/jpr-10-175.PMC5245911.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/9f/24/imcrj-10-019.PMC5245912.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/9f/24/imcrj-10-019.PMC5245912.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).International Medical Case Reports Journal 2017:10 19–23International Medical Case Reports Journal Dovepress submit your manuscript | www.dovepress.com Dovepress 19 CASE REPORT open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IMCRJ.S120558Osteopathic treatment in a patient with  left‑ventricular assist device with left   brachialgia: a case report Bruno Bordoni1–3 Fabiola Marelli2,3 Bruno Morabito2–4 Beatrice Sacconi5 1Foundation Don Carlo Gnocchi  IRCCS, Department of Cardiology,   Institute of Hospitalization and Care with Scientific Address, Milan,   2CRESO, School of Osteopathic  Centre for Research and Studies,  Gorla Minore,  3CRESO, School of  Osteopathic Centre for Research and Studies, Falconara Marittima,   4Department of Radiological,   Oncological and Anatomopathological Sciences, Sapienza University of Rome,  5Center for Life Nano Science,   CLNS@Sapienza, Istituto Italiano di T ecnologia, Rome, ItalyAbstract: This study deals with an osteopathic approach used for a patient with left-ventricular  assist device (L-V AD) affected by left brachialgia.",Non-OADS,/arxiv_data1/oa_pdf/9f/24/imcrj-10-019.PMC5245912.pdf
"6 Patients undergoing a sternotomy may present transient or permanent injury  to the brachial plexus and trauma to the first rib, probably because of the position Correspondence: Bruno Bordoni Foundation Don Carlo Gnocchi IRCCS, Department of Cardiology, Institute of Hospitalization and Care with Scientific Address, Santa Maria Nascente, Via Capecelatro 66, Milan 20100, ItalyTel +39 34 9630 0617Email bordonibruno@hotmail.comJournal name: International Medical Case Reports Journal Article Designation: CASE REPORTY ear: 2017V olume: 10Running head verso: Bordoni et alRunning head recto: Osteopathic treatment in a patient with L-V ADDOI: http://dx.doi.org/10.2147/IMCRJ.S120558",Non-OADS,/arxiv_data1/oa_pdf/9f/24/imcrj-10-019.PMC5245912.pdf
"International Medical Case Reports Journal 2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress International Medical Case Reports Journal Publish your work in this journal Submit your manuscript here:  https://www.dovepress.com/international-medical-case-reports-journal-journalThe International Medical Case Reports Journal is an international,  peer-reviewed open-access journal publishing original case reports from all medical specialties.",Non-OADS,/arxiv_data1/oa_pdf/9f/24/imcrj-10-019.PMC5245912.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 23 Osteopathic treatment in a patient with L‑VAD,Non-OADS,/arxiv_data1/oa_pdf/9f/24/imcrj-10-019.PMC5245912.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/bf/6d/ott-10-361.PMC5245913.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2017:10 361–362OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  361LeTTeropen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OTT .S12824 0 Letter to the editor regarding “Prognostic role   of microrNA-150 in various carcinomas:   a meta-analysis” Correspondence: Ying Yang Department of Orthopaedic Surgery,  Shanghai Ninth People’s Hospital,  Shanghai Jiao Tong University School of  Medicine, 639 Zhizaoju road, Shanghai  200011, People’s republic of China Tel +86 21 2327 1133 Fax +86 21 6313 7020 email leeny520@126.co m Journal name: OncoTargets and Therapy Article Designation: Letter Y ear: 2017 Volume: 10 Running head verso: Li and Y ang Running head recto: Prognostic role of microRNA-150 in various carcinomas DOI: http://dx.doi.org/10.2147/OTT.S128240 Min Li1 Ying Yang2 1Department of Oncology, Changsha  Central Hospital, Changsha, Hunan,   2Department of Orthopaedic Surgery,   Shanghai Ninth People’s Hospital,   Shanghai Jiao Tong University School  of Medicine, Shanghai, People’s  republic of ChinaDear editor Emerging evidence has shown that aberrant microRNA expression has the potential to be  used for predicting survival and treatment response of carcinomas.1–3 Recently, the role  of miR-150 was investigated in various types of cancers, but the results were inconsistent  and inconclusive.4–7 Therefore, we read with great interest the enlightening work of Wang  et al8 published in OncoTargets and Therapy .",Non-OADS,/arxiv_data1/oa_pdf/bf/6d/ott-10-361.PMC5245913.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/bf/6d/ott-10-361.PMC5245913.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/bf/6d/ott-10-361.PMC5245913.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/3a/af/jpr-10-145.PMC5245914.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/3a/af/jpr-10-145.PMC5245914.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Pain Research  2017:10 145–156Journal of Pain Research Dovepress submit your manuscript | www.dovepress.com Dovepress  145 REVIEW open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JPR.S99337Anterior cutaneous nerve entrapment syndrome:  management challenges Eleni Chrona1,2 Georgia Kostopanagiotou1 Dimitrios Damigos3 Chrysanthi Batistaki1 1Second Department of  Anesthesiology, School of Medicine,   National and Kapodistrian University of Athens, “Attikon” Hospital, Athens,   2Department of  Anesthesiology, General Hospital of “Ag.",Non-OADS,/arxiv_data1/oa_pdf/3a/af/jpr-10-145.PMC5245914.pdf
"1,7 The muscle contraction at this location may cause additional Correspondence : Chrysanthi Batistaki Second Department of Anesthesiology,  School of Medicine, National and Kapodistrian University of Athens, Attikon Hospital, 1 Rimini str, Athens, 124 62, GreeceTel +30 21 0583 2371Email chrysabatistaki@yahoo.grJournal name: Journal of Pain Research  Article Designation: REVIEWY ear: 2017V olume: 10Running head verso: Chrona et alRunning head recto: Management of anterior cutaneous nerve entrapment syndromeDOI: http://dx.doi.org/10.2147/JPR.S99337",Non-OADS,/arxiv_data1/oa_pdf/3a/af/jpr-10-145.PMC5245914.pdf
"Journal of Pain Research  2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Pain Research  Publish your work in this journal Submit your manuscript here:  https://www.dovepress.com/journal-of-pain-research-journal The Journal of Pain Research is an international, peer reviewed, open  access, online journal that welcomes laboratory and clinical findings   in the fields of pain research and the prevention and management of pain.",Non-OADS,/arxiv_data1/oa_pdf/3a/af/jpr-10-145.PMC5245914.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 156 Chrona et al 12.,Non-OADS,/arxiv_data1/oa_pdf/3a/af/jpr-10-145.PMC5245914.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/95/13/jpr-10-183.PMC5245915.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/95/13/jpr-10-183.PMC5245915.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Pain Research  2017:10 183–190Journal of Pain Research Dovepress submit your manuscript | www.dovepress.com Dovepress  183 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JPR.S121897Influence of BMI, gender, and sports on pain  decrease and medication usage after facet–medial  branch neurotomy or SI joint lateral branch  cooled RF-neurotomy in case of low back pain: original research in the Austrian population Wolfgang Stelzer1 Valentin Stelzer1 Dominik Stelzer1 Monika Braune1 Christine Duller2 1Medizinisches Zentrum SchmerzLOS  Linz and Baden/Vienna, Vienna,   2Johannes Kepler University Linz,    Linz, AustriaPurpose: This retrospective original research was designed to illustrate the general outcome after  radiofrequency (RF) neurotomy of lumbar medial branch (MB) and posterior ramus of the sacro- iliac joint of 160 patients with chronic low back pain (LBP) 1, 6, and 12 months after treatment.",Non-OADS,/arxiv_data1/oa_pdf/95/13/jpr-10-183.PMC5245915.pdf
"4–6 Studies that were well designed and conducted Correspondence: Wolfgang Stelzer Medizinisches Zentrum SchmerzLOS, Johann Wilhelm Klein Strasse 18, Linz 4020, AustriaTel +43 70 66 4205 8967Fax +43 70 732 7719 4648Email dr.stelzer@medicentbaden.comJournal name: Journal of Pain Research  Article Designation: ORIGINAL RESEARCHY ear: 2017V olume: 10Running head verso: Stelzer et alRunning head recto: Influence of BMI, gender and sports after radiofrequency treatment of LBPDOI: http://dx.doi.org/10.2147/JPR.S121897",Non-OADS,/arxiv_data1/oa_pdf/95/13/jpr-10-183.PMC5245915.pdf
"Journal of Pain Research  2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Pain Research  Publish your work in this journal Submit your manuscript here:  https://www.dovepress.com/journal-of-pain-research-journal The Journal of Pain Research is an international, peer reviewed, open  access, online journal that welcomes laboratory and clinical findings   in the fields of pain research and the prevention and management of pain.",Non-OADS,/arxiv_data1/oa_pdf/95/13/jpr-10-183.PMC5245915.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 190 Stelzer et al  14.,Non-OADS,/arxiv_data1/oa_pdf/95/13/jpr-10-183.PMC5245915.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/59/d0/tacg-10-009.PMC5245916.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/59/d0/tacg-10-009.PMC5245916.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).The Application of Clinical Genetics 2017:10 9–19The Application of Clinical Genetics Dovepress submit your manuscript | www.dovepress.com Dovepress 9 REVIEW open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/TACG.S79121 Update on the clinical management   of Wilson’s disease Peter Hedera Department of Neurology, Vanderbilt  University Medical Center, Nashville,  TN, USAAbstract: Wilson’ s disease (WD), albeit relatively rare, is an important genetic metabolic  disease because of highly effective therapies that can be lifesaving.",Non-OADS,/arxiv_data1/oa_pdf/59/d0/tacg-10-009.PMC5245916.pdf
"4–6 Neuro- logic symptoms tend to develop later by nearly one decade than hepatic presentation, but  Correspondence: Peter Hedera   Department of Neurology, Vanderbilt  University Medical Center, 465 21st Avenue South, 6140 MRB III, Nashville, TN 37232, USA Tel +1 615 936 3920   Fax +1 615 322 0486   Email peter.hedera@vanderbilt.eduJournal name: The Application of Clinical Genetics Article Designation: REVIEWY ear: 2017V olume: 10Running head verso: HederaRunning head recto: Wilson’ s disease updateDOI: http://dx.doi.org/10.2147/TACG.S79121",Non-OADS,/arxiv_data1/oa_pdf/59/d0/tacg-10-009.PMC5245916.pdf
"The Application of Clinical Genetics 2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress The Application of Clinical Genetics Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/the-application-of-clinical-genetics-journalThe Application of Clinical Genetics is an international, peer-reviewed  open access journal that welcomes laboratory and clinical findings in the field of human genetics.",Non-OADS,/arxiv_data1/oa_pdf/59/d0/tacg-10-009.PMC5245916.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes   from published authors.Dovepress 19 Wilson’s disease update  79.,Non-OADS,/arxiv_data1/oa_pdf/59/d0/tacg-10-009.PMC5245916.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/f3/ee/ijwh-9-033.PMC5245917.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Women’s Health 2017:9 33–42International Journal of Women’s Health Dove press submit your manuscript | www.dovepress.co m Dove press  33RevIeWopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJWH.S10610 7 Osteosarcopenic obesity in women: impact,  prevalence, and management challenges Pegah JafariNasabian1 Julia e Inglis1 Owen J Kelly2 Jasminka Z Ilich1 1Department of Nutrition, Food  and exercise Sciences, Florida State  University, Tallahassee, FL, 2Abbott  Nutrition, Columbus, OH, USAAbstract:  Osteosarcopenic obesity syndrome (OSO) has recently been identified as a condition  encompassing osteopenia/osteoporosis, sarcopenia and obesity.",Non-OADS,/arxiv_data1/oa_pdf/f3/ee/ijwh-9-033.PMC5245917.pdf
DOI: http://dx.doi.org/10.2147/IJWH.S106107,Non-OADS,/arxiv_data1/oa_pdf/f3/ee/ijwh-9-033.PMC5245917.pdf
"Available from: http://www.aoa.acl.gov/Aging_Statistics/ index.asp x. Accessed January 1, 2016.",OADS,/arxiv_data1/oa_pdf/f3/ee/ijwh-9-033.PMC5245917.pdf
Available from: https://consensus.nih.,Non-OADS,/arxiv_data1/oa_pdf/f3/ee/ijwh-9-033.PMC5245917.pdf
Available from: https://www.nof.org/ about-us/nof-background/.,Non-OADS,/arxiv_data1/oa_pdf/f3/ee/ijwh-9-033.PMC5245917.pdf
"Available from: http://assets.aarp.org/ rgcenter/ppi/ltc/i51-caregiving.pd f. Accessed November 29, 2016.",Non-OADS,/arxiv_data1/oa_pdf/f3/ee/ijwh-9-033.PMC5245917.pdf
Available from: http://newsroom.aaos.org/media-resources/ Press-releases/american-academy-of-orthopaedic-surgeons-releases- new-guidelines-on-hip-fractures-in-older-adults-acl-injuries-and- infant-dysplasia-of-the-hip.htm.,Non-OADS,/arxiv_data1/oa_pdf/f3/ee/ijwh-9-033.PMC5245917.pdf
Available from: http://www.ncbi.nlm.nih.gov/pubmed/2415274 2.,Non-OADS,/arxiv_data1/oa_pdf/f3/ee/ijwh-9-033.PMC5245917.pdf
Available from:  http://www.cdc.gov/nchs/data/databriefs/db82.htm#Ref 6.,OADS,/arxiv_data1/oa_pdf/f3/ee/ijwh-9-033.PMC5245917.pdf
Available  from: http://www.asbmr.org/education/AbstractDetail?aid=da7d06cc- 1551-4abf-8445-51dc6e53bcf 7.,Non-OADS,/arxiv_data1/oa_pdf/f3/ee/ijwh-9-033.PMC5245917.pdf
"Available from: http://www.nap.edu/ catalog/12967.htm l. Accessed October 16, 2016.",Non-OADS,/arxiv_data1/oa_pdf/f3/ee/ijwh-9-033.PMC5245917.pdf
"International Journal of Women’s Health Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-womens-health-journa lThe International Journal of Women’s Health is an international, peer- reviewed open-access journal publishing original research, reports,  editorials, reviews and commentaries on all aspects of women’s  healthcare including gynecology, obstetrics, and breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/f3/ee/ijwh-9-033.PMC5245917.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/f3/ee/ijwh-9-033.PMC5245917.pdf
Available  from: https://ods.od.nih.gov/factsheets/ Magnesium -HealthProfessional /.,Non-OADS,/arxiv_data1/oa_pdf/f3/ee/ijwh-9-033.PMC5245917.pdf
Available  from: https://ods.od.nih.gov/factsheets/VitaminD- HealthProfessional /.,Non-OADS,/arxiv_data1/oa_pdf/f3/ee/ijwh-9-033.PMC5245917.pdf
"Available from: https://www.nia.nih.gov/health/publication/ falls-and-fracture s. Accessed December 16, 2016.",Non-OADS,/arxiv_data1/oa_pdf/f3/ee/ijwh-9-033.PMC5245917.pdf
"30 C. Y. Legault, CYLview, version 1.0b , Universit ´ed e Sherbrooke, 2009, http://www.cylview.org.",Non-OADS,/arxiv_data1/oa_pdf/f4/be/SC-007-C6SC01457G.PMC5245920.pdf
"Sarcoma Volume 2013, Article ID  205832. http://dx.doi.org/10.1155/2013/205832.",Non-OADS,/arxiv_data1/oa_pdf/1b/40/JOCR-6-16.PMC5245926.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/b0/ad/ijn-12-575.PMC5245973.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2017:12 575–576International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  575Letteropen access to scientific and medical research Open Access Full text Article http: //dx.doi.org/10.2147/IJN.S12874 9 Nanoscale tiO2 nanotubes as a basis for governing  cell behaviors and application challenges Min Li1 Ying Yang2 1Department of Oncology, Changsha  Central Hospital, Changsha, People’s  republic of China; 2Department  of Orthopaedic Surgery, Shanghai  Ninth People’s Hospital, Shanghai Jiao  tong University, School of Medicine,   Shanghai, People’s republic of ChinaDear editor TiO2 nanotube arrays with well-ordered nanotubular structures and controllable  dimensions have emerged as a favorable substrate for advanced cell culturing with  regulable cell behavior and differentiation.1,2 Unfortunately, the biological effects of  nanotubes with different surface features on various cell lines are still inconsistent  and inconclusive.",Non-OADS,/arxiv_data1/oa_pdf/b0/ad/ijn-12-575.PMC5245973.pdf
"Oh et al8 observed that small ( ~30 nm  diameter) nanotubes promoted MSC adhesion without noticeable differentiation,  whereas larger ( ~70–100  nm diameter) nanotubes elicited a dramatic MSC elongation, Correspondence: Ying Yang Department of Orthopaedic Surgery,  Shanghai Ninth People’s Hospital,  Shanghai Jiao tong University School of  Medicine, 639 Zhizaoju road, Shanghai  200011, People’s republic of China tel +86 212 327 1133 Fax +86 216 313 7020 email leeny520@126.co m Journal name: International Journal of Nanomedicine Article Designation: Letter Y ear: 2017 Volume: 12 Running head verso: Li and Y ang Running head recto: TiO2 nanotubes for cell behaviors and application challenges DOI: http://dx.doi.org/10.2147/IJN.S128749",Non-OADS,/arxiv_data1/oa_pdf/b0/ad/ijn-12-575.PMC5245973.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/b0/ad/ijn-12-575.PMC5245973.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/b0/ad/ijn-12-575.PMC5245973.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/80/03/ijn-12-559.PMC5245974.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2017:12 559–574International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  559OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S12351 4 In vitro determination of the efficacy of scorpion  venoms as anti-cancer agents against colorectal  cancer cells: a nano-liposomal delivery approach abdulrahman K al-asmari1 Zabih Ullah1 ali al Balowi2 Mozaffarul Islam1 1Department of research, Prince  Sultan Military Medical City, Riyadh,   2Department of Pharmacy, King  Fahad armed Forces hospital,   Jeddah, saudi arabiaAbstract:  The use of liposomes in biological and medicinal sciences is a relatively new  approach.",Non-OADS,/arxiv_data1/oa_pdf/80/03/ijn-12-559.PMC5245974.pdf
"In the natural form, the phospholipids are present  in stable membranes composed of a bilayer.1 Liposome or lipid vesicles emerged from  self-forming enclosed lipid bilayers upon hydration, which has played a leading role  in the formulation of potent drugs to improve their therapeutic efficacy.2 Among the  macromolecular systems that are useful for the targeted drug delivery, liposomes are correspondence: abdulrahman K  al-asmari Research Center, Prince Sultan, Military  Medical City, PO Box 7897 (S-775),  Riyadh 11159, Saudi Arabia Tel +966 1 479 1000 ext 25100 Fax +966 1 477 7714 ext 23060 email abdulrahman.alasmari@gmail.co m Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Al-Asmari et al Running head recto: Nanomedicine mediated delivery of scorpion venoms to colon carcinoma cells DOI: http://dx.doi.org/10.2147/IJN.S123514",Non-OADS,/arxiv_data1/oa_pdf/80/03/ijn-12-559.PMC5245974.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/80/03/ijn-12-559.PMC5245974.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/80/03/ijn-12-559.PMC5245974.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/e3/a6/ijgm-10-023.PMC5245975.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/e3/a6/ijgm-10-023.PMC5245975.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).International Journal of General Medicine 2017:10 23–26International Journal of General Medicine Dovepress submit your manuscript | www.dovepress.com Dovepress 23 COMMENTARY open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJGM.S115566Following the results of the EMPA-REG  OUTCOME trial with empagliflozin, is it possible  to speak of a class effect?",Non-OADS,/arxiv_data1/oa_pdf/e3/a6/ijgm-10-023.PMC5245975.pdf
"2 As regard the cardiovascular benefits observed with empagliflozin, it has been Correspondence: Francisco Javier  Ampudia-BlascoEndocrinology and Nutrition Department, Clinic University Hospital Valencia, Avenida de Blasco Ibáñez, 17, 46010 Valencia, Spain Tel +34 961 97 3500   Email ampudia_fra@gva.esJournal name: International Journal of General Medicine Article Designation: COMMENTAR YY ear: 2017V olume: 10Running head verso: Ampudia-Blasco et alRunning head recto: EMPA-REG OUTCOME trial: is it possible to speak of a class effect?DOI: http://dx.doi.org/10.2147/IJGM.S115566",Non-OADS,/arxiv_data1/oa_pdf/e3/a6/ijgm-10-023.PMC5245975.pdf
Available from: http://www.ema.,Non-OADS,/arxiv_data1/oa_pdf/e3/a6/ijgm-10-023.PMC5245975.pdf
Available from: https://clinicaltrials.gov/ct2/show/NCT01730534?term= declare+ timi+ 58&rank=1.,Non-OADS,/arxiv_data1/oa_pdf/e3/a6/ijgm-10-023.PMC5245975.pdf
"International Journal of General Medicine 2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress International Journal of General Medicine Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/international-journal-of-general-medicine-journalThe International Journal of General Medicine is an international,  peer-reviewed open-access journal that focuses on general and internal medicine, pathogenesis, epidemiology, diagnosis, monitoring and treat-ment protocols.",Non-OADS,/arxiv_data1/oa_pdf/e3/a6/ijgm-10-023.PMC5245975.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 26 Ampudia-Blasco et al 15.,Non-OADS,/arxiv_data1/oa_pdf/e3/a6/ijgm-10-023.PMC5245975.pdf
Available from: https://clinicaltrials.gov/ct2/show/NCT01032629?term= canvas&rank= 1.,Non-OADS,/arxiv_data1/oa_pdf/e3/a6/ijgm-10-023.PMC5245975.pdf
Available from: https://clinicaltrials.gov/ct2/show/NCT01989754?term =canvas&rank =5.,Non-OADS,/arxiv_data1/oa_pdf/e3/a6/ijgm-10-023.PMC5245975.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/28/03/idr-10-019.PMC5245976.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/28/03/idr-10-019.PMC5245976.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Infection and Drug Resistance  2017:10 19–25Infection and Drug Resistance Dovepress submit your manuscript | www.dovepress.com Dovepress 19 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IDR.S123646Occurrence of extended-spectrum and AmpC  b-lactamases in multiple drug resistant Salmonella   isolates from clinical samples in Lagos, Nigeria KO Akinyemi1 Bamidele Abiodun  Iwalokun2 Akeeb O Bola Oyefolu1 CO Fakorede1 1Department of Microbiology, Lagos  State University, Ojo, 2Molecular  Biology and Biotechnology Division,   Nigerian Institute of Medical Research, Yaba, Lagos, NigeriaPurpose: Salmonella spp.",Non-OADS,/arxiv_data1/oa_pdf/28/03/idr-10-019.PMC5245976.pdf
"Fortunately, unlike the past two decades when the lack of standard guidelines Correspondence: KO Akinyemi Department of Microbiology, Lagos State University, PMB 1087, Km 15 Badagry Express Way, Ojo, Lagos, NigeriaTel +234 1 802 908 8676Email akinyemiko@yahoo.comJournal name: Infection and Drug Resistance  Article Designation: ORIGINAL RESEARCHY ear: 2017V olume: 10Running head verso: Akinyemi et alRunning head recto: ESBL and AmpC b-lactamases in MDR Salmonella isolatesDOI: http://dx.doi.org/10.2147/IDR.S123646 Video abstract Point your SmartPhone at the code above.",Non-OADS,/arxiv_data1/oa_pdf/28/03/idr-10-019.PMC5245976.pdf
Or use: http://youtu.be/WgLNw4zwmV4,Non-OADS,/arxiv_data1/oa_pdf/28/03/idr-10-019.PMC5245976.pdf
"Infection and Drug Resistance  2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress Infection and Drug Resistance  Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/infection-and-drug-resistance-journalInfection and Drug Resistance is an international, peer-reviewed open- access journal that focuses on the optimal treatment of infection (bacte-rial, fungal and viral) and the development and institution of preventive strategies to minimize the development and spread of resistance.",Non-OADS,/arxiv_data1/oa_pdf/28/03/idr-10-019.PMC5245976.pdf
"Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 25 ESBL and AmpC b-lactamases in MDR Salmonella  isolates Nigerian Institute of Medical Research for providing con- sumables and technical support, respectively.",Non-OADS,/arxiv_data1/oa_pdf/28/03/idr-10-019.PMC5245976.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/3f/41/ijgm-10-015.PMC5245977.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/3f/41/ijgm-10-015.PMC5245977.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).International Journal of General Medicine 2017:10 15–21International Journal of General Medicine Dovepress submit your manuscript | www.dovepress.com Dovepress 15 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJGM.S121904The correlation between preoperative  erythrocyte sedimentation rate and postoperative  outcome in adult cardiac surgery Eissa Bilehjani1  Solmaz Fakhari1  Haleh Farzin1  Alireza Yaghoubi2  Moussa Mirinazhad1  Kamran Shadvar1  Abbasali Dehghani1  Pariasadat Aboalaiy1 1Department of Anesthesiology,   Tabriz University of Medical Sciences,   Tabriz, 2Department of Cardiovascular  Surgery, Iran University of Medical Sciences, T ehran, IranIntroduction: Over the past decades, it has been recommended that preoperative assessment  mainly relies on history and physical examination rather than unnecessary laboratory tests.",Non-OADS,/arxiv_data1/oa_pdf/3f/41/ijgm-10-015.PMC5245977.pdf
"Keywords: erythrocyte sedimentation rate, heart surgery, postoperative complication, post- operative mortality Introduction There exists a myriad of modalities to optimize the preoperative status and reduce the  postoperative complications.1–3 Physical examination, basic laboratory tests (complete  blood count, blood sugar (BS), Na, K, blood urea nitrogen (BUN), creatinine, prothrom-bin time (pt), partial thromboplastin time (ptt), erythrocyte sedimentation rate (ESR) and C-reactive protein [CRP]), chest X-ray, echocardiography, electrocardiography Correspondence: Solmaz Fakhari   Cardiovascular Research Center, Madani  Heart Hospital, Tabriz University of Medical Sciences, Daneshgah Street, Tabriz 5166615573, Iran Tel +98 914 116 0647   Fax +98 411 337 3950   Email solmaz_fakhari@yahoo.comJournal name: International Journal of General Medicine Article Designation: ORIGINAL RESEARCHY ear: 2017V olume: 10Running head verso: Bilehjani et alRunning head recto: Preoperative ESR and postcardiac surgery outcomeDOI: http://dx.doi.org/10.2147/IJGM.S121904",Non-OADS,/arxiv_data1/oa_pdf/3f/41/ijgm-10-015.PMC5245977.pdf
"International Journal of General Medicine 2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress International Journal of General Medicine Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/international-journal-of-general-medicine-journalThe International Journal of General Medicine is an international,  peer-reviewed open-access journal that focuses on general and internal medicine, pathogenesis, epidemiology, diagnosis, monitoring and treat-ment protocols.",Non-OADS,/arxiv_data1/oa_pdf/3f/41/ijgm-10-015.PMC5245977.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 21 Preoperative ESR and postcardiac surgery outcome,Non-OADS,/arxiv_data1/oa_pdf/3f/41/ijgm-10-015.PMC5245977.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/67/76/ijn-12-577.PMC5245978.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2017:12 577–591International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  577OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S11128 4 renal targeting potential of a polymeric drug  carrier, poly -l-glutamic acid, in normal and  diabetic rats hann-Juang chai1 lik-Voon Kiew1 Yunni chin1 anwar Norazit2 suzita Mohd Noor2 Y oke-lin lo3,4 chung-Yeng looi1 Yeh-siang lau1 T uck-Meng lim5 Won-Fen Wong6 Nor azizan abdullah1 Munavvar Zubaid abdul  sattar7 edward J Johns8 Zamri chik1 lip-Y ong chung3 1Department of Pharmacology,   2Department of Biomedical science,   3Department of Pharmacy, Faculty  of Medicine, University of Malaya,   4school of Pharmacy, International  Medical University, Kuala lumpur,   5Department of chemical science,   Faculty of science, Universiti Tunku  abdul rahman, Kampar, 6Department  of Medical Microbiology, Faculty of  Medicine, University of Malaya, Kuala  lumpur, 7school of Pharmaceutical  sciences, Universiti sains Malaysia,   Minden, Malaysia; 8Department of  Physiology, University college cork,   cork, republic of IrelandBackground and purpose:  Poly -l-glutamic acid (PG) has been used widely as a carrier to  deliver anticancer chemotherapeutics.",Non-OADS,/arxiv_data1/oa_pdf/67/76/ijn-12-577.PMC5245978.pdf
"Various renoprotective compounds have been assessed for  their ability to improve renal functions.8–10 Poor solubility in plasma, a lack of specific correspondence: lik-Voon Kiew Department of Pharmacology, Faculty of  Medicine, University of Malaya, 50603  Kuala lumpur, Malaysia Tel +60 3 7967 5720 Fax +60 3 7967 4791 email lvkiew@um.edu.m y Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Chai et al Running head recto: Renal targeting potential of PG in normal and diabetic rats DOI: http://dx.doi.org/10.2147/IJN.S111284",Non-OADS,/arxiv_data1/oa_pdf/67/76/ijn-12-577.PMC5245978.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/67/76/ijn-12-577.PMC5245978.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/67/76/ijn-12-577.PMC5245978.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/58/23/ijn-12-593.PMC5245979.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2017:12 593–603International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  593OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S12258 0 In vitro toxicity of FemOn, FemOn-siO2 composite,  and siO2-FemOn core-shell magnetic nanoparticles Yana g T oropova,1 alexey  s golovkin,2 anna B  Malashicheva,3,4 Dmitry  V Korolev,5,6 andrey N  gorshkov,7 Kamil g gareev,8  Michael V afonin,9 Michael M  galagudza10,11 1laboratory of cardioprotection, Institute  of experimental Medicine, Federal almazov  North-West Medical research centre,  saint Petersburg, russian Federation; 2gene  and cell engineering group, Institute of  Molecular Biology and genetics, Federal  almazov North-West Medical research  centre, saint Petersburg, russian Federation;  3laboratory of Molecular cardiology,  Institute of Molecular Biology and genetics,  Federal almazov North-West Medical  research centre, saint Petersburg, russian  Federation; 4Department of embryology,  Faculty of Biology, saint Petersburg state  University, saint Petersburg, russian  Federation; 5laboratory of Nanotechnology,  Institute of experimental Medicine, Federal  almazov North-West Medical research  centre, saint Petersburg, russian Federation;  6Department of Photonics and Optical  Information T echnology ITMO University,  saint Petersburg, russian Federation;  7laboratory of Intracellular signaling and  Transport research Institute of Influenza,  saint Petersburg, russian Federation;  8Department of Micro and Nanoelectronics,  Faculty of electronics, saint Petersburg  electrotechnical University leTI, saint  Petersburg, russian Federation; 9Department  of Inorganic chemistry saint Petersburg  state Technological Institute (Technical  University), saint Petersburg, russian  Federation; 10Institute of experimental  Medicine, Federal almazov North-West  Medical research centre, saint Petersburg,  russian Federation; 11Departament of  Pathophysiology, First Pavlov state Medical  University of saint Petersburg, saint  Petersburg, russian FederationAbstract:  Over the last decade, magnetic iron oxide nanoparticles (IONPs) have drawn  much attention for their potential biomedical applications.",Non-OADS,/arxiv_data1/oa_pdf/58/23/ijn-12-593.PMC5245979.pdf
"Numerous in vitro and in vivo studies correspondence: Michael M galagudza Institute of experimental Medicine, Federal  almazov North-West Medical research  centre, Parkhomenko str., 15B, saint  Petersburg 194156, russian Federation email galagudza@almazovcentre.r u Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Toropova et al Running head recto: In vitro toxicity of magnetic nanoparticles DOI: http://dx.doi.org/10.2147/IJN.S122580",Non-OADS,/arxiv_data1/oa_pdf/58/23/ijn-12-593.PMC5245979.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/58/23/ijn-12-593.PMC5245979.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/58/23/ijn-12-593.PMC5245979.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/48/9a/ijn-12-501.PMC5245980.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2017:12 501–514International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  501OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S11360 7 liposomes derivatized with multimeric copies of  KccY sl peptide as targeting agents for her-2- overexpressing tumor cells Paola ringhieri1 silvia Mannucci2 giamaica conti2 elena Nicolato2 giulio Fracasso3 Pasquina Marzola4 giancarlo Morelli1 antonella accardo1 1Department of Pharmacy and  Interuniversity research centre  on Bioactive Peptides (cIrPeB),   University of Naples “Federico II”,   Napoli, 2Department of Neurological  Biomedical and Movement sciences,   3section of Immunology, Department  of Medicine, 4Department of  Informatics, University of Verona,   Verona, ItalyAbstract:  Mixed liposomes, obtained by coaggregation of 1,2-dioleoyl-sn-glycero- 3-phosphocholine and of the synthetic monomer containing a gadolinium complex  ([C18]2DTPA[Gd]) have been prepared.",Non-OADS,/arxiv_data1/oa_pdf/48/9a/ijn-12-501.PMC5245980.pdf
"Unfortunately, a significant number  of patients are resistant to the treatment initially or become resistant eventually.3correspondence: antonella accardo Department of Pharmacy, Interuniversity  research centre on Bioactive Peptides  (cIrPeB), University of Naples  “Federico II”, via Mezzocannone 16,  Napoli 80134, Italy email antonella.accardo@unina.i tJournal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Ringhieri et al Running head recto: Liposome derivatized with P6.1 for HER-2-overexpressing tumor cells DOI: http://dx.doi.org/10.2147/IJN.S113607",Non-OADS,/arxiv_data1/oa_pdf/48/9a/ijn-12-501.PMC5245980.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/48/9a/ijn-12-501.PMC5245980.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/48/9a/ijn-12-501.PMC5245980.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/1f/53/ijn-12-533.PMC5245982.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2017:12 533–558International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  533OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S12425 2 Plaque-hyaluronidase-responsive high-density- lipoprotein-mimetic nanoparticles for multistage  intimal-macrophage-targeted drug delivery and  enhanced anti-atherosclerotic therapy Mengyuan Zhang Jianhua he cuiping Jiang Wenli Zhang Yun Yang Zhiyu Wang Jianping liu Department of Pharmaceutics, china  Pharmaceutical University, Nanjing,   People’s republic of chinaAbstract:  Increasing evidence has highlighted the pivotal role that intimal macrophage (iM Φ)  plays in the pathophysiology of atherosclerotic plaques, which represents an attractive target  for atherosclerosis treatment.",Non-OADS,/arxiv_data1/oa_pdf/1f/53/ijn-12-533.PMC5245982.pdf
"These cells appear to  participate in all stages in evolving atherosclerotic plaques as modulators of aber - rant lipid metabolism and inflammatory responses.2–4 Abnormalities in cholesterol correspondence: Jianping liu Department of Pharmaceutics,  china Pharmaceutical University,  24 Tongjiaxiang, Nanjing 210009,  People’s republic of china Tel +86 25 8327 1293 email jianpingliu1293@163.co m Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Zhang et al Running head recto: HDL-mimetic nanocarrier for multistage iM Φ-targeted drug delivery DOI: http://dx.doi.org/10.2147/IJN.S124252",Non-OADS,/arxiv_data1/oa_pdf/1f/53/ijn-12-533.PMC5245982.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/1f/53/ijn-12-533.PMC5245982.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/1f/53/ijn-12-533.PMC5245982.pdf
This  is  an  open access article under the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/27/a3/main.PMC5247273.pdf
"In the  radiographic evaluation, the  condyle  was  elongated;  the  ramus height  was  increased  with  a  downward  bowed  lower  border  of  the http://dx.doi.org/10.1016/j.ijscr.2016.12.021 2210-2612/© 2017  The  Authors.",Non-OADS,/arxiv_data1/oa_pdf/27/a3/main.PMC5247273.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/58/ef/main.PMC5247275.pdf
Contents lists available at ScienceDirect Annals of Medicine and Surgery journal homepage: www.annalsjournal.com http://dx.doi.org/10.1016/j.amsu.2016.12.049 2049-0801/ ©2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/58/ef/main.PMC5247275.pdf
"[12] http://www.nccn.org/professionals/physician_gls/pdf/rectal.pdf ., [cited 2014 March 5].",Non-OADS,/arxiv_data1/oa_pdf/58/ef/main.PMC5247275.pdf
This  is  an  open access article under the CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/40/78/main.PMC5247277.pdf
http://dx.doi.org/10.1016/j.ijscr.2017.01.002 2210-2612/© 2017  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/40/78/main.PMC5247277.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/64/d9/main.PMC5247278.pdf
http://dx.doi.org/10.1016/j.gore.2017.01.002 2352-5789/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/64/d9/main.PMC5247278.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/64/d9/main.PMC5247278.pdf
"http://dx.doi.org/10.1080/ 2162402X.2015.1111505 (December).Erfani, N., Hamedi-shahraki, M., Rezaeifard, S., Haghshenas, M., Rasouli, M., Dehaghani, A.S., 2014.",Non-OADS,/arxiv_data1/oa_pdf/64/d9/main.PMC5247278.pdf
http://dx.doi.org/10.1016/j.ccell.2015.10.012 (December).,OADS,/arxiv_data1/oa_pdf/64/d9/main.PMC5247278.pdf
11 (1):149. http://dx.doi.org/10.1186/1479-5876-11- 149(June).,Non-OADS,/arxiv_data1/oa_pdf/64/d9/main.PMC5247278.pdf
http://dx.doi.org/10.1111/j.,Non-OADS,/arxiv_data1/oa_pdf/64/d9/main.PMC5247278.pdf
http://dx.doi.org/10.1111/j.1600- 065X.2009.00787.x .,Non-OADS,/arxiv_data1/oa_pdf/64/d9/main.PMC5247278.pdf
http://dx.doi.org/10.1016/j.ygyno.2016.05.007 (May).,OADS,/arxiv_data1/oa_pdf/64/d9/main.PMC5247278.pdf
http://dx.doi.org/10.1126/ scitranslmed.aad8307 (April).58 T. Baert et al.,OADS,/arxiv_data1/oa_pdf/64/d9/main.PMC5247278.pdf
"Finally,the roadmap of the solar cell ef ﬁciency for an industrial PERCContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/dibData in Brief http://dx.doi.org/10.1016/j.dib.2016.12.031 2352-3409/ &2017 The Authors.",OADS,/arxiv_data1/oa_pdf/b9/0c/main.PMC5247280.pdf
"This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).DOI of original article: http://dx.doi.org/10.1016/j.solmat.2016.11.018 nCorresponding author at: China Sunergy, No.123.",Non-OADS,/arxiv_data1/oa_pdf/b9/0c/main.PMC5247280.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b9/0c/main.PMC5247280.pdf
Supporting material Transparency data associated with this paper can be found in the online version at http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b9/0c/main.PMC5247280.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/21/ea/main.PMC5247282.pdf
"In  addition,  special  tests  used  to  identify  any  kind http://dx.doi.org/10.1016/j.ijscr.2017.01.007 2210-2612/© 2017  The  Authors.",Non-OADS,/arxiv_data1/oa_pdf/21/ea/main.PMC5247282.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/72/61/main.PMC5247283.pdf
Routine  blood  investigations http://dx.doi.org/10.1016/j.ijscr.2016.12.023 2210-2612/© 2017  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/72/61/main.PMC5247283.pdf
1476-5586http://dx.do i.org/10.1016/j.neo.2016.12.003,OADS,/arxiv_data1/oa_pdf/23/a7/main.PMC5247285.pdf
Our methods also offer the flexibility toReceived: 23 September 2016 Revised: 16 December 2016 Accepted: 9 January 2017 Heliyon 3 (2017) e00233 http://dx.doi.org/10.1016/j.heliyon.2017.e00233 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/50/45/main.PMC5247286.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/50/45/main.PMC5247286.pdf
These methods work quite Article No~e00233 2 http://dx.doi.org/10.1016/j.heliyon.2017.e00233 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/50/45/main.PMC5247286.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/50/45/main.PMC5247286.pdf
While the method EES also works in both small Article No~e00233 3 http://dx.doi.org/10.1016/j.heliyon.2017.e00233 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/50/45/main.PMC5247286.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/50/45/main.PMC5247286.pdf
"Panel Number of reference genes Genes in the Panel Stable Upregulated Downregulated P-I 9 A, C, F E, G, H B, D, I P-II 4 F, A G IP-III 4 F G I, D P-IV 4 F G, H I P-V 3 F G I Article No~e00233 4 http://dx.doi.org/10.1016/j.heliyon.2017.e00233 2405-8440/© 2017 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/50/45/main.PMC5247286.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/50/45/main.PMC5247286.pdf
Pearson correlation coefficient between two Article No~e00233 5 http://dx.doi.org/10.1016/j.heliyon.2017.e00233 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/50/45/main.PMC5247286.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/50/45/main.PMC5247286.pdf
Note that the Q-Q plot of gene A is closer to the standardnormal curve than B or E. Article No~e00233 6 http://dx.doi.org/10.1016/j.heliyon.2017.e00233 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/50/45/main.PMC5247286.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/50/45/main.PMC5247286.pdf
Article No~e00233 7 http://dx.doi.org/10.1016/j.heliyon.2017.e00233 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/50/45/main.PMC5247286.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/50/45/main.PMC5247286.pdf
EES Value Panel Gene → E↓A B C D E F GHI P-I α 0 0 0 - 2 0000 1 * β 2* 2* 1 2* -4 2* -4 -4 1 γ 2* 2* 1 2* -4 2* -4 -4 1 P-II α 0* –– – – 0* 0* – 0* β 1* –– – – 1* -3 – 1* γ 1* –– – – 1* -3 – 1* P-III α –– – -1 – 0* -1 – 0* β –– – 1* – 1* -3 – 1* γ –– – 1* – 1* -3 – 1* P-IV α –– –– – 01 *1 * 0 β –– –– – -1* -1* -1* -1* γ –– –– – -1* -1* -1* -1* P-V α –– –– – 01 * – 1* β –– –– – 0* -2 – 0* γ –– –– – 0* -2 – 0* Article No~e00233 8 http://dx.doi.org/10.1016/j.heliyon.2017.e00233 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/50/45/main.PMC5247286.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/50/45/main.PMC5247286.pdf
Panel Stability Rank → E↓1st2nd3rd4th5th6th7th8th9th P-I α B(0.872) D(0.862) A(0.831) F(0.828) E(0.823) H(0.823) I(0.820) G(0.819) C(0.701) β A(0.980) C(0.978) F(0.978) G(0.964) I(0.961) D(0.952) B(0.951) H(0.951) E(0.950) γ A(0.977) F(0.976) C(0.975) I(0.973) D(0.951) B(0.949) G(0.947) E(0.942) H(0.942) P-II α A(0.873) I(0.865) G(0.851) F(0.789) ––––– β G(0.975) A(0.973) F(0.967) I(0.961) ––––– γ G(0.977) A(0.967) F(0.958) I(0.950) ––––– P-III α D(0.971) G(0.907) I(0.902) F(0.855) ––––– β F(0.989) G(0.969) D(0.950) I(0.957) ––––– γ F(0.989) I(0.974) G(0.968) D(0.963) ––––– P-IV α I(0.921) G(0.866) H(0.842) F(0.770) ––––– β F(0.984) G(0.968) H(0.959) I(0.956) ––––– γ F(0.977) I(0.953) G(0.947) H(0.945) ––––– P-V α I(0.851) G(0.815) F(0.739) –––––– β F(0.986) G(0.976) I(0.959) –––––– γ F(0.978) G(0.976) I(0.950) –––––– Article No~e00233 9 http://dx.doi.org/10.1016/j.heliyon.2017.e00233 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/50/45/main.PMC5247286.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/50/45/main.PMC5247286.pdf
Nature of the genes included in the panel Panel PCR efficiency (E) value employedStable Upregulated Downregulated A CF EGHB DI P-I α 0.415* 8.27 2.25 20.28 11.96 15.7 28.02 17.35 1.72 β 0.137* 0.592 0.674 81.86 30.33 87.63 119.06 63.76 27.13 γ 0.184* 0.624 0.6 74.55 39.73 73.14 106.84 92.36 20 P-II α 0.26* – 3.38 – 10.84 –– – 1.78 β 0.163* – 0.872 – 82.07 –– – 60.91 γ 0.138* – 1.27 – 98.83 –– – 47.34 P- III α –– 1.185 – 17.34 –– 13.45 0.57* β –– 1.93* – 90.34 –– 35.11 7.99 γ –– 1.62* – 8.041 –– 49.63 3.91 P- IV α –– 6.38 – 5.28 9.12 –– 3.18# β –– 4.63#– 7.12 45.12 –– 60.23 γ –– 5.75#– 11.16 33.98 –– 58.74 P- V α –– 2.95 – 7.94 –– – 0.935* β –– 0.576* – 64.51 –– – 40.79 γ –– 0.871* – 75.81 –– – 32.63 Article No~e00233 10 http://dx.doi.org/10.1016/j.heliyon.2017.e00233 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/50/45/main.PMC5247286.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/50/45/main.PMC5247286.pdf
Article No~e00233 11 http://dx.doi.org/10.1016/j.heliyon.2017.e00233 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/50/45/main.PMC5247286.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/50/45/main.PMC5247286.pdf
In place of Cp values ofgene ‘A’a given sample S 1would have the expression ratios of ‘A’normalized Article No~e00233 12 http://dx.doi.org/10.1016/j.heliyon.2017.e00233 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/50/45/main.PMC5247286.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/50/45/main.PMC5247286.pdf
"When validated with a real life dataset (data not shown), there were disagreements with BestKeeper, but not with Article No~e00233 13 http://dx.doi.org/10.1016/j.heliyon.2017.e00233 2405-8440/© 2017 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/50/45/main.PMC5247286.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/50/45/main.PMC5247286.pdf
"The other two methods, geNorm ( Vandesompele et al., 2002 ) and NormFinder ( Andersen et al., 2004 ) provide a correction factor, Article No~e00233 14 http://dx.doi.org/10.1016/j.heliyon.2017.e00233 2405-8440/© 2017 The Authors.",OADS,/arxiv_data1/oa_pdf/50/45/main.PMC5247286.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/50/45/main.PMC5247286.pdf
Article No~e00233 15 http://dx.doi.org/10.1016/j.heliyon.2017.e00233 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/50/45/main.PMC5247286.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/50/45/main.PMC5247286.pdf
Article No~e00233 16 http://dx.doi.org/10.1016/j.heliyon.2017.e00233 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/50/45/main.PMC5247286.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/50/45/main.PMC5247286.pdf
Article No~e00233 17 http://dx.doi.org/10.1016/j.heliyon.2017.e00233 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/50/45/main.PMC5247286.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/50/45/main.PMC5247286.pdf
Article No~e00233 18 http://dx.doi.org/10.1016/j.heliyon.2017.e00233 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/50/45/main.PMC5247286.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/50/45/main.PMC5247286.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a9/5c/main.PMC5247287.pdf
Contents lists available at ScienceDirect Respiratory Medicine Case Reports journal homepage: www.elsevier.com/locate/rmcr http://dx.doi.org/10.1016/j.rmcr.2017.01.003 2213-0071/ ©2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/a9/5c/main.PMC5247287.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Respiratory Medicine Case Reports 20 (2017) 95 e97,Non-OADS,/arxiv_data1/oa_pdf/a9/5c/main.PMC5247287.pdf
"Moreover, there are serious side e ﬀects associated with fotemustine including myelosuppression, leucopenia, thrombocytopenia and toxic http://dx.doi.org/10.1016/j.redox.2017.01.010 Received 29 November 2016; Received in revised form 11 January 2017; Accepted 11 January 2017⁎Corresponding authors.",Non-OADS,/arxiv_data1/oa_pdf/1e/f3/main.PMC5247288.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/1e/f3/main.PMC5247288.pdf
"DNA migration wasanalyzed using the CaspLab software ( http://www.casp.of.pl ), by measuring 50 cells per slides and the data was expressed as percent of DNA in the comet tail (Tail DNA%).",OADS,/arxiv_data1/oa_pdf/1e/f3/main.PMC5247288.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/98/b5/main.PMC5247293.pdf
This is an open access article under the CC BY- NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/98/b5/main.PMC5247293.pdf
URL: www.ksu.edu.sahttp://dx.doi.org/10.1016/j.jsha.2016.04.082 Production and hosting by Elsevier,Non-OADS,/arxiv_data1/oa_pdf/98/b5/main.PMC5247293.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/92/89/main.PMC5247294.pdf
This is an open access article under the CC BY- NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/92/89/main.PMC5247294.pdf
URL: www.ksu.edu.sahttp://dx.doi.org/10.1016/j.jsha.2016.05.003Production and hosting by Elsevier,OADS,/arxiv_data1/oa_pdf/92/89/main.PMC5247294.pdf
This is an open access article under the CC BY- NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/05/19/main.PMC5247295.pdf
URL: www.ksu.edu.sahttp://dx.doi.org/10.1016/j.jsha.2016.03.005 Production and hosting by Elsevier,Non-OADS,/arxiv_data1/oa_pdf/05/19/main.PMC5247295.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d6/77/main.PMC5247296.pdf
This is an open access article under the CC BY- NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d6/77/main.PMC5247296.pdf
URL: www.ksu.edu.sahttp://dx.doi.org/10.1016/j.jsha.2016.06.005Production and hosting by Elsevier,OADS,/arxiv_data1/oa_pdf/d6/77/main.PMC5247296.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/42/6b/main.PMC5247297.pdf
This is an open access article under the CC BY-NC- ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/42/6b/main.PMC5247297.pdf
URL: www.ksu.edu.sahttp://dx.doi.org/10.1016/j.jsha.2016.07.003 Production and hosting by Elsevier,Non-OADS,/arxiv_data1/oa_pdf/42/6b/main.PMC5247297.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/44/5f/main.PMC5247298.pdf
This is an open access article under the CC BY- NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/44/5f/main.PMC5247298.pdf
URL: www.ksu.edu.sahttp://dx.doi.org/10.1016/j.jsha.2016.05.004 Production and hosting by Elsevier,Non-OADS,/arxiv_data1/oa_pdf/44/5f/main.PMC5247298.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/97/04/main.PMC5247299.pdf
This is an open access article under the CC BY- NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/97/04/main.PMC5247299.pdf
URL: www.ksu.edu.sahttp://dx.doi.org/10.1016/j.jsha.2016.06.001Production and hosting by Elsevier,OADS,/arxiv_data1/oa_pdf/97/04/main.PMC5247299.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org /licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/59/19/main.PMC5247300.pdf
This is an open access article under the CC BY- NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/59/19/main.PMC5247300.pdf
URL: www.ksu.edu.sahttp://dx.doi.org/10.1016/j.jsha.2016.06.004Production and hosting by Elsevier,OADS,/arxiv_data1/oa_pdf/59/19/main.PMC5247300.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/bc/1a/main.PMC5247301.pdf
This is an open access article under the CC BY-NC- ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/bc/1a/main.PMC5247301.pdf
URL: www.ksu.edu.sahttp://dx.doi.org/10.1016/j.jsha.2015.12.003 Production and hosting by Elsevier,Non-OADS,/arxiv_data1/oa_pdf/bc/1a/main.PMC5247301.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/92/ac/main.PMC5247302.pdf
This is an open access article under the CC BY- NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/92/ac/main.PMC5247302.pdf
URL: www.ksu.edu.sahttp://dx.doi.org/10.1016/j.jsha.2016.05.002 Production and hosting by Elsevier,Non-OADS,/arxiv_data1/oa_pdf/92/ac/main.PMC5247302.pdf
http://dx.doi.org/10.1016/S0735-1097 (13)61716-7 .,OADS,/arxiv_data1/oa_pdf/92/ac/main.PMC5247302.pdf
This is an open access article under the CC BY- NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/28/2b/main.PMC5247303.pdf
URL: www.ksu.edu.sahttp://dx.doi.org/10.1016/j.jsha.2016.07.005 Production and hosting by Elsevier,Non-OADS,/arxiv_data1/oa_pdf/28/2b/main.PMC5247303.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c1/76/main.PMC5247304.pdf
This is an open access article under the CC BY-NC- ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c1/76/main.PMC5247304.pdf
URL: www.ksu.edu.sahttp://dx.doi.org/10.1016/j.jsha.2016.07.004 Production and hosting by Elsevier,Non-OADS,/arxiv_data1/oa_pdf/c1/76/main.PMC5247304.pdf
Heart Rhythm 2016.http://dx.doi.org/10.1016/j.hrthm.2016.06.013 .,OADS,/arxiv_data1/oa_pdf/c1/76/main.PMC5247304.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/60/af/main.PMC5247315.pdf
2352-345X http://dx.doi.org/10.1016/j.jcmgh.2016.08.002 Chairman ’s Rules 1.,Non-OADS,/arxiv_data1/oa_pdf/60/af/main.PMC5247315.pdf
(Cell Mol Gastroenterol Hepatol 2016;2:750 –766; http://dx.doi.org/ 10.1016/j.jcmgh.2016.06.004 ) Keywords: Microbiome; Metabolomics; In ﬂammatory Bowel Disease; Family Cohort.,OADS,/arxiv_data1/oa_pdf/17/a4/main.PMC5247316.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/17/a4/main.PMC5247316.pdf
2352-345X http://dx.doi.org/10.1016/j.jcmgh.2016.06.004,OADS,/arxiv_data1/oa_pdf/17/a4/main.PMC5247316.pdf
"Operational taxonomic units (OTUs) were picked in QIIME1.8.0 against the May 2013 version of the Greengenesdatabase ( http://greengenes.secondgenome.com ), pre ﬁl- tered at 97% identity.",OADS,/arxiv_data1/oa_pdf/17/a4/main.PMC5247316.pdf
bDi- versity was assessed on unrare ﬁed data using the square root of the Jensen –Shannon divergence (calculated in R with a script available at http://enterotype.embl.de/enterotypes.,OADS,/arxiv_data1/oa_pdf/17/a4/main.PMC5247316.pdf
The resulting ﬁltered data sets were analyzed using DESeq2 (http://www.bioconductor.org/p ackages/release/bioc/html/ DESeq2.html ).,OADS,/arxiv_data1/oa_pdf/17/a4/main.PMC5247316.pdf
"This was implemented with the R script q value ( https://github.com/jdstorey/ qvalue ), which for each Pvalue estimates the false- discovery rate based on the distribution of Pvalues.",OADS,/arxiv_data1/oa_pdf/17/a4/main.PMC5247316.pdf
Hier- archical clustering of metabolite abundance data and visu-alization with heat maps were performed in GENE-E(http://www.broadinstitute.org/cancer/software/GENE-E ).752 Jacobs et al Cellular and Molecular Gastroenterology and Hepatology Vol.,OADS,/arxiv_data1/oa_pdf/17/a4/main.PMC5247316.pdf
"Random Forest Classi ﬁers Random forest classi ﬁers to predict OTU type, metabotype, and CD were created in R using the random-Forest package ( https://cran.r-project.org/web/packages/ randomForest ) with 1001 trees and mtry ¼2.",OADS,/arxiv_data1/oa_pdf/17/a4/main.PMC5247316.pdf
An inter ’omic network was constructed in Cytoscape 3.2.1 ( http://cytoscape.org ) from OTUs and spectral fea- tures that had a random forest importance score greaterthan 2 in classi ﬁers for OTU type and metabotype.,OADS,/arxiv_data1/oa_pdf/17/a4/main.PMC5247316.pdf
(Cell Mol Gastroenterol Hepatol 2016;2:796 –810; http://dx.doi.org/ 10.1016/j.jcmgh.2016.06.003 ) Keywords: Ovarian Cancer G-Protein –Coupled Receptor; Inﬂammation; In ﬂammatory Bowel Disease; TDAG8; GRP65.,Non-OADS,/arxiv_data1/oa_pdf/df/56/main.PMC5247318.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/df/56/main.PMC5247318.pdf
2352-345X http://dx.doi.org/10.1016/j.jcmgh.2016.06.003,OADS,/arxiv_data1/oa_pdf/df/56/main.PMC5247318.pdf
(Cell Mol Gastroenterol Hepatol 2016;2:767 –782; http://dx.doi.org/10.1016/j.jcmgh.2016.08.001 )Keywords: Paneth Cell; Intermediate Cell; Wnt; Gnaq ;Gna11 .,OADS,/arxiv_data1/oa_pdf/28/89/main.PMC5247319.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/28/89/main.PMC5247319.pdf
2352-345X http://dx.doi.org/10.1016/j.jcmgh.2016.08.001,OADS,/arxiv_data1/oa_pdf/28/89/main.PMC5247319.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5a/6c/main.PMC5247340.pdf
2352-345X http://dx.doi.org/10.1016/j.jcmgh.2016.09.004November 2016 Editorial 713,Non-OADS,/arxiv_data1/oa_pdf/5a/6c/main.PMC5247340.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d1/bc/main.PMC5247341.pdf
2352-345X http://dx.doi.org/10.1016/j.jcmgh.2016.09.006November 2016 Editorial 715,Non-OADS,/arxiv_data1/oa_pdf/d1/bc/main.PMC5247341.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ee/fe/main.PMC5247342.pdf
2352-345X http://dx.doi.org/10.1016/j.jcmgh.2016.08.005706 Paths and Places Cellular and Molecular Gastroenterology and Hepatology Vol.,Non-OADS,/arxiv_data1/oa_pdf/ee/fe/main.PMC5247342.pdf
Available from: http://www.onehealthinitiative.com .,Non-OADS,/arxiv_data1/oa_pdf/47/9f/main.PMC5247343.pdf
Available from: http://www.zoobiquity.com .,Non-OADS,/arxiv_data1/oa_pdf/47/9f/main.PMC5247343.pdf
Available from: https://ccrod.cancer.gov/con ﬂuence/ display/CCRCOPWeb/Home .,Non-OADS,/arxiv_data1/oa_pdf/47/9f/main.PMC5247343.pdf
Available from: http://omia.angis.org.au .,Non-OADS,/arxiv_data1/oa_pdf/47/9f/main.PMC5247343.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/47/9f/main.PMC5247343.pdf
2352-345X http://dx.doi.org/10.1016/j.jcmgh.2016.09.008November 2016 Commentary 703,Non-OADS,/arxiv_data1/oa_pdf/47/9f/main.PMC5247343.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/49/0e/main.PMC5247345.pdf
2352-345X http://dx.doi.org/10.1016/j.jcmgh.2016.09.005November 2016 Editorial 711,Non-OADS,/arxiv_data1/oa_pdf/49/0e/main.PMC5247345.pdf
(Cell Mol Gastroenterol Hepatol 2016;2:725 –732; http://dx.doi.org/ 10.1016/j.jcmgh.2016.08.004 ) Keywords: Bile Acid Diarrhea; Enterohepatic Circulation; FGF-19; Chloride Secretion; Epithelium.,Non-OADS,/arxiv_data1/oa_pdf/b4/54/main.PMC5247348.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b4/54/main.PMC5247348.pdf
2352-345X http://dx.doi.org/10.1016/j.jcmgh.2016.08.004,OADS,/arxiv_data1/oa_pdf/b4/54/main.PMC5247348.pdf
(Cell Mol Gastroenterol Hepatol 2017;3:72 –81;http://dx.doi.org/10.1016/ j.jcmgh.2016.09.007 ) Keywords: Caspase-1; Mucosal Innate and Adaptive Immunity; Roferon; DKK1.,OADS,/arxiv_data1/oa_pdf/ed/54/main.PMC5247398.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ed/54/main.PMC5247398.pdf
2352-345X http://dx.doi.org/10.1016/j.jcmgh.2016.09.007,OADS,/arxiv_data1/oa_pdf/ed/54/main.PMC5247398.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e8/5b/main.PMC5247415.pdf
2352-345X http://dx.doi.org/10.1016/j.jcmgh.2016.11.002January 2017 Editorial 5,Non-OADS,/arxiv_data1/oa_pdf/e8/5b/main.PMC5247415.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/01/3b/main.PMC5247416.pdf
2352-345X http://dx.doi.org/10.1016/j.jcmgh.2016.11.005 Cellular and Molecular Gastroenterology and Hepatology 2017;3:1,OADS,/arxiv_data1/oa_pdf/01/3b/main.PMC5247416.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3e/98/main.PMC5247417.pdf
2352-345X http://dx.doi.org/10.1016/j.jcmgh.2016.11.00310 Paths and Places Cellular and Molecular Gastroenterology and Hepatology Vol.,Non-OADS,/arxiv_data1/oa_pdf/3e/98/main.PMC5247417.pdf
(Cell Mol Gastroenterol Hepatol 2017;3:41 –50; http://dx.doi.org/10.1016/j.jcmgh.2016.10.004 ) Keywords: Tight Junctions; Intestinal Permeability; Inﬂammatory Bowel Disease.,Non-OADS,/arxiv_data1/oa_pdf/13/25/main.PMC5247418.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/13/25/main.PMC5247418.pdf
2352-345X http://dx.doi.org/10.1016/j.jcmgh.2016.10.004,OADS,/arxiv_data1/oa_pdf/13/25/main.PMC5247418.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/45/dc/main.PMC5247419.pdf
2352-345X http://dx.doi.org/10.1016/j.jcmgh.2016.10.005January 2017 Editorial 7,Non-OADS,/arxiv_data1/oa_pdf/45/dc/main.PMC5247419.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/8b/bf/main.PMC5247420.pdf
2352-345X http://dx.doi.org/10.1016/j.jcmgh.2016.11.004January 2017 Editorial 3,Non-OADS,/arxiv_data1/oa_pdf/8b/bf/main.PMC5247420.pdf
(Cell Mol Gastroenterol Hepatol 2017;3:11 –26; http://dx.doi.org/ 10.1016/j.jcmgh.2016.11.001 ) Keywords: SPEM; Intestinal Metaplasia; Gastric Cancer; TFF2; Chief Cell; Hyperplasia.,Non-OADS,/arxiv_data1/oa_pdf/bf/7c/main.PMC5247421.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/bf/7c/main.PMC5247421.pdf
2352-345X http://dx.doi.org/10.1016/j.jcmgh.2016.11.001,OADS,/arxiv_data1/oa_pdf/bf/7c/main.PMC5247421.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ff/ed/main.PMC5247424.pdf
2352-345X http://dx.doi.org/10.1016/j.jcmgh.2016.10.001,OADS,/arxiv_data1/oa_pdf/ff/ed/main.PMC5247424.pdf
"Gene Ontology Analysis Gene ontology (GO) analysis was performed with Database for Annotation, Visualization, and IntegratedDiscovery (DAVID; available: http://david.abcc.ncifcrf.gov/ ) using the ATOH1 targetome genes lists ( Figure 5 ) to identify the biological processes and molecular functions in which the input gene lists are enriched.",OADS,/arxiv_data1/oa_pdf/ff/ed/main.PMC5247424.pdf
"36Compared with the reference values for the quality metrics generated from 392 data sets from ENCODE ( https:// www.encodeproject.org/ ), the QES from our ATOH1 ChIP-seq (QES, 0.24 in colon; QES, 0.16 in ileum) was ranked at a levelbetween moderate high to very high ( http://charite.github.io/ Q/tutorial.html#output_of_q ), suggesting a high quality of these ATOH1 peaks ( Supplementary Table 8 ).",OADS,/arxiv_data1/oa_pdf/ff/ed/main.PMC5247424.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/59/de/main.PMC5247510.pdf
For full disclosure statements refer to http://dx.doi.org/10.1016/j.artd.2015.12.004 .,OADS,/arxiv_data1/oa_pdf/59/de/main.PMC5247510.pdf
E-mail address: berry.Daniel@mayo.edu Contents lists available at ScienceDirect Arthroplasty Today journal homepage: http://www.arthr oplastytoday.org/ http://dx.doi.org/10.1016/j.artd.2015.12.004 2352-3441/ ©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/59/de/main.PMC5247510.pdf
This is an open access article under the CC B Y-NC- ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Arthroplasty Today 2 (2016) 183 e186,Non-OADS,/arxiv_data1/oa_pdf/59/de/main.PMC5247510.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f3/96/main.PMC5247511.pdf
For full disclosure statements refer to http://dx.doi.org/10.1016/j.artd.2015.10.004 .,OADS,/arxiv_data1/oa_pdf/f3/96/main.PMC5247511.pdf
E-mail address: cnacca@lifespan.org Contents lists available at ScienceDirect Arthroplasty Today journal homepage: http://www.arthr oplastytoday.org/ http://dx.doi.org/10.1016/j.artd.2015.10.004 2352-3441/ ©2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/f3/96/main.PMC5247511.pdf
This is an open access article under the CC B Y-NC- ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Arthroplasty Today 2 (2016) 177 e182,Non-OADS,/arxiv_data1/oa_pdf/f3/96/main.PMC5247511.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/86/e8/main.PMC5247512.pdf
For full disclosure statements refer to http://dx.doi.org/10.1016/j.artd.2016.05.002 .,OADS,/arxiv_data1/oa_pdf/86/e8/main.PMC5247512.pdf
: (650) 493-5000 E-mail address: pindelli@stanford.edu Contents lists available at ScienceDirect Arthroplasty Today journal homepage: http://www.arthr oplastytoday.org/ http://dx.doi.org/10.1016/j.artd.2016.05.002 2352-3441/Published by Elsevier Inc. on behalf of The American Association of Hip and Knee Surgeons.,Non-OADS,/arxiv_data1/oa_pdf/86/e8/main.PMC5247512.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/46/d1/main.PMC5247513.pdf
For full disclosure statements refer to http://dx.doi.org/10.1016/j.artd.2016.02.004 .,OADS,/arxiv_data1/oa_pdf/46/d1/main.PMC5247513.pdf
E-mail address: c@drlavernia.com Contents lists available at ScienceDirect Arthroplasty Today journal homepage: http://www.arthr oplastytoday.org/ http://dx.doi.org/10.1016/j.artd.2016.02.004 2352-3441/ ©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/46/d1/main.PMC5247513.pdf
This is an open access article under the CC B Y-NC- ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Arthroplasty Today 2 (2016) 147 e152,Non-OADS,/arxiv_data1/oa_pdf/46/d1/main.PMC5247513.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9b/6a/main.PMC5247514.pdf
For full disclosure statements refer to http://dx.doi.org/10.1016/j.artd.2016.04.001 .,OADS,/arxiv_data1/oa_pdf/9b/6a/main.PMC5247514.pdf
E-mail address: dfa@stanford.edu Contents lists available at ScienceDirect Arthroplasty Today journal homepage: http://www.arthr oplastytoday.org/ http://dx.doi.org/10.1016/j.artd.2016.04.001 2352-3441/ ©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/9b/6a/main.PMC5247514.pdf
This is an open access article under the CC B Y-NC- ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Arthroplasty Today 2 (2016) 153 e156,Non-OADS,/arxiv_data1/oa_pdf/9b/6a/main.PMC5247514.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/62/bf/main.PMC5247515.pdf
For full disclosure statements refer to http://dx.doi.org/10.1016/j.artd.2016.02.002 .,OADS,/arxiv_data1/oa_pdf/62/bf/main.PMC5247515.pdf
E-mail address: urban.hedlundh@vgregion.se Contents lists available at ScienceDirect Arthroplasty Today journal homepage: http://www.arthr oplastytoday.org/ http://dx.doi.org/10.1016/j.artd.2016.02.002 2352-3441/ ©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/62/bf/main.PMC5247515.pdf
This is an open access article under the CC B Y-NC- ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Arthroplasty Today 2 (2016) 141 e145,Non-OADS,/arxiv_data1/oa_pdf/62/bf/main.PMC5247515.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9d/a4/main.PMC5247516.pdf
For full disclosure statements refer to http://dx.doi.org/10.1016/j.artd.2016.02.001 .,OADS,/arxiv_data1/oa_pdf/9d/a4/main.PMC5247516.pdf
E-mail address: jtmoskal@carilionclinic.org Contents lists available at ScienceDirect Arthroplasty Today journal homepage: http://www.arthr oplastytoday.org/ http://dx.doi.org/10.1016/j.artd.2016.02.001 2352-3441/ ©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/9d/a4/main.PMC5247516.pdf
This is an open access article under the CC B Y-NC- ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Arthroplasty Today 2 (2016) 211 e218,Non-OADS,/arxiv_data1/oa_pdf/9d/a4/main.PMC5247516.pdf
2015. https://ripo.cineca.it/pdf/relaz ione_2014_inglese_rev1.pdf .,Non-OADS,/arxiv_data1/oa_pdf/9d/a4/main.PMC5247516.pdf
2012. https://aoanjrr.sahmri.com/ documents/10180/217745/Hip%20and%20Knee%20Arthroplasty .,Non-OADS,/arxiv_data1/oa_pdf/9d/a4/main.PMC5247516.pdf
http://www.cebm.net/index.,Non-OADS,/arxiv_data1/oa_pdf/9d/a4/main.PMC5247516.pdf
National Joint Registry for England and Wales; 2011. http://www.njrcentre.org.uk/njrcentre/portals/0/documents/njr%208th%20an nual%20report%202011.pdf .,Non-OADS,/arxiv_data1/oa_pdf/9d/a4/main.PMC5247516.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7a/46/main.PMC5247517.pdf
For full disclosure statements refer to http://dx.doi.org/10.1016/j.artd.2016.05.004 .,OADS,/arxiv_data1/oa_pdf/7a/46/main.PMC5247517.pdf
E-mail address: s8058@nms.ac.jp Contents lists available at ScienceDirect Arthroplasty Today journal homepage: http://www.arthr oplastytoday.org/ http://dx.doi.org/10.1016/j.artd.2016.05.004 2352-3441/ ©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/7a/46/main.PMC5247517.pdf
This is an open access article under the CC B Y-NC- ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Arthroplasty Today 2 (2016) 199 e204,Non-OADS,/arxiv_data1/oa_pdf/7a/46/main.PMC5247517.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/80/1b/main.PMC5247518.pdf
For full disclosure statements refer to http://dx.doi.org/10.1016/j.artd.2016.05.005 .,OADS,/arxiv_data1/oa_pdf/80/1b/main.PMC5247518.pdf
E-mail address: johrmart@gmail.com Contents lists available at ScienceDirect Arthroplasty Today journal homepage: http://www.arthr oplastytoday.org/ http://dx.doi.org/10.1016/j.artd.2016.05.005 2352-3441/ ©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/80/1b/main.PMC5247518.pdf
This is an open access article under the CC B Y-NC- ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Arthroplasty Today 2 (2016) 171 e175,Non-OADS,/arxiv_data1/oa_pdf/80/1b/main.PMC5247518.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f2/af/main.PMC5247519.pdf
For full disclosure statements refer to http://dx.doi.org/10.1016/j.artd.2016.04.004 .,OADS,/arxiv_data1/oa_pdf/f2/af/main.PMC5247519.pdf
E-mail address: sunjunyingsuda@163.com Contents lists available at ScienceDirect Arthroplasty Today journal homepage: http://www.arthr oplastytoday.org/ http://dx.doi.org/10.1016/j.artd.2016.04.004 2352-3441/ ©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/f2/af/main.PMC5247519.pdf
This is an open access article under the CC B Y-NC- ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Arthroplasty Today 2 (2016) 205 e209,Non-OADS,/arxiv_data1/oa_pdf/f2/af/main.PMC5247519.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 InternationalLicense (http://creativecommons.org/licenses/by-nc/4.0/), which per- mits any noncommercial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the originalauthor(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/3e/7d/40262_2016_Article_493.PMC5247543.pdf
PRAXBIND prescribing information 2015. http://www.accessdata.,Non-OADS,/arxiv_data1/oa_pdf/3e/7d/40262_2016_Article_493.PMC5247543.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 InternationalLicense (http://creativecommons.org/licenses/by-nc/4.0/), which per-mits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commonslicense, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/2a/b9/40262_2016_Article_432.PMC5247551.pdf
2015. http://www.accessdata.fda.gov/ drugsatfda_docs/label/2015/208462lbl.pdf .,Non-OADS,/arxiv_data1/oa_pdf/2a/b9/40262_2016_Article_432.PMC5247551.pdf
2015. http://packageinserts.bms.com/pi/ pi_empliciti.pdf .,Non-OADS,/arxiv_data1/oa_pdf/2a/b9/40262_2016_Article_432.PMC5247551.pdf
2015. http://www.ema.europa.eu/docs/en_GB/ document_library/EPAR_-_Product_Information/human/003790/ WC500197692.pdf .,Non-OADS,/arxiv_data1/oa_pdf/2a/b9/40262_2016_Article_432.PMC5247551.pdf
2015. http://pi.amgen.com/united_states/kyprolis/kyprolis_pi.pdf .,Non-OADS,/arxiv_data1/oa_pdf/2a/b9/40262_2016_Article_432.PMC5247551.pdf
2015. http://www.revlimid.com/wp-content/uploads/ 2013/11/PI.pdf .,Non-OADS,/arxiv_data1/oa_pdf/2a/b9/40262_2016_Article_432.PMC5247551.pdf
2015. https://www.medicines.org.uk/emc/ medicine/29478 .,Non-OADS,/arxiv_data1/oa_pdf/2a/b9/40262_2016_Article_432.PMC5247551.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 InternationalLicense (http://creativecommons.org/licenses/by-nc/4.0/), which per- mits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the originalauthor(s) and the source, provide a link to the Creative Commonslicense, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/89/43/40262_2016_Article_433.PMC5247555.pdf
Available at: http://evs.nci.nih.gov/ftp1/CTCAE/Archive/ CTCAE_4.0_2009-05-29_QuickReference_8.5x11.pdf .,OADS,/arxiv_data1/oa_pdf/89/43/40262_2016_Article_433.PMC5247555.pdf
For full disclosure statements refer to http://dx.doi.org/10.1016/j.artd.2016.09.005 .,OADS,/arxiv_data1/oa_pdf/ab/9c/main.PMC5247557.pdf
Contents lists available at ScienceDirect Arthroplasty Today journal homepage: http://www.arthr oplastytoday.org/ Arthroplasty Today 2 (2016) 137 http://dx.doi.org/10.1016/j.artd.2016.09.005 2352-3441/ ©2016 The Author.,Non-OADS,/arxiv_data1/oa_pdf/ab/9c/main.PMC5247557.pdf
This is an open access article under the CC BY -NC- ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ab/9c/main.PMC5247557.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/15/72/main.PMC5247559.pdf
For full disclosure statements refer to http://dx.doi.org/10.1016/j.artd.2016.08.006 .,OADS,/arxiv_data1/oa_pdf/15/72/main.PMC5247559.pdf
E-mail address: korshjm@scarletmail.rutgers.edu Contents lists available at ScienceDirect Arthroplasty Today journal homepage: http://www.arthr oplastytoday.org/ http://dx.doi.org/10.1016/j.artd.2016.08.006 2352-3441/ ©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/15/72/main.PMC5247559.pdf
This is an open access article under the CC B Y-NC- ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Arthroplasty Today 2 (2016) 165 e169,Non-OADS,/arxiv_data1/oa_pdf/15/72/main.PMC5247559.pdf
2016. http://dx.doi.org/10.1007/s11999-016-4757-8 .,Non-OADS,/arxiv_data1/oa_pdf/15/72/main.PMC5247559.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f7/07/main.PMC5247560.pdf
"For full disclosure statements refer to http://dx.doi.org/10.1016/j.artd.2016.09.006 *Corresponding author: 5 Bucknam Road, Suite 1D, Falmouth, ME 04105, USA.",Non-OADS,/arxiv_data1/oa_pdf/f7/07/main.PMC5247560.pdf
E-mail address: mcgrob1@mmc.org Contents lists available at ScienceDirect Arthroplasty Today journal homepage: http://www.arthr oplastytoday.org/ http://dx.doi.org/10.1016/j.artd.2016.09.006 2352-3441/ ©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/f7/07/main.PMC5247560.pdf
This is an open access article under the CC B Y-NC- ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Arthroplasty Today 2 (2016) 187 e192,Non-OADS,/arxiv_data1/oa_pdf/f7/07/main.PMC5247560.pdf
For full disclosure statements refer to http://dx.doi.org/10.1016/j.artd.2016.09.011 .,OADS,/arxiv_data1/oa_pdf/77/50/main.PMC5247561.pdf
E-mail address: Christopher_M_Melnic@rush.edu Contents lists available at ScienceDirect Arthroplasty Today journal homepage: http://www.arthr oplastytoday.org/ http://dx.doi.org/10.1016/j.artd.2016.09.011 2352-3441/ ©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/77/50/main.PMC5247561.pdf
This is an open access article under the CC B Y-NC- ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Arthroplasty Today 2 (2016) 139 e140,Non-OADS,/arxiv_data1/oa_pdf/77/50/main.PMC5247561.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/2a/3a/main.PMC5247562.pdf
For full disclosure statements refer to http://dx.doi.org/10.1016/j.artd.2016.05.006 .,OADS,/arxiv_data1/oa_pdf/2a/3a/main.PMC5247562.pdf
E-mail address: tanikake61@yahoo.co.jp Contents lists available at ScienceDirect Arthroplasty Today journal homepage: http://www.arthr oplastytoday.org/ http://dx.doi.org/10.1016/j.artd.2016.05.006 2352-3441/ ©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/2a/3a/main.PMC5247562.pdf
This is an open access article under the CC B Y- NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Arthroplasty Today 2 (2016) 157 e163,Non-OADS,/arxiv_data1/oa_pdf/2a/3a/main.PMC5247562.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/11/60/main.PMC5247564.pdf
Contents lists available at ScienceDirect Annals of Medicine and Surgery journal homepage: www.annalsjournal.com http://dx.doi.org/10.1016/j.amsu.2017.01.015 2049-0801/ ©2017 The Author(s).,Non-OADS,/arxiv_data1/oa_pdf/11/60/main.PMC5247564.pdf
"22 (6) (2016 Sep) 548 e553, http://dx.doi.org/10.1177/ 1076029615619486 .",Non-OADS,/arxiv_data1/oa_pdf/11/60/main.PMC5247564.pdf
The MALDI-TOF-MS spectrum of ‘Bittarella massiliensis ’is available athttp://mediterranee-infection.com/article.php?,Non-OADS,/arxiv_data1/oa_pdf/bf/50/main.PMC5247565.pdf
Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious DiseasesThis is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ) http://dx.doi.org/10.1016/j.nmni.2016.12.014,Non-OADS,/arxiv_data1/oa_pdf/bf/50/main.PMC5247565.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,16,2 8 –29 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/bf/50/main.PMC5247565.pdf
Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious DiseasesThis is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ) http://dx.doi.org/10.1016/j.nmni.2016.12.006,Non-OADS,/arxiv_data1/oa_pdf/4a/f3/main.PMC5247566.pdf
The MALDI-TOF-MS spectrum of M. massiliensis is available at http://www.mediterraneeinfection.com/article.php?,Non-OADS,/arxiv_data1/oa_pdf/4a/f3/main.PMC5247566.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,16,3 0 –31 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/4a/f3/main.PMC5247566.pdf
This  is  an  open access article under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/50/f1/main.PMC5247567.pdf
"Secondly,  patient was  placed  to  left-side  up  position  for  better  exposure  of  the  aber- http://dx.doi.org/10.1016/j.ijscr.2017.01.011 2210-2612/© 2017  The  Authors.",Non-OADS,/arxiv_data1/oa_pdf/50/f1/main.PMC5247567.pdf
"CBD also acts as a reactive oxygen species (ROS) scavenger, reducing lipid peroxidation, and restores caspase 12, caspase 3, Bcl-2, http://dx.doi.org/10.1016/j.redox.2016.12.029 Received 14 November 2016; Received in revised form 25 December 2016; Accepted 27 December 2016⁎Corresponding authors at: Eye & ENT Hospital, State Key Laboratory of Medical Neurobiology, Institutes of Brain Science, Shanghai Medical College, Fudan University, Shanghai 200032, China.",Non-OADS,/arxiv_data1/oa_pdf/fd/8b/main.PMC5247568.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/fd/8b/main.PMC5247568.pdf
105 (2013) 24 –48.http://dx.doi.org/10.1016/j.pneuro- bio.2013.03.002 .,OADS,/arxiv_data1/oa_pdf/fd/8b/main.PMC5247568.pdf
http://dx.doi.org/10.1089/ ars.2010.3576 .,Non-OADS,/arxiv_data1/oa_pdf/fd/8b/main.PMC5247568.pdf
Acta 1802 (2010) 80 –91.http://dx.doi.org/10.1016/ j.bbadis.2009.09.003 .,OADS,/arxiv_data1/oa_pdf/fd/8b/main.PMC5247568.pdf
http://dx.doi.org/ 10.1016/j.phrs.2016.01.033 .,OADS,/arxiv_data1/oa_pdf/fd/8b/main.PMC5247568.pdf
"Martinez-Orgado, Mechanisms of cannabidiol neuroprotection in hypoxic- ischemic newborn pigs: role of 5HT(1A) and CB2 receptors, Neuropharmacology 71 (2013) 282– 291. http://dx.doi.org/10.1016/j.neuropharm.2013.03.027 .",OADS,/arxiv_data1/oa_pdf/fd/8b/main.PMC5247568.pdf
"Smid, Contrasting protective e ﬀects of cannabinoids against oxidative stress and amyloid-beta evoked neurotoxicity in vitro, Neurotoxicology 33 (2012) 138– 146. http://dx.doi.org/ 10.1016/j.neuro.2011.12.015 .",Non-OADS,/arxiv_data1/oa_pdf/fd/8b/main.PMC5247568.pdf
USA 95 (1998) 8268 –8273 (https://www.ncbi.nlm.nih.gov/pubmed/9653176) .,Non-OADS,/arxiv_data1/oa_pdf/fd/8b/main.PMC5247568.pdf
http://dx.doi.org/10.1038/cddis.2012.71 .,OADS,/arxiv_data1/oa_pdf/fd/8b/main.PMC5247568.pdf
89(2004) 134– 141. http://dx.doi.org/10.1111/j.1471-4159.2003.02327.x .,Non-OADS,/arxiv_data1/oa_pdf/fd/8b/main.PMC5247568.pdf
http://dx.doi.org/ 10.1111/febs.12260 .,Non-OADS,/arxiv_data1/oa_pdf/fd/8b/main.PMC5247568.pdf
21 (2015) 38 –45.http://dx.doi.org/10.2119/molmed.2014.00261 .,Non-OADS,/arxiv_data1/oa_pdf/fd/8b/main.PMC5247568.pdf
http://dx.doi.org/10.1152/aj- pheart.00795.2008 .,Non-OADS,/arxiv_data1/oa_pdf/fd/8b/main.PMC5247568.pdf
http://dx.doi.org/10.1016/j.pneuro- bio.2016.06.006 .,OADS,/arxiv_data1/oa_pdf/fd/8b/main.PMC5247568.pdf
"Turner, C, American heart association statistics, s. stroke statistics, heart disease and stroke statistics-2016 update: aa report from the american heart association, Circulation 133 (2016) e38– 360. http://dx.doi.org/10.1161/ CIR.0000000000000350 .",Non-OADS,/arxiv_data1/oa_pdf/fd/8b/main.PMC5247568.pdf
http://dx.doi.org/10.1196/annals.1344.011 .,Non-OADS,/arxiv_data1/oa_pdf/fd/8b/main.PMC5247568.pdf
"Stenzel-Poore, Mechanisms of ischemic brain damage, Neuropharmacology 55 (2008) 310– 318. http://dx.doi.org/10.1016/ j.neuropharm.2008.01.005 .",OADS,/arxiv_data1/oa_pdf/fd/8b/main.PMC5247568.pdf
30 (2009) 515– 527. http://dx.doi.org/10.1016/j.tips.2009.07.006 .,OADS,/arxiv_data1/oa_pdf/fd/8b/main.PMC5247568.pdf
Med 38 (2016) 567– 573. http://dx.doi.org/10.3892/ijmm.2016.2623 .,Non-OADS,/arxiv_data1/oa_pdf/fd/8b/main.PMC5247568.pdf
48 (2016) 342– 353. http://dx.doi.org/10.1093/abbs/gmw011 .,Non-OADS,/arxiv_data1/oa_pdf/fd/8b/main.PMC5247568.pdf
168 (2006) 235– 244. http://dx.doi.org/ 10.2353/ajpath.2006.050500 .,Non-OADS,/arxiv_data1/oa_pdf/fd/8b/main.PMC5247568.pdf
http://dx.doi.org/ 10.1371/journal.pone.0100126 .,Non-OADS,/arxiv_data1/oa_pdf/fd/8b/main.PMC5247568.pdf
http://dx.doi.org/10.3390/nu8010041 .,Non-OADS,/arxiv_data1/oa_pdf/fd/8b/main.PMC5247568.pdf
http://dx.doi.org/10.1038/em- boj.2012.38 .,OADS,/arxiv_data1/oa_pdf/fd/8b/main.PMC5247568.pdf
2 (2014) 702– 714. http://dx.doi.org/10.1016/j.redox.2014.05.006 .,OADS,/arxiv_data1/oa_pdf/fd/8b/main.PMC5247568.pdf
"[31] H. Uchino, Y. Ogihara, H. Fukui, M. Chijiiwa, S. Sekine, N. Hara, E. Elmer, Brain injury following cardiac arrest: pathophysiology for neurocritical care, J. IntensiveCare 4 (2016) 31. http://dx.doi.org/10.1186/s40560-016-0140-9 .",Non-OADS,/arxiv_data1/oa_pdf/fd/8b/main.PMC5247568.pdf
47 (2013) 9 –23.http://dx.doi.org/10.1007/s12035-012-8344-z .,Non-OADS,/arxiv_data1/oa_pdf/fd/8b/main.PMC5247568.pdf
Psiquiatr 35 (2013) 380– 386. http://dx.doi.org/10.1590/ 1516-4446-2012-0886 .,Non-OADS,/arxiv_data1/oa_pdf/fd/8b/main.PMC5247568.pdf
http://dx.doi.org/10.1523/JNEUROSCI.4212-08.2009 .,Non-OADS,/arxiv_data1/oa_pdf/fd/8b/main.PMC5247568.pdf
31 (2008) 703– 717. http://dx.doi.org/10.1007/s10545-008-1015-6 .,Non-OADS,/arxiv_data1/oa_pdf/fd/8b/main.PMC5247568.pdf
62 (2013) 750– 756. http://dx.doi.org/10.1016/j.neuint.2013.02.005 .,OADS,/arxiv_data1/oa_pdf/fd/8b/main.PMC5247568.pdf
7 (2015) 89. http://dx.doi.org/10.3389/fnagi.2015.00089 .,Non-OADS,/arxiv_data1/oa_pdf/fd/8b/main.PMC5247568.pdf
62 (2010) 14 –18.http://dx.doi.org/ 10.1002/iub.280 .,Non-OADS,/arxiv_data1/oa_pdf/fd/8b/main.PMC5247568.pdf
35 (2010) 145– 149. http://dx.doi.org/10.1016/ j.tibs.2009.10.006 .,Non-OADS,/arxiv_data1/oa_pdf/fd/8b/main.PMC5247568.pdf
http://dx.doi.org/10.1111/jnc.13486 .S.,Non-OADS,/arxiv_data1/oa_pdf/fd/8b/main.PMC5247568.pdf
"Therefore, administration http://dx.doi.org/10.1016/j.redox.2016.12.034 Received 7 October 2016; Received in revised form 27 December 2016; Accepted 29 December 2016⁎Correspondence to: Department of Food and Nutrition, Chungnam National University, 99 Daehak-ro, Yuseong-gu, Daejeon 34134, Republic of Korea.",Non-OADS,/arxiv_data1/oa_pdf/60/d9/main.PMC5247570.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/60/d9/main.PMC5247570.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6a/8a/main.PMC5247571.pdf
Contents lists available at ScienceDirect International Journal for Parasitology: Drugs and Drug Resistance journal homepage: www.elsevier.c om/locate/ijpddr http://dx.doi.org/10.1016/j.ijpddr.2017.01.001 2211-3207/ ©2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/6a/8a/main.PMC5247571.pdf
"The http://dx.doi.org/10.1016/j.redox.2017.01.008 Received 9 December 2016; Received in revised form 9 January 2017; Accepted 11 January 2017⁎Correspondence to: Research Group on Quality, Safety, and Bioactivity of Plant Foods, Department of Food Science and Technology, CEBAS (CSIC), P.O.",Non-OADS,/arxiv_data1/oa_pdf/32/8c/main.PMC5247572.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/32/8c/main.PMC5247572.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0.",Non-OADS,/arxiv_data1/oa_pdf/70/f0/CG-CGCR160157.PMC5247624.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0.",Non-OADS,/arxiv_data1/oa_pdf/c9/62/CG-CGCR160153.PMC5247625.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0.",Non-OADS,/arxiv_data1/oa_pdf/4c/34/CG-CGCR160158.PMC5247626.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0.",Non-OADS,/arxiv_data1/oa_pdf/a2/43/CG-CGCR160149.PMC5247627.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0.",Non-OADS,/arxiv_data1/oa_pdf/dd/90/CG-CGCR160160.PMC5247628.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0.",Non-OADS,/arxiv_data1/oa_pdf/34/35/CG-CGCR160152.PMC5247629.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0.",Non-OADS,/arxiv_data1/oa_pdf/5b/4a/CG-CGCR160163.PMC5247630.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0.",Non-OADS,/arxiv_data1/oa_pdf/28/cb/CG-CGCR160162.PMC5247631.pdf
Available FREE in open access from: http://www.jpathinformatics.org/text.,Non-OADS,/arxiv_data1/oa_pdf/a5/70/JPI-7-55.PMC5248399.pdf
"J Pathol Inform 2016, 1:55 http://www.jpathinformatics.org/content/7/1/55have been noted with the use of EHRs.",Non-OADS,/arxiv_data1/oa_pdf/a5/70/JPI-7-55.PMC5248399.pdf
"J Pathol Inform 2016, 1:55 http://www.jpathinformatics.org/content/7/1/55MESSAGE DIGEST 5 ALGORITHM An MD is a cryptographic hash function encompassing  a string of digits created by a one‑way hashing function  to protect the integrity of exchanged data.",OADS,/arxiv_data1/oa_pdf/a5/70/JPI-7-55.PMC5248399.pdf
"The software can be accessed online through the following link: https://github.com/ClinicalLaboratory/Generating‑Unique‑IDs‑from‑Pateint‑identification‑ Data‑Using‑Security‑Models Using the Software To us, the encryption tool, R and RStudio, must be  installed on the machine that has the patient record file.",Non-OADS,/arxiv_data1/oa_pdf/a5/70/JPI-7-55.PMC5248399.pdf
"J Pathol Inform 2016, 1:55 http://www.jpathinformatics.org/content/7/1/55platform.",Non-OADS,/arxiv_data1/oa_pdf/a5/70/JPI-7-55.PMC5248399.pdf
"J Pathol Inform 2016, 1:55 http://www.jpathinformatics.org/content/7/1/55access to the patients’ medical records, for example, vital  signs, and can track these records locally, i.e., between  physicians; however, the original personal data will remain secure.",Non-OADS,/arxiv_data1/oa_pdf/a5/70/JPI-7-55.PMC5248399.pdf
Available FREE in open access from: http://www.jpathinformatics.org/text.,Non-OADS,/arxiv_data1/oa_pdf/e2/2c/JPI-7-53.PMC5248400.pdf
"J Pathol Inform 2016, 1:53 http://www.jpathinformatics.org/content/7/1/53the reproducibility of individual applications and analysis  pipelines,[5,6] but significant work remains to increase  this reliability, particularly for experiments performed in resource‑limited environments or on computational clusters.",Non-OADS,/arxiv_data1/oa_pdf/e2/2c/JPI-7-53.PMC5248400.pdf
"J Pathol Inform 2016, 1:53 http://www.jpathinformatics.org/content/7/1/53include automated fault tolerance, primarily for issues  that resulted in sequence download failures due to brief losses in network connectivity.",Non-OADS,/arxiv_data1/oa_pdf/e2/2c/JPI-7-53.PMC5248400.pdf
"J Pathol Inform 2016, 1:53 http://www.jpathinformatics.org/content/7/1/53bioinformatics.",Non-OADS,/arxiv_data1/oa_pdf/e2/2c/JPI-7-53.PMC5248400.pdf
"J Pathol Inform 2016, 1:53 http://www.jpathinformatics.org/content/7/1/53done even with limited local computational capacity.",Non-OADS,/arxiv_data1/oa_pdf/e2/2c/JPI-7-53.PMC5248400.pdf
Available from: https://www.docker.com.,Non-OADS,/arxiv_data1/oa_pdf/e2/2c/JPI-7-53.PMC5248400.pdf
Available from: https://www.github.com/spotify/luigi.,Non-OADS,/arxiv_data1/oa_pdf/e2/2c/JPI-7-53.PMC5248400.pdf
Available from: https://www.gdc.cancer.gov.,Non-OADS,/arxiv_data1/oa_pdf/e2/2c/JPI-7-53.PMC5248400.pdf
Available from: https://www.github.com/pharmbio/ sciluigi.,Non-OADS,/arxiv_data1/oa_pdf/e2/2c/JPI-7-53.PMC5248400.pdf
Available FREE in open access from: http://www.jpathinformatics.org/text.,Non-OADS,/arxiv_data1/oa_pdf/71/4a/JPI-7-51.PMC5248401.pdf
"J Pathol Inform 2016, 1:51 http://www.jpathinformatics.org/content/7/1/51Screening tests to detect cervical cancer and its precursor  lesions include Pap, colposcopy to visually inspect the  cervix, and microscopic interpretation of histology slides  by a pathologist when biopsied cervix tissue is available.",Non-OADS,/arxiv_data1/oa_pdf/71/4a/JPI-7-51.PMC5248401.pdf
"J Pathol Inform 2016, 1:51 http://www.jpathinformatics.org/content/7/1/51Pathologist Ground Truth Description For the image and CIN classification techniques explored  in this research, 118 full-color digitized histology images are	used	with	H	and	E	stain	preparations	 of	tissue	 sections of normal cervical tissue and three grades of cervical carcinoma in situ.",Non-OADS,/arxiv_data1/oa_pdf/71/4a/JPI-7-51.PMC5248401.pdf
"J Pathol Inform 2016, 1:51 http://www.jpathinformatics.org/content/7/1/51The resulting medial axis is partitioned into ten segments  of approximately equal length, perpendicular line slopes are estimated at the mid-points of each segment, and vertical lines are projected at the end points of each segment to generate ten vertical segments for analysis.",OADS,/arxiv_data1/oa_pdf/71/4a/JPI-7-51.PMC5248401.pdf
"J Pathol Inform 2016, 1:51 http://www.jpathinformatics.org/content/7/1/51•	 Step	 2:	Perform	 adaptive	 histogram	 equalization	 on	 the image from Step 1 using Matlab’s adapthisteq.",OADS,/arxiv_data1/oa_pdf/71/4a/JPI-7-51.PMC5248401.pdf
"J Pathol Inform 2016, 1:51 http://www.jpathinformatics.org/content/7/1/51vector sampled with the same distribution for all trees in  the forest.",Non-OADS,/arxiv_data1/oa_pdf/71/4a/JPI-7-51.PMC5248401.pdf
"J Pathol Inform 2016, 1:51 http://www.jpathinformatics.org/content/7/1/51LDA, logistic regression, and random forest classifiers.",OADS,/arxiv_data1/oa_pdf/71/4a/JPI-7-51.PMC5248401.pdf
"J Pathol Inform 2016, 1:51 http://www.jpathinformatics.org/content/7/1/51random forest) and (b) a performance comparison  between previous research[4] and this study, (c) the  impact on performance using intra- and inter -pathologist  CIN truth labels for the classifier training and testing sets, and (d) a performance comparison between our classification results and the baseline results from  the pathologists.",OADS,/arxiv_data1/oa_pdf/71/4a/JPI-7-51.PMC5248401.pdf
"J Pathol Inform 2016, 1:51 http://www.jpathinformatics.org/content/7/1/51the correct recognition rate of 81.29%.",OADS,/arxiv_data1/oa_pdf/71/4a/JPI-7-51.PMC5248401.pdf
"J Pathol Inform 2016, 1:51 http://www.jpathinformatics.org/content/7/1/51image CIN label for each individual vertical segment,  a 12.96%/5.94% (RZ-RZ/SF-SF) improvement for single expert over the baseline method.",OADS,/arxiv_data1/oa_pdf/71/4a/JPI-7-51.PMC5248401.pdf
"J Pathol Inform 2016, 1:51 http://www.jpathinformatics.org/content/7/1/51feature set, and an improvement of 12.96/5.94% (from  LDA classifier 76.02%/79.57% [RZ-RZ/SF-SF]) to logistic regression 88.98%/85.51% from [Table 4]) using all 27 features.",OADS,/arxiv_data1/oa_pdf/71/4a/JPI-7-51.PMC5248401.pdf
"J Pathol Inform 2016, 1:51 http://www.jpathinformatics.org/content/7/1/51expert over the baseline method[4] using the reduced  features.",OADS,/arxiv_data1/oa_pdf/71/4a/JPI-7-51.PMC5248401.pdf
Available from:  https://www.stat.berkeley.edu/~breiman/ Using_random_forests_V3.1.pdf.,Non-OADS,/arxiv_data1/oa_pdf/71/4a/JPI-7-51.PMC5248401.pdf
Available FREE in open access from: http://www.jpathinformatics.org/text.,Non-OADS,/arxiv_data1/oa_pdf/1a/6b/JPI-7-50.PMC5248402.pdf
"J Pathol Inform 2016, 1:50 http://www.jpathinformatics.org/content/7/1/50that allow one to analyze time series data.",OADS,/arxiv_data1/oa_pdf/1a/6b/JPI-7-50.PMC5248402.pdf
"J Pathol Inform 2016, 1:50 http://www.jpathinformatics.org/content/7/1/50for the follow-up screening in year 1, whereas 49.3%  appeared for year 2, etc., Only 0.8% of all patients appeared in year 10 (this corresponds to 1,678 patients).",Non-OADS,/arxiv_data1/oa_pdf/1a/6b/JPI-7-50.PMC5248402.pdf
"J Pathol Inform 2016, 1:50 http://www.jpathinformatics.org/content/7/1/50instead of presenting a survival function, we will be  plotting a 100% - survival function.",Non-OADS,/arxiv_data1/oa_pdf/1a/6b/JPI-7-50.PMC5248402.pdf
"J Pathol Inform 2016, 1:50 http://www.jpathinformatics.org/content/7/1/50once the result goes from negative to positive, the risk  increases by 675% (please note that exp (1.91) =6.75).",Non-OADS,/arxiv_data1/oa_pdf/1a/6b/JPI-7-50.PMC5248402.pdf
"J Pathol Inform 2016, 1:50 http://www.jpathinformatics.org/content/7/1/50CIN3+ depends on the initial result of the hrHPV test,  i.e., positive hrHPV test result at t  = 0 leads to the risk  of 3.9% after 5 years while negative hrHPV test result at t = 0 leads to the risk of 0.5% after 5 years.",Non-OADS,/arxiv_data1/oa_pdf/1a/6b/JPI-7-50.PMC5248402.pdf
"J Pathol Inform 2016, 1:50 http://www.jpathinformatics.org/content/7/1/50the KM estimator or the CPHR model is a data-driven  process.",Non-OADS,/arxiv_data1/oa_pdf/1a/6b/JPI-7-50.PMC5248402.pdf
"J Pathol Inform 2016, 1:50 http://www.jpathinformatics.org/content/7/1/50Theoretically, for a DBN model we could also choose a  day as a possible transition interval between two slices, although in the presented application to cervical cancer screening it would be counter -productive to quantify  the model with a day transition interval.",Non-OADS,/arxiv_data1/oa_pdf/1a/6b/JPI-7-50.PMC5248402.pdf
"J Pathol Inform 2016, 1:50 http://www.jpathinformatics.org/content/7/1/50classification of new cases.",Non-OADS,/arxiv_data1/oa_pdf/1a/6b/JPI-7-50.PMC5248402.pdf
"J Pathol Inform 2016, 1:50 http://www.jpathinformatics.org/content/7/1/50between covariates and the response variable.",OADS,/arxiv_data1/oa_pdf/1a/6b/JPI-7-50.PMC5248402.pdf
"J Pathol Inform 2016, 1:50 http://www.jpathinformatics.org/content/7/1/50networks.",Non-OADS,/arxiv_data1/oa_pdf/1a/6b/JPI-7-50.PMC5248402.pdf
Available FREE in open access from: http://www.jpathinformatics.org/text.,Non-OADS,/arxiv_data1/oa_pdf/ff/71/JPI-7-54.PMC5248403.pdf
"J Pathol Inform 2016, 1:54 http://www.jpathinformatics.org/content/7/1/54the Gleason grading system (primary pattern, secondary  pattern, tertiary pattern, and total score) be reported on separate lines as separate and distinct RDEs, [1] despite  the fact that in the biopsy setting these elements are reported on one line as primary pattern + secondary  pattern = total score with tertiary pattern on a separate line if and only if it is present.",Non-OADS,/arxiv_data1/oa_pdf/ff/71/JPI-7-54.PMC5248403.pdf
"J Pathol Inform 2016, 1:54 http://www.jpathinformatics.org/content/7/1/54Quiz three contained 32 questions and compared  the standard format [Figure 1] with a biopsy format, [Figure 4], where Gleason grades are reported as primary  pattern + secondary pattern + (tertiary pattern) -> total  score on one line.",Non-OADS,/arxiv_data1/oa_pdf/ff/71/JPI-7-54.PMC5248403.pdf
"J Pathol Inform 2016, 1:54 http://www.jpathinformatics.org/content/7/1/54needed to extract the data decreased 18% with the biopsy  format (P < 0.001).",OADS,/arxiv_data1/oa_pdf/ff/71/JPI-7-54.PMC5248403.pdf
"J Pathol Inform 2016, 1:54 http://www.jpathinformatics.org/content/7/1/54of multiple pieces of information from a single line  both easy and routine.",Non-OADS,/arxiv_data1/oa_pdf/ff/71/JPI-7-54.PMC5248403.pdf
"J Pathol Inform 2016, 1:54 http://www.jpathinformatics.org/content/7/1/54nonmedical participants noted that while they could  perform the study, they really did not understand the meaning of the phrases they were looking for.",Non-OADS,/arxiv_data1/oa_pdf/ff/71/JPI-7-54.PMC5248403.pdf
Available from: http://www.cap.,Non-OADS,/arxiv_data1/oa_pdf/ff/71/JPI-7-54.PMC5248403.pdf
The  Pages: 417To order online visit: https://estore.cap.org or call 1 ‑800‑ 323‑4040.,Non-OADS,/arxiv_data1/oa_pdf/f6/1e/JPI-7-52.PMC5248404.pdf
Available FREE in open access from: http://www.jpathinformatics.org/text.,Non-OADS,/arxiv_data1/oa_pdf/f6/1e/JPI-7-52.PMC5248404.pdf
"J Pathol Inform 2016, 1:52  http://www.jpathinformatics.org/content/7/1/52seventh section provides numerous educational resources,  and the eighth section focuses on insights from digital pathology adopters from outside of the United States.",Non-OADS,/arxiv_data1/oa_pdf/f6/1e/JPI-7-52.PMC5248404.pdf
Available from: http://www.mohfw.nic.in/ WriteReadData/1892s/5628564789562315.pdf.,Non-OADS,/arxiv_data1/oa_pdf/3e/a6/JFCM-24-13.PMC5248428.pdf
Available from: http://www.who.int/ immunization/diseases/HepatitisatitisB/en/.,Non-OADS,/arxiv_data1/oa_pdf/3e/a6/JFCM-24-13.PMC5248428.pdf
Available from:  http://www.lrgaf.org/guide/ability.htm.,Non-OADS,/arxiv_data1/oa_pdf/84/5b/JFCM-24-18.PMC5248429.pdf
Available from: http://www.dressageridertraining.com/ blog/7 ‑simple ‑ways ‑to ‑improve ‑your ‑core ‑strength ‑for  ‑dressage ‑riders/.,Non-OADS,/arxiv_data1/oa_pdf/84/5b/JFCM-24-18.PMC5248429.pdf
Available from: http://www.bioriderfitness.com/strength ‑training  ‑lower ‑level ‑training ‑verses ‑upper ‑level/.,Non-OADS,/arxiv_data1/oa_pdf/84/5b/JFCM-24-18.PMC5248429.pdf
Available from: http://www.arabnews.com/news/464678.,Non-OADS,/arxiv_data1/oa_pdf/0f/98/JFCM-24-30.PMC5248431.pdf
Available from: http://www.who.int/bulletin/ volumes/84/7/editorial20706html/en/print.html.,Non-OADS,/arxiv_data1/oa_pdf/0f/98/JFCM-24-30.PMC5248431.pdf
We also applied the NHS physical  activity guidelines (http://www.nhs.uk/Livewell/fitness/ Pages/physical‑activity‑guidelines‑for‑young‑people.aspx)  in the study.,Non-OADS,/arxiv_data1/oa_pdf/c4/65/JFCM-24-55.PMC5248435.pdf
We also applied the NHS physical  activity guidelines (http://www.nhs.uk/Livewell/fitness/ Pages/physical‑activity‑guidelines‑for‑young‑people.aspx)  in the study.,Non-OADS,/arxiv_data1/oa_pdf/9e/68/JFCM-24-56.PMC5248436.pdf
"This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits any non-commercial use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.DIABETES TECHNOLOGY & THERAPEUTICS Volume 19, Number 1, 2017 Mary Ann Liebert, Inc.DOI: 10.1089/dia.2016.0350 25",Non-OADS,/arxiv_data1/oa_pdf/31/5d/dia.2016.0350.PMC5248540.pdf
"Online doucument at: http://nccam.nih.gov/about/plans/ 2011, accessed July 17, 2013.",Non-OADS,/arxiv_data1/oa_pdf/56/66/acm.2016.0291.PMC5248545.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/45/02/amep-8-075.PMC5248584.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/45/02/amep-8-075.PMC5248584.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Advances in Medical Education and Practice 2017:8 75–78Advances in Medical Education and Practice Dovepress submit your manuscript | www.dovepress.com Dovepress 75 LETTER open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/AMEP .S129953 Improving electrocardiogram interpretation skills  for medical students Kunj Patel1 Omar El T okhy1 Shlok Patel2 Hanna Maroof3 1Department of Investigative Medicine,   Faculty of Medicine, Imperial College  London, 2Department of Medical  Research, Faculty of Medicine, Barts and The London School of Medicine and Dentistry,  3GKT School of  Medical Education, Faculty of Life Sciences and Medicine, King’s College of London, London, UKDear editor We read with great interest the article by Zeng at al1 who propose a new electrocar - diogram (ECG) teaching method called the “graphics-sequence memory method”.",Non-OADS,/arxiv_data1/oa_pdf/45/02/amep-8-075.PMC5248584.pdf
"At Imperial College London, a combination of e-modules alongside traditional  learning methods is applied in an effort to familiarize students with common Correspondence: Shlok Patel Faculty of Medicine, Barts and The London School of Medicine and Dentistry, 64 Turner Street, London E1 2AD, UKEmail shlok.patel@smd15.qmul.ac.ukJournal name: Advances in Medical Education and Practice Article Designation: LETTERY ear: 2017V olume: 8Running head verso: Patel et alRunning head recto: Improving electrocardiogram interpretation skillsDOI: http://dx.doi.org/10.2147/AMEP .S129953",Non-OADS,/arxiv_data1/oa_pdf/45/02/amep-8-075.PMC5248584.pdf
"Advances in Medical Education and Practice Publish your work in this journal Submit your manuscript here: http://www.dovepress.com/advances-in-medical-education-and-practice-journalAdvances in Medical Education and Practice is an international, peer-  reviewed, open access journal that aims to present and publish research on Medical Education covering medical, dental, nursing and allied   health care professional education.",Non-OADS,/arxiv_data1/oa_pdf/45/02/amep-8-075.PMC5248584.pdf
"Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Advances in Medical Education and Practice 2017:8submit your manuscript | www.dovepress.com Dovepress Dovepress Dovepress 78 Patel et al Dove Medical Press encourages responsible, free and frank academic debate.",Non-OADS,/arxiv_data1/oa_pdf/45/02/amep-8-075.PMC5248584.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/53/8a/cia-12-145.PMC5248585.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Interventions in Aging 2017:12 145–152Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  145RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S10296 1 Dysmobility syndrome: current perspectives Keith D Hill1 Kaela Farrier1 Melissa Russell2 elissa Burton1 1School of Physiotherapy and  exercise Science, Faculty of Health  Sciences, Curtin University, Perth,   wA, Australia; 2Department of  epidemiology and Biostatistics,   School of Population and Global  Health, The University of Melbourne,   Parkville, vIC, AustraliaBackground:  A new term, dysmobility syndrome, has recently been described as a new  approach to identify older people at risk of poor health outcomes.",Non-OADS,/arxiv_data1/oa_pdf/53/8a/cia-12-145.PMC5248585.pdf
"Over  25 years ago, the term sarcopenia was introduced following a meeting of researchers  and clinicians in the USA seeking to identify and group key components of functional  decline.1 There are a number of consensus definitions of sarcopenia, and although there  is variability in the criteria used to define sarcopenia, each includes measures of muscle Correspondence: Keith D Hill School of Physiotherapy and exercise  Science, Faculty of Health Sciences,  Curtin University, GPO Box U1987,  Perth, wA 6845, Australia Tel +61 8 9266 3618 Fax +61 8 9266 2399 email k eith.hill@curtin.edu.a u Journal name: Clinical Interventions in Aging Article Designation: Review Y ear: 2017 Volume: 12 Running head verso: Hill et al Running head recto: Dysmobility syndrome DOI: http://dx.doi.org/10.2147/CIA.S102961",Non-OADS,/arxiv_data1/oa_pdf/53/8a/cia-12-145.PMC5248585.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/53/8a/cia-12-145.PMC5248585.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/53/8a/cia-12-145.PMC5248585.pdf
"Retrieved from http://ec.europa.eu/eurostat/data/database Garmezy, N. (1993).",OADS,/arxiv_data1/oa_pdf/6d/d2/IJOP-52-19.PMC5248588.pdf
"Retrieved fromhttp://www.europeansocialsurvey.org Schwartz, S. H., & Bilsky, W. (1987).",Non-OADS,/arxiv_data1/oa_pdf/6d/d2/IJOP-52-19.PMC5248588.pdf
Detailed information regarding our phenotypic analysis can befound online at http://www.cgris.net/query/croplist.,Non-OADS,/arxiv_data1/oa_pdf/ac/dc/JIPB-59-60.PMC5248594.pdf
"All mutants with abnormal visual phenotypes, compared to their parental line cv.Zhongpin661, were cataloged on our searchable web-based database http://www.cgris.net/query/croplist.",OADS,/arxiv_data1/oa_pdf/ac/dc/JIPB-59-60.PMC5248594.pdf
Five hundred and forty-threeSSR markers ( http://soybase.org/dlpages/#ssrprimer ) were selected for comparative analysis of the gyl mutant and JD12.,OADS,/arxiv_data1/oa_pdf/ac/dc/JIPB-59-60.PMC5248594.pdf
Primers were designed using the Primer3 Input at http://primer3.ut.ee/ based on the Williams 82 genomic sequence.,OADS,/arxiv_data1/oa_pdf/ac/dc/JIPB-59-60.PMC5248594.pdf
A detailed description of the protocol we used is present at the GATK web-site ( https://www.broadinstitute.org/gatk/guide/best- practices?bpm=DNAseq#variant-discovery-ovw ).,Non-OADS,/arxiv_data1/oa_pdf/ac/dc/JIPB-59-60.PMC5248594.pdf
Available at: https://www.ssb.no/en/helse/statistikker/royk (accessed 21 April 2016) (Archived at http://www.webcitation.org/ 6llQEo0zy on 4 November 2016).,OADS,/arxiv_data1/oa_pdf/cb/4d/ADD-112-340.PMC5248595.pdf
"Next, we analyzed the promoter regions(1,500 bp upstream of the ATG translation startcodon) of GmSIZ1a and GmSIZ1b using the PlantCARE database ( http://bioinformatics.psb.ugent.be/webtools/ plantcare/html/search_CARE.html/ ), and identi ﬁed sev- eral putative abiotic stress, biotic stress, and hormoneresponse cis-acting regulatory elements, including those related to heat, low-temperature, defense,ABA, SA, jasmonic acid, and light ( Table S1 ).",OADS,/arxiv_data1/oa_pdf/2c/83/JIPB-59-2.PMC5248596.pdf
The homology model of the three-dimensional (3D) structure was constructed using thePhyre server ( http://www.sbg.bio.ic.ac.uk/phyre2/html/ page.cgi?id=index ) and the ﬁgures were generated using PyMOL ( http://pymol.org/ ).,OADS,/arxiv_data1/oa_pdf/2c/83/JIPB-59-2.PMC5248596.pdf
"For the detection of the se- quence variant, the reference sequence NM_033337.2 (NCBI: http://www.ncbi.nlm.nih.gov/pubmed) was used.",OADS,/arxiv_data1/oa_pdf/a4/93/PRCA-11-0.PMC5248598.pdf
Protein references were as follows: NP203123 (NCBI) and P56539 (UniProtKB: http://www.uniprot.org).,OADS,/arxiv_data1/oa_pdf/a4/93/PRCA-11-0.PMC5248598.pdf
"Densitometric analyses of the immunoblots were performed using the ImageJ program (Open source: Wayne Rasband, NIH, Bethesda, MD, USA, v. 1,45e, 4-2-2011; http://imagej.nih.gov/ij/download.html).",OADS,/arxiv_data1/oa_pdf/a4/93/PRCA-11-0.PMC5248598.pdf
2.7.5 Functional classiﬁcation of proteome alterations Proteins were categorized manually according to the informa- tion found on the Uniprot website http://www.uniprot.org.,OADS,/arxiv_data1/oa_pdf/a4/93/PRCA-11-0.PMC5248598.pdf
"3.4 Occurrence of the Caveolin-3 G56S variant in genetic resources The Exome Aggregation Consortium (ExAC, containing ex- ome sequencing data from a wide variety of large-scale sequencing projects; http://exac.broadinstitute.org/) reports the heterozygous G56S CAV3 variant in 1130 and the ho- mozygous variant in 84 out of 60495 individuals (allele frequency 1.07%).",OADS,/arxiv_data1/oa_pdf/a4/93/PRCA-11-0.PMC5248598.pdf
"Another resource, the Exome Variant Server (http://evs.gs.washington.edu/EVS/), provides fre- quency information for distinct ethnic groups.",OADS,/arxiv_data1/oa_pdf/a4/93/PRCA-11-0.PMC5248598.pdf
Most protein functions are assigned according to the information listed in the UniPro- tKB website (http://www.uniprot.org) as of July 2015.,OADS,/arxiv_data1/oa_pdf/a4/93/PRCA-11-0.PMC5248598.pdf
Meaning of the altered abundance of paradigmatic proteins is dis- cussed according to their respective functions listed on the Uniprot website (http://www.uniprot.org).,OADS,/arxiv_data1/oa_pdf/a4/93/PRCA-11-0.PMC5248598.pdf
"Interestingly, two patients listed with the G56S variant in the database of the Leiden Muscular dystrophy Pages (http://www.dmd.nl) are reported to present with “double trouble”: they addi- tionally carry mutations in the Calpain 3 (CAPN3 ) and the Fukutin-related protein (FKRP ) gene, respectively.",Non-OADS,/arxiv_data1/oa_pdf/a4/93/PRCA-11-0.PMC5248598.pdf
Perceptual training paradigm An E-Prime (http://www.pstnet.com/eprime.cfm) script was modiﬁed from Penton-Voaket al.,Non-OADS,/arxiv_data1/oa_pdf/f2/93/BJHP-22-60.PMC5248599.pdf
Copy Number Variation (CNV) and overexpression of Frizzled (FZD) receptor 1 to 10 in primary breast cancer samples mined using the COSMIC repository (http://cancer.sanger.ac.uk/cancergenome/projects/cosmic/about).,Non-OADS,/arxiv_data1/oa_pdf/7a/f4/PATH-241-350.PMC5248601.pdf
"Luxembourg: Publications Ofﬁce of the European Union: JRC (Joint Research Centre) Science and Policy Report, 2015: https://ec.europa.eu/jrc.",Non-OADS,/arxiv_data1/oa_pdf/15/21/ALL-71-1513.PMC5248602.pdf
"Characterization of Strains by Phenotype MicroArray The PM assay was performed using the 96-well microplates PM1, PM2A, PM3B, PM4A, PM9, andPM10 (http://www.biolog.com/pdf/pm_lit/PM1-PM10.",Non-OADS,/arxiv_data1/oa_pdf/ac/3c/HEL-22-0.PMC5248604.pdf
Annotated proteins sequences were used to map against KEGG pathwaydatabases (KEGG (http://www.genome.jp/kegg) todetermine metabolic pathways to which the proteinswere assigned [10].,OADS,/arxiv_data1/oa_pdf/ac/3c/HEL-22-0.PMC5248604.pdf
Community management of opioid overdose .G e n e v a :W H O ;2 0 1 4 .A v a i l a b l ea t :h t t p : / / www.who.int/substance_abuse/publications/management_ opioid_overdose/en/ (accessed 2 February 2015) (Archived athttp://www.webcitation.org/6l24psk2Y on 5 October 2016).,Non-OADS,/arxiv_data1/oa_pdf/d2/a7/ADD-112-301.PMC5248605.pdf
Availableat: http://www.nta.nhs.uk/uploads/2012.pdf (accessed 2February 2015) (Archived at http://www.webcitation.org/6l24wnW1f on 5 October 2016).,Non-OADS,/arxiv_data1/oa_pdf/d2/a7/ADD-112-301.PMC5248605.pdf
Avail-able at: http://www.emcdda.europa.eu/online/annual- report/2011 (accessed 25 November 2014) (Archived at http://www.webcitation.org/6l24BVmWe on 5 October2016).,Non-OADS,/arxiv_data1/oa_pdf/d2/a7/ADD-112-301.PMC5248605.pdf
uk/government/uploads/system/uploads/attachment_data/ﬁle/494423/horr91-reduction-heroin-supply .pdf (a ccessed 2February 2016) (Archived at http://www.webcitation.org/ 6l24LQPaG on 5 October 2016).,Non-OADS,/arxiv_data1/oa_pdf/d2/a7/ADD-112-301.PMC5248605.pdf
Available at: http://www.nrscotland.gov .uk/statistics-and-data/statistics/statistics-by- theme/vital-events/deaths/drug-related-deaths-in-scotland/ 2014 (accessed 26 August 2015) (Archived at http://www.webcitation.org/6l24Qox2v on 5 October 2016).,OADS,/arxiv_data1/oa_pdf/d2/a7/ADD-112-301.PMC5248605.pdf
Available at: http://www.accessdata.fda.gov/drugsatfda_docs/ label/2009/020622s057lbl.pdf.,Non-OADS,/arxiv_data1/oa_pdf/ed/4d/JON-27-97.PMC5248608.pdf
Uridine triacetate (Vistogard; https://www.vistogard.com/) was approved by the FDA in December 2015 and is available commercially.,Non-OADS,/arxiv_data1/oa_pdf/58/b0/CNCR-123-345.PMC5248610.pdf
"Fluorouracil incident root cause analysis, 2007. http://www.ismp-canada.org/download/reports/FluorouracilIncident- May2007.pdf.",OADS,/arxiv_data1/oa_pdf/58/b0/CNCR-123-345.PMC5248610.pdf
Vistogard approved prescribing in- formation 2015. https://www.vistogard.com/Vistogard/media/Main- Media/final-labeling-text-vistogard.pdf.,Non-OADS,/arxiv_data1/oa_pdf/58/b0/CNCR-123-345.PMC5248610.pdf
"We aligned the reads to the pig reference genome (SGSC Sscrofa10.2, http://hgdownload.soe.ucsc.edu/goldenPath/susScr3/bigZips/) using BURROWS - WHEELER ALIGNER (BWAver 0.7.5) (Li & Durbin 2009) with the default settings and the steps of the GGRS approach.",OADS,/arxiv_data1/oa_pdf/77/e1/AGE-48-38.PMC5248613.pdf
Function annotation The Ensembl pig gene annotation set (Ensembl release 78)was downloaded from the Ensembl website (ftp://ftp.ensembl.org/pub/release-78/gtf/sus_scrofa/) (Flicek et al.,OADS,/arxiv_data1/oa_pdf/77/e1/AGE-48-38.PMC5248613.pdf
"Additionally, the pig QTL database (Animal QTLrelease 25) was downloaded from the Animal QTL databasewebsite (http://www.animalgenome.org/cgi-bin/QTLdb/GG/index, updated Dec 29, 2014) (Hu et al.",OADS,/arxiv_data1/oa_pdf/77/e1/AGE-48-38.PMC5248613.pdf
Phenotypic records related to reproduction and pedigree information have been uploaded to our website (http://klab.sjtu.edu.cn/pigbreeds/).,Non-OADS,/arxiv_data1/oa_pdf/77/e1/AGE-48-38.PMC5248613.pdf
Available at https://www.cdc.gov/diabetes/pubs/statsreport14/national-diabetes-report-web.pdf Last accessed 26 July 2016.,Non-OADS,/arxiv_data1/oa_pdf/81/2c/DME-34-197.PMC5248619.pdf
Available at http://www.cdc.gov/nchs/fastats/black-health.htm Last accessed 26 July 2016.,Non-OADS,/arxiv_data1/oa_pdf/81/2c/DME-34-197.PMC5248619.pdf
"Wedesigned and synthesized anN-terminal-protecte d hexapeptide containing strongly helix-promoting a-amino- isobutyric acid (Aib)[13,15]residues with thesequence Boc-l- Leu-Aib- l-Leu2-Aib-Gly- (Boc=tert-butoxycarbonyl) and itsenantiomer asapendant ofC60(l-1ord-1,Figure 1a andScheme S1intheSupporting Information), because ofits predictable helical structure ,[13,15]such as310-anda-helices , where theC-terminal Gly residue was incorporated as aflexible spacer toreduce thestructural strain during the inclusion complex formation within thest-PMMA helical cavity .Thetheoretical studies ofl-1andanl-1/st-PMMA (72mer) inclusion complex revealed thatencapsulation ofthe[*]Dr.N.Ousaka, F.Mamiya, Y.Iwata, Prof. Dr.E.Yashima Department ofMolecular Design andEngineeri ng,Graduate School ofEngineeri ng Nagoya Universi ty Chikusa-ku, Nagoya 464-8603 (Japan) E-mail :yashima@ap chem.nagoy a-u.ac.jp Homepag e:http://helix.mo l.nagoya-u.ac.",OADS,/arxiv_data1/oa_pdf/cf/4f/ANIE-56-791.PMC5248627.pdf
"jp/ Dr.K.Nishimura Institute forMolecu larScience 38Nishigo-Na ka,Myodaiji, Okazaki 444-8585 (Japan) Supportin ginformation forthisarticle canbefound under : http://dx.do i.org/10.1002/a nie.2016113 49.",Non-OADS,/arxiv_data1/oa_pdf/cf/4f/ANIE-56-791.PMC5248627.pdf
Available at: http://www.prisma-statement.org/ (accessed 04 augustus 2015).,Non-OADS,/arxiv_data1/oa_pdf/61/10/JCPE-44-67.PMC5248642.pdf
"ISBN 3-900051-07-0, URL http://www.R-project.org).",Non-OADS,/arxiv_data1/oa_pdf/0c/72/EJP-21-322.PMC5248647.pdf
Supportin ginformation forthisarticle (anextended data table of utilized redox-act ivematerials) canbefound under :http://dx.doi.,OADS,/arxiv_data1/oa_pdf/36/6e/ANIE-56-686.PMC5248651.pdf
"The incorpo- ration ofPdnanop articles inclose proximity tothe acid sites inbifunc tional Pd/H-Y catalys tsalso afforded aflexible mean s tocontro laromatic products selectivity ,asfurthe rdemonstrat- edinthe arom atizati onofhydr ogenated DA adducts from other diene/dieno philecombination s. [a]Dr.H.C.Genuino, Dr.S.Thiyag arajan, Prof. Dr.B.M.Weckhuysen, Dr.P.C.A.Bruijnincx Inorganic Chemi stryand Cata lysis Debye Institute forNano materia lsScience Utrecht Univ ersity Universi teitsweg 99,3584 CGUtrecht (The Netherl ands) E-mail :p.c.a.bru ijnincx@ uu.nl [b]Dr.S.Thiyagarajan, Dr.J.vanHavere n,Dr.D.S.vanEs Food &Bio-based Resear ch Wagening enUniversi tyand Resear chCentre P.O.Box17,6700 AAWageni ngen (The Nethe rlands) E-mail :daan.va nes@wu r.nl [c]Dr.J.C.vanderWaal, Dr.E.deJong Avantium Chem icals Zekeringst raat 29,1014BVAmsterdam (The Netherla nds) E-mail :ed.dejong @avantiu m.com Supp orting informa tionandtheORCID identification numb er(s) forthe autho r(s)ofthis article canbefoundunde rhttp://dx.doi.org/ 10.1002 / cssc.2 01600776.",Non-OADS,/arxiv_data1/oa_pdf/1a/a1/CSSC-10-277.PMC5248658.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/d2/be/copd-12-291.PMC5248928.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2017:12 291–298International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  291OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S12163 7 evaluation of carbon dioxide rebreathing during  exercise assisted by noninvasive ventilation  with plateau exhalation valve Y ong-er Ou* Zhi-min lin* Dong-ming hua Ying Jiang Ya-ting huo Qun luo rong-Chang Chen state Key laboratory of respiratory  Disease, national Clinical  research Center for respiratory  Disease, guangzhou Institute of  respiratory Disease, First affiliated  hospital of guangzhou Medical  University, guangzhou, People’s  republic of China *These authors contributed equally  to this workAbstract:  Noninvasive ventilation with a plateau exhalation valve (PEV) is often used as an  adjunct to exercise to achieve a physiologic training effect in severe chronic obstructive pul - monary disease (COPD) patients.",Non-OADS,/arxiv_data1/oa_pdf/d2/be/copd-12-291.PMC5248928.pdf
"Evidence  from Moga et al19 and Highcock et al20 indicated that NIV with a single-limb circuit  Correspondence: rong-Chang Chen state Key laboratory of respiratory  Disease, national Clinical research  Center for respiratory Disease,  guangzhou Institute of respiratory  Disease, First Affiliated Hospital of  guangzhou Medical University, 151  Yanjiang road, guangzhou, guangdong  510120, People’s republic of China Tel/fax +86 20 8306 2882 email rcchengird@163.co m Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Ou et al Running head recto: NIV and CO2 rebreathing during exercise DOI: http://dx.doi.org/10.2147/COPD.S121637",Non-OADS,/arxiv_data1/oa_pdf/d2/be/copd-12-291.PMC5248928.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/d2/be/copd-12-291.PMC5248928.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/d2/be/copd-12-291.PMC5248928.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/5f/3f/dhps-9-001.PMC5248929.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/5f/3f/dhps-9-001.PMC5248929.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Drug, Healthcare and Patient Safety 2017:9 1–8Drug, Healthcare and Patient Safety Dovepress submit your manuscript | www.dovepress.com Dovepress 1 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DHPS.S107065 Quantifying the relationship between patient  characteristics and involvement in developing   and implementing a treatment plan Natalie T Roy   Erin E Ulrich Department of Pharmaceutical,   Biomedical, and Administrative Sciences, College of Pharmacy and Health Sciences, Drake University,  Des Moines, IA, USAObjective: Improving the patient-physician relationship through patient involvement in the  care may lead to improved patient safety and better health outcomes.",Non-OADS,/arxiv_data1/oa_pdf/5f/3f/dhps-9-001.PMC5248929.pdf
"5–9 One study even researched the extent to which  trust between the patient and health care professionals can affect one’ s health care Correspondence: Erin E Ulrich   College of Pharmacy and Health Sciences,  Drake University, Fitch Hall 113, 2507 University Avenue, Des Moines, IA 50311-4505, USA Tel +1 515 271 1846   Fax +1 515 271 1867   Email erin.ulrich@drake.eduJournal name: Drug, Healthcare and Patient Safety Article Designation: ORIGINAL RESEARCHY ear: 2017V olume: 9Running head verso: Roy and UlrichRunning head recto: Patient characteristics and involvement in health outcomesDOI: http://dx.doi.org/10.2147/DHPS.S107065",Non-OADS,/arxiv_data1/oa_pdf/5f/3f/dhps-9-001.PMC5248929.pdf
Available from: http://www.ncqa.org/HEDISQualityMeasurement/HEDISMea   sures.aspx.,OADS,/arxiv_data1/oa_pdf/5f/3f/dhps-9-001.PMC5248929.pdf
Available from: http://www.ncqa.org/Portals/0/Public%20Policy/2014%20Comment%20Letters/The_Future_of_PCMH.pdf.,Non-OADS,/arxiv_data1/oa_pdf/5f/3f/dhps-9-001.PMC5248929.pdf
"Drug, Healthcare and Patient Safety 2017:9submit your manuscript | www.dovepress.com Dovepress Dovepress Drug, Healthcare and Patient Safety Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/drug-healthcare-and-patient-safety-journalDrug, Healthcare and Patient Safety is an international, peer-reviewed  open access journal exploring patient safety issues in the healthcare continuum from diagnostic and screening interventions through to treat-ment, drug therapy and surgery.",Non-OADS,/arxiv_data1/oa_pdf/5f/3f/dhps-9-001.PMC5248929.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 8 Roy and Ulrich  11.,Non-OADS,/arxiv_data1/oa_pdf/5f/3f/dhps-9-001.PMC5248929.pdf
Available from: https://www.sccgov.org/sites/dads/Adult%20System%20of%20Care%20Policy%20-   %20Procedure/Documents/Clinician_Gde_toolkit.pdf.,Non-OADS,/arxiv_data1/oa_pdf/5f/3f/dhps-9-001.PMC5248929.pdf
Available from: https://www.cms.gov/Regulations-and-Guidance/Legislation/EHRIncentivePrograms/downloads/3_Maintain_Problem_   ListEP .pdf.,Non-OADS,/arxiv_data1/oa_pdf/5f/3f/dhps-9-001.PMC5248929.pdf
Available  from: http://www.who.int/chp/knowledge/publications/icccglobalre-port.pdf?ua=1.,OADS,/arxiv_data1/oa_pdf/5f/3f/dhps-9-001.PMC5248929.pdf
Available from: http://www.fiercehealthcare.,Non-OADS,/arxiv_data1/oa_pdf/5f/3f/dhps-9-001.PMC5248929.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/1f/4a/dmso-10-037.PMC5248930.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/1f/4a/dmso-10-037.PMC5248930.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2017:10 37–45Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Dovepress submit your manuscript | www.dovepress.com Dovepress 37 Original reSearch open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DMSO.S122110 Different consecutive training protocols to design  an intervention program for overweight youth: a  controlled study giovanni Fiorilli1 enzo iuliano1  giovanna aquino1 emidio campanella1 Despina Tsopani2 alfonso Di costanzo1 giuseppe calcagno1  alessandra di cagno3 1Department of Medicine and health  Sciences, University of Molise,   campobasso, italy; 2Department of  Motor and health Sciences, national  Kapodistrian University of athens,   athens, greece; 3Department of  Motor, human and health Sciences,   University of rome “Foro italico”,   rome, italyObjective: To find the optimal exercise program to be recommended in reducing adiposity  and promoting long-term physical activity adherence in a sample of overweight adolescents.",Non-OADS,/arxiv_data1/oa_pdf/1f/4a/dmso-10-037.PMC5248930.pdf
"6,7 Although overweight youth  have traditionally been encouraged to participate in aerobic activities, the excess of correspondence: giuseppe calcagno Department of Medicine and health Sciences, University of Molise, Via de Sanctis, 1 86100 campobasso, italyTel +39 87 440 4402email giuseppe.calcagno@unimol.itJournal name: Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Article Designation: Original ResearchY ear: 2017V olume: 10Running head verso: Fiorilli et alRunning head recto: The optimal protocol of physical activity for overweight adolescentsDOI: http://dx.doi.org/10.2147/DMSO.S122110",Non-OADS,/arxiv_data1/oa_pdf/1f/4a/dmso-10-037.PMC5248930.pdf
"Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/diabetes-metabolic-syndrome-and-obesity-targets-and-therapy-journal Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy is  an international, peer-reviewed open-access journal committed to   the rapid publication of the latest laboratory and clinical findings   in the fields of diabetes, metabolic syndrome and obesity research.",Non-OADS,/arxiv_data1/oa_pdf/1f/4a/dmso-10-037.PMC5248930.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 45 The optimal protocol of physical activity for overweight adolescents  30.,Non-OADS,/arxiv_data1/oa_pdf/1f/4a/dmso-10-037.PMC5248930.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/30/3c/ppa-11-095.PMC5248937.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Patient Preference and Adherence 2017:11 95–106Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  95OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S11980 8 Persistence and costs with subcutaneous  TnF-alpha inhibitors in immune-mediated  rheumatic disease stratified by treatment line Axel svedbom1 Johan Dalén1 christopher M Black2 sumesh Kachroo2 1Mapi group, stockholm, sweden;   2Merck & co., inc., Kenilworth,   nJ, UsAObjectives:  The objectives of this study were to 1) describe and compare treatment persistence  with first- and second-line subcutaneous tumor necrosis factor-alpha inhibitors (SC-TNFis)  in patients with ankylosing spondylitis (AS), psoriatic arthritis (PsA), or rheumatoid arthritis  (RA) (collectively immune-mediated rheumatic disease) in Sweden and 2) estimate and contrast  health care costs in the two groups.",Non-OADS,/arxiv_data1/oa_pdf/30/3c/ppa-11-095.PMC5248937.pdf
"Keywords:  persistence, rheumatic disease, biologics, rheumatoid arthritis, psoriatic arthritis,  ankylosing spondylitis Introduction Ankylosing spondylitis (AS), psoriatic arthritis (PsA), and rheumatoid arthritis  (RA) are chronic progressive immune-mediated rheumatic diseases (IMRDs) result - ing in pain, deformity, and disability.1 IMRDs confer substantial humanistic and  economic burden.2,3 The advent of biologic medications such as subcutaneous tumor necrosis factor- alpha inhibitors (SC-TNFis) has transformed the management of IMRDs.4 Despite the  benefits of biologic treatment, a significant proportion of patients with IMRDs fail to  respond, lose response, or experience adverse events with first-line biologic treatment  and may therefore require treatment with other biologics.5correspondence: sumesh Kachroo Merck & co., inc., 126 e. lincoln Avenue,  Rahway, NJ 07065, USA Tel +1 732 594 3847 Fax +1 732 594 4910 email sumesh.kachroo@merck.co m Journal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2017 Volume: 11 Running head verso: Svedbom et al Running head recto: Persistence and costs with subcutaneous TNF-alpha inhibitors DOI: http://dx.doi.org/10.2147/PPA.S119808",Non-OADS,/arxiv_data1/oa_pdf/30/3c/ppa-11-095.PMC5248937.pdf
Available from: https://www.socialstyrelsen.,Non-OADS,/arxiv_data1/oa_pdf/30/3c/ppa-11-095.PMC5248937.pdf
Available from: https://www.socialstyrelsen.,Non-OADS,/arxiv_data1/oa_pdf/30/3c/ppa-11-095.PMC5248937.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/30/3c/ppa-11-095.PMC5248937.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/18/2e/ndt-13-147.PMC5248938.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2017:13 147–154Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  147OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S12125 0 Factor structure of the Persian version of  general, social, and negative self-consciousness  of appearance domains of Derriford appearance  Scale 59: an application in the field of burn injuries homayoun  sadeghi-Bazargani1 Zahra Zare2 Fatemeh Ranjbar3 1Road Traffic Injury Research  center, Department of statistics  and epidemiology, Faculty of health,   Tabriz University of Medical Sciences,   Tabriz, Iran; 2Department of statistics  and epidemiology, Faculty of health,   Tabriz University of Medical Science,   Tabriz, Iran; 3research center of  Psychiatry and Behavioral sciences,   Tabriz University of Medical Sciences,   Tabriz, IranBackground:  The Derriford Appearance Scale 59 (DAS59) is a widely used measure of the  spectrum of psychological distress and dysfunction that is characteristic of disfigurement.",Non-OADS,/arxiv_data1/oa_pdf/18/2e/ndt-13-147.PMC5248938.pdf
"The second perspective is “view from the inside” such as impacts correspondence: Zahra Zare Department of statistics and  epidemiology, Faculty of health,  Tabriz University of Medical Sciences,  Golgasht Street, Tabriz 51666147661,  iran Tel +98 912 412 9019 email z are.zahra59@yahoo.co m Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2017 Volume: 13 Running head verso: Sadeghi-Bazargani et al Running head recto: The Derriford Appearance Scale 59 in the field of burn injuries DOI: http://dx.doi.org/10.2147/NDT.S121250",Non-OADS,/arxiv_data1/oa_pdf/18/2e/ndt-13-147.PMC5248938.pdf
"Available from: http://apps.who.int/iris/bitstream/10665/97852/ 1/  9789241596299_eng.pd f. Accessed September 16, 2009.",OADS,/arxiv_data1/oa_pdf/18/2e/ndt-13-147.PMC5248938.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/18/2e/ndt-13-147.PMC5248938.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/18/2e/ndt-13-147.PMC5248938.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/65/92/ott-10-371.PMC5248939.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2017:10 371–385OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  371Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S12306 1 Overall survival in renal cell carcinoma after  introduction of targeted therapies: a norwegian  population-based study christian Beisland1,2 T om B Johannesen3 Olbjorn Klepp4 Ulrika axcrona5 Knut Martin T orgersen6 Jan Kowalski7 Oddvar solli6 rickard sandin8 Jan Oldenburg9,10 1Department of Urology,   haukeland University hospital,   2Department of clinical Medicine,   University of Bergen, Bergen,   3Department of registration,   cancer registry of norway, Oslo,   4Department of Oncology, Ålesund  hospital, Ålesund, 5Department of  Pathology, Oslo University hospital,   the norwegian radium hospital,   Oslo, 6Pfizer as, Oslo, norway;   7JK Biostatistics aB, stockholm, 8Pfizer  aB, sollentuna, sweden; 9Department  of Oncology, akershus University  hospital, lørenskog, 10Medical Faculty,   University of Oslo, Oslo, norwayBackground:  This population-wide retrospective, non-interventional registry study assessed  changes in overall survival (OS) and factors influencing OS in Norwegian patients with renal  cell carcinoma (RCC).",Non-OADS,/arxiv_data1/oa_pdf/65/92/ott-10-371.PMC5248939.pdf
"Keywords:  nephrectomy, Norway, overall survival, renal cell carcinoma, targeted therapy Introduction Better understanding of the biological processes underlying renal cell carcinoma (RCC)  has allowed the development and approval of targeted therapies for first-, second-, or  subsequent-line therapy for metastatic RCC (mRCC) since 2005.1–3 These therapies  include the tyrosine kinase inhibitors (TKIs) sorafenib, sunitinib, pazopanib, and  axitinib;4–7 the anti-vascular endothelial growth factor (VEGF) monoclonal antibody  bevacizumab;8,9 and the mammalian target of rapamycin inhibitors temsirolimus and  everolimus.10,11 RCCs may be classified according to the pattern of genetic mutations, morphology,  growth pattern, histology, and underlying molecular mechanisms.12 The majority  of RCCs (75%–80%) are classified histologically as clear cell, and non-clear cell  subtypes include papillary RCC and chromophobe RCC, which account for 10%–15%  and 5% of RCCs, respectively.13 Clear cell RCC has a strong association with altera - tions in the von Hippel–Lindau gene14 and resultant deregulation of hypoxia-inducible correspondence: christian Beisland Department of Urology, haukeland  University hospital, PO Box 1400,  n-5021 Bergen, norway Tel +47 55 97 29 02 Fax +47 55 97 27 57 email christian.beisland@helse-bergen.n o Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2017 Volume: 10 Running head verso: Beisland et al Running head recto: Norwegian population-based survival study in RCC DOI: http://dx.doi.org/10.2147/OTT.S123061",Non-OADS,/arxiv_data1/oa_pdf/65/92/ott-10-371.PMC5248939.pdf
Available  from: http://www.nccn.org/professionals/physician_gls/pdf/kidney.,Non-OADS,/arxiv_data1/oa_pdf/65/92/ott-10-371.PMC5248939.pdf
"Available from: https://www.kreftregisteret.no/ globalassets /cancer_survival_by_county_and_health_region_in_ norway_2000-2009.pd f. Accessed July 13, 2016.",Non-OADS,/arxiv_data1/oa_pdf/65/92/ott-10-371.PMC5248939.pdf
Available from: http://www.norpd.no /.,Non-OADS,/arxiv_data1/oa_pdf/65/92/ott-10-371.PMC5248939.pdf
Available from:  https://www.regjeringen.no/en/topics/health-and-care/public-health/ Act-of-18-May-2001-No-24-on-Personal-Health-Data-Filing-Systems- and-the-Processing-of-Personal-Health-Data-Personal-Health-Data- Filing-System-Act-/id224129 /.,OADS,/arxiv_data1/oa_pdf/65/92/ott-10-371.PMC5248939.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/65/92/ott-10-371.PMC5248939.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/65/92/ott-10-371.PMC5248939.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/51/64/ijn-12-515.PMC5248940.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2017:12 515–531International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  515RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJN.S11447 7 CpG oligodeoxynucleotide nanomedicines for the  prophylaxis or treatment of cancers, infectious  diseases, and allergies Nobutaka Hanagata1,2 1Nanotechnology Innovation Station,   National Institute for Materials  Science, Tsukuba, Ibaraki, 2Graduate  School of Life Science, Hokkaido  University, Sapporo, Hokkaido, JapanAbstract:  Unmethylated cytosine-guanine dinucleotide-containing oligodeoxynucleotides (CpG  ODNs), which are synthetic agonists of Toll-like receptor 9 (TLR9), activate humoral and cellular  immunity and are being developed as vaccine adjuvants to prevent or treat cancers, infectious  diseases, and allergies.",Non-OADS,/arxiv_data1/oa_pdf/51/64/ijn-12-515.PMC5248940.pdf
"All the nucleotides of CpG-B  ODNs are phosphorothioated and contain one or more nonpalindromic CpGs in the  base sequence.10–13 Phosphorothioated DNA is more resistant to DNase than natural  phosphodiester DNA,14,15 which makes it possible to extend the length of time that the Correspondence: Nobutaka Hanagata Nanotechnology Innovation Station,  National Institute for Materials Science,  1-2-1 Sengen, Tsukuba, Ibaraki 305-0047,  Japan Tel +81 29 860 4774 Fax +81 29 859 2475 email hanagata.nobutaka@nims.go.j p Journal name: International Journal of Nanomedicine Article Designation: Review Y ear: 2017 Volume: 12 Running head verso: Hanagata Running head recto: CpG ODN nanomedicines for immunotherapy DOI: http://dx.doi.org/10.2147/IJN.S114477",OADS,/arxiv_data1/oa_pdf/51/64/ijn-12-515.PMC5248940.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/51/64/ijn-12-515.PMC5248940.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/51/64/ijn-12-515.PMC5248940.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/30/df/ijn-12-605.PMC5248941.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2017:12 605–614International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  605OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S11922 6 ascorbyl palmitate/ d-α-tocopheryl polyethylene  glycol 1000 succinate monoester mixed micelles  for prolonged circulation and targeted delivery of  compound K for antilung cancer therapy in vitro  and in vivo Y ouwen Zhang Deyin T ong Daobiao che Bing Pei Xiaodong Xia gaofeng Yuan Xin Jin Department of hospital Pharmacy,   The First hospital of suqian, suqian,   People’s republic of chinaAbstract:  The roles of ginsenoside compound K (CK) in inhibiting tumor have been widely  recognized in recent years.",Non-OADS,/arxiv_data1/oa_pdf/30/df/ijn-12-605.PMC5248941.pdf
"Ginsenosides, the major active compounds of ginseng, have been widely used for  different applications, especially for cancer.2,3 Compound K (CK) is one of the major  metabolites of ginsenosides that exhibits maximal antitumor effect.4,5 However, its low  water solubility, poor permeability, and significant P-gp efflux restrict its application.6,7  Therefore, the goal of this study was to increase the solubility, targeted efficacy, and  antitumor effect via formation of mixed micelles.correspondence: Xin Jin Department of hospital Pharmacy,  The First hospital of suqian, 120 suzhilu,  suqian 223800, People’s republic  of china Tel +86 159 5189 6676 email jinxin871211@163.co m Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Zhang et al Running head recto: AP/TPGS mixed micelles DOI: http://dx.doi.org/10.2147/IJN.S119226",Non-OADS,/arxiv_data1/oa_pdf/30/df/ijn-12-605.PMC5248941.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/30/df/ijn-12-605.PMC5248941.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/30/df/ijn-12-605.PMC5248941.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/d8/d0/tcrm-13-081.PMC5248942.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Therapeutics and Clinical Risk Management 2017:13 81–86Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  81ORiginal ReseaRChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/TCRM.S12555 1 Can achilles tendon be used as a new distal  landmark for coronal tibial component  alignment in total knee replacement surgery?",Non-OADS,/arxiv_data1/oa_pdf/d8/d0/tcrm-13-081.PMC5248942.pdf
"Km,  Yahşihan, Kırıkkale 71450, Turkey Tel +90 533 554 5080 Fax +90 318 225 2819 email dr.sancarserbest@hotmail.co m Journal name: Therapeutics and Clinical Risk Management Article Designation: Original Research Y ear: 2017 Volume: 13 Running head verso: Tiftikçi et al Running head recto: Can Achilles tendon be used as a new distal landmark DOI: http://dx.doi.org/10.2147/TCRM.S125551",Non-OADS,/arxiv_data1/oa_pdf/d8/d0/tcrm-13-081.PMC5248942.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/d8/d0/tcrm-13-081.PMC5248942.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/d8/d0/tcrm-13-081.PMC5248942.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/46/5c/ijn-12-615.PMC5248943.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2017:12 615–632International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  615OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S11658 3 conductive polymer-based nanoparticles for  laser-mediated photothermal ablation of cancer:  synthesis, characterization, and in vitro evaluation Travis cantu,1 Kyle Walsh,2  Varun P Pattani,3 austin J   Moy,3 James W T unnell,3  Jennifer a Irvin,1,2 Tania  Betancourt1,2 1Materials science, engineering, and  commercialization Program, Texas  state University, san Marcos, TX,   Usa; 2Department of chemistry and  Biochemistry, T exas state University,   san Marcos, TX, Usa; 3Department  of Biomedical engineering, The  University of T exas at austin,   austin, TX, UsaAbstract:  Laser-mediated photothermal ablation of cancer cells aided by photothermal agents  is a promising strategy for localized, externally controlled cancer treatment.",Non-OADS,/arxiv_data1/oa_pdf/46/5c/ijn-12-615.PMC5248943.pdf
"Several different methods  have been used to achieve thermal therapy, the most common method to date being correspondence: Tania Betancourt Department of chemistry and  Biochemistry, Texas state University,  601 University Drive, san Marcos,  TX 78666, Usa Tel +1 512 245 7703 Fax +1 512 245 2374 email tb26@txstate.ed u Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Cantu et al Running head recto: Conductive polymer nanoparticles for cancer ablation DOI: http://dx.doi.org/10.2147/IJN.S116583 Point your SmartPhone at the code above.",Non-OADS,/arxiv_data1/oa_pdf/46/5c/ijn-12-615.PMC5248943.pdf
Or use: https://youtu.be/4bHwCIR9Dg 4Video abstract,Non-OADS,/arxiv_data1/oa_pdf/46/5c/ijn-12-615.PMC5248943.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/46/5c/ijn-12-615.PMC5248943.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/46/5c/ijn-12-615.PMC5248943.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/d1/04/ijn-12-633.PMC5248944.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2017:12 633–643International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  633OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S12164 2 Thermosensitive hydrogel based on chitosan and  its derivatives containing medicated nanoparticles  for transcorneal administration of 5-fluorouracil angela Fabiano1 ranieri Bizzarri2 Ylenia Zambito1 1Department of Pharmacy, University  of Pisa, 2NesT, Istituto Nanoscienze  cNr (cNr-NaNO) and scuola  Normale superiore, Pisa, ItalyAbstract:  A thermosensitive ophthalmic hydrogel (TSOH) – fluid at 4 °C (instillation  temperature), semisolid at 35 °C (eye temperature), which coupled the dosing accuracy and  administration ease of eyedrops with the increased ocular bioavailability of a hydrogel – was  prepared by gelling a chitosan hydrochloride (ChHCl) solution (27.8 mg/mL) medicated with  1.25 mg/mL 5-fluorouracil (5-FU) with β-glycerophosphate 0.8 mg/mL.",Non-OADS,/arxiv_data1/oa_pdf/d1/04/ijn-12-633.PMC5248944.pdf
"Moreover, the human cornea, comprising the epithelium, substantia propria,  and endothelium, restricts the entry of drug molecules.1 As a result of the action of  these factors, less than 5% of the administered drug enters the eye.correspondence: Ylenia Zambito Department of Pharmacy, University of  Pisa, 33 Via Bonanno, Pisa 56126, Italy Tel +39 050 221 9657 Fax +39 050 221 9660 email ylenia.zambito@unipi.i t Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Fabiano et al Running head recto: Hydrogel with NPs for intraocular 5-FU absorption DOI: http://dx.doi.org/10.2147/IJN.S121642",Non-OADS,/arxiv_data1/oa_pdf/d1/04/ijn-12-633.PMC5248944.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/d1/04/ijn-12-633.PMC5248944.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/d1/04/ijn-12-633.PMC5248944.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/6b/34/ndt-13-155.PMC5248945.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2017:13 155–159Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  155OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S12261 5 evaluation of the risk factors of depressive  disorders comorbid with obstructive sleep apnea liqiang cai1 luoyi Xu1 lili Wei1 Yi sun2 Wei chen1,3 1Department of Psychiatry, sir run  run shaw hospital, collaborative  innovation center for Brain  science, Zhejiang University school  of Medicine, 2Department of  electroencephalogram, sir run run  shaw hospital, 3Key laboratory  of Medical Neurobiology, chinese  Ministry of health, Zhejiang  University school of Medicine,   hangzhou, Zhejiang, People’s  republic of chinaObjective:  Overlap of obstructive sleep apnea (OSA) complicates diagnosis of depressive  disorder and renders antidepressant treatment challenging.",Non-OADS,/arxiv_data1/oa_pdf/6b/34/ndt-13-155.PMC5248945.pdf
"Antidepressant medication is a standard treatment and the first choice for depressed  patients in current psychiatric guidelines.1 Approximately 60% of patients respond  well to active treatment,2–4 but ~40%–50% of patients using the full dosage and dura - tion of antidepressant medications still have residual symptoms and cannot obtain  full remission.4–6 One reason for this may be that some depressed patients discontinue  treatment because of adverse effects or higher economic burden.2 Moreover, misdiag - nosis, genetic inheritance, and comorbid somatic disease also influence the outcome  of treatment.7,8 In a 5-year follow-up study, Riihimäki et al9 studied 137 major depres - sive disorders (MDDs) and found that the patients spent 34% of the follow-up time correspondence: Wei chen Department of Psychiatry, sir run run  shaw hospital, collaborative innovation  center for Brain science, Zhejiang  University school of Medicine, 3 east  Qingchun road, hangzhou 310016,  Zhejiang, People’s republic of china Tel +86 571 8788 7801 email srrcw@zju.edu.c n Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2017 Volume: 13 Running head verso: Cai et al Running head recto: OSA and depressive disorders DOI: http://dx.doi.org/10.2147/NDT.S122615",Non-OADS,/arxiv_data1/oa_pdf/6b/34/ndt-13-155.PMC5248945.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/6b/34/ndt-13-155.PMC5248945.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/6b/34/ndt-13-155.PMC5248945.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/0c/45/ndt-13-161.PMC5248946.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2017:13 161–175Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  161Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/NDT .S11843 8 Neuroleptic malignant syndrome: an easily  overlooked neurologic emergency Ramadhan Oruch1 ian F Pryme2 Bernt A engelsen3 Anders Lund4 1Department of Pharmacology and  T oxicology, School of Pharmacy,   Benghazi University, Benghazi,   Libya; 2Department of Biomedicine,   3Department of Clinical Medicine,   Section of Neurology, 4Department  of Clinical Medicine, Section of  Psychiatry, University of Bergen,   Bergen, NorwayAbstract:  Neuroleptic malignant syndrome is an unpredictable iatrogenic neurologic  emergency condition, mainly arising as an idiosyncratic reaction to antipsychotic agent use.",Non-OADS,/arxiv_data1/oa_pdf/0c/45/ndt-13-161.PMC5248946.pdf
"If NMS is Correspondence: Ramadhan Oruch Department of Pharmacology and  Toxicology, School of Pharmacy,  Benghazi University, Post Box 5341,  Benghazi, Libya Tel +218 61 916 879 672 Fax +218 61 223 1520 email churoki@outlook.co m Journal name: Neuropsychiatric Disease and Treatment Article Designation: Review Y ear: 2017 Volume: 13 Running head verso: Oruch et al Running head recto: Neuroleptic malignant syndrome  DOI: http://dx.doi.org/10.2147/NDT.S118438",Non-OADS,/arxiv_data1/oa_pdf/0c/45/ndt-13-161.PMC5248946.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/0c/45/ndt-13-161.PMC5248946.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/0c/45/ndt-13-161.PMC5248946.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/5e/00/ott-10-387.PMC5248947.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2017:10 387–395OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  387Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S11716 5 FBLN4  as candidate gene associated with  long-term and short-term survival with  primary glioblastoma Fubin li1,* Yiping li1,* Kewei Zhang1,* Ye li1,* Ping he1,* Yujia liu1,* hongyan Yuan2,* honghua lu1,* Jinxiang liu1,* songtian che3,* Zhenju li4,* li Bie1,5 1Department of n eurosurgery of the  First clinical hospital, 2Department  of immunology, norman  Bethune  college of Medicine, 3Department  of neurosurgery of the second  clinical hospital, 4Department  of neurosurgery of the Fourth  clinical hospital, Jilin University,   changchun, People’s republic of  china; 5Department of Pathology  and laboratory Medicine, school  of Medicine, University of  california – irvine, irvine, ca, Usa *These authors contributed equally  to this workBackground:  Glioblastoma multiforme (GBM) is the most common malignant and lethal  type of primary central nervous system tumor in humans.",Non-OADS,/arxiv_data1/oa_pdf/5e/00/ott-10-387.PMC5248947.pdf
"Clinical  characteristics of LTS patients include younger age, higher Karnofsky performance  scores (KPS) at diagnosis, and extent of resection.8,9 In addition, previous studies have correspondence: li Bie Department of neurosurgery of the  First clinical hospital, Jilin University,  changchun 130021, People’s republic of  china email bieli@aliyun.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2017 Volume: 10 Running head verso: Li et al Running head recto: FBLN4  association with survival in primary glioblastoma DOI: http://dx.doi.org/10.2147/OTT.S117165",Non-OADS,/arxiv_data1/oa_pdf/5e/00/ott-10-387.PMC5248947.pdf
"Images of the agarose gels  were analyzed using ImageJ software (National Institutes of  Health, Bethesda, MD, USA; http://rsb.info.nih.gov/i j).",OADS,/arxiv_data1/oa_pdf/5e/00/ott-10-387.PMC5248947.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/5e/00/ott-10-387.PMC5248947.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/5e/00/ott-10-387.PMC5248947.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/c5/de/jpr-10-191.PMC5248976.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/c5/de/jpr-10-191.PMC5248976.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Pain Research  2017:10 191–196Journal of Pain Research Dovepress 191CASE REPORT open access to scientific and medical research Open Access Full T ext Article submit your manuscript | www.dovepress.com Dovepress  http: //dx.doi.org/10.2147/JPR.S111589Thoracic epidural catheter for postoperative  pain control following an ineffective transversus  abdominis plane block using liposome bupivacaine Brian D T errien1 David Espinoza2 Charles C Stehman3 Gabriel A Rodriguez1 Nicholas C Connolly1 1Department of Anesthesiology, Naval  Medical Center San Diego, 2Surface  Warfare Medical Institute, San Diego,   3Department of Anesthesiology,   Robert E. Bush Naval Hospital,    T wenty Nine Palms, CA, USAAbstract: A 24-year-old female with a history of ulcerative colitis underwent colectomy.",Non-OADS,/arxiv_data1/oa_pdf/c5/de/jpr-10-191.PMC5248976.pdf
"5 The bupivacaine is unaltered and is released over a  period of time due to erosion and/or reorganization of the lipid membranes.6Correspondence: Brian D Terrien Department of Anesthesiology, Naval Medical Center San Diego, 34800 Bob Wilson Drive, San Diego, CA 92134, USATel +1 619 303 725 8799Email brian.terrien@gmail.comJournal name: Journal of Pain Research  Article Designation: CASE REPORTY ear: 2017V olume: 10Running head verso: Terrien et alRunning head recto: Ineffective transversus abdominis plane block using liposome bupivacaineDOI: http://dx.doi.org/10.2147/JPR.S111589",Non-OADS,/arxiv_data1/oa_pdf/c5/de/jpr-10-191.PMC5248976.pdf
"Journal of Pain Research  2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Pain Research  Publish your work in this journal Submit your manuscript here:  https://www.dovepress.com/journal-of-pain-research-journal The Journal of Pain Research is an international, peer reviewed, open  access, online journal that welcomes laboratory and clinical findings   in the fields of pain research and the prevention and management of pain.",Non-OADS,/arxiv_data1/oa_pdf/c5/de/jpr-10-191.PMC5248976.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 196 T errien et al  11.,Non-OADS,/arxiv_data1/oa_pdf/c5/de/jpr-10-191.PMC5248976.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/c4/c3/oaem-9-019.PMC5248977.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/c4/c3/oaem-9-019.PMC5248977.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Open Access Emergency Medicine 2017:9 19–22Open Access Emergency Medicine Dovepress submit your manuscript | www.dovepress.com Dovepress 19 PERSPECTIVES open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OAEM.S125593 The forgotten cause of stridor in the emergency  department Tian-T ee Ng Ear, Nose and Throat Unit,   Department of Surgery, Frankston Hospital, Peninsula Health,  Frankston,  VIC, AustraliaAbstract: Paradoxical V ocal Fold Movement Disorder is where the larynx exhibits paradoxical  vocal cords closure during respiration, creating partial airway obstruction.",Non-OADS,/arxiv_data1/oa_pdf/c4/c3/oaem-9-019.PMC5248977.pdf
"1 PVFMD is more common than previously recognized and should be considered  when dyspnea is present without pulmonary disease or is out of proportion to the Correspondence: Tian-Tee Ng ENT Unit, Department of Surgery, Frankston Hospital, PO Box 52, Frankston 3199, VIC, AustraliaTel +61 4 2626 6890Fax +61 3 9784 7568Email tntdynamites@yahoo.comJournal name: Open Access Emergency Medicine Article Designation: PERSPECTIVESY ear: 2017V olume: 9Running head verso: NgRunning head recto: Forgotten cause of stridor in the emergency departmentDOI: http://dx.doi.org/10.2147/OAEM.S125593",Non-OADS,/arxiv_data1/oa_pdf/c4/c3/oaem-9-019.PMC5248977.pdf
"Open Access Emergency Medicine 2017:9submit your manuscript | www.dovepress.com Dovepress Dovepress Open Access Emergency Medicine Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/open-access-emergency-medicine-journalThe Open Access Emergency Medicine is an international, peer- reviewed, open access journal publishing original research, reports, editorials, reviews and commentaries on all aspects of emergency medicine.",Non-OADS,/arxiv_data1/oa_pdf/c4/c3/oaem-9-019.PMC5248977.pdf
"Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 22 Ng Long-term management Long-term management of PVFMD involves a combination  of pharmacological, psychological, psychiatric, and speech training.",Non-OADS,/arxiv_data1/oa_pdf/c4/c3/oaem-9-019.PMC5248977.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/9f/3c/oaem-9-009.PMC5248978.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/9f/3c/oaem-9-009.PMC5248978.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Open Access Emergency Medicine 2017:9 9–17Open Access Emergency Medicine Dovepress submit your manuscript | www.dovepress.com Dovepress 9 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OAEM.S109339 A multicenter prospective randomized study  comparing the efficacy of escalating higher  biphasic versus low biphasic energy defibrillations  in patients presenting with cardiac arrest in the in-hospital environment Venkataraman  Anantharaman1  Seow Yian Tay2  Peter George Manning3  Swee Han Lim1  T errance Siang Jin Chua4  Mohan Tiru5  Rabind Antony Charles1  Vidya Sudarshan1 1Department of Emergency Medicine,   Singapore General Hospital,   2Department of Emergency Medicine,   Tan T ock Seng Hospital, 3Emergency  Medicine Department, National  University Hospital, 4Department  of Cardiology, National Heart Centre,  5Accident and Emergency  Department, Changi General Hospital,  SingaporeBackground: Biphasic defibrillation has been practiced worldwide for >15 years.",Non-OADS,/arxiv_data1/oa_pdf/9f/3c/oaem-9-009.PMC5248978.pdf
"Keywords: defibrillation, sudden cardiac arrest, cardiopulmonary resuscitation, high-energy,  low-energy Introduction Cardiac arrest occurs in ~ 300,000 people annually out-of-hospital in the US and  ~1,400 in Singapore.1 The World Health Organization estimates ~7.3 million deaths from heart disease  every year, with the top three countries contributing to this figure largely being the Correspondence: Venkataraman   Anantharaman   Department of Emergency Medicine,  Singapore General Hospital, Duke-NUS Medical School, Outram Road, 169608 Singapore   Tel +65 9656 7401 Fax +65 6226 0294 Email anantharaman@singhealth.com.sgJournal name: Open Access Emergency Medicine Article Designation: ORIGINAL RESEARCHY ear: 2017V olume: 9Running head verso: Anantharaman et alRunning head recto: Higher energy versus low energy biphasic defibrillationDOI: http://dx.doi.org/10.2147/OAEM.S109339",Non-OADS,/arxiv_data1/oa_pdf/9f/3c/oaem-9-009.PMC5248978.pdf
Available from: http://www.who.int/healthinfo/statistics/mortal ity_rawdata/en/.,OADS,/arxiv_data1/oa_pdf/9f/3c/oaem-9-009.PMC5248978.pdf
"Open Access Emergency Medicine 2017:9submit your manuscript | www.dovepress.com Dovepress Dovepress Open Access Emergency Medicine Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/open-access-emergency-medicine-journalThe Open Access Emergency Medicine is an international, peer- reviewed, open access journal publishing original research, reports, editorials, reviews and commentaries on all aspects of emergency medicine.",Non-OADS,/arxiv_data1/oa_pdf/9f/3c/oaem-9-009.PMC5248978.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 17 Higher energy versus low energy biphasic defibrillation  9.,Non-OADS,/arxiv_data1/oa_pdf/9f/3c/oaem-9-009.PMC5248978.pdf
Available from: http://www.fda.gov/MedicalDevices/Safety/Alertsand Notices/ucm189259.htm.,Non-OADS,/arxiv_data1/oa_pdf/9f/3c/oaem-9-009.PMC5248978.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/6e/82/jhc-4-015.PMC5248979.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/6e/82/jhc-4-015.PMC5248979.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Hepatocellular Carcinoma 2017:4 15–21Journal of Hepatocellular Carcinoma Dovepress submit your manuscript | www.dovepress.com Dovepress 15 REVIEW open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JHC.S94008 Pediatric hepatocellular carcinoma: challenges and  solutions Irene Schmid1  Dietrich von Schweinitz2 1Department of Pediatric Hematology  and Oncology, 2Department of  Pediatric Surgery, Dr. von Hauner  Children`s Hospital, Ludwig-Maximilians-University, Munich,  GermanyAbstract:  Hepatocellular carcinoma (HCC) is a very rare entity in children, making it nearly  impossible to orchestrate Phase II/III studies even as multinational cooperative trials.",Non-OADS,/arxiv_data1/oa_pdf/6e/82/jhc-4-015.PMC5248979.pdf
"3 In HCC, the results with unresectable tumor  especially are rather dismal.Correspondence: Irene Schmid Department of Pediatric Hematology and Oncology, Dr. von Hauner Children`s Hospital, Ludwig-Maximilians-University Munich, Lindwurmstr 4, 80337 Munich, GermanyTel +49 89 4400 52645Fax +49 89 4400 52984Email irene.schmid@med.uni-muenchen.de Journal name: Journal of Hepatocellular Carcinoma Article Designation: REVIEWY ear: 2017V olume: 4Running head verso: Schmid and von SchweinitzRunning head recto: Pediatric HCCDOI: http://dx.doi.org/10.2147/JHC.S94008",Non-OADS,/arxiv_data1/oa_pdf/6e/82/jhc-4-015.PMC5248979.pdf
"Journal of Hepatocellular Carcinoma 2017:4submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Hepatocellular Carcinoma Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/journal-of-hepatocellular-carcinoma-journalThe Journal of Hepatocellular Carcinoma is an international, peer- reviewed, open access journal that offers a platform for the dissemina-tion and study of clinical, translational and basic research findings in this rapidly developing field.",Non-OADS,/arxiv_data1/oa_pdf/6e/82/jhc-4-015.PMC5248979.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 21 Pediatric HCC,Non-OADS,/arxiv_data1/oa_pdf/6e/82/jhc-4-015.PMC5248979.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/71/a2/jep-9-001.PMC5248980.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/71/a2/jep-9-001.PMC5248980.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Experimental Pharmacology 2017:9 1–11Journal of Experimental Pharmacology Dovepress submit your manuscript | www.dovepress.com Dovepress  1 Original rEsEarch open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JEP .S125383Evaluation of anti-ulcer activity of the leaf extract  of Osyris quadripartita Decne.",Non-OADS,/arxiv_data1/oa_pdf/71/a2/jep-9-001.PMC5248980.pdf
"(locally called qeret in Amharic and correspondence: Dessalegn asmelashe  gelayeeDepartment of Pharmacology, college of Medicine and health sciences, University of gondar, PO Box 196, gondar, EthiopiaEmail desefikir@gmail.comJournal name: Journal of Experimental Pharmacology Article Designation: Original ResearchY ear: 2017V olume: 9Running head verso: Abebaw et alRunning head recto: Osyris quadripartita possesses anti-ulcer activityDOI: http://dx.doi.org/10.2147/JEP .S125383",Non-OADS,/arxiv_data1/oa_pdf/71/a2/jep-9-001.PMC5248980.pdf
"Journal of Experimental Pharmacology 2017:9submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Experimental Pharmacology Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/journal-of-experimental-pharmacology-journalThe Journal of Experimental Pharmacology is an international, peer- reviewed, open access journal publishing original research, reports, reviews and commentaries on all areas of laboratory and experimental pharmacology.",Non-OADS,/arxiv_data1/oa_pdf/71/a2/jep-9-001.PMC5248980.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/71/a2/jep-9-001.PMC5248980.pdf
Raw sequence reads from the FASTQ files of the six ChIP-seq samples were trimmed using sickle (https://github.com/najoshi/sickle) (58) with the Phred quality score threshold of 20 bases and the length threshold of 50 bases.,OADS,/arxiv_data1/oa_pdf/05/79/1601602.PMC5249256.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/3/1/e1601602/DC1 fig.,Non-OADS,/arxiv_data1/oa_pdf/05/79/1601602.PMC5249256.pdf
"N. Joshi, J. Fass, Sickle: A sliding-window, adaptive, quality-based trimming tool for FastQ files [Software] (Version 1.33); https://github.com/najoshi/sickle (2011).",OADS,/arxiv_data1/oa_pdf/05/79/1601602.PMC5249256.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/3/1/e1601814/DC1section S1.,Non-OADS,/arxiv_data1/oa_pdf/2a/92/1601814.PMC5249257.pdf
Statistical analysis The statistical methods used in this s tudy are described in detail in the Supplementary Materials.SUPPLEMETARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/3/1/e1601603/DC1Supplementary Materials and Methodstable S1.,Non-OADS,/arxiv_data1/oa_pdf/dc/98/1601603.PMC5249259.pdf
Algorithms for drift correction and Gaussian fitting were adapted and modified from GDSC Single Molecule Light Micros- copy (SMLM) plug-in (https://github.com/aherbert/GDSC-SMLM).Sample drift caused by mechanical r elaxation of the stage was signif- icant in DNA walking experiments as a result of the long experimental time.,OADS,/arxiv_data1/oa_pdf/28/ff/1601600.PMC5249260.pdf
An interfuel spacing of l= 5 nm and a mean velocity of 7.8 nm min−1were used.SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/3/1/e1601600/DC1Supplementary Methodsfig.,Non-OADS,/arxiv_data1/oa_pdf/28/ff/1601600.PMC5249260.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 InternationalLicense (http://creativecommons.org/licenses/by-nc/4.0/), which per- mits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the originalauthor(s) and the source, provide a link to the Creative Commonslicense, and indicate if changes were made.References 1.",Non-OADS,/arxiv_data1/oa_pdf/95/48/40261_2016_Article_471.PMC5250638.pdf
European Medicines Agency: Gilenya (ﬁngolimod) Product infor- mation EMEA/H/C/002202 -II-26-G. http://www.ema.europa.eu/ ema/index.jsp?curl=pages/medicines/human/medicines/002202/ human_med_001433.jsp&mid=WC0b01ac058001d125 .,Non-OADS,/arxiv_data1/oa_pdf/95/48/40261_2016_Article_471.PMC5250638.pdf
Novartis Pharmaceuticals Q2 2016 Condensed Interim Financial Report; Data as of second quarter of 2016. https://www.novartis.com/ sites/www.novartis.com/ﬁles/2016- 07-interim-ﬁnancial-report- en.pdf .,Non-OADS,/arxiv_data1/oa_pdf/95/48/40261_2016_Article_471.PMC5250638.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which per- mits any noncommercial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the originalauthor(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/92/49/40291_2016_Article_237.PMC5250639.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 InternationalLicense (http://creativecommons.org/licenses/by-nc/4.0/), which per- mits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the originalauthor(s) and the source, provide a link to the Creative Commonslicense, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/7c/a4/40291_2016_Article_238.PMC5250641.pdf
2012. http://www.statcan.gc.ca/pub/82-625-x/2012001/article/ 11732-eng.htm .,OADS,/arxiv_data1/oa_pdf/7c/a4/40291_2016_Article_238.PMC5250641.pdf
2012. http://www.theglobeandmail.com/life/health- and-ﬁtness/health/conditions/are-we-overdosing-on-this-wonder-drug/article4101464/ .,Non-OADS,/arxiv_data1/oa_pdf/7c/a4/40291_2016_Article_238.PMC5250641.pdf
2014. http://globalnews.ca/news/ 1082282/doctors-warn-of-rhabdo-a-deadly-condition-linked-to- over-exercising/ .,Non-OADS,/arxiv_data1/oa_pdf/7c/a4/40291_2016_Article_238.PMC5250641.pdf
2014. http://www.ramq.,Non-OADS,/arxiv_data1/oa_pdf/7c/a4/40291_2016_Article_238.PMC5250641.pdf
2014. https://www.prod.ramq.gouv.qc.ca/ DPI/PO/Commun/PDF/Liste_Me d/Liste_Med/liste_med_2014_ 03_14_fr.pdf .,Non-OADS,/arxiv_data1/oa_pdf/7c/a4/40291_2016_Article_238.PMC5250641.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which per- mits any noncommercial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the originalauthor(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/e2/03/40271_2016_Article_184.PMC5250642.pdf
"Figure was plotted withTagxedo ( http://www.tagxedo.com/app.html ) using words from the abstracts of 21 publications related to miRNAs in AMD [51,52,56,57,71,73–75,77,82,89,90,99,103–110]34 P. Berber et al.",OADS,/arxiv_data1/oa_pdf/84/b9/40291_2016_Article_234.PMC5250647.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 InternationalLicense (http://creativecommons.org/licenses/by-nc/4.0/), which per- mits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the originalauthor(s) and the source, provide a link to the Creative Commonslicense, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/84/b9/40291_2016_Article_234.PMC5250647.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 InternationalLicense (http://creativecommons.org/licenses/by-nc/4.0/), which per- mits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the originalauthor(s) and the source, provide a link to the Creative Commonslicense, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/d6/f0/40271_2016_Article_183.PMC5250651.pdf
Available at: http://www.fda.gov/ downloads/Drugs/GuidanceComplianceRegulatoryInformation/ Guidances/UCM193282.pdf .,Non-OADS,/arxiv_data1/oa_pdf/d6/f0/40271_2016_Article_183.PMC5250651.pdf
Available at http://phl.sagepub.com/content/ early/2016/03/23/0268355516635386.abstract?rss=1 .,Non-OADS,/arxiv_data1/oa_pdf/d6/f0/40271_2016_Article_183.PMC5250651.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which per-mits any noncommercial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/99/ae/40261_2016_Article_476.PMC5250654.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 InternationalLicense (http://creativecommons.org/licenses/by-nc/4.0/), which per- mits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the originalauthor(s) and the source, provide a link to the Creative Commonslicense, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/8f/55/40271_2016_Article_185.PMC5250672.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d5/b2/atr-05-04-33377.PMC5251191.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/02/f4/atr-05-04-33361.PMC5251203.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7a/7f/atr-05-04-34343.PMC5251205.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/55/39/atr-05-04-33298.PMC5251206.pdf
This is an Open Access article distributed under the terms  of the Creative Commons Attribution-Non-Commercial License (https://creativecommons.org/licenses/by-nc/3.0)DOI 10.1080/17453674.2016.1269273Low-intensity pulsed ultrasound stimulation (LIPUS) is com- monly used to stimulate healing of tibial fractures.,Non-OADS,/arxiv_data1/oa_pdf/41/8e/iort-88-1.PMC5251253.pdf
This is an Open Access article distributed under  the terms  of the Creative Commons Attribution-Non-Commercial License (https://creativecommons.org/licenses/by-nc/3.0) DOI 10.1080/17453674.2016.1251255Background and purpose — Hip dislocation is one of the most  common complications following total hip arthroplasty (THA).,Non-OADS,/arxiv_data1/oa_pdf/76/70/iort-88-10.PMC5251254.pdf
Supplementary data Tables 4–7 are available as supplementary data with the online  version of this article at http://dx.doi.org/10.1080/17453674.2016.1251255.,OADS,/arxiv_data1/oa_pdf/76/70/iort-88-10.PMC5251254.pdf
"This is an Open Access article distributed under the  terms of the Creative Commons Attribution-Non-Commercial License (https://creativecommons.org/licenses/by-nc/3.0) DOI 10.1080/17453674.2016.1255784Background and purpose — Manipulation and cast immobiliza- tion is the primary management for diaphyseal forearm fractures in children, and re-displacement is the most common complica-tion.",Non-OADS,/arxiv_data1/oa_pdf/50/d1/iort-88-101.PMC5251255.pdf
"This is an Open Access article distributed under the  terms of the Creative Commons Attribution-Non-Commercial License (https://creativecommons.org/licenses/by-nc/3.0) DOI 10.1080/17453674.2016.1250058Background and purpose — The quality of pin fixation of dis- placed supracondylar humerus fractures in children has not been assessed, and the clinical value of radiographic examinations after pin fixation is unclear.",Non-OADS,/arxiv_data1/oa_pdf/41/5a/iort-88-109.PMC5251256.pdf
"This is an Open Access artic le distributed under the terms  of the Creative Commons Attribution-Non-Commercial License (https://creativecommons.org/licenses/by-nc/3.0)DOI 10.1080/17453674.2016.1196429Background and purpose —  Soft-tissue sarcoma (STS) is rare,  with challenging individualized treatment, so diagnostics and treatment should be centralized.",Non-OADS,/arxiv_data1/oa_pdf/93/42/iort-88-116.PMC5251257.pdf
"Available from http://www.ancr.nu, accessed on 22.4.2016.",Non-OADS,/arxiv_data1/oa_pdf/93/42/iort-88-116.PMC5251257.pdf
"Available from http://www.iarc.fr/en/publications/pdfs- online/epi/sp164/, accessed 22.4.2016.",Non-OADS,/arxiv_data1/oa_pdf/93/42/iort-88-116.PMC5251257.pdf
This is an Open Access article distributed under the  terms of the Creative Commons Attribution-Non-Commercial License (https://creativecommons.org/licenses/by-nc/3.0) DOI 10.1080/17453674.2016.1255482Background and purpose — Revision total hip arthroplasty  (THA) is associated with higher dislocation rates than primary THA.,Non-OADS,/arxiv_data1/oa_pdf/ca/80/iort-88-18.PMC5251258.pdf
This is an Open Access article distributed under the  terms of the Creative Commons Attribution-Non-Commercial License (https://creativecommons.org/licenses/by-nc/3.0) DOI 10.1080/17453674.2016.1246276Background and purpose — It is unclear whether metal parti- cles and ions produced by mechanical wear and corrosion of hip prostheses with metal-on-metal (MoM) bearings have systemic adverse effects on health.,Non-OADS,/arxiv_data1/oa_pdf/97/e1/iort-88-2.PMC5251259.pdf
Australian Government Department of Health; 2016.  http://www.health.gov.au/internet/main/publishing.nsf/content/health-pri-vatehealth-prostheseslist.htm.,Non-OADS,/arxiv_data1/oa_pdf/97/e1/iort-88-2.PMC5251259.pdf
"Australian Institute of Health and Welfare: Canberra: AIHW; 2008, http://www.aihw.gov.au/publication-detail/?id=6442468071.",Non-OADS,/arxiv_data1/oa_pdf/97/e1/iort-88-2.PMC5251259.pdf
This is an Open Access article distributed under the  terms of the Creative Commons Attribution-Non-Commercial License (https://creativecommons.org/licenses/by-nc/3.0) DOI 10.1080/17453674.2016.1236229Background and purpose — The length of stay after total hip  arthroplasty has been reduced to 2–4 days after implementing fast-track surgery.,Non-OADS,/arxiv_data1/oa_pdf/c1/e5/iort-88-24.PMC5251260.pdf
This is an Open Access article distributed under the  terms of the Creative Commons Attribution-Non-Commercial License (https://creativecommons.org/licenses/by-nc/3.0) DOI 10.1080/17453674.2016.1250480Background and purpose — Hemiarthroplasty (HA) is the most  common treatment for displaced femoral neck fractures in many countries.,Non-OADS,/arxiv_data1/oa_pdf/9f/f8/iort-88-29.PMC5251261.pdf
https://cran.r-project.org).,Non-OADS,/arxiv_data1/oa_pdf/9f/f8/iort-88-29.PMC5251261.pdf
This is an Open Access article distributed under the  terms of the Creative Commons Attribution-Non-Commercial License (https://creativecommons.org/licenses/by-nc/3.0) DOI 10.1080/17453674.2016.1248315Background and purpose — Porous tantalum cups have been  introduced as an alternative to various reinforcement rings in revision hip surgery.,Non-OADS,/arxiv_data1/oa_pdf/a6/d5/iort-88-35.PMC5251262.pdf
Supplementary data Tables 4–7 are available as supplementary data in the online  version of this article http://dx.doi.org/10.1080/17453674.2016.1248315.,OADS,/arxiv_data1/oa_pdf/a6/d5/iort-88-35.PMC5251262.pdf
“R: A language and environment for statistical comput- ing.” http://www.R-project.org/.,Non-OADS,/arxiv_data1/oa_pdf/a6/d5/iort-88-35.PMC5251262.pdf
This is an Open Access article distributed under the  terms of the Creative Commons Attribution-Non-Commercial License (https://creativecommons.org/licenses/by-nc/3.0) DOI 10.1080/17453674.2016.1256939,Non-OADS,/arxiv_data1/oa_pdf/89/c5/iort-88-41.PMC5251263.pdf
"2012; https://ec.europa.eu/digital-single-market/en/news/2012-transatlantic-health-itehealth-co-operation-assembly Gazmararian J A, Baker D W, Williams M V , Parker R M, Scott T L, Green  D C, Fehrenbach S N, Ren J, Koplan J P. Health literacy among medicare enrollees in a managed care organization.",Non-OADS,/arxiv_data1/oa_pdf/89/c5/iort-88-41.PMC5251263.pdf
2010; http://www.nhsidentity.,Non-OADS,/arxiv_data1/oa_pdf/89/c5/iort-88-41.PMC5251263.pdf
"2006; https://www.rigshospitalet.dk/.../Vejledning-til-udarbejdelse-Inf... Russell T G, Buttrum P, Wootton R, Jull G A. Internet-based outpatient telere- habilitation for patients following total knee arthroplasty: A randomized controlled trial.",OADS,/arxiv_data1/oa_pdf/89/c5/iort-88-41.PMC5251263.pdf
"https://www.sundhed.dk/Winther S B, Foss O A, Wik T S, Davis S P, Engdal M, Jessen V , Husby O S.  1-year follow-up of 920 hip and knee arthroplasty patients after implement-ing fast-track.",Non-OADS,/arxiv_data1/oa_pdf/89/c5/iort-88-41.PMC5251263.pdf
This is an Open Access article distributed under the  terms of the Creative Commons Attribution-Non-Commercial License (https://creativecommons.org/licenses/by-nc/3.0) DOI 10.1080/17453674.2016.1235427Background and purpose — Controversies exist regarding throm- boprophylaxis in orthopedic surgery.,Non-OADS,/arxiv_data1/oa_pdf/34/2a/iort-88-48.PMC5251264.pdf
"For the statistical analyses, we used IBM SPSS Statistics ver - sion 22.0 and the statistical package R version 3.0.2 (http://www.R-project.org).",OADS,/arxiv_data1/oa_pdf/34/2a/iort-88-48.PMC5251264.pdf
"Norwegian Arthroplasty Register 2014 www.http://nrlweb.ihelse.net/Rap-porter/Rapport2014.pdf Heidari N, Jehan S, Alazzawi S, Bynoth S, Bottle A, Loeffler M. Mortality  and morbidity following hip fractures related to hospital thromboprophy-laxis policy.",Non-OADS,/arxiv_data1/oa_pdf/34/2a/iort-88-48.PMC5251264.pdf
"This is an Open Access article distributed under the  terms of the Creative Commons Attribution-Non-Commercial License (https://creativecommons.org/licenses/by-nc/3.0) DOI 10.1080/17453674.2016.1245998Background — The benefit of preoperative bridging in surgical  patients with continuous anticoagulant therapy is debatable, and drawing of meaningful conclusions may have been limited by mixed procedures with different thromboembolic and bleeding risks in most published studies.",Non-OADS,/arxiv_data1/oa_pdf/44/a4/iort-88-55.PMC5251265.pdf
Statistical analysis was performed using SPSS version 22 with a PS-matching add-on (Thoemmes 2012; http://www.vassarstats.net/prop1.html).,OADS,/arxiv_data1/oa_pdf/44/a4/iort-88-55.PMC5251265.pdf
"This is an Open Access article distributed under the  terms of the Creative Commons Attribution-Non-Commercial License (https://creativecommons.org/licenses/by-nc/3.0) DOI 10.1080/17453674.2016.1248202Background and purpose — Severe backside wear, observed in  older generations of total knee replacements (TKRs), led to rede - sign of locking mechanisms to reduce micromotions between tibial tray and inlay.",Non-OADS,/arxiv_data1/oa_pdf/d9/5f/iort-88-62.PMC5251266.pdf
This is an Open Access article distributed under the  terms of the Creative Commons Attribution-Non-Commercial License (https://creativecommons.org/licenses/by-nc/3.0) DOI 10.1080/17453674.2016.1253327Background and purpose — Medial unicompartmental knee  arthroplasty (UKA) is undertaken in patients with a passively correctable varus deformity.,Non-OADS,/arxiv_data1/oa_pdf/60/aa/iort-88-70.PMC5251267.pdf
This is an Open Access article distributed under  the terms  of the Creative Commons Attribution-Non-Commercial License (https://creativecommons.org/licenses/by-nc/3.0) DOI 10.1080/17453674.2016.1256937Background and purpose — The bone cement market for total  knee arthroplasty (TKA) in Norway has been dominated by a few products and distributors.,Non-OADS,/arxiv_data1/oa_pdf/1e/4a/iort-88-75.PMC5251268.pdf
The NAR publishes annual reports with descriptive statistics (http://nrlweb.ihelse.net).,OADS,/arxiv_data1/oa_pdf/1e/4a/iort-88-75.PMC5251268.pdf
Available from: http://www.kofa.no.,Non-OADS,/arxiv_data1/oa_pdf/1e/4a/iort-88-75.PMC5251268.pdf
Available from: http://www.skatteetaten.no/en/Person/National-Registry/This-is-the-National-Registry/.,OADS,/arxiv_data1/oa_pdf/1e/4a/iort-88-75.PMC5251268.pdf
"This is an Open Access article distributed under the  terms of the Creative Commons Attribution-Non-Commercial License (https://creativecommons.org/licenses/by-nc/3.0) DOI 10.1080/17453674.2016.1255484Background and purpose — The natural history of focal carti- lage defects (FCDs) is still unresolved, as is the long-term cartilage quality after cartilage surgery.",Non-OADS,/arxiv_data1/oa_pdf/d0/82/iort-88-82.PMC5251269.pdf
Supplementary data Tables 5 and 6 are available online at: http://dx.doi.org/10.108 0/17453674.2016.1255484.,OADS,/arxiv_data1/oa_pdf/d0/82/iort-88-82.PMC5251269.pdf
This is an Open Access article distributed under the  terms of the Creative Commons Attribution-Non-Commercial License (https://creativecommons.org/licenses/by-nc/3.0) DOI 10.1080/17453674.2016.1253329Background and purpose — Recent evidence has questioned the  effect of arthroscopic knee surgery for middle-aged and older patients with degenerative meniscal tears with or without con-comitant radiographic knee osteoarthritis (OA).,Non-OADS,/arxiv_data1/oa_pdf/8c/07/iort-88-90.PMC5251270.pdf
This is an Open Access article distributed under the  terms of the Creative Commons Attribution-Non-Commercial License (https://creativecommons.org/licenses/by-nc/3.0) DOI 10.1080/17453674.2016.1227055Background and purpose — The incidence of Perthes’ disease as  reported in the literature varies widely between and within coun-tries.,Non-OADS,/arxiv_data1/oa_pdf/ff/e6/iort-88-96.PMC5251271.pdf
2003- 112-3) Available at: http://www.socialstyrelsen.se/Lists/Artikelkatalog/ Attachments/10655/2003-112-3_20031123.pdf.,Non-OADS,/arxiv_data1/oa_pdf/ff/e6/iort-88-96.PMC5251271.pdf
Available at: http://www.socialstyrelsen.se/Lists/Artikelkatalog/Attachments/18014/2010-4-31.pdf.,Non-OADS,/arxiv_data1/oa_pdf/ff/e6/iort-88-96.PMC5251271.pdf
Available at: http://www.scb.se/statis-tik/_publikationer/BE0101_2008A01_BR_BE0109TEXT.pdf.,Non-OADS,/arxiv_data1/oa_pdf/ff/e6/iort-88-96.PMC5251271.pdf
Available at: http://www.scb.se/statistik/_publikationer/BE9999_2009A01_BR_BE96BR1003.pdf.,Non-OADS,/arxiv_data1/oa_pdf/ff/e6/iort-88-96.PMC5251271.pdf
(http://www.scb.se).,Non-OADS,/arxiv_data1/oa_pdf/ff/e6/iort-88-96.PMC5251271.pdf
Available at: http://www.scb.se/Statistik/UF/UF0506/2008A01D/UF0506_2008A01D_SM_UF37SM0901.pdf.,OADS,/arxiv_data1/oa_pdf/ff/e6/iort-88-96.PMC5251271.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e6/7c/atr-05-04-36406.PMC5251347.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/da/aa/atr-05-04-30796.PMC5251886.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 InternationalLicense (http://creativecommons.org/licenses/by-nc/4.0/), which per- mits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the originalauthor(s) and the source, provide a link to the Creative Commonslicense, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/2b/21/40258_2016_Article_272.PMC5253143.pdf
Available at: http://www.ukuks.org/anketa/ poruka.php .,Non-OADS,/arxiv_data1/oa_pdf/2b/21/40258_2016_Article_272.PMC5253143.pdf
"Pension and Disability Insurance Fund, Republic of Serbia; Available at: http://www.pio.rs/lat/novcane-naknade.html .",Non-OADS,/arxiv_data1/oa_pdf/2b/21/40258_2016_Article_272.PMC5253143.pdf
Available at: https://www.medicines.org.,Non-OADS,/arxiv_data1/oa_pdf/e5/51/11523_2016_Article_472.PMC5253154.pdf
Available at: http://www.astellas.us/docs/us/12 A005-ENZ-WPI.pdf?v=1 .,Non-OADS,/arxiv_data1/oa_pdf/e5/51/11523_2016_Article_472.PMC5253154.pdf
Available at: http://www.nice.org.uk/article /pmg9/resources/non-guidance- guide-to-the-methods-of-technology-appraisal-2013-pdf .,Non-OADS,/arxiv_data1/oa_pdf/e5/51/11523_2016_Article_472.PMC5253154.pdf
Available at: http://www.nice.org.uk/guidance/cg175 .,Non-OADS,/arxiv_data1/oa_pdf/e5/51/11523_2016_Article_472.PMC5253154.pdf
Available at:http://www.nicedsu.org.uk/TS D16_Treatment_Switching.pdf .,Non-OADS,/arxiv_data1/oa_pdf/e5/51/11523_2016_Article_472.PMC5253154.pdf
Available at: https://www.nice.org.uk/guidance/ta296/documents/lung- cancer-nonsmallcell-an aplastic-lymphoma-ki nase-fusion-gene- previously-treated-crizotinib -final-appraisal-determination3 .,Non-OADS,/arxiv_data1/oa_pdf/e5/51/11523_2016_Article_472.PMC5253154.pdf
2011.Available at: http://guidance.nice.org.uk/TA219 .,Non-OADS,/arxiv_data1/oa_pdf/e5/51/11523_2016_Article_472.PMC5253154.pdf
"However, it should be noted that this STA did not consider enzalutamide, which is now recommendedas an option for treating chemotherapy-naı ¨ve mCRPC, and hence no statements can be made regarding the cost effectiveness of AAP versus enzalutamide for thispopulation.Compliance with Ethical Standards Funding This project was funded by the National Institute for Health Research (NIHR) Health Technology Assessment (HTA) Programme (see the HTA programme website for further project information[http://www.hta.ac.uk ]).",Non-OADS,/arxiv_data1/oa_pdf/16/2a/40273_2016_Article_445.PMC5253156.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 InternationalLicense (http://creativecommons.org/licenses/by-nc/4.0/), which per- mits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the originalauthor(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/16/2a/40273_2016_Article_445.PMC5253156.pdf
London: NICE; 2014. https://www.nice.org.uk/article/pmg19/chapter/foreword .,Non-OADS,/arxiv_data1/oa_pdf/16/2a/40273_2016_Article_445.PMC5253156.pdf
London: NICE; 2012. https://www.nice.org.uk/guidance/ta259/history .,Non-OADS,/arxiv_data1/oa_pdf/16/2a/40273_2016_Article_445.PMC5253156.pdf
London: NICE; 2014. https://www.nice.org.uk/guidance/cg175 .,Non-OADS,/arxiv_data1/oa_pdf/16/2a/40273_2016_Article_445.PMC5253156.pdf
2016. http://emedicine.medscape.com/ article/458011-overview#showall .,Non-OADS,/arxiv_data1/oa_pdf/16/2a/40273_2016_Article_445.PMC5253156.pdf
London: EMA; 2014. http://www.ema.,Non-OADS,/arxiv_data1/oa_pdf/16/2a/40273_2016_Article_445.PMC5253156.pdf
London: NICE; 2016. https://www.nice.org.uk/guidance/ta377/history .,Non-OADS,/arxiv_data1/oa_pdf/16/2a/40273_2016_Article_445.PMC5253156.pdf
2015. https://www.nice.org.uk/guidance/TA387/ documents/appraisal-consultation-document-2 .,Non-OADS,/arxiv_data1/oa_pdf/16/2a/40273_2016_Article_445.PMC5253156.pdf
London: NICE; 2013. https://www.nice.org.uk/process/pmg9/resources/guide-to- the-methods-of-technology-appraisal-2013-pdf-2007975843781 .,Non-OADS,/arxiv_data1/oa_pdf/16/2a/40273_2016_Article_445.PMC5253156.pdf
London: NICE;2016. https://www.nice.org.uk/news/press-and-media/nice- recommends-abiraterone-for-prostate-cancer .,Non-OADS,/arxiv_data1/oa_pdf/16/2a/40273_2016_Article_445.PMC5253156.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which per- mits any noncommercial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the originalauthor(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.Economic Evaluation in DMD 257",Non-OADS,/arxiv_data1/oa_pdf/23/d8/40273_2016_Article_461.PMC5253157.pdf
http://www.ons.gov.uk .,Non-OADS,/arxiv_data1/oa_pdf/23/d8/40273_2016_Article_461.PMC5253157.pdf
https://www.nice.org.uk/guidance/ hst3?unlid=7891072072016831154657 .,Non-OADS,/arxiv_data1/oa_pdf/23/d8/40273_2016_Article_461.PMC5253157.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to:  Kanya Honoki, MD, PhD, MMedSci,  Associate Professor, Department of Orthopedic Surgery, Nara  Medical University, 840 Shijo-cho, Kashihara, Nara 634-8521,  Japan.",Non-OADS,/arxiv_data1/oa_pdf/47/34/WJSC-9-1.PMC5253185.pdf
"kahonoki@naramed-u.ac.jp Telephone:  +81-744-223051 Fax: +81-744-256449 Received: July 5, 2016 Peer-review started:  July 5, 2016 First decision:  August 11, 2016 Revised:  August 22, 2016 Accepted:  October 1, 2016 Article in press:  October 9, 2016 Published online:  January 26, 2017 Abstract Characterized by dysfunction of tissues, organs, organ  systems and the whole organism, aging results from Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 0.4252/wjsc.v9.i.World J Stem Cells  207 January 26; 9(): -8 ISSN 948-020 (online) © 207 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/47/34/WJSC-9-1.PMC5253185.pdf
World J Stem Cells  2017; 9(1): 1-8  Available from:  URL: http://www.wjgnet.com/1948-0210/full/v9/i1/ 1.htm  DOI:  http://dx.doi.org/10.4252/wjsc.v9.i1.,OADS,/arxiv_data1/oa_pdf/47/34/WJSC-9-1.PMC5253185.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/47/34/WJSC-9-1.PMC5253185.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source: Invited manuscript Correspondence to:  Nicolas Noiseux, MD, FRCS(C), MSc  (Molecular Biology),  BSc (Biochemistry), Cardiac Surgeon,  Full Professor  of Surgery,  Director  of Research Cardiac Surgery,  Department of Surgery, Faculté de Médecine, Université de  Montréal, Pavillon Hôtel-Dieu 3840, Saint-Urbain St., Local  2-420, Montreal, QC H3C 3J7,  Canada.",Non-OADS,/arxiv_data1/oa_pdf/28/8f/WJSC-9-9.PMC5253186.pdf
"noiseuxn@videotron.c a Telephone:  +1-514-8908131 Fax: +1-514-4127231 Received:  July 1, 2016  Peer-review started:  July 3, 2016  First decision:  September 5, 2016 Revised:  September 29, 2016   Accepted:  October 22, 2016 Article in press:  October 24, 2016 Published online:  January 26, 2017Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.4252/wjsc.v.i1.World J Stem Cells  2017 January 26; (1): -25 ISSN 148-0210 (online) © 2017 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/28/8f/WJSC-9-9.PMC5253186.pdf
World J Stem Cells  2017; 9(1): 9-25  Available from:  URL: http://www.wjgnet.com/1948-0210/full/v9/i1/ 9.htm  DOI:  http://dx.doi.org/10.4252/wjsc.v9.i1.,OADS,/arxiv_data1/oa_pdf/28/8f/WJSC-9-9.PMC5253186.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/28/8f/WJSC-9-9.PMC5253186.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/5a/db/atr-05-04-36273.PMC5253187.pdf
Available from: http://www.ellipse-tech.com /?q=ip.,Non-OADS,/arxiv_data1/oa_pdf/5a/db/atr-05-04-36273.PMC5253187.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/21/c2/atr-05-04-37976.PMC5253188.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to:  Dr. Kully Sandhu, BSc, DM, MRCP,  Cardiology Research Registrar,  Department of Cardiology,  Royal Stoke University Hospital, University Hospital of North  Midlands, Stoke on Trent, Stafford ST4 6QG,  United Kingdom.",Non-OADS,/arxiv_data1/oa_pdf/c6/7a/WJC-9-1.PMC5253189.pdf
"World J Cardiol  REVIEWSubmit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.4330/wjc.v9.i1.1 1 January  26, 2017 |Volume 9 |Issue 1| WJC|www.wjgnet.comWorld J Cardiol  2017 January 26; 9(1): 1-13 ISSN 1949-8462 (online) © 2017 Baishideng Publishing Group Inc. All rights reserved.World Journal of  Cardiology WJC",Non-OADS,/arxiv_data1/oa_pdf/c6/7a/WJC-9-1.PMC5253189.pdf
2017; 9(1): 1-13  Available from: URL:  http://www.wjgnet.,Non-OADS,/arxiv_data1/oa_pdf/c6/7a/WJC-9-1.PMC5253189.pdf
com/ 1949-8462 /full/v9/i1/ 1.htm  DOI: http://dx.doi.org/ 10.4330 / wjc.v9.i1.,Non-OADS,/arxiv_data1/oa_pdf/c6/7a/WJC-9-1.PMC5253189.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/c6/7a/WJC-9-1.PMC5253189.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Giancarlo Marenzi, MD, Centro Cardio - logico Monzino, I.R.C.C.S., Via Parea 4, 20138 Milan,  Italy.",Non-OADS,/arxiv_data1/oa_pdf/19/76/WJC-9-14.PMC5253190.pdf
"wjgnet.com/ 1949-84 62/full/v9/i1/ 14.htm   DOI: http://dx.doi.REVIEWSubmit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.4330/wjc.v9.i1.14 14 January  26, 2017 |Volume 9 |Issue 1| WJC|www.wjgnet.comWorld J Cardiol  2017 January 26; 9(1): 14-20 ISSN 1949-8462 (online) © 2017 Baishideng Publishing Group Inc. All rights reserved.World Journal of  Cardiology WJC",Non-OADS,/arxiv_data1/oa_pdf/19/76/WJC-9-14.PMC5253190.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/19/76/WJC-9-14.PMC5253190.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to:  Wilbert S Aronow, MD, FACC, FAHA,  Professor  of Medicine, Department of Cardiology, New York  Medical College at Westchester Medical Center, Macy Pavilion,  Room 141, Valhalla, NY 10595,  United States.",Non-OADS,/arxiv_data1/oa_pdf/9f/a7/WJC-9-21.PMC5253191.pdf
"Remote pulmonary artery pressure  monitoring via CardioMEMSTM heart failure system  identified heart failure exacerbations earlier and more  accurately than clinical signs, and timely medical MINIREVIEWSSubmit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.4330/wjc.v9.i1.21 21 January  26, 2017 |Volume 9 |Issue 1| WJC|www.wjgnet.comWorld J Cardiol  2017 January 26; 9(1): 21-26 ISSN 1949-8462 (online) © 2017 Baishideng Publishing Group Inc. All rights reserved.World Journal of  Cardiology WJC",Non-OADS,/arxiv_data1/oa_pdf/9f/a7/WJC-9-21.PMC5253191.pdf
World J Cardiol  2017; 9(1): 21-26  Available from:  URL:  http://www.wjgnet.com/ 1949-8462 /full/v9/i1/ 21.htm  DOI:  http://dx.doi.org/ 10.4330 /wjc.v9.i1.,Non-OADS,/arxiv_data1/oa_pdf/9f/a7/WJC-9-21.PMC5253191.pdf
"Although cardiac transplantation  is the gold standard treatment in such patients,  limited organ availability restricts the number of heart  transplants to around 2500 per year (https://www.unos.org/data/transplant ­trends/#transplants_by_organ).",Non-OADS,/arxiv_data1/oa_pdf/9f/a7/WJC-9-21.PMC5253191.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/9f/a7/WJC-9-21.PMC5253191.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source: Invited manuscript Correspondence to: Leonida Compostella, MD, Preventive  Cardiology and Rehabilitation, Istituto Codivilla-Putti, Via  Codivilla, I-32043 Cortina d’Ampezzo (BL),  Italy.",Non-OADS,/arxiv_data1/oa_pdf/ec/8f/WJC-9-27.PMC5253192.pdf
"METHODS Time-domain HRV (obtained from 24-h Holter record - ings) was assessed in 326 patients (63.5 ± 12.1 years  old; 80% males), two weeks after a complicated MI  treated by early reperfusion: 208 ST-elevation myocardial  infarction (STEMI) p atients (in which reperfusion was ORIGINAL ARTICLESubmit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.4330/wjc.v9.i1.27 27 January  26, 2017 |Volume 9 |Issue 1| WJC|www.wjgnet.comWorld J Cardiol  2017 January 26; 9(1): 27-38 ISSN 1949-8462 (online) © 2017 Baishideng Publishing Group Inc. All rights reserved.World Journal of  Cardiology WJC Retrospective Cohort Study",Non-OADS,/arxiv_data1/oa_pdf/ec/8f/WJC-9-27.PMC5253192.pdf
World J Cardiol  2017; 9(1): 27-38  Available  from: URL:  http://www.wjgnet.com/ 1949-8462 /full/v9/i1/ 27.htm   DOI: http://dx.doi.org/ 10.4330 /wjc.v9.i1.,Non-OADS,/arxiv_data1/oa_pdf/ec/8f/WJC-9-27.PMC5253192.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/ec/8f/WJC-9-27.PMC5253192.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to:  Michael Gotzmann, MD, Associate  Professor  of Internal Medicine, Department of Cardiology, Marien-Hospital Witten, Ruhr-University Bochum, Marienplatz 2,  58452 Witten,  Germany.",Non-OADS,/arxiv_data1/oa_pdf/4a/75/WJC-9-39.PMC5253193.pdf
"The mortality rates 30 d and one year after  percutaneous mitral va lve repair were 4.3% and 19.5%, ORIGINAL ARTICLESubmit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.4330/wjc.v9.i1.39 39 January  26, 2017 |Volume 9 |Issue 1| WJC|www.wjgnet.comWorld J Cardiol  2017 January 26; 9(1): 39-46 ISSN 1949-8462 (online) © 2017 Baishideng Publishing Group Inc. All rights reserved.World Journal of  Cardiology WJC Observational Study",Non-OADS,/arxiv_data1/oa_pdf/4a/75/WJC-9-39.PMC5253193.pdf
wjgnet.com/ 1949-8462 /full/v9/i1/ 39.htm  DOI: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/4a/75/WJC-9-39.PMC5253193.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/4a/75/WJC-9-39.PMC5253193.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to:  Nizal Sarrafzadegan, Professor,  Isfahan  Cardiovascul ar Research Center, Cardiovascular Research  Institute, Isfahan University of Medical Sciences, Khorram St,  PO Box: 81465-1148, Isfahan 8187698191,  Iran.",Non-OADS,/arxiv_data1/oa_pdf/a3/0a/WJC-9-47.PMC5253194.pdf
"Salt Sensitivity  was defined based on the difference in mean arterial  pressure with infusion of 2 L of normal saline followed  by a low sodium diet and administration of three doses ORIGINAL ARTICLESubmit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.4330/wjc.v9.i1.47 47 January  26, 2017 |Volume 9 |Issue 1| WJC|www.wjgnet.comWorld J Cardiol  2017 January 26; 9(1): 47-54 ISSN 1949-8462 (online) © 2017 Baishideng Publishing Group Inc. All rights reserved.World Journal of  Cardiology WJC Observational Study",Non-OADS,/arxiv_data1/oa_pdf/a3/0a/WJC-9-47.PMC5253194.pdf
Available  from: URL: http://www.who.int/iris/handle/10665/43376 25 Global Atlas on Cardiovascular Disease Prevention and Control.,Non-OADS,/arxiv_data1/oa_pdf/a3/0a/WJC-9-47.PMC5253194.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/a3/0a/WJC-9-47.PMC5253194.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source: Invited manuscript Correspondence to: Dipanjan Banerjee, MD, MS,  Divisions  of Cardiovascular Medicine, Stanford University School of  Medicine,  Falk CVRB 275, 870 Quarry Rd, Stanford, CA 94305,  United States.",Non-OADS,/arxiv_data1/oa_pdf/66/b0/WJC-9-55.PMC5253195.pdf
"Core tip:  Commercially available left ventricular assist CASE REPORTSubmit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.4330/wjc.v9.i1.55 55 January  26, 2017 |Volume 9 |Issue 1| WJC|www.wjgnet.comWorld J Cardiol  2017 January 26; 9(1): 55-59 ISSN 1949-8462 (online) © 2017 Baishideng Publishing Group Inc. All rights reserved.World Journal of  Cardiology WJC",Non-OADS,/arxiv_data1/oa_pdf/66/b0/WJC-9-55.PMC5253195.pdf
wjgnet.com/ 1949-8462 /full/v9/i1/ 55.htm  DOI: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/66/b0/WJC-9-55.PMC5253195.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/66/b0/WJC-9-55.PMC5253195.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to:  Dr. Vasileios F Panoulas, MD, PhD,  MRCP, FESC,  Department of Cardiology, Royal Brompton and  Harefield, NHS Foundation Trust , Harefield Hospital, Hill End  Road, Harefield, Greater London UB9 6JH, United Kingdom.",Non-OADS,/arxiv_data1/oa_pdf/c1/af/WJC-9-60.PMC5253196.pdf
"CASE REPORTSubmit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.4330/wjc.v9.i1.60 60 January  26, 2017 |Volume 9 |Issue 1| WJC|www.wjgnet.comWorld J Cardiol  2017 January 26; 9(1): 60-64 ISSN 1949-8462 (online) © 2017 Baishideng Publishing Group Inc. All rights reserved.World Journal of  Cardiology WJC",Non-OADS,/arxiv_data1/oa_pdf/c1/af/WJC-9-60.PMC5253196.pdf
"Panoulas VF, Demir OM, Ruparelia N, Malik I. Longitudinal  deformation of a third generation zotarolimus eluting stent: “The  concertina returns!”  World J Cardiol  2017; 9(1): 60-64  Available  from: URL:  http://www.wjgnet.com/ 1949-8462 /full/v9/i1/ 60.htm   DOI: http://dx.doi.org/ 10.4330 /wjc.v9.i1.",Non-OADS,/arxiv_data1/oa_pdf/c1/af/WJC-9-60.PMC5253196.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/c1/af/WJC-9-60.PMC5253196.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source: Unsolicited manuscript Correspondence to:  Grigorios Korosoglou, MD, Professor  of Medicine, Department of Internal Medicine III, University  Hospital Heidelberg, Im Neuenheimer Feld 410, 69120 Heidelberg,  Germany.",Non-OADS,/arxiv_data1/oa_pdf/20/bd/WJC-9-65.PMC5253197.pdf
"World J Cardiol   2017; 9(1): 65-70  Available from: URL:  http://www.wjgnet.CASE REPORTSubmit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.4330/wjc.v9.i1.65 65 January  26, 2017 |Volume 9 |Issue 1| WJC|www.wjgnet.comWorld J Cardiol  2017 January 26; 9(1): 65-70 ISSN 1949-8462 (online) © 2017 Baishideng Publishing Group Inc. All rights reserved.World Journal of  Cardiology WJC",Non-OADS,/arxiv_data1/oa_pdf/20/bd/WJC-9-65.PMC5253197.pdf
com/ 1949-8462 /full/v9/i1/ 65.htm  DOI: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/20/bd/WJC-9-65.PMC5253197.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/20/bd/WJC-9-65.PMC5253197.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Unsolicited manuscript Correspondence to: Benoit Daneault, MD,  Division of  Cardiology, Centre hospitalier universitaire de Sherbrooke, 12e  avenue nord, Sherbrooke J1H 5N4,  Canada.",Non-OADS,/arxiv_data1/oa_pdf/f7/5e/WJC-9-71.PMC5253198.pdf
World J Cardiol  2017; 9(1): 71-75  Available from: URL:   http://www.wjgnet.com/ 1949-8462 /full/v9/i1/ 71.htm  DOI: http:// dx.doi.org/ 10.4330 /wjc.v9.i1.,Non-OADS,/arxiv_data1/oa_pdf/f7/5e/WJC-9-71.PMC5253198.pdf
"71CASE REPORTSubmit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.4330/wjc.v9.i1.71 71 January  26, 2017 |Volume 9 |Issue 1| WJC|www.wjgnet.comWorld J Cardiol  2017 January 26; 9(1): 71-75 ISSN 1949-8462 (online) © 2017 Baishideng Publishing Group Inc. All rights reserved.World Journal of  Cardiology WJC",Non-OADS,/arxiv_data1/oa_pdf/f7/5e/WJC-9-71.PMC5253198.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/f7/5e/WJC-9-71.PMC5253198.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/2a/70/atr-05-04-30574.PMC5253199.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/20/7f/ijem-14-04-38256.PMC5253200.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e8/8d/atr-05-04-37070.PMC5253201.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/58/4b/atr-05-04-41482.PMC5253203.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d6/70/ircmj-18-09-28566.PMC5253204.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ec/cc/ircmj-18-09-29771.PMC5253205.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f2/84/ircmj-18-09-31218.PMC5253206.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/19/21/ijem-14-04-41110.PMC5253207.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/fb/54/ircmj-18-09-23768.PMC5253208.pdf
Available from: http://reference.medscape.com/drug/zonegran-zonisamide- 343025 4.,Non-OADS,/arxiv_data1/oa_pdf/fb/54/ircmj-18-09-23768.PMC5253208.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c1/01/ircmj-18-09-25569.PMC5253209.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/42/07/ircmj-18-09-31314.PMC5253210.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/66/0a/ijem-14-04-42228.PMC5253211.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/0a/7d/ircmj-18-09-30902.PMC5253212.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b7/b3/ircmj-18-09-31737.PMC5253213.pdf
Available from: http://www.nap.edu/readingroom/ books/labrats .,Non-OADS,/arxiv_data1/oa_pdf/b7/b3/ircmj-18-09-31737.PMC5253213.pdf
